0001104659-26-048545.txt : 20260424 0001104659-26-048545.hdr.sgml : 20260424 20260424160237 ACCESSION NUMBER: 0001104659-26-048545 CONFORMED SUBMISSION TYPE: N-6/A PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20260424 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT CENTRAL INDEX KEY: 0000948923 ORGANIZATION NAME: EIN: 630169720 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-6/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-07337 FILM NUMBER: 26893485 BUSINESS ADDRESS: STREET 1: 2801 STREET 2: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 BUSINESS PHONE: 2058683586 MAIL ADDRESS: STREET 1: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT CENTRAL INDEX KEY: 0000948923 ORGANIZATION NAME: EIN: 630169720 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-6/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-292264 FILM NUMBER: 26893484 BUSINESS ADDRESS: STREET 1: 2801 STREET 2: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 BUSINESS PHONE: 2058683586 MAIL ADDRESS: STREET 1: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 0000948923 S000010421 PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT C000272129 Protective DualCare VUL N-6/A 1 tm268049d6_n6a.htm N-6/A

 

As Filed with the Securities and Exchange Commission on April 24, 2026

 

Registration File No. 333-292264

811-7337

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-6

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933  ☒

Pre-Effective Amendment No. 1  

Post-Effective Amendment No.  

and

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940  

Amendment No. 399

(Check appropriate box or boxes)

 

Protective Variable Life Separate Account

(Exact name of registrant)

 

Protective Life Insurance Company

(Name of depositor)

 

2801 Highway 280 South

Birmingham, Alabama 35223

(Address of depositor’s principal executive offices)

 

(800) 265-1545

Depositor’s Telephone Number, including Area Code

 

BRANDON J. CAGE, Esq.

2801 Highway 280 South

Birmingham, Alabama 35223

(Name and address of agent for service)

 

Copy to:

STEPHEN E. ROTH, Esquire

THOMAS E. BISSET, Esquire

Eversheds Sutherland (US) LLP

700 Sixth Street, N.W., Suite 700

Washington, DC 20001-3980

 

Approximate date of proposed public offering: As soon as practicable after the effective date of this Registration Statement.

 

Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until Registrant shall file a further amendment which specifically states that this Registration Statement shall become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

It is proposed that this filing will become effective (check appropriate box):

 

immediately upon filing pursuant to paragraph (b) of Rule 485

on                    pursuant to paragraph (b) of Rule 485

60 days after filing pursuant to paragraph (a)(1) of Rule 485

on pursuant to paragraph (a)(1) of Rule 485

 

 

 

 

 

 

PROSPECTUS
May 1, 2026
Protective DualCare VUL An Individual Flexible Premium Variable and Fixed Life Insurance Policy
  Issued by Protective Variable Life
Separate Account
and
Protective Life Insurance Company
2801 Highway 280 South Birmingham,
Alabama 35223
Telephone: (800) 265-1545
 

This Prospectus describes an individual flexible premium variable and fixed life insurance policy (the "Policy") issued by Protective Life Insurance Company (the "Company", "we", "our" and "us") with variable investment options offered under the Company's Protective Variable Life Separate Account (the "Variable Account"). Variable and fixed life insurance policies are complex investment vehicles and you should speak with a financial professional about Policy features, benefits, risks, and fees and whether the Policy is appropriate for you based on your financial situation and objectives.

If you are a new investor, you may cancel your Policy within 10 days of receiving it without paying fees or penalties. In some states, this Cancellation Period may be longer. Upon cancellation, we will refund the full amount you paid with your application or the total Policy Value plus any charges that were deducted less any outstanding loan and accrued loan interest. You should review the Prospectus, or consult with your investment professional, for additional information about the specific cancellation terms that apply.

Protective DualCare VUL provides life insurance coverage, plus the opportunity to earn a return in (i) our guaranteed interest option, and/or (ii) one or more variable investment options set forth in "Fund Appendix: Funds Available Under The Policy" to the Prospectus.

This Prospectus sets forth a description of all material features of the Policy and the Variable Account that you should know before investing. This Prospectus also describes all material state variations to the Policy. Information about certain investment products, including variable life insurance, has been prepared by the SEC staff and is available at Investor.gov.

The SEC has not approved or disapproved these securities or passed upon the adequacy of this Prospectus. Any representation to the contrary is a criminal offense.


TABLE OF CONTENTS

SPECIAL TERMS

   

3

   
IMPORTANT INFORMATION YOU
SHOULD CONSIDER ABOUT THE
POLICY
   

5

   
FEES AND EXPENSES    

5

   
RISKS    

6

   
RESTRICTIONS    

7

   
TAXES    

7

   
CONFLICTS OF INTEREST    

7

   
OVERVIEW OF THE PROTECTIVE
STRATEGIC OBJECTIVES II
VUL POLICY
   

8

   
FEE TABLE    

9

   
ANNUAL FUND EXPENSES    

13

   
PRINCIPAL RISKS OF INVESTING
IN THE POLICY
   

13

   
THE COMPANY AND THE
FIXED ACCOUNT
   

16

   
THE VARIABLE ACCOUNT AND
THE FUNDS
   

17

   
CHARGES AND DEDUCTIONS    

20

   
THE POLICY    

24

   
PREMIUMS    

25

   
CALCULATION OF POLICY VALUE    

27

   
STANDARD DEATH BENEFITS    

27

   
OTHER BENEFITS AVAILABLE
UNDER THE POLICY
   

31

   
SUPPLEMENTAL RIDERS AND
ENDORSEMENTS
   

33

   
LOANS    

43

   
TRANSFERS    

45

   
SURRENDERS AND WITHDRAWALS    

47

   
SUSPENSION OR DELAYS IN
PAYMENTS
   

47

   
LAPSE AND REINSTATEMENT    

48

   
TAX CONSIDERATIONS    

48

   
USE OF THE POLICY    

53

   
STATE VARIATIONS    

53

   
SALE OF THE POLICIES    

53

   
LEGAL PROCEEDINGS    

55

   
FINANCIAL STATEMENTS    

55

   
FUND APPENDIX: FUNDS
AVAILABLE UNDER
THE POLICY
   

56

   

APPENDIX: RIGHT TO CANCEL

   

60

   

APPENDIX: FINANCIAL INTERMEDIARY VARIATIONS

   

61

   


2


SPECIAL TERMS

"We", "us", "our", "Protective Life", and "Company": Refer to Protective Life Insurance Company. "You", "your" and "Owner" refer to the person(s) who have been issued a Policy.

Attained Age: The Insured's age as of the nearest birthday on the Policy Effective Date, plus the number of complete Policy Years since the Policy Effective Date.

Beneficiary: The person, persons or entity whom the Owner designates to receive the proceeds of the Policy upon the death of the Insured. The Owner may designate a primary Beneficiary or Beneficiaries, as well as a contingent Beneficiary or Beneficiaries to receive the proceeds if there is no primary Beneficiary(ies) living at the time of the Insured's death. A Beneficiary may also be designated as irrevocable which may limit the Owner's ability to alter that designation or make future Policy changes.

Cash Value: Policy Value minus any applicable Surrender Charge.

Code (the "Code"): The Internal Revenue Code of 1986, as amended (the "Code").

Death Benefit: The amount of insurance provided under the Policy used to determine the Death Benefit Proceeds.

Death Benefit Proceeds: The amount payable to the Beneficiary if the Insured dies while the Policy is in force. It is equal to the Death Benefit plus any Death Benefit under any rider or endorsement to the Policy less (1) any Policy Debt (2) any liens and (3) less any unpaid Monthly Deductions if the Insured dies during a grace period.

Due Proof of Death: Receipt at our Home Office of a certified death certificate or judicial order from a court of competent jurisdiction or similar tribunal.

Evidence of Insurability: Information about an Insured which is used to approve or reinstate this Policy or any additional benefit.

Face Amount: A dollar amount selected by the Owner and shown in the Policy on the Policy Specifications Page or Supplemental Policy Specifications Page. The minimum Face Amount permitted under the Policy is $50,000 and the maximum is $500,000 (which may increase due to market performance).

Fixed Account: Part of Protective Life's General Account to or from which Policy Value may be transferred and into which Net Premiums may be allocated under a Policy.

Fixed Account Value: The Policy Value in the Fixed Account.

Fund: A separate investment portfolio of an open-end management investment company or unit investment trust in which a Sub-Account invests. Also referred to as an "Investment Option".

General Account: All of the Company's assets other than those allocated to the Variable Account or any other separate account. The Company has complete ownership and control of the assets in the General Account.

Good Order: A Request or transaction generally is considered in "Good Order" if we receive it at our Home Office within the time limits, if any, we prescribe for a particular transaction or instruction, it includes all information necessary for us to execute the requested instruction or transaction, and is signed by the individual or individuals authorized to provide the instruction or engage in the transaction. A Request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet as described above) along with all forms, information and supporting legal documentation we require to affect the instruction or transaction. This information and documentation generally includes, to the extent applicable: the completed application or instruction form; Evidence of Insurability; your Policy number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Funds affected by the requested transaction; the signatures of the Policy Owner (exactly as indicated on the Policy), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that we may require, including any consents. With respect to premium payments, Good Order also generally includes receipt by us of sufficient funds to affect the purchase. We may, in our sole discretion, determine whether any particular transaction Request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have questions, you should contact us or your financial professional before submitting the form or Request.

Home Office: 2801 Highway 280 South, Birmingham, Alabama 35223. The mailing address for the Home Office is P.O. Box 292 Birmingham, AL 35201-0292. The Home Office is referred to as the "Administrative Office" in the Policy.

Initial Face Amount: The Face Amount on the Policy Effective Date.

Insured: The person whose life is covered by the Policy.

Issue Age: The Insured's age as of the nearest birthday on the Policy Effective Date.


3


Lapse: Termination of the Policy at the expiration of the grace period while the Insured is still living.

Loan Account: An account within Protective Life's General Account to which Fixed Account Value and/or Variable Account Value plus interest credited on the portion of the Policy Value being used as collateral for the outstanding Policy loans is transferred as collateral for Policy loans.

Loan Account Value: The Policy Value in the Loan Account.

Monthly Anniversary Day: The same day in each month as the Policy Effective Date.

Monthly Deduction: The fees and charges deducted monthly from the Fixed Account Value and/or Variable Account Value as described on the Policy Specifications Page of the Policy Schedule.

Net Amount at Risk: The Net Amount at Risk as of any Monthly Anniversary Day is equal to: (a) the Death Benefit discounted at one plus the monthly guaranteed interest rate (the minimum interest rate that may be credited to Fixed Account Value) minus the Policy Value (prior to deducting the Cost of Insurance)..

Net Premium: A premium payment minus the applicable premium expense charges.

Owner: The person, or persons, or entity entitled to all rights in this Policy while the Insured is living including designation as a Beneficiary. These rights are subject to any assignment and to the rights of any irrevocable Beneficiary. The Owner may name a contingent Owner who will own this Policy if the Owner dies while this Policy is in force. If the Owner dies before the Insured, any contingent Owner named in the application, or subsequent endorsement, will become the new Owner. If no contingent Owner is named, the Owner's estate becomes the new Owner. The Owner may change the Owner (including a contingent Owner) by Written Notice.

Policy Anniversary: The same day and month in each Policy Year as the Policy Effective Date.

Policy Debt: The sum of all outstanding Policy loans plus accrued interest.

Policy Effective Date: The date shown in the Policy as of which coverage under the Policy begins.

Policy Month: The Policy Month begins on a Monthly Anniversary Day and ends on the day prior to the next Monthly Anniversary Day.

Policy Value:  The sum of the Variable Account Value, the Fixed Account Value, and the Loan Account Value.

Policy Year: Each period of twelve months commencing with the Policy Effective Date and each Policy Anniversary thereafter.

Request: Any written, telephoned, electronic or computerized instruction in a form satisfactory to the Company and received at the Home or Administrative Office from the Owner or an assignee of record, as specified in a form acceptable to the Company and which may be required in writing, or the Beneficiary (as applicable) as required by any provision of the Policy or as required by the Company. In addition, subject to the Company's administrative requirements as they may exist from time to time and to any requirements that may be imposed by the Funds or other investments, the Company reserves the right to require advance Written Notice from the Owner.

Settlement Option: The proceeds of the policy are distributed over a period rather than paying them in a lump sum. If a Settlement Option is not selected, the Beneficiary may select a Settlement Option from among those available at that time, or may take the amount due immediately in a lump sum.

Sub-Account: A separate division of the Variable Account established to invest in a particular Fund.

Sub-Account Value: The sum of the values of the Sub-Accounts credited to the Owner as Policy Value.

Surrender Charge: A charge deducted from the Policy Value if the Policy is surrendered, Lapses, or the Initial Face Amount is decreased during the applicable surrender charge period.

Surrender Value: The Cash Value minus any outstanding Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement plus accrued interest.

Valuation Day: Each day the New York Stock Exchange and the Home Office are open for business except for a day that a Sub-Account's corresponding Fund does not value its shares.

Valuation Period: The period commencing with the close of regular trading on the New York Stock Exchange on any Valuation Date and ending at the close of regular trading on the New York Stock Exchange on the next succeeding Valuation Date.

Variable Account: Protective Variable Life Separate Account, a separate investment account of Protective Life to and from which Policy Value may be transferred and into which Net Premiums may be allocated.

Variable Account Value: The sum of all Sub-Account Values.

Written Notice: A notice or Request submitted in writing in a form satisfactory to Protective Life and received at the Home Office via U.S. postal service or nationally recognized overnight delivery service.


4


IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY

FEES AND EXPENSES

 

 

Charges for Early Withdrawals

  If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.
If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.80% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,800.
For additional information about charges for surrenders and early withdrawals, see "CHARGES AND DEDUCTIONS" in the Prospectus.
 

Transaction Charges

  In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy's Face Amount and transfer fees.
For additional information about transaction charges, see "CHARGES AND DEDUCTIONS" in the Prospectus.
 

 

Ongoing Fees and Expenses (annual
charges)
  In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance ("COI") under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.
You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:
 

          

 

Annual Fee

 

Minimum

 

Maximum

 

          

  Fund Options
(Fund fees and expenses)(1)
 
0.09%
 
1.18%
 

          

 

(1)As a percentage of Fund assets.

 
   

For additional information about ongoing fees and expenses, see "CHARGES AND DEDUCTIONS" in the Prospectus.

 


5


RISKS

 

Risk of Loss

  You can lose money by investing in this Policy, including loss of principal.
For additional information about the risk of loss, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" in the Prospectus.
 

Not a Short-Term Investment

  The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.
For additional information about the investment profile of the Policy, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "CHARGES AND DEDUCTIONS," "USE OF THE POLICY" and "TAX CONSIDERATIONS — Taxation of Insurance Polices" in the Prospectus.
 

 

Risks Associated with Investment
Options
  An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.
For additional information about the risks associated with Investment Options, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "THE COMPANY AND THE FIXED ACCOUNT," "THE VARIABLE ACCOUNT AND THE FUNDS" and "FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY" in the Prospectus.
 

 

Insurance Company Risks

  An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.
For additional information about Company risks, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" and "THE COMPANY AND THE FIXED ACCOUNT" in the Prospectus.
 

 

Policy Lapse

  Your Policy could terminate if the value of your Policy becomes too low to support the Policy's monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.
For additional information about Policy Lapse, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "PREMIUMS," "LOANS," and "LAPSE AND REINSTATEMENT" in the Prospectus.
 


6


RESTRICTIONS

 

Investments

  While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing polices described in the Prospectus.
We reserve the right to remove or substitute Funds as investment options.
For additional information about Investment Options, see "TRANSFERS" and "ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS" in the Prospectus.
 

Optional Benefits

  Optional benefits, including Policy loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy's Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.
For additional information about the optional benefits, see "OTHER BENEFITS AVAILABLE UNDER THE POLICY" and "SUPPLEMENTAL RIDERS AND ENDORSEMENTS" in the Prospectus.
 

TAXES

 

Tax Implications

  You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.
For additional information about tax implications, see "TAX CONSIDERATIONS" in the Prospectus.
 

CONFLICTS OF INTEREST

 
Investment Professional
Compensation
  Some investment professionals have and may receive compensation for selling the Policy to investors, which may include commissions, revenue sharing, and compensation from affiliates and third parties. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment.
For additional information about compensation, see "SALE OF THE POLICIES" in the Prospectus.
 

Exchanges

  Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy.
For additional information about exchanges, see "TAX CONSIDERATIONS — Section 1035 Exchanges" in the Prospectus.
 


7


OVERVIEW OF THE PROTECTIVE DUALCARE VUL POLICY

Q: What is the Policy, and what is it designed to do?

A: The Policy is an individual flexible premium variable and fixed life insurance policy the primary purpose of which is to provide a Death Benefit which is paid upon the death of the Insured person and help cover qualified long-term care expenses. The Owner of the Policy is the person, persons, or entity entitled to all rights in this Policy while the Insured (the person whose life is covered by the Policy) is living, including designation of a Beneficiary.

Your Policy is a "flexible premium" policy because you have considerable flexibility in determining when and how much premium you want to pay. Your Policy is "variable" because the Death Benefit and Policy Value vary according to the investment performance of the Sub-Accounts to which you have allocated your premiums and Policy Value. The Policy provides you with an opportunity to take advantage of any increase in your Policy Value but you also bear the risk of any decrease.

Because the Policy is designed to provide benefits on a long-term basis and is not intended for short-term investing, the Policy may not be appropriate for those who have a short-term investment horizon.

Q: What are the Premiums for this Policy?

A: The Policy is designed to be flexible to meet your specific life insurance needs. You have the flexibility to choose the investment options and premiums you pay.

Premium is an amount you pay to the Company to establish and maintain life insurance coverage. The minimum initial premium will vary based on various factors, including the age of the Insured. Thereafter, you have the flexibility to choose the amount and timing of premium payments, within certain limits. Before your premiums are allocated to a Sub-Account, we deduct a premium expense charge.

You may establish a planned periodic premium. You are not required to pay the planned periodic premium and we will not terminate your Policy merely because you did not. However, payment of insufficient premiums may result in a Lapse of the Policy. Your Policy could Lapse if the value of your Policy becomes too low to support the Policy's monthly charges.

You may allocate premium to your choice of numerous different investment options available in the Sub-Accounts, as well as a Fixed Account, within your Policy. The Sub-Accounts are separate divisions of the Variable Account (Protective Variable Life Separate Account) that invest in a particular Fund (an underlying mutual fund).

ADDITIONAL INFORMATION ABOUT EACH FUND IS PROVIDED IN AN APPENDIX TO THIS PROSPECTUS. See FUND APPENDIX — Funds Available Under the Policy.

The Fixed Account is part of the Company's General Account, which holds all of the Company's assets other than those held in the Variable Account or other separate accounts.

Q: What are the primary features and options that this Policy offers?

Death Benefit. Upon the death of the Insured and while the Policy is in force, we will pay a Death Benefit to your Beneficiary. The Death Benefit is the Face Amount on the Insured's date of death or the minimum death benefit on the date of death.

Transfers. At any time after the Cancellation Period (period during which the Owner may return the Policy for a refund), you may transfer Policy Value among the Sub-Accounts and the Fixed Account, subject to restrictions on the amount and frequency of transfers. The Company also may restrict or refuse to honor frequent transfers, including "market timing" transfers.

Withdrawals. You may request a partial withdrawal of your Policy at any time after the first Policy Year. The amount of any partial withdrawal must be at least $500. We will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals. Withdrawals may have tax consequences.

Surrender Benefit. The Owner may surrender this Policy for the surrender benefit. The surrender benefit is the Surrender Value on the date of surrender. The Surrender Value is the Cash Value minus Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement, plus accrued interest. All coverage will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of surrender of the Policy. Surrenders may have tax consequences.

Loans. While the Policy is in force, the Owner may obtain a loan on the security of the Policy. Policy loan amounts will be withdrawn first on a pro rata basis from the Sub-Accounts and/or Fixed Account unless the Owner specifies otherwise.


8


Loans may be treated as taxable income if your Policy is a "modified endowment contract" ("MEC") for federal income tax purposes. See "Tax Considerations".

Additional Benefits. The following additional benefits are available:

Long-Term Care Rider (Automatically included): This endorsement provides for a monthly benefit payment to the Owner if the Insured has qualifying long term care expenses and all the terms and conditions of the endorsement are met.

Terminal Illness Accelerated Death Benefit Endorsement (Automatically included): This endorsement provides for an accelerated Death Benefit payment to the Owner if the Insured has a qualifying terminal illness and all the terms and conditions of the endorsement are met.

Lapse Protection Endorsement (Automatically included): This rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule as long as all of the terms and conditions of this rider are met.

Long-Term Care Inflation Protection Option: This provides a 5% compound increase on each Policy Anniversary with no evidence of insurability on each Policy Anniversary. The increase purchased on each Policy Anniversary will be factored into the calculation of certain benefit values under the Long-Term Care Rider. The increase must be elected each Policy Anniversary. There is an additional monthly charge for this optional benefit rider.

Dollar Cost Averaging: This program allows for the systematic and automatic transfer, on a monthly or quarterly basis, of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub- Accounts.

Portfolio Rebalancing: This program allows for the automatic transfer, on a quarterly, semi-annual or annual basis, of Variable Account Value among specified Sub-Accounts to maintain a particular percentage allocation of Variable Account Value.

See "OTHER BENEFITS AVAILABLE UNDER THE POLICY" and "SUPPLEMENTAL RIDERS AND ENDORSEMENTS" in the Prospectus for details on obtaining optional benefits.

FEE TABLE

The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).

The first table describes the fees and expenses that you will pay at the time that you pay premiums, surrender the Policy, allow the Policy to Lapse, decrease the Initial Face Amount, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals.

Transaction Fees

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Premium Expense Charge:

 

Upon receipt of each premium payment

 

5% of each premium payment

 

3.5% of each premium payment

 

Surrender Charge:(1)

             

Minimum and Maximum Charge

 

At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

 

$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

 

$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

 


9


Transaction Fees

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Charge for a 49 year old male in the standard unismoke class during the first Policy Year

 

At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

 

$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

 

$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

 

(1)​  The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Transaction Fees

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Transfer Fee:(2)

 

Upon each transfer in excess of 12 in a Policy Year

  $25 per transfer   $0 per transfer  

Withdrawal Charge:

 

At the time of each withdrawal of Policy Value

 

The lesser of 2.0% of the amount withdrawn or $25

 

The lesser of 2.0% of the amount withdrawn or $25

 

(2)​  Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.

The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds' fees and expenses.

Periodic Charges Other Than Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Base Contract Charge:

             

Cost of Insurance:(1)(2)

             

Minimum and Maximum Charge

 

On the Policy Effective Date and each Monthly Anniversary Day

 

$0.01 – $83.33 per $1,000 of Net Amount at Risk(2)

 

$0.00 – $70.46 per $1,000 of Net Amount at Risk(2)

 

Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.

 

On the Policy Effective Date and each Monthly Anniversary Day

 

$0.23 per $1,000 of Net Amount at Risk

 

$0.03 per $1,000 of Net Amount at Risk

 

(1)​  Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges


10


shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".

(2)​  See definition of Net Amount at Risk in the Special Terms.

Periodic Charges Other Than Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Mortality and Expense Risk Charge:

 

On the Policy Effective Date and each Monthly Anniversary Day

 

0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount

 

0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.

 

Standard Administrative Fee:

 

On the Policy Effective Date and each Monthly Anniversary Day

  $9.00   $9.00  

Administrative Charge:(3)

             

Minimum and Maximum Charge

 

On the Policy Effective Date and each Monthly Anniversary Day

 

$0.36 – $3.89 per $1,000 of Initial Face Amount

 

$0.29 – $2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16 – $1.46 per $1,000 of Initial Face Amount thereafter

 

Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.

 

On the Policy Effective Date and each Monthly Anniversary Day

 

$1.11 per $1,000 of Initial Face Amount

 

$0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter

 

(3)​  We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.


11


Periodic Charges Other Than Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Administrative Charge For Face Amount Increases:(4)

             

Minimum and Maximum Charge

 

On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

 

$1.95 – $4.95 per $1,000 of any increase in Face Amount

 

$1.95 – $4.95 per $1,000 of any increase in Face Amount

 

Charge for a 49 year old male in the standard unismoke rate class

 

On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

 

$3.45 per $1,000 of any increase in Face Amount

 

$3.45 per $1,000 of any increase in Face Amount

 

Long-Term Care Rider Charge:(5)

             

Minimum and Maximum Charge

 

On each Monthly Anniversary Day starting from the Effective Date

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

 

Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000

 

On each Monthly Anniversary Day starting from the Effective Date

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

 

(4)​  The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

(5)  The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.

Periodic Charges Other Than Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Optional Benefit Charges:

             

Long-Term Care Inflation Protection Option(#)

 

On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

 

The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

 


12


Periodic Charges Other Than Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Net Cost of Loans(6)

 

On each Policy Anniversary, as applicable(7)

 

2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.

 

2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter

 

(6)​  The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).

(7)​  As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.

Periodic Charges Other Than Series Fund Operating Expenses

 

Charge

  When Charge
is Deducted
  Amount Deducted —
Maximum Guaranteed
Charge
  Amount Deducted —
Current Charge
 

Lapse Protection Endorsement

             

Minimum and Maximum Charge

 

Upon receipt of each premium payment

 

1% of each premium payment

 

1% of each premium payment

 

ANNUAL FUND EXPENSES

The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See "FUND APPENDIX — FUNDS AVAILABLE UNDER THE POLICY".

ANNUAL FUND EXPENSES

   

Minimum

     

Maximum

 
Total Annual Fund Expenses
(expenses that are deducted from Fund assets,
including management fees, distribution and/or
service 12b-1 fees, and other expenses)
 

0.09

%

 

 

1.18

%(1)

 

(1)​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.

PRINCIPAL RISKS OF INVESTING IN THE POLICY

Investment Risk

If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the


13


Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See "The Variable Account and The Funds."

Risk of Lapse

There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Surrender Charge, Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See "Lapse and Reinstatement — Lapse" and "Lapse Protection."

Withdrawal and Surrender Risks. The Surrender Charge under the Policy applies during the first 14 Policy Years. The Surrender Value of the Policy is generally the Policy Value less the Surrender Charge and Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.

Even if you do not ask to surrender your Policy, Surrender Charges may play a role in determining whether your Policy will Lapse (terminate without value), because Surrender Charges decrease the Surrender Value.

Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.

A surrender or withdrawal may have tax consequences. See "Tax Considerations."

Tax Risks

Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.

Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 591/2 at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.

If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.

See "Tax Considerations." You should consult a qualified tax adviser for assistance in all Policy related tax matters.

Loan Risks

A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.


14


Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "Policy Loans" and "Tax Considerations — Tax Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.

If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

If a Policy Loan is taken from the Policy while the Long-Term Care Rider is on Active Claim Status, the Long-Term Care Rider will terminate.

Specialized Uses of the Policy

Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See "Tax Considerations — Other Considerations."

Fund Risks

A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.

Business Disruption and Cyber Security Risks

We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds' ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.

We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.


15


THE COMPANY AND THE FIXED ACCOUNT

Protective Life Insurance Company

The Policies are issued by Protective Life. Protective Life is a Nebraska corporation that was founded in 1907. Following its receipt of an Order Approving Redomestication on December 20, 2024, Protective Life redomesticated from Tennessee to Nebraska, and became an insurance company domiciled in the State of Nebraska as of December 31, 2024. Protective Life's address is P.O. Box 10648, Birmingham, Alabama 35202-0648. Protective Life markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities and extended service contracts. Protective Life is currently licensed to transact life insurance business in 49 states and the District of Columbia. Protective Life is the principal operating subsidiary of Protective Life Corporation ("PLC"), a U.S. insurance holding company and a wholly-owned subsidiary of Dai-ichi Life Holdings, Inc. ("Dai-ichi"). Dai-ichi's stock is traded on the Tokyo Stock Exchange. For more information about us, go to www.protective.com.

The Fixed Account

The Fixed Account consists of assets owned by Protective Life with respect to the Policies, other than those in the Variable Account. Subject to applicable law, Protective Life has sole discretion over the investment of the assets of the Fixed Account. The Loan Account is part of the Fixed Account. Guarantees of Net Premiums allocated to the Fixed Account, and interest credited thereto, are backed by Protective Life. The Fixed Account Value is calculated daily.

You generally may allocate some or all of your Net Premium and may transfer some or all of your Policy Value to the Fixed Account. However, there are limitations on transfers involving the Fixed Account. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. You should carefully consider whether the Fixed Account meets your investment needs. See "Transfers of Policy Value."

Because of exemptive and exclusionary provisions, interests in the Fixed Account have not been registered under the Securities Act of 1933 nor has the Fixed Account been registered as an investment company under the Investment Company Act of 1940. Accordingly, neither the Fixed Account nor any interests therein are subject to the provisions of these Acts. The disclosure regarding the Fixed Account may, however, be subject to certain generally applicable provisions of the federal securities laws relating to the accuracy and completeness of statements made in prospectuses.

Interest Credited on Fixed Account Value. The interest rate credited to subsequent Net Premiums allocated to or amounts transferred to the Fixed Account will be the annual effective interest rate in effect on the date that the Net Premium(s) is received by Protective Life or the date that the transfer is made. Protective Life, in its sole discretion, may declare a new current interest rate from time to time. Protective Life will credit annual effective interest rates of not less than 1.00%. For purposes of crediting interest, amounts deducted, transferred or withdrawn from the Fixed Account are accounted for on a "first-in-first-out" (FIFO) basis.

Protective Life guarantees that the interest credited during the first Policy Year to the inital Net Premiums allocated to the Fixed Account will not be less than the initial annual effective interest rate show in the Policy. The interest rate is guaranteed to apply to such amounts for a twelve-month period which begins on the date that the Net Premium(s) is allocated or the date that the transfer is made. After an interest rate guarantee expires as to a Net Premium or amount transferred, (i.e., 12 months after the Net Premium or transfer is placed in the Fixed Account) Protective Life will credit interest on the Fixed Account Value attributable to such Net Premium or transferred amount at the current interest rate in effect. New current interest rates are effective for such Fixed Account Value for 12 months from the time that they are first applied.

Payments from the Fixed Account. Payments from the Fixed Account for a withdrawal, surrender or loan request may be deferred for up to six months from the date Protective Life receives the Written Notice in Good Order. If a payment from the Fixed Account is deferred for 30 days or more, it will bear interest at a rate of 3% per year (or an alternative rate if required by applicable state insurance law), compounded annually while payment is deferred.

Our General Account

The Fixed Account is part of our General Account. Unlike premiums and Policy Value allocated to the Variable Account, we assume the risk of investment gain or loss on amounts held in the Fixed Account.


16


The assets of our General Account support our insurance and annuity obligations and are subject to our general liabilities from business operations and to claims by our creditors. Because amounts allocated to the Fixed Account, plus any guarantees under the Policy that exceed your Policy Value (such as those that may be associated with the Death Benefit), are paid from our General Account, any amounts that we may pay under the Policy in excess of Variable Account Value are subject to our financial strength and claims-paying ability. It is important to note that there is no guarantee that we will always be able to meet our claims-paying obligations, and that there are risks to purchasing any insurance product.

We encourage both existing and prospective Policy Owners to read and understand our financial statements. We prepare our financial statements on a statutory basis, as required by state regulators. Our audited financial statements are incorporated by reference in the Statement of Additional Information (which is available at no charge by calling us at 1-800-456-6330 or writing us at the address shown on the cover page of this Prospectus). In addition, the Statement of Additional Information is available on the SEC's website at http://www.sec.gov.

You also will find on our website information on ratings assigned to us by one or more independent rating organizations. These ratings are opinions of our financial capacity to meet the obligations of our insurance and annuity contracts based on our financial strength and/or claims-paying ability.

THE VARIABLE ACCOUNT AND THE FUNDS

Protective Variable Life Separate Account

Protective Variable Life Separate Account is a separate investment account of Protective Life established under Tennessee law by the board of directors of Protective Life on February 22, 1995. On December 31, 2024, Protective Life changed to a Nebraska corporation and, accordingly, the Variable Account currently operates under the laws and regulations of Nebraska. The Variable Account is registered with the SEC as a unit investment trust under the 1940 Act and is a "separate account" within the meaning of the federal securities laws.

Protective Life owns the assets of the Variable Account. These assets are held separate from other assets and are not part of Protective Life's General Account. You assume all of the investment risk for premiums and Policy Value allocated to the Sub-Accounts. Your Policy Value in the Sub-Accounts is part of the assets of the Variable Account. Assets of the Variable Account equal to the reserves or other contract liabilities of the Variable Account will not be charged with liabilities that arise from any other business that Protective Life conducts. Protective Life may transfer to its General Account any assets of the Variable Account which exceed the reserves and other contract liabilities of the Variable Account (which are always at least equal to the aggregate Variable Account Values under the Policies). Protective Life may accumulate in the Variable Account the charge for mortality and expense risks and investment results applicable to those assets that are in excess of the reserves and other contract liabilities related to the Policies. Protective Life is obligated to pay all benefits provided under the Policies.

The Variable Account is divided into Sub-Accounts. The income, gains or losses, whether or not realized, from the assets of each Sub-Account are credited to or charged against that Sub-Account without regard to any other income, gains or losses of Protective Life. Each Sub-Account invests exclusively in shares of a corresponding Fund. Therefore, the investment experience of your Policy depends on the experience of the Sub-Accounts you select. In the future, the Variable Account may include other Sub-Accounts that are not available under the Policies and are not otherwise discussed in this Prospectus.

The Funds

Information regarding each Fund is included in an Appendix to this Prospectus. (See Fund Appendix — Funds Available Under the Policy). The Appendix includes the following information about each fund:

•  Fund Name;

•  Type of Fund;

•  Investment adviser and any sub-advisor;

•  Current expenses; and

•  Performance.


17


There is no assurance that the stated objectives and policies of any of the Funds will be achieved. Each Fund also has a prospectus that contains more detailed information about the Fund. You may obtain a prospectus or a Statement of Additional Information for any of the Funds by contacting Protective Life or by asking your financial professional. You should read the Funds' prospectuses carefully before making any decision concerning the allocation of Net Premiums or transfers among the Sub-Accounts.

Selection of Funds

We select the Funds offered through the Policies based on several criteria, including the following:

•  asset class coverage;

•  the strength of the investment adviser's (or sub-adviser's) reputation and tenure;

•  brand recognition;

•  performance;

•  the capability and qualification of each investment firm; and

•  whether our distributors are likely to recommend the Funds to Policy Owners.

Another factor we consider during the selection process is whether the Fund, its adviser, its sub-adviser, or an affiliate will make payments to us or our affiliates. For a discussion of these arrangements, see "Certain Payments We Receive With Regard to the Funds." We also consider whether the Fund, its adviser, sub-adviser, or distributor (or an affiliate) can provide marketing and distribution support for sale of the Policies. We review each Fund periodically after it is selected. Upon review, we may remove a Fund or restrict allocation of additional Purchase Payments and/or transfers of Policy Value to a Fund if we determine the Fund no longer meets one or more of the criteria and/or if the Fund has not attracted significant Policy Owner assets. We do not recommend or endorse any particular Fund, and we do not provide investment advice.

Asset Allocation Model Portfolios. Four asset allocation models ("Model Portfolios") are available at no additional charge as Investment Options under your Policy.

Each Model Portfolio invests different percentages of Policy Value in some or all of the Sub-Accounts under your Policy, and these Model Portfolios range from conservative to aggressive. The Model Portfolios are intended to provide a diversified investment portfolio by combining different asset classes to help you reach your investment goal. Also, while diversification may help reduce overall risk, it does not eliminate the risk of losses and it does not protect against losses in a declining market. There can be no assurance that any of the Model Portfolios will achieve their investment objectives.

Pursuant to an agreement with Protective, Milliman Financial Risk Management LLC ("Milliman"), a diversified financial services firm and registered investment adviser under the Investment Advisers Act of 1940, as amended, Milliman provides consulting services to Protective Life regarding the composition and review of the Model Portfolios and is compensated by Protective for doing so. There is no investment advisory relationship between Milliman and Owners with respect to the Model Portfolios. In the future, Protective Life may modify or discontinue its arrangement with Milliman, in which case Protective may contract with another firm to provide similar asset allocation models, provide its own asset allocation models, or cease offering asset allocation models. Protective does not provide investment advisory services in making the Model Portfolios or any other service or feature available under the Policy.

The selection of Investment Options in the Model Portfolios involves balancing a number of factors including, but not limited to, the investment objectives, policies and expenses of the Fund in each Model Portfolio, the overall historical performance and volatility of the Funds, marketability of individual Funds and Fund families, marketing support provided to Protective Life and the broker-dealers who sell the Policies and administrative services and marketing support payments made by the Fund's manager to Protective Life or Investment Distributors, Inc. ("IDI"). Unlike 12b-1 fees, these payments are not paid out of Fund assets.

The available Model Portfolios may change from time to time. In addition, the target asset allocations of these Model Portfolios may vary from time to time in response to market conditions and changes in the portfolio holdings of the Funds in the underlying Sub-Accounts. We will provide written notice if the composition of a model portfolio changes, if there is a material change in our arrangement with Milliman, or if we cease offering asset allocation models altogether. We will not change your existing Policy Value or premium allocation or percentages in response to these changes, however, if you desire to change your Policy Value or premium allocation or percentages to reflect a revised or different Model Portfolio, you must submit new allocation instructions to us in writing to the Home Office.


18


The following is a brief description of the Model Portfolios currently available. They are more fully described in a separate brochure. Your sales representative can provide additional information about the Model Portfolios and help you select which Model Portfolio, if any, may be suitable for you. Please talk to him or her if you have additional questions about these Model Portfolios.

•  Conservative Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 50% in equity and 50% in fixed income investments. The largest of the asset class target allocations are in fixed income, large cap blend and global equity.

•  Moderate Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 65% in equity and 35% in fixed income investments. The largest asset class target allocations are in fixed income, global equity and large cap blend.

•  Growth and Income portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 75% in equity and 25% in fixed income investments. The largest asset class target allocations are in fixed income, large cap blend and global equity.

•  Aggressive Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 90% in equity and 10% in fixed income investments. The largest asset class target allocations are in large cap blend, global equity, large cap growth, large cap value and small cap growth.

Other Information About the Funds

Shares of these Funds are offered only to: (1) the Variable Account, (2) other separate accounts of Protective Life supporting variable annuity contracts or variable life insurance policies, (3) separate accounts of other life insurance companies supporting variable annuity contracts or variable life insurance policies, and (4) certain qualified retirement plans. Such shares are not offered directly to investors but are available only through the purchase of such variable annuity contracts or variable life insurance policies or through such qualified retirement plans. See the prospectus for each Fund for details about that Fund.

Certain Funds may have investment objectives and policies similar to other mutual funds (sometimes having similar names) that are managed by the same investment adviser or manager. The investment results of the Funds, however, may be more or less favorable than the results of such other mutual funds. Protective Life does not guarantee or make any representation that the investment results of any Fund is, or will be, comparable to any other mutual fund, even one with the same investment adviser or manager.

Certain Payments We Receive With Regard to the Funds from Advisers and/or Distributors

We (and our affiliates) may receive payments from the Funds' advisers, sub-advisers, distributors, or affiliates thereof. These payments are negotiated and thus differ by Fund (sometimes substantially), and the amounts we (or our affiliates) receive may be significant. These payments are made for various purposes, including payment for services provided and expenses incurred by us (and our affiliates) in promoting, marketing, distributing, and administering the Policies; and, in our role as intermediary to the Funds. We (and our affiliates) may profit from these payments. Unlike 12b-1 fees, these payments are not paid out of Fund assets.

We (or our affiliates) also receive payments from the investment advisers, sub-advisers, or distributors (or affiliates thereof) of the Funds. Unlike12b-1 fees, these payments are not paid out of Fund assets. These payments may be derived, in whole or in part, from the investment advisory fees deducted from Fund assets. Owners, through their indirect investment in the Funds, bear the costs of these investment advisory fees. See the Funds' prospectuses for more information. The amount of the payments we receive is based on a percentage of the average daily net assets of the particular Fund attributable to the Policies and to certain other variable insurance policies issued or administered by us (or our affiliate). The payments we receive from the investment advisers, sub-advisers or distributors of the Funds currently range from 0.00% to 0.50% of Fund assets attributable to our variable insurance policies. The amount of the payments may be significant.

Other Payments A Fund's adviser, sub-adviser, or distributor or its affiliates may provide us (or our affiliates) and/ or broker-dealers that sell the Policies ("selling firms") with marketing support, may pay us (or our affiliates) and/or selling firms amounts to participate in national and regional sales conferences and meetings with the sales desks, and may occasionally provide us (or our affiliates) and/or selling firms with items of relatively small value, such as promotional gifts, meals, tickets, or other similar items in the normal course of business.

For details about the compensation payments we make in connection with the sale of the Policies, see "Sale of the Policies."


19


Addition, Deletion, or Substitution of Investments

Protective Life may make additions to, deletions from, or substitutions for the shares that are held in or purchased by the Variable Account. If the shares of a Fund are no longer available for investment or further investment in any Fund should become inappropriate in view of the purposes of the Variable Account, Protective Life may redeem the shares of that Fund and substitute shares of another Fund. Substituted Funds may have higher fees and expenses or may be available only to certain classes of purchasers. Protective Life will not substitute any shares without notice and any necessary approval of the SEC and state insurance authorities.

Protective Life also reserves the right to establish additional Sub-Accounts of the Variable Account, which would each invest in shares corresponding to a new Fund. Subject to applicable law and any required SEC approval, Protective Life may establish new Sub-Accounts or eliminate one or more Sub-Accounts if marketing needs, tax considerations or investment conditions warrant. Any new Sub-Accounts may be made available to existing Owner(s) or may be closed to certain classes of purchasers. Protective Life may prohibit the allocation of Net Premium and transfer of Policy Value to a Sub-Account.

If any of these substitutions or changes are made, Protective Life may by appropriate endorsement change the Policy to reflect the substitution or other change. If Protective Life deems it to be in the best interest of Owner(s), the Variable Account may be operated as a management investment company under the 1940 Act, it may be deregistered under that Act if registration is no longer required, or it may be combined with other Protective Life separate accounts, or its assets may be transferred to other Protective Life separate accounts, subject to any required Owner and/or regulatory approval. Protective Life may make any changes to the Variable Account required by the 1940 Act or other applicable law or regulation.

Voting Fund Shares

Protective Life is the legal owner of Fund shares held by the Sub-Accounts and has the right to vote on all matters submitted to shareholders of the Funds. However, in accordance with applicable law, Protective Life will vote shares held in the Sub-Accounts at meetings of shareholders of the Funds in accordance with instructions received from Owners with Policy Value in the Sub-Accounts. Should Protective Life determine that it is permitted to vote such shares in its own right, it may elect to do so.

Protective Life will send or make available to Owners voting instruction forms and other voting materials (such as Fund proxy statements, reports and other proxy materials) prior to shareholders meetings. The number of votes as to which an Owner may give instructions is calculated separately for each Sub-Account and may include fractional votes.

An Owner holds a voting interest in each Sub-Account to which Variable Account Value is allocated under his or her Policy. Owners only have voting interests while the Insured is alive. The number of votes for which an Owner may give instructions is based on the Owner's percentage interest of a Sub-Account determined as of the date established by the Fund for determining shareholders eligible to vote at the meeting of that Fund.

It is important that each Owner provide voting instructions to Protective Life because shares as to which no timely instructions are received and shares held directly by Protective Life are voted by Protective Life in proportion to the voting instructions that are received with respect to all Policies participating in a Sub-Account. As a result, a small number of Owners may control the outcome of a vote. Voting instructions to abstain on any item are applied to reduce the votes eligible to be cast on that item.

Protective Life may, if required by state insurance officials, disregard Owner voting instructions if such instructions would require shares to be voted so as to cause a change in sub-classification or investment objectives of one or more of the Funds, or to approve or disapprove the investment management agreement or an investment advisory agreement. In addition, Protective Life may under certain circumstances disregard voting instructions that would require changes in the investment management agreement, investment manager, an investment advisory agreement or an investment adviser of one or more of the Funds, provided that Protective Life reasonably disapproves of such changes in accordance with applicable regulations under the 1940 Act. If Protective Life ever disregards voting instructions, Owners will be advised of that action and of the reasons for such action in the next semiannual report.

CHARGES AND DEDUCTIONS

This section describes the charges and deductions we make under the Policy to compensate us for the services and benefits we provide, costs and expenses we incur, and risks we assume. We may profit from the charges deducted, and we may use any such profits for any purpose, including payment of distribution expenses. On and after the Policy Anniversary when the Insured is age 121, we do not make any charges and deductions under the Policy, other than the interest charged on loans (if a loan is outstanding).


20


Premium Expense Charge

We deduct a premium expense charge from each premium you pay. The premium expense charge compensates us for certain sales and premium tax expenses associated with the Policies and the Variable Account. Currently, the premium expense charge is equal to 3.5% (5% on a guaranteed basis) of each premium payment you make.

Monthly Deduction

Each month we will deduct an amount from your Policy Value to pay for the benefits provided by your Policy. This amount is called the Monthly Deduction and equals the sum of:

•  the cost of insurance charges;

•  the monthly administration fees and charges;

•  the mortality and expense risk charge; and

•  any charges for supplemental riders.

If you do not select the Sub-Account(s) from which the Monthly Deduction is deducted, the Monthly Deduction, except for the mortality and expense risk charge, will be deducted from the Sub-Accounts and the Fixed Account pro-rata on the basis of the unloaned Policy Value. The mortality and expense risk charge will be deducted from the Sub-Accounts.

The Owner may select the Sub-Accounts from which you want us to deduct the Monthly Deduction, other than the mortality and expense risk charge. However, if as of the date the Monthly Deduction is to be deducted, the value in any of the selected Sub-Accounts is less than the charge to be deducted from that Sub-Account, Protective Life will instead deduct the Monthly Deduction on a pro-rata basis from each Sub-Account and the Fixed Account under the Policy based on the unloaned Policy Value attributable to each Sub-Account and the Fixed Account. Protective Life deducts the mortality and expense risk charge prior to the deduction of the other charges that comprise the Monthly Deduction.

Cost of Insurance Charge. This charge compensates Protective Life for the expense of underwriting the Death Benefit. The charge depends on a number of variables and therefore will vary from Policy to Policy and from Monthly Anniversary Day to Monthly Anniversary Day.

The cost of insurance is equal to:

•  the cost of insurance rate, multiplied by

•  the Net Amount at Risk under the Policy for that Monthly Anniversary Day.

The Net Amount at Risk is equal to:

•  the Death Benefit discounted at one plus the monthly guaranteed interest rate minus the Policy Value (prior to deducting the Cost of Insurance).

Anything that decreases Policy Value, such as negative investment experience or withdrawals, will increase the Net Amount at Risk and result in higher cost of insurance charges. The Net Amount at Risk is affected by investment performance, loans, payments of premiums, Policy fees and charges, withdrawals, and increases or decreases in Face Amount.

The cost of insurance charge for each increment of Face Amount is calculated separately to the extent a different cost of insurance rate applies. Because the Net Amount at Risk is equal to the Death Benefit less Policy Value, the entire Policy Value is applied first to offset the Death Benefit derived from the Initial Face Amount. Only if the Policy Value exceeds the Initial Face Amount is the excess applied to offset the portion of the Death Benefit derived from increases in Face Amount in the order of the increases. If there is a decrease in Face Amount after an increase, the decrease is applied first to decrease any prior increases in Face Amount, starting with the most recent increase.

Cost of Insurance Rates. The cost of insurance rate for a Policy is based on and varies with the Issue Age, sex and rate class of the Insured, Face Amount and on the number of years that a Policy has been in force. Protective Life places Insureds in the following rate classes, based on underwriting: Standard Unismoke (30-70). Protective Life guarantees that the cost of insurance rates used to calculate the monthly cost of insurance charge will not exceed the maximum cost of insurance rates set forth in the Policies. The guaranteed rates for standard classes are based on the 2017 Commissioners' Standard Ordinary Mortality Tables, Male or Female, composite Mortality Rates ("2017 CSO Tables").

Protective Life's current cost of insurance rates may be less than the guaranteed rates that are set forth in the Policy. Current cost of insurance rates will be determined based on Protective Life's expectations as to future mortality,


21


investment earnings, expenses, taxes, and persistency experience. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience.

Protective Life will also determine a separate cost of insurance rate for each increment of Face Amount above the Initial Face Amount based on the Policy duration and the Issue Age, sex and rate class of the Insured at the time of the request for an increase. The following rules will apply for purposes of determining the Net Amount at Risk for each rate class.

Protective Life places the Insured in a rate class when the Policy is issued, based on Protective Life's underwriting of the application. This original rate class applies to the Initial Face Amount. When an increase in Face Amount is requested, Protective Life conducts underwriting before approving the increase (except as noted below) to determine whether a different rate class will apply to the increase. If the rate class for the increase has lower cost of insurance rates than the original rate class (or the rate class of a previous increase), the rate class for the increase also will be applied to the Initial Face Amount and any previous increases in Face Amount beginning as of the effective date of the current increase. If the rate class for the increase has a higher cost of insurance rate than the original rate class (or the rate class of a previous increase), the rate class for the increase will apply only to the increase in Face Amount.

Protective Life does not conduct underwriting for an increase in Face Amount if the increase is requested as part of an exercise of any available guaranteed option to increase the Face Amount without underwriting. See "Supplemental Riders and Endorsements."

In the case of a term conversion, the rate class that applies is the same rate class that applied to the term contract, where applicable. In the case of a guaranteed option, the Insured's rate class for an increase will be the class in effect when the guaranteed option rider was issued.

Legal Considerations Relating to Sex Distinct Premium Payments and Benefits. Mortality tables for the Policies generally distinguish between males and females. Thus, premiums and benefits under Policies covering males and females of the same age will generally differ.

Protective Life does, however, also offer Policies based on unisex mortality tables on Policies issued in Montana. Employers and employee organizations considering purchase of a Policy should consult with their legal advisors to determine whether purchase of a Policy based on sex-distinct actuarial tables is consistent with Title VII of the Civil Rights Act of 1964 or other applicable law. Upon request, Protective Life may offer Policies with unisex mortality tables to such prospective purchasers.

Monthly Administration Fees. We deduct a monthly administrative charge from your Policy Value to compensate us for issue and administrative costs. The monthly administrative charge is $9 per month. We also deduct a monthly administrative charge for the Initial Face Amount which is equal to a fee per $1,000 of Initial Face Amount per month for all Policy Years to age 120. This monthly administrative charge will be higher in the first 2 Policy Years compared to later years. The actual fee varies depending on the Insured's Issue Age, sex and rate classification, and Face Amount. We guarantee that the current monthly administrative charge per $1,000 of Initial Face Amount will not exceed the maximum monthly administrative charge per $1,000 of Initial Face Amount set forth in your Policy. Representative guaranteed administrative charges per $1,000 of Initial Face Amount for an Insured male standard unismoker at each specified Issue Age, and a Face Amount of $100,000 are set forth below:

Issue Age   Administrative Charge
Per $1,000 of Initial
Face Amount
 
35  

$

2.57

   
40    

2.80

   
45    

3.12

   
50    

3.55

   
55    

4.02

   
60    

4.61

   
65    

4.95

   
70    

4.95

   

Supplemental Rider Charges. We deduct a monthly charge from your Policy Value to cover administrative expenses for any riders as part of the Monthly Deduction. See "Fee Table — Periodic Charges Other Than Annual Fund Expenses."

Mortality and Expense Risk Charge. We deduct a mortality and expense risk charge each month from your Policy Value. This charge compensates Protective Life for the mortality risk it assumes under the Policies. The mortality risk


22


is that the Insureds will live for a shorter time than we project. The expense risk Protective Life assumes is that the expenses that we incur in issuing and administering the Policies and the Variable Account will exceed the amounts realized from the administrative charges assessed against the Policies.

We deduct a monthly charge from assets in the Sub-Accounts attributable to the Policies. This charge does not apply to Fixed Account assets attributable to the Policies. The maximum monthly mortality and expense risk charge to be deducted is generally equal to 0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount. Protective Life reserves the right to charge less than the maximum charge.

The current monthly mortality and expense risk charge is 0.017% multiplied by the Variable Account Value for the first 10 Policy Years, which is equivalent to an annual rate of 0.204% of such amount. After the tenth Policy Year, the current monthly mortality and expense risk charge is 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096%.

Transfer Fee

We allow you to make 12 free transfers of Policy Value each Policy Year. However, Protective Life may charge a $25 transfer fee on any additional transfers in a Policy Year to cover administrative expenses. Currently, we do not assess the transfer fee but reserve the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee or limit the number of transfers. If the fee is imposed, it will be deducted from the amount requested to be transferred. If an amount is being transferred from more than one Sub-Account or the Fixed Account, the transfer fee will be deducted proportionately from the amount being transferred from each.

Surrender Charge

During the first 14 Policy Years, a Surrender Charge will be deducted from your Policy Value if: (1) the Policy is surrendered; (2) the Policy lapses at the end of a grace period or (3) the Initial Face Amount is reduced. The Surrender Charge is deducted before any Surrender Value is paid.

The Surrender Charge varies depending on Issue Age, sex and rate class of the Insured and is set forth in your Policy. Representative Surrender Charges per $1,000 of Initial Face Amount for the first Policy Year for an Insured male standard unismoker at each specified Issue Age are set forth below. The Surrender Charge decreases over the applicable surrender charge period (after the applicable surrender charge period, there is no charge). For a decrease in the Initial Face Amount, the charge shown is per $1,000 of decrease.

Issue Age   Surrender Charge (First Year)
per $1,000 of Initial
Face Amount
 
30    

2.850

%

 
35    

3.100

%

 
40    

3.375

%

 
45    

3.725

%

 
50    

4.175

%

 
55    

4.750

%

 
60    

5.525

%

 
65    

5.775

%

 
70    

5.725

%

 

In the event of a decrease in the Initial Face Amount, the pro-rated Surrender Charge will be allocated to each Sub-Account and to the Fixed Account based on the proportion of unloaned Policy Value in each Sub-Account and in the Fixed Account. A Surrender Charge imposed in connection with a reduction in the Initial Face Amount reduces the remaining Surrender Charge that may be imposed in connection with a surrender of the Policy.

The purpose of the Surrender Charge is to reimburse Protective Life for some of the expenses incurred in the distribution of the Policies. Protective Life also deducts a premium expense charge for this purpose from each premium paid. See "Premium Expense Charge."

Withdrawal Charges

Protective Life will deduct an administrative charge upon a withdrawal. This charge is the lesser of 2% of the amount withdrawn or $25. This charge will be deducted from the Policy Value in addition to the amount requested to be withdrawn. See "Withdrawal Privilege" for rules for allocating the deduction.


23


Net Cost of Loans

The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% (3.25% guaranteed) for all loans (standard and carry-over in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed)..

Fund Expenses

The value of the net assets of each Sub-Account reflects the investment management fees and other expenses incurred by the corresponding Fund in which the Sub-Account invests. For further information, consult the Funds' prospectuses.

Other Information

We sell the Policies through registered representatives of broker-dealers. These registered representatives are also appointed and licensed as insurance agents of Protective Life. We pay commissions and other compensation to the broker-dealers for selling the Policies. You do not directly pay the commissions and other compensation, we do. We intend to recover commissions and other compensation, marketing, administrative and other expenses and costs of Policy benefits through the fees and charges imposed under the Policies. See "Sale of the Policies" for more information about payments we make to the broker-dealers.

Corporate Purchasers or Eligible Groups

The Policy is available for individuals and for corporations and other institutions. For corporate or other group or sponsored arrangements, fee-only arrangements or clients of registered investment advisers purchasing one or more Policies, Protective Life may reduce the amount of the premium expense fee, monthly administration charge, or other charges where the expenses associated with the sale of the Policy or Policies or the underwriting or other administrative costs associated with the Policy or Policies are reduced. Sales, underwriting or other administrative expenses may be reduced for reasons such as expected economies resulting from a corporate purchase, a group or sponsored arrangement or arrangements, fee-only arrangements or clients of registered investment advisers.

THE POLICY

Purchasing a Policy

For insurance coverage to take effect under a Policy, you must submit a completed application and at least the minimum initial premium payment through a licensed representative of Protective Life who is also a registered representative of a broker-dealer having a distribution agreement with Investment Distributors, Inc. Protective Life requires satisfactory evidence of insurability, which may include a medical examination of the Insured. Generally, Protective Life will issue a Policy covering an Insured up to age 70 if evidence of insurability satisfies Protective Life's underwriting rules. Minimum age requirements may apply. Acceptance of an application depends on Protective Life's underwriting rules, and Protective Life may reject an application for any reason. With your consent, a Policy may be issued on a basis other than that applied for (e.g., on a higher premium class basis due to increased risk factors). A Policy is issued after Protective Life approves the application. Payment of Premium is not a requirement to issue a Policy but your insurance will not take effect until you pay your minimum initial premium. Premium may be collected at the time of Policy delivery.

Insurance coverage under a Policy begins on the Policy Effective Date. Temporary life insurance coverage also may be provided under the terms of a temporary insurance agreement. Under such agreements, the total amount of insurance which may become effective prior to the Policy Effective Date may not exceed $500,000 (including the amount of any life insurance and accidental death benefits then in force or applied for with the Company), may be dependent on satisfactory underwriting and other conditions and may not be in effect for more than 60 days. In addition, such agreement may not be issued on proposed Insureds under 15 days of age.

In order to obtain a more favorable Issue Age, Protective Life may permit the Owner to "backdate" a Policy by electing a Policy Effective Date up to six months prior to the date of the original application, subject to state requirements (3 months in Ohio, not allowed in Montana). Charges for the Monthly Deduction for the backdated period are deducted as of the Policy Effective Date and the calculation of the Policy's lapse protection will include the Minimum Monthly Premiums for the backdated period.


24


The Owner of the Policy may exercise all rights provided under the Policy. The Insured is the Owner, unless a different person or entity is named as Owner in the application. By Written Notice received by Protective Life at the Home Office while the Insured is living, the Owner may name a contingent Owner or a new Owner. If there are joint Owners, all Owners must authorize the exercise of any right under the Policy. Unless the Owner provides otherwise, in the event of one joint Owner's death, ownership passes to any surviving joint Owner(s). Unless a contingent Owner has been named, ownership of the Policy passes to the estate of the last surviving Owner upon his or her death. A change in Owner may have tax consequences. See "Tax Considerations — Other Considerations" in the Prospectus.

Fees, charges and benefits available under the Policy may vary depending on the state in which the Policy is issued.

Cancellation Privilege

You may cancel your Policy for a refund during the Cancellation Period by returning it to Protective Life's Home Office or to the sales representative who sold it along with a written cancellation request. The Cancellation Period is determined by the law of the state in which the application is signed and is shown in your Policy. In most states it expires at the latest of

1.  10 days after you receive your Policy, or

2.  45 days after you sign your application.

Within seven calendar days after receiving the returned Policy, Protective Life will refund either:

1.  the premiums paid (if required by law), or

2.  the total Policy Value plus any charges that were deducted less any outstanding loan and accrued loan interest. This amount may be more or less than the aggregate premiums paid.

In states requiring the return of premiums paid, Protective Life will refund the greater of 1 and 2 above.

Changes in the Policy or Benefits

At any time Protective Life may make such changes in the Policy as are necessary to assure compliance with any applicable laws or with regulations or rulings issued by a government agency. This includes, but is not limited to, changes necessary to comply at all times with the definition of life insurance prescribed by the Internal Revenue Code of 1986, as amended ("Internal Revenue Code" or "Code"). Any such changes will apply uniformly to all affected Policies and Owners will receive notification of such changes.

PREMIUMS

Minimum Initial Premium. The minimum initial premium required depends on a number of factors, including the age, sex and rate class of the proposed Insured, the Initial Face Amount requested by the applicant, any supplemental riders requested by the applicant and the planned periodic premiums that the applicant selects. Consult your sales representative for information about the initial premium required for the coverage you desire.

Planned Periodic Premiums. In the application the Owner selects a plan for paying level premiums at specified intervals (i.e., quarterly, semi-annually or annually). At the Owner's election, we will also arrange for payment of planned periodic premiums on a monthly basis (on any day except the 29th​, 30th​, or 31st​ of a month) under a pre-authorized payment arrangement. You are not required to pay premiums in accordance with these plans. You can pay more or less than planned or skip a planned periodic premium entirely. See "Lapse and Reinstatement." Subject to the limits described below, you can change the amount and frequency of planned periodic premiums at any time by Written Notice to Protective Life at the Home Office. Additional premiums may be required to maintain the Policy, depending on a number of factors including past premiums paid, investment experience and loans and/or withdrawals on the Policy.

Unless you have arranged to pay planned periodic premiums by pre-authorized payment arrangement or have otherwise requested, you will be sent reminder notices for planned periodic premiums.

Unscheduled Premiums. Subject to the limitations described below, additional unscheduled premiums may be paid in any amount and at any time. By Written Notice to Protective Life at the Home Office, the Owner may specify that all unscheduled premiums are to be applied as repayments of Policy Debt, if any, otherwise any unscheduled premiums are allocated to the Sub-Accounts based on the most recent allocation instructions we have on file.


25


Premium Limitations. Premiums are accepted until Attained Age of 121. Premiums may be paid by any method acceptable to Protective Life. If by check, the check must be from an Owner (or the Owner's designee other than a sales representative), payable to Protective Life, and be dated prior to its receipt at the Home Office.

Additional limitations apply to premiums. Premium payments must be at least $150 ($50 if paid monthly by a pre-authorized payment arrangement) and must be remitted to the Home Office. Protective Life also reserves the right to limit the amount and frequency of any premium payment. In addition, at any point in time aggregate premiums paid under a Policy may not exceed limitations for life insurance policies as set forth in the Internal Revenue Code. See "Tax Considerations" in the Prospectus and the discussion of Cash Value Accumulation Test under "Calculation of Death Benefit Proceeds." Protective Life will immediately refund any portion of any premium payment, with interest thereon, that is determined to be in excess of the limits established by law to qualify a Policy as a contract for life insurance. Protective Life will also monitor Policies and will attempt to notify the Owner on a timely basis if his or her Policy is in jeopardy of becoming a modified endowment contract under the Internal Revenue Code, if applicable. See "Tax Considerations" in the Prospectus.

Premium Payments Upon Increase in Face Amount. Depending on the Policy Value at the time of an increase in the Face Amount and the amount of the increase requested, an additional premium payment may be necessary to keep the Policy in force or a change in the amount of planned periodic premiums may be advisable. You will be notified if a premium payment is necessary or a change is appropriate.

Net Premium Allocations

You must indicate in the application how Net Premiums are to be allocated to the Sub-Accounts and/or to the Fixed Account. These allocation instructions apply to both initial and subsequent Net Premiums. You may change the allocation instructions in effect at any time by Written Notice to Protective Life at the Home Office or by telephone, facsimile, automated telephone system, or via the Internet at www.protective.com. Whole percentages must be used. The sum of the allocations to the Sub-Accounts and the Fixed Account must be equal to 100% of any Net Premiums. Protective Life reserves the right to establish (i) a limitation on the number of Sub-Accounts to which Net Premiums may be allocated and/or (ii) a minimum allocation requirement for the Sub-Accounts and the Fixed Account.

For Policies issued in states where, upon cancellation during the Cancellation Period, Protective Life returns at least your premiums, Protective Life reserves the right to allocate your initial Net Premium (and any subsequent Net Premiums paid during the Cancellation Period) to the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account until the expiration of the number of days in the Cancellation Period plus 6 days starting from the date that the Policy is mailed from the Home Office. Thereafter, the Policy Value in the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account and all Net Premiums will be allocated according to your allocation instructions then in effect.

If Protective Life receives a premium payment at the Home Office before 3:00 P.M. Central Time, Protective Life will process the payment as of the Valuation Day it is received. Protective Life processes premium payments received at the Home Office at or after 3:00 P.M. Central Time as of the next Valuation Day. However, premium will not be accepted in connection with an increase in Face Amount until underwriting has been completed. When approved, Net Premium received will be allocated in accordance to your allocation instructions then in effect.

Unless designated by the Owner as a loan repayment, premiums received from Owners (other than planned periodic premiums) are treated as unscheduled premiums.

Protective Life reserves the right to limit the amount and frequency of planned periodic premiums and additional unscheduled premiums (each an "additional premium") under the Policy or the amount and frequency of Net Premiums that may be allocated to the Fixed Account at any time. Protective Life also reserves the right to refuse to accept such additional premium under the Policy or allocate additional Net Premium to the Fixed Account at any time without prior notice. In all cases, Protective Life will accept additional premium necessary to prevent the Policy from lapsing. Protective Life will attempt to notify the Owner that a premium payment may result in a Policy becoming a Modified Endowment Contract ("MEC"), and will accept the premium payment unless otherwise instructed by the Owner. If a premium payment would cause the Policy to no longer qualify as life insurance under the Internal Revenue Code, the Company will refuse to accept the premium payment.

If mandated by law, we may reject a premium payment. We may also provide information about you and your account to a government regulator.


26


CALCULATION OF POLICY VALUE

Variable Account Value

The Variable Account Value reflects the investment experience of the Sub-Accounts to which it is allocated, any premiums allocated to the Sub-Accounts, transfers in or out of the Sub-Accounts (including loans), any withdrawals of Variable Account Value, any Surrender Charges deducted, and Monthly Deductions. There is no guaranteed minimum Variable Account Value. A Policy's Variable Account Value therefore depends upon a number of factors. The Variable Account Value for a Policy at any time is the sum of the Sub-Account Values for the Policy on the Valuation Day most recently completed.

Determination of Units

For each Sub-Account, the Net Premium(s) or unloaned Policy Value transferred are converted into units. The number of units credited is determined by dividing the dollar amount directed to each Sub-Account by the value of the unit for that Sub-Account for the Valuation Day on which the Net Premium(s) or transferred amount is invested in the Sub-Account. Therefore, Net Premiums allocated to or amounts transferred to a Sub-Account under a Policy increase the number of units of that Sub-Account credited to the Policy.

Determination of Unit Value

The unit value at the end of every Valuation Day is the unit value at the end of the previous Valuation Day times the net investment factor, as described below. The Sub-Account Value for a Policy is determined on any day by multiplying the number of units attributable to the Policy in that Sub-Account by the unit value for that Sub-Account on that day.

Net Investment Factor

The net investment factor is an index applied to measure the investment performance of a Sub-Account from one Valuation Period to the next. Each Sub-Account has a net investment factor for each Valuation Period which may be greater or less than one. Therefore, the value of a unit may increase or decrease. The net investment factor for any Sub-Account for any Valuation Period is determined by dividing (1) by (2), where:

1.  is the result of:

a.  the net asset value per share of the Fund held in the Sub-Account, determined at the end of the current Valuation Period; plus

b.  the per share amount of any dividend or capital gain distributions made by the Fund to the Sub-Account, if the "ex-dividend" date occurs during the current Valuation Period; plus or minus

c.  a per share charge or credit for any taxes reserved for, which is determined by Protective Life to have resulted from the operations of the Sub-Account.

2.  is the net asset value per share of the Fund held in the Sub-Account, determined at the end of the last prior Valuation Period.

Fixed Account Value

The Fixed Account Value under a Policy at any time is equal to: (1) the Net Premium(s) allocated to the Fixed Account, plus (2) amounts transferred to the Fixed Account, plus (3) interest credited to the Fixed Account, less (4) transfers from the Fixed Account (including any transfer fees deducted), less (5) withdrawals from the Fixed Account (including any withdrawal charges deducted), less (6) Surrender Charges deducted in the event of a decrease in initial Face Amount, less (7) loan balances, less (8) Monthly Deductions. See "The Fixed Account," for a discussion of how interest is credited to the Fixed Account.

STANDARD DEATH BENEFITS

As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner's estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment


27


of the Death Benefit Proceeds may have tax consequences. See "Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds" in the Prospectus.

Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.

Limits on Policy Rights

Incontestability. Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider accept as stated below, after the Policy or rider has been in force during the Insured's lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.

We have the right to void and rescind the Long-Term Care rider or resist an otherwise valid claim based on a misstatement in any application we accept and make part of the Policy as follows:

•  If this rider has been in force for less than 6 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was material to the issuance of this rider.

•  If this rider has been in force for at least 6 months but less than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was materials to the issuance of this rider and pertains to the condition for which benefits are sought.

•  If this rider has been in force for more than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the Insured knowingly and intentionally misrepresented relevant facts relating to the Insured's health.

Suicide Exclusion. If the Insured dies by suicide, while sane or insane, within two years (or shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide, while sane or insane, within two years (or any shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.

Misstatement of Age or Sex. If the Insured's age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.

Calculation of Death Benefit Proceeds

The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured's death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.

Federal Tax Compliance Tests. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test. This Policy will only be issued using the Cash Value Accumulation Test.

The Cash Value Accumulation Test ("CVAT") does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy's cash value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.

Under this Policy, which provides a level Death Benefit, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater than the Face Amount under the Policy.

The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary,


28


or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured's death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.

Cash Value Accumulation Test. This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured's death, or (2) the minimum death benefit described below.

The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

Changing the Face Amount

On or after the first Policy Anniversary, the Owner may request an increase in the Face Amount. The request must be received in writing in Good Order at the Home Office.

Increasing the Face Amount. Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. The maximum Face Amount is $500,000. In addition, the Insured's current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See "Premiums Upon Increase in Face Amount." The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy's lapse protection is in effect, the Policy's Minimum Monthly Premium amount will also generally be increased.

An administrative fee will be charged on the Effective Date of the increase and the subsequent eleven (11) Monthly Anniversary Days following an increase in the Face Amount.

As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "Tax Considerations — Other Considerations." Please consult your tax advisor.

On or after the third Policy Anniversary, the Owner may request a decrease in the Face Amount. The request must be received in writing in Good Order at the Home Office.

Decreasing the Face Amount. If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See "Tax Considerations — Policies which are MECs."


29


The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.

Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. However, if the initial Face Amount is decreased during the first 14 Policy Years, a Surrender Charge will apply. Decreasing the Face Amount also may have tax consequences. See "Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years."

Settlement Options

The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.

The following settlement options may be elected.

Option 1 — Payment for a Fixed Period.  Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

Option 2 — Life Income with Payments for a Guaranteed Period.  Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

Option 3 — Interest Income.  Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

Option 4 — Payments for a Fixed Amount.  Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

Minimum Amounts. Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life's option.

Other Requirements. Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured's lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner's estate.

If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.

Escheatment of Death Benefit

Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely


30


manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This "escheatment" is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.

OTHER BENEFITS AVAILABLE UNDER THE POLICY

In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.

Name of Benefit

 

Purpose

  Is Benefit
Standard
or
Optional?
  Brief Description of
Restrictions/Limitations
 

Long-Term Care Rider

 

Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.

 

Standard

  • Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.
• Additional cost applies.
• Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.
• Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).
• Benefit payments are made monthly and may not cover all long-term care expenses incurred.
• If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.
• If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.
 


31


Name of Benefit

 

Purpose

  Is Benefit
Standard
or
Optional?
  Brief Description of
Restrictions/Limitations
 

Long-Term Care Inflation Protection Option

 

On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.

 

Optional

  • This rider must be elected at Policy issue.
• Additional cost applies.
• On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.
• If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.
 

Terminal Illness Accelerated Death Benefit Endorsement (Automatically included at Policy Issue)

 

Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.

 

Standard

  Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:
• The lesser of 60% of the current face amount of the Policy or $1,000,000; minus
• Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.
• Minimum acceleration permitted is $15,000
• The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.
• Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.
 

Lapse Protection Endorsement (Automatically issued with this Policy)

 

Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.

 

Standard

  • The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.
• Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.
 


32


Name of Benefit

 

Purpose

  Is Benefit
Standard
or
Optional?
  Brief Description of
Restrictions/Limitations
 

Dollar-Cost Averaging

 

Allows for the systematic transfer of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub-Accounts.

 

Optional

  • No transfers may be made into the Fixed Account.
• Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.
 

Portfolio Rebalancing

 

Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.

 

Optional

  • Rebalancing transfers cannot be made into Fixed Account.
• Minimum Variable Account Value of $100 required.
 

Policy Loans

 

Allows Owner to borrow from Policy's Cash Value.

 

Standard

  • Not available during the first Policy Year.
• Maximum loan amount is 99% of Cash Value.
• Minimum loan amount is $500.
• Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.
• If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.
 

SUPPLEMENTAL RIDERS AND ENDORSEMENTS

The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See "Monthly Deduction." Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The Long-Term Care Rider, the Terminal Illness Accelerated Death Benefit Endorsement, and the Lapse Protection Endorsement are automatically added to all Policies at the time of issue. Also, this Policy will not be issued without the Long-Term Care Rider. The Long-Term Care Inflation Protection Option must be purchased at the time the Policy is issued. Please ask your Protective Life agent for further information or contact the Home Office.

Long-Term Care Rider. This rider is automatically issued with the Policy. This rider provides an acceleration of the death benefits and extended benefits under the Policy for long-term care benefits for Qualified Long-Term Care Services incurred for Home Health Care Services, Adult Day Care Services, Assisted Living Facility Services, and Nursing Home Services. You may make a claim for a Long-Term Care Benefit (the "LTC Benefit"). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met. If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.

30-Day Right to Cancel

You have 30 days after the rider is first delivered to you to examine and return to us or to the financial professional who sold it to you, if you decide not to keep this rider. We will cancel the rider and the Policy. The returned Policy and rider will be treated if they had never been issued. We will refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to us, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to us.


33


Rider Terms

Activities of Daily Living: Means the six basic human functions necessary for a person to live independently are:

•  Eating

•  Toileting

•  Transferring oneself into or out of bed, chair, wheelchair

•  Bathing

•  Dressing

•  Continence

The rider attached to your Policy contains more detailed information about these self-care functions.

Active Claim Status: Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.

Assistive Device: Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.

Chronically Ill: Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:

•  Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity, or

•  Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Sever Cognitive Impairment.

The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.

Elimination Period: Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.

Family Member: Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.

Hands-on Assistance: Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.

Home: Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision or Substantial Assistance with Activities of Daily Living.

Insured: Means the person shown on the Policy Schedule upon whose life the Policy insures.

Licensed Health Care Practitioner: Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.

Plan of Care: Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured's needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured's care requirements.


34


Qualified Long-Term Care Services: Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a chronically ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

Severe Cognitive Impairment: Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:

•  The Insured's short or long-term memory,

•  The Insured's orientation as to person (such as who they are), place (such as their location), or time (such as day, date, and year), and

•  The Insured's deductive or abstract reasoning.

Standby Assistance: Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.

Substantial Assistance: Means Hands-On Assistance or Standby Assistance.

Substantial Supervision: Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.

Written Certification: Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.

Eligibility, Limitations, and Exclusions

To become eligible for the LTC Benefit payments, the following conditions must be met:

•  We receive your written request for the LTC Benefit,

•  A Licensed Health Care Practitioner certifies that the Insured is Chronically Ill and prescribes a Plan of Care,

•  The Policy and this rider are in force,

•  The applicable Elimination Period has been satisfied,

•  We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy, and

•  The benefit payment is made in respect to a month when the Insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by, received from, a provider of health care services, within six months preceding the effective date of this rider.

The rider will not pay benefits for any Chronic Illness caused by:

•  Any attempt at suicide or intentionally self-inflicted injury, while sane or insane,

•  Committing or attempting to commit or participating in a riot, insurrection, or involvement in an illegal occupation,

•  Alcoholism or drug addiction, or

•  Declared or undeclared war or any act of war.

Maximum Monthly LTC Benefit Amount

The Base Maximum Monthly LTC Benefit Amount on the Policy Effective Date, is equal to the amount shown in the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the "Long-Term Care Inflation Protection Option" section and "Impact on Your Policy" section.


35


The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date and is equal to:

•  The Base Maximum Monthly LTC Benefit Amount, plus

•  80% of the result of the following:

a)  1/48 of the Current LTC Benefit Pool minus

b)  the Base Maximum Monthly LTC Benefit Amount

On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, that amount may increase and/or decrease as described in the "Benefits While on Claim" section below.

The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown in the Policy Schedule.

Current LTC Benefit Pool

The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:

•  The Base LTC Benefit Pool,

•  The Market Value LTC Benefit Pool, and

•  The Protected LTC Benefit Pool.

On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the "Benefits While on Claim" provision below.

Unless you have requested a decrease in the Policy's Face Amount or make a withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown in the Policy Schedule minus the sum of any LTC Benefits paid under this rider.

The Base LTC Benefit Pool on the Policy Effective Date, is equal to the Base LTC Benefit Pool shown in the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the "Long-Term Care Inflation Protection Option", and "Impact on Your Policy" sections.

The Market Value LTC Benefit Pool is equal to the Unloaned Policy Value multiplied by the Market Benefit Multiplier shown on your Policy schedule. This pool may increase or decrease daily and is adjusted as described in the "Long-Term Care Inflation Protection Option" section.

The Protected LTC Benefit Pool on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on your Policy schedule) multiplied by the Unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on your Policy schedule.

On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:

•  The Protected LTC Percentage (shown on the Policy schedule) multiplied by the Unloaned Policy Value as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier, and

•  The Protected LTC Pool in effect immediately prior to that Policy Anniversary.

The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to the Long-Term Care Inflation Protection Option Increases, LTC Benefit payments, withdrawals, loans, and Policy changes.

Claims Provisions

We prefer that either you or the Insured notify us as soon as the Insured first becomes eligible and may soon need care covered by this rider. We must receive your intent to file a claim for the LTC Benefit at our Administrative Office via written request or by telephone. The Request should include at least the Insured's name, Policy number and the address to which claim forms should be sent.

We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you


36


provide Written Certification and proof of loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.

Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Confirmation from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date of proof would otherwise by required.

A licensed Health Care Practitioner must re-certify that the Insured is Chronically Ill and prescribe a Plan of Care at least once every 12 months. We reserve the right to request a re-certification that the Insured remains Chronically Ill, but not more often than every 90 days, following an initial certification. The practitioner should either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification. After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be conducted until the 90-day period has passed.

We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agree upon by the Insured and us. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.

If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Accumulation Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.

If, on the date your claim is closed, the Policy's Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as in the Maximum Monthly LTC Benefit Amount and Current LTC Benefit Pool section above, but will be floored at the amounts during claim.

LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issues. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.

According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.

Extension of LTC Benefits

If the Policy terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:

•  The death of the Insured,

•  Transition from Active Claim Status has completed, or

•  The Maximum LTC Benefit Pool has been exhausted.

Any extension of benefit is subject to all terms and conditions of this rider including eligibility for LTC Benefits and claim requirements. If the current maximum LTC benefit pool has been exhausted, no death benefit will be due upon the death of the Insured.

Benefits While on Claim

On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date. Also, on the date a claim under this rider is approved,


37


we will automatically transfer out any Variable Account Value and transfer to the Fixed Account. See "Impact on Your Policy" below for additional information.

Any amounts paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.

If purchased, the Long-term Care Inflation Protection Option increase will increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Long-Term Care Inflation Protection Option" section.

An increase and/or decrease in the Policy's Face Amount or a Withdrawal under the Policy will likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Impact on Your Policy" section.

If your claim is closed, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the "Current LTC Benefit Pool" and "Maximum Monthly LTC Benefit Amount" sections, but will be floored at the amounts during claim.

Impact on Your Policy

Automatic Transfer to Fixed Account. On the date a claim under this rider is approved, we will automatically transfer any Variable Account Value out of the Sub-Accounts and transfer into the Fixed Account. While this rider is in Active Claim Status, no transfers out of the Fixed Account into Sub-Accounts will be permitted. In addition, Net Premiums received during this period will be allocated to the Fixed Account.

LTC Benefit Payments. While Policy Value is greater than zero, LTC Benefit payments will reduce the Policy Value dollar for dollar and will be taken from the Fixed Account.

LTC Benefit Payments on Face Amount. While the Policy's Face Amount is greater than zero, benefit payments under this rider will reduce the Policy's Face Amount dollar for dollar. This may reduce the Policy's Face Amount below the minimum.

Monthly Deductions. When this rider is in Active Claim Status, Monthly Deductions required to maintain the Policy continue, however the LTC Rider Monthly Charge is waived.

Policy Changes, Loans, and Withdrawals. When the rider is in Active Claim Status, Policy Changes, Loans, and withdrawals are not permitted.

Interaction with Terminal Illness Accelerated Death Benefit Endorsement. Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under this endorsement.

Residual Death Benefit. If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:

•  5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment, or

•  $10,000.

The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.

Protection Against Unintended Lapse

To protect against unintended lapse, you may designate at least one person, other than the Owner, to receive notices about potential lapse or Policy termination due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the third-party for services provided to the Insured.


38


Termination

The rider will terminate on the earliest of:

•  Your written notice to terminate this rider. If you request to terminate this rider the Policy to which it is attached will also be terminated. We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination,

•  Policy termination,

•  Failure to pay sufficient premium to maintain the rider,

•  Death of the Insured,

•  Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness or rider attached to the Policy,

•  The date that the Maximum LTC Benefit is exhausted, and

•  The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.

Reinstatement

If the Policy terminates and is subsequently reinstated, this rider may also be reinstated subject to the terms and conditions for reinstatement in the Policy. Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement.

We will reinstate the Policy and this rider without evidence of insurability, if we receive:

•  The Owner's written request within 5 months after the end of the Grace Period,

•  Due proof that is satisfactory to us that the Insured was Chronically Ill at the end of the Grace Period outlined in the Policy, and

•  Payment of overdue premium and/or charges for this rider.

Rider LTC Nonforfeiture Benefit

After the Policy and this rider have been In Force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:

•  The death of the Insured, or

•  The date the LTC Nonforfeiture Benefit Limit has been reduced to zero.

The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:

•  One month's Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates, or

•  An amount equal to the sum of Monthly rider Charges paid for this rider.

The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider Lapses or terminates, and will not change.

The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Long-Term Care Inflation Protection Option increases.

No benefits are payable under this provision until benefits, if any, under the "Extension of LTC Benefits" section are no longer in effect. The sum of any benefits paid under the "Extension of LTC Benefits" section plus any benefits paid under this Rider LTC Nonforfeiture Benefit" section will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.

Long-Term Care Inflation Protection Option. If you selected optional inflation protection, you can purchase a 5% compound inflation protection increase on each Policy Anniversary, with no evidence of insurability. The right to purchase the inflation protection increase in effect on the date the Policy is issued is shown on the Schedule Page.


39


Every annual inflation protection increase purchased by you will be factored into the calculation of the following values: Base Maximum Monthly LTC Benefit Value, Base LTC Benefit Pool, Current Maximum Monthly LTC Benefit Value, Current LTC Benefit Pool, if any.

Starting with the first Policy Anniversary, and for as long as you continue to purchase each year's inflation protection increase, we will send you written notification regarding that year's right to purchase. You must return your request to purchase that year's inflation protection increase within the timeframe stated in the notification.

If you decline to purchase any annual inflation protection increase, you will no longer have the right to purchase an inflation protection increase on any future Policy Anniversary. The right to purchase inflation protection under this rider cannot be reinstated once terminated.

The right to purchase annual inflation protection increases will continue without regard to the Insured's Attained Age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:

•  You continue to purchase each year's inflation protection increase,

•  The LTC Benefit Limit is greater than zero, and

•  This rider remains in force.

On the Policy Anniversary on which you do not purchase that year's inflation protection increase, the following will occur:

•  Your right to purchase any future annual inflation protection increase will terminate, and

•  You will no longer be charged the optional Inflation Protection monthly LTC charge.

Even if your right to purchase this rider is terminated, any previously purchased increases will continue to be included in the calculation of benefits under this rider.

Terminal Illness Accelerated Death Benefit Endorsement. This endorsement is automatically issued with the Policy. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest. If a claim is filed under this endorsement, the LTC Rider will terminate and when the benefits under the LTC Rider are being utilized (claim is filed under the LTC Rider) no claims under the Terminal Illness Accelerated Death Benefit are allowed.

The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.

The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

•  the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•  any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

Lapse Protection Endorsement. The rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule, as long as the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirement and the Policy Debt does not exceed the Cash Value.

For the Maximum Lapse Protection Period, the Policy Value at the end of this period may not be sufficient to keep the Policy in force unless additional premiums are made. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of this period. In addition, during this period any change to the


40


benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement, will be provided to you on a supplemental Policy Schedule, along with any applicable effective date.

The Accumulated Minimum Monthly Requirement each month is equal to the Minimum Monthly Requirement for a given month plus the Accumulated Minimum Monthly Requirement as of the prior month ($0 for the first month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor shown in the Policy Schedule.

The Accumulated Net Payments Received (calculated as of the last day of the month) for each month is equal to:

•  the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year), plus

•  the sum of all the Lapse Protection Net Premium received since the beginning of the month, Plus

•  the Lapse Protection Interest for the month, less

•  the reduction in Policy Value for any Withdrawal taken and any applicable Surrender Charges assessed since the beginning of the month.

The Lapse Protection Net Premium is the amount after deducting the Lapse Protection Premium Expense Charge for that Policy Year, as shown on the Policy Schedule, for each premium payment.

The Lapse Protection Interest is calculated as:

•  the lesser of the Accumulated Fund Threshold and the sum of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year) PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, MULTIPLIED by the Threshold Accumulation Factor, shown in the Policy Schedule, plus

•  the amount of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, in excess of the Accumulated Fund Threshold, if any, MULTIPLIED by the Excess Accumulation Factor, shown on the Policy Schedule.

The Accumulated Fund Threshold for the first month of a Policy Year is equal to:

•  the Accumulated Fund Threshold for the prior month ($0 for the first month of the first Policy Year) multiplied by 1 plus the Threshold Accumulation Factor, PLUS

•  the Annual Threshold Premium, as shown on the Policy Schedule, for that Policy Year.

For all other months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior month multiplied buy 1 plus the Threshold Accumulation Factor.

Any adjustments made due to a decrease in Face Amount, including payments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.

If the Policy is maintained under this endorsement, Monthly Deductions will continue.

This endorsement terminates when the Policy terminates. If the Policy is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.

Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $250,000 Face Amount. The Policy Schedule indicates a Lapse Protection Premium Expense Charge of 1.00%, the initial Minimum Monthly Requirement is $161.88, the Threshold Accumulation Factor is 0.446150%, the Excess Accumulation Factor is 0.105844%, and an initial Threshold Premium of $5,980.25. The owner makes an initial premium payment of $200, which is an Lapse Protection Net Premium Received of $198 ($200 less 1.00%, the Lapse Protection Premium Expense Charge).

In the first Policy month, the Accumulated Fund Threshold ($5,980.25) is equal to the initial Threshold Premium. The Accumulated Minimum Monthly Requirement is $162.60 which is $161.88 (the initial Minimum Monthly Requirement) multiplied by 1.00446150 (one plus the Threshold Accumulation Factor). The Accumulated Net Payments Received ($198.00) is less than the Accumulated Fund Threshold ($5,980.25), so the Threshold Accumulation Factor is applied to the entire Accumulated Net Payments Received value. The Accumulated Net Payments Received in the first Policy


41


month, after accumulation, is $198.88 ($198.00 multiplied by 1.00446150). Because the Accumulated Net Payments Received of $198.88 equals or exceeds the Accumulated Minimum Monthly Requirement $162.60, the conditions have been met for the first month for the rider to remain in effect guaranteeing the Policy remains in force.

Assume on each of the 23 subsequent monthly anniversaries, the owner has made premium payments of the same amount and taken no partial surrenders or Policy Loans. The total premiums paid for the Policy equals $4,800.00. The Accumulated Net Payments Received at the end of Policy month 24 is $5,026.30 and the Accumulated Minimum Monthly Requirement is $4,109.26. Because the Accumulated Net Payments Received equals or exceeds the Accumulated Minimum Monthly Requirement, the conditions have been met on this monthly anniversary day. Since the rider remains in effect, the Policy is guaranteed to remain in force. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $250,000.

Assume that starting with the 24th monthly anniversary, the owner misses the next six anticipated monthly premium payments. At the end of Policy month 30, the Accumulated Net Payments Received has accumulated to $5,162.36 while the Accumulated Minimum Monthly Requirement has accumulated to $5,207.02. Also assume that the Cash Value of the Policy is zero. Because the Accumulated Net Payments Received is less than the Accumulated Minimum Monthly Requirement, the owner must pay additional premiums within the 60-day grace period to keep the rider in effect and the Policy in force. Under these circumstances, if the insured dies outside of the 60-day grace period without having made the necessary additional premium payments, the death benefit will be $0.

Dollar-Cost Averaging

If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account ("Source Sub-Account") or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.

Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th​, 30th​, or 31st​. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.

Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate Source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.

Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

Portfolio Rebalancing

At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th​, 30th​ or 31st​. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.


42


Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.

Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.

LOANS

You may obtain two types of loans under a Policy, a standard loan and/or a carry-over loan. A carry-over loan is a loan which is transferred from another policy that is exchanged for the Policy under Section 1035 of the Internal Revenue Code. A carry-over loan must be approved by Protective Life and can only be executed at the time of issue. After the first Policy Year while the Policy has Cash Value and the Insured is still living, you may borrow from Protective Life under a standard loan using the Policy as the security for the loan. A standard loan is any loan that is not a carry-over loan. Policy loans must be requested by Written Notice in Good Order received at the Home Office. Generally the minimum loan amount is $500 and the maximum loan amount is 99% of the Policy's Cash Value. This maximum is reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received. Outstanding Policy Debt and any lien therefore reduces the amount available for new Policy loans. Loan proceeds generally are mailed within seven calendar days of the loan being approved.

Loan Collateral

When a Policy loan is made, an amount equal to the loan is transferred out of the Sub-Accounts and the Fixed Account and into a Loan Account established for the Policy. Like the Fixed Account, a Policy's Loan Account is part of Protective Life's General Account and amounts therein earn interest as credited by Protective Life from time to time. Because Loan Account values are part of Policy Value, a loan will have no immediate effect on the Policy Value. In contrast, Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is reduced immediately by the amount transferred to the Loan Account. The Owner can specify the Sub-Accounts and the Fixed Account from which collateral is transferred to the Loan Account. If no allocation is specified, collateral is transferred from each Sub-Account and from the Fixed Account in the same proportion that the value in each Sub-Account and the Fixed Account bears to the total unloaned Policy Value on the date that the loan is made.

On each Policy Anniversary, an amount of Policy Value equal to any due and unpaid loan interest (explained below), is also transferred to the Loan Account. Such interest is transferred from each Sub-Account and the Fixed Account in the same proportion that each Sub-Account Value and the Fixed Account Value bears to the total unloaned Policy Value.

Loan Repayment

You may repay all or part of your Policy Debt (the amount borrowed plus unpaid interest) at any time while the Insured is living and the Policy is in force. Loan repayments in Good Order must be sent to the Home Office and are credited as of the Valuation Day received. The Owner may specify by Written Notice that any unscheduled premiums paid while a loan is outstanding be applied as loan repayments. (Loan repayments, unlike unscheduled premium payments, are not subject to the premium expense charge.) When a loan repayment is made, Policy Value in the Loan Account in an amount equal to the repayment is transferred from the Loan Account to the Sub-Accounts and the Fixed Account. Thus, a loan repayment will have no immediate effect on the Policy Value, but the Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is increased immediately by the amount transferred from the Loan Account. Unless specified otherwise by the Owner(s), amounts are transferred to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated.


43


Protective Life's ability to credit interest on Policy Value in the Loan Account is subject to the Company's financial strength and claims paying ability.

Interest

Protective Life charges interest daily on any outstanding loan at the following effective annual rates:

Loan Interest Rates

 
    Current
Standard Loan
Charge
  Guaranteed
Standard Loan
Charge
  Current
Carry-Over
Loan Charge
  Guaranteed
Carry-Over
Loan Charge
 

Policy Years 1-10

   

5.00

%

   

5.00

%

   

4.00

%

   

5.00

%

 

Policy Years 11 and greater

   

3.00

%

   

3.25

%

   

3.00

%

   

3.25

%

 

Interest will accrue daily on any outstanding loan, and is considered part of Policy Debt. Interest is due and payable at the end of each Policy Year. We will notify you of the amount due. If interest is not paid when due, the amount of the interest is added to the principal amount of the loan. If the interest payment is received prior to or on the Policy Anniversary date it will be applied as of the anniversary date. If the interest payment is received after the anniversary date it will be applied as of the Valuation Day it is received and credited as a partial loan repayment.

The Loan Account is credited with an effective annual interest rate of not less than 3.00%. Protective Life determines the rate of interest to be credited to the Loan Account and may redetermine it at any time. Once determined, the new rate of interest to be credited is applied beginning at the next Policy Year following the date on which Protective Life determined the new rate of interest to be credited to the Loan Account. The Policy Owner will be notified in advance about any change to the interest rate credited to the Loan Account. On each Policy Anniversary, the interest earned on the Loan Account since the previous Policy Anniversary is transferred to the Sub-Accounts and to the Fixed Account. The interest is transferred and allocated to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated. Protective Life's ability to credit interest on Policy Value in the Loan Account is subject to the Company's financial strength and claims paying ability.

The difference between the rate of interest charged on borrowed money and the rate credited on the Loan Account is the net cost of the loan. The net cost of loans is set forth in the table below.

Net Cost of Loans

 
    Current
Standard Loan
  Guaranteed
Standard Loan
  Current
Carry-Over
Loan
  Guaranteed
Carry-Over
Loan
 

Policy Years 1-10

   

2.00

%

   

2.00

%

   

1.00

%

   

2.00

%

 

Policy Years 11 and greater

   

0.00

%

   

0.25

%

   

0.00

%

   

0.25

%

 

Non-Payment of Policy Loan

If the Insured dies while a loan is outstanding, the Policy Debt (which includes any accrued but unpaid interest) is deducted from the Death Benefit in calculating the Death Benefit Proceeds.

If the Loan Account Value exceeds the Cash Value less any lien and accrued interest (i.e., the Surrender Value becomes zero) on any Valuation Day, you must pay that excess amount. The Company will send you (or any assignee of record) a notice of the amount you must pay. You must pay this amount within 31 days after the notice is sent, or the Policy will Lapse.

Effect of Policy Loans

A loan, whether or not repaid, has a permanent effect on the Death Benefit and Policy Value because the investment results of the Sub-Accounts and current interest rates credited on Fixed Account Value do not apply to Policy Value in the Loan Account. The larger the loan and longer the loan is outstanding, the greater will be the effect of Policy Value held as collateral in the Loan Account. Depending on the investment results of the Sub-Accounts or credited interest rates for the Fixed Account while the loan is outstanding, the effect could be favorable or unfavorable. Policy loans also may increase the potential for Lapse if investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan balance and will increase Policy Debt. If a Policy lapses with loans outstanding, certain amounts may be subject to income tax. In addition, if your Policy is a MEC, loans may be


44


currently taxable and subject to a 10% additional tax. See "Tax Considerations," for a discussion of the tax treatment of Policy loans.

TRANSFERS

On or after the later of thirty days after the Policy Effective Date or 6 days after the 30-day cancellation period, you may, upon receipt of Written Notice in Good Order to Protective Life at the Home Office transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See "Suspension or Delay of Payments." The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.

Limitations on frequent transfers, including "market timing" transfers. Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund's portfolio securities and the reflection of that change in the Fund's share price. This strategy, sometimes referred to as "market timing," involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.

When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:

•  Increased brokerage trading and transaction costs;

•  Disruption of planned investment strategies;

•  Forced and unplanned liquidation and portfolio turnover;

•  Lost opportunity costs; and

•  Large asset swings that decrease the Fund's ability to provide maximum investment return to all Policy Owners.

In order to try to protect our Policy Owners and the Funds from the potential adverse effects of frequent transfer activity, the Company has implemented certain market timing policies and procedures (the "Market Timing Procedures"). Our Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners' beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.

We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.

When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.


45


In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds' policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.

Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund's investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund's refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner's transfer request. Some Funds also may impose redemption fees on short-term trading (i.e., redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or tranfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.

We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.

Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.

Reservation of Rights

Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

Telephone Transfers

Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.

Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.

A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.


46


SURRENDERS AND WITHDRAWALS

Surrender Privileges

At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. A Surrender Charge may apply. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See "Tax Considerations.").

Withdrawal Privileges

At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge and, if applicable, a Surrender Charge, from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.

Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.

The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.

Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life's then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See "Tax Considerations."

SUSPENSION OR DELAYS IN PAYMENTS

Protective Life will ordinarily pay any Death Benefit proceeds, Policy loans, withdrawals, or surrenders within seven calendar days after receipt at the Home Office of all the documents required for such a payment. Other than the Death Benefit, which is determined as of the date of death of the Insured, the amount will be determined as of the Valuation Day of receipt of all required documents in Good Order at the Home Office. However, Protective Life may delay making a payment or processing a transfer request if (1) the New York Stock Exchange is closed for other than a regular holiday or weekend, trading on the Exchange is restricted by the SEC, or the SEC declares that an emergency exists as a result of which the disposal or valuation of Variable Account assets is not reasonably practicable; (2) the SEC by order permits postponement of payment to protect Owners; or (3) your Premium check has not cleared your bank. See "Payments from the Fixed Account."

In certain circumstances, applicable federal law may require Protective Life to "freeze" your account and refuse your request for a transfer, withdrawal, surrender, loan or death proceeds until receipt of instructions from the appropriate regulator. We also may be required to provide information about you and your account to a government regulator.

If, pursuant to SEC rules, the Invesco V.I. U.S. Government Money Portfolio suspends payment of redemption proceeds in connection with a liquidation of the Fund, we will delay payment of any transfer, partial withdrawal, surrender, loan, or death benefit from the Invesco V.I. U.S. Government Money Portfolio Sub-Account until the Fund is liquidated.


47


We may delay the payment of proceeds of any partial withdrawal, surrender or loan for up to six months after our receipt of Written Notice in Good Order of your request where the proceeds would be taken from Fixed Account Value.

LAPSE AND REINSTATEMENT

Lapse

Failure to pay planned periodic premiums will not necessarily cause a Policy to Lapse (terminate without value). Paying all planned periodic premiums will not necessarily prevent a Policy from lapsing. Except when the Lapse Protection Endorsement is in effect, a Policy will Lapse if its Policy Value less the Surrender Charge and Policy Debt is insufficient to cover the Monthly Deduction on the Monthly Anniversary Day. Absent any lapse protection, if the Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. This could happen if investment experience has been sufficiently unfavorable that it has resulted in a decrease in Surrender Value or the Surrender Value has decreased because you have not paid sufficient Net Premiums to offset prior Monthly Deductions.

You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions. Protective Life will send you, at your last known address and the last known address of any assignee of record, notice of the premium required to prevent Lapse. A Policy will remain in effect during the grace period. If the Insured should die during the grace period, the Death Benefit Proceeds payable to the Beneficiary will reflect a reduction for the Monthly Deductions due on or before the date of the Insured's death as well as any unpaid Policy Debt or liens (including accrued interest). See "Calculation of Death Benefit Proceeds." Unless the premium stated in the notice is paid before the grace period ends, the Policy will Lapse. A Policy Lapse may have tax consequences. See "Tax Considerations" in the Prospectus.

Age 121. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse and the Death Benefit will remain in effect, regardless of your Surrender Value.

Lapse Protection. Lapse protection is provided by the Lapse Protection Endorsement that is automatically added to the Policy on the Issue Date. For additional information about the Lapse Protection Endorsement, see "OTHER BENEFITS AVAILABLE UNDER THE POLICY" and "SUPPLEMENTAL RIDERS AND ENDORSEMENTS" in the Prospectus.

Reinstatement

An Owner may reinstate a Policy within 5 years of its Lapse provided that: (1) a request for reinstatement is made by Written Notice received by Protective Life at the Home Office, (2) the Insured is still living, (3) the Owner pays Net Premiums equal to (a) all Monthly Deductions that were due but unpaid during the grace period, and (b) which are at least sufficient to keep the reinstated Policy in force for three months, (4) the Insured provides Protective Life with satisfactory evidence of insurability, (5) the Owner repays or reinstates any Policy Debt and/or lien (including accrued interest) which existed at the end of the grace period; and (6) the Policy has not been surrendered. The "Approval Date" of a reinstated Policy is the date that Protective Life approves the Owner's request for reinstatement and requirements 1-6 above have been met.

TAX CONSIDERATIONS

The following discussion of the federal income tax treatment of the Policy is not exhaustive, does not purport to cover all situations, and is not intended as tax advice. The federal income tax treatment of the Policy is unclear in certain circumstances, and a qualified tax adviser should always be consulted with regard to the application of law to individual circumstances. This discussion is based on the Internal Revenue Code of 1986, as amended (the "Code"), Treasury Department regulations, and interpretations existing on the date of this Prospectus. These authorities, however, are subject to change by Congress, the Treasury Department, and judicial decisions.

This discussion does not address state or local tax consequences associated with the purchase of the Policy. The state and local tax consequences with respect to your Policy may be different than the federal tax consequences. In addition, PROTECTIVE LIFE MAKES NO GUARANTEE REGARDING ANY TAX TREATMENT — FEDERAL, STATE OR LOCAL — OF ANY POLICY OR OF ANY TRANSACTION INVOLVING A POLICY.

Tax Status of Protective Life

Protective Life is taxed as a life insurance company under the Code. Since the operations of the Variable Account are a part of, and are taxed with, the operations of Protective Life, the Variable Account is not separately taxed as a


48


"regulated investment company" under the Code. Under existing federal income tax laws, Protective Life's federal taxes are not increased from the Variable Account's premiums, investment income, and realized capital gains. This is because these items generally cause Protective Life's tax-basis policy benefit reserves to increase by a similar amount. Currently, a charge for federal income taxes is not deducted from the Sub-Accounts or the Policy's Cash Value. However, Protective Life does deduct a premium expense charge from each premium payment in all Policy Years in part to compensate us for the federal tax treatment of deferred acquisition costs. Protective Life reserves the right in the future to make a charge against the Variable Account or the Cash Values of a Policy for any federal, state, or local income taxes that we incur and determine to be properly attributable to the Variable Account or the Policy. Protective Life will promptly notify the Owner of any such charge.

Taxation of Insurance Policies

Tax Status of the Policies. Section 7702 of the Code establishes a statutory definition of life insurance for federal tax purposes. While the requirements of this section of the Code are complex, and limited guidance has been provided from the Internal Revenue Service ("IRS") or otherwise, Protective Life believes that the Policy will meet the current statutory definition of life insurance, which places limitations on the amount of premiums that may be paid and the Policy Values that can accumulate relative to the Death Benefit. As a result, the Death Benefit payable under the Policy will generally be excludable from the Beneficiary's gross income, and interest and other income credited under the Policy will not be taxable unless certain withdrawals are made (or are deemed to be made) from the Policy prior to the Insured's death, as discussed below. This tax treatment will only apply, however, if (1) the investments of the Variable Account are "adequately diversified" in accordance with Treasury Department regulations, and (2) Protective Life, rather than the Owner, is considered the owner of the assets of the Variable Account for federal income tax purposes.

Diversification Requirements. The Code and Treasury Department regulations prescribe the manner in which the investments of a segregated asset account, such as the Variable Account, are to be "adequately diversified". If the Variable Account fails to comply with these diversification standards, the Policy will not be treated as a life insurance contract for federal income tax purposes and the Owner would generally be taxed currently on the income on the contract (as defined in the tax law). Protective Life expects that the Variable Account, through the Funds, will comply with the diversification requirements prescribed by the Code and Treasury Department regulations.

Ownership Treatment. In certain circumstances, variable life insurance contract owners may be considered the owners, for federal income tax purposes, of the assets of a segregated asset account, such as the Variable Account, used to support their contracts. In those circumstances, income and gains from the segregated asset account would be includible in the contract owners' gross income. The IRS has stated in published rulings that a variable contract owner will be considered the owner of the assets of a segregated asset account if the owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets.

The ownership rights under the Policy are similar to, but differ in certain respects from, the ownership rights described by the IRS in certain rulings where it was determined that contract owners were not owners of the assets of a segregated asset account (and thus were not currently taxable on the income and gains). For example, the Owner of this Policy has the choice of more investment options to which to allocate premium payments and Variable Account Values than were addressed in such rulings. These differences could result in the Policy Owner being treated as the owner of a portion of the assets of the Variable Account and thus subject to current taxation on the income and gains from those assets. In addition, Protective Life does not know what standards will be set forth in any further regulations or rulings which the Treasury Department or IRS may issue. Protective Life therefore reserves the right to modify the Policy as necessary to attempt to prevent Owners from being considered the owners of the assets of the Variable Account. However, there is no assurance that such efforts would be successful.

The remainder of this discussion assumes that the Policy will be treated as a life insurance contract for federal tax purposes.

Tax Treatment of Life Insurance Death Benefit Proceeds. In general, the amount of the Death Benefit Proceeds payable from a Policy by reason of the death of the Insured is excludable from gross income under Section 101 of the Code. Certain transfers of the Policy for valuable consideration, however, may result in a portion of the Death Benefit Proceeds being taxable.

If the Death Benefit Proceeds are not received in a lump sum and are, instead, applied under either Settlement Options 1, 2, or 4, generally payments will be prorated between amounts attributable to the Death Benefit which will


49


be excludable from the Beneficiary's income and amounts attributable to interest (accruing after the Insured's death) which will be includible in the Beneficiary's income. If the Death Benefit Proceeds are applied under Option 3 (Interest Income), the interest credited will be currently includible in the Beneficiary's income.

Accelerated death benefits paid under this Policy upon a terminal illness generally will be excludable from income under Section 101 of the Code. Certain exceptions apply for certain business-related policies.

Tax Deferral During Accumulation Period. Under existing provisions of the Code, except as described below, any increase in an Owner's Policy Value is generally not taxable to the Owner unless amounts are received (or are deemed to be received) from the Policy prior to the Insured's death. If there is a surrender of the Policy, an amount equal to the excess of the amount received over the "investment in the contract" will generally be includible in the Owner's income. The "investment in the contract" generally is the aggregate premiums paid less the aggregate amount previously received under the Policy to the extent such amounts received were excludable from gross income. Whether withdrawals (or other amounts deemed to be distributed) from the Policy constitute income to the Owner depends, in part, upon whether the Policy is considered a MEC for federal income tax purposes.

Policies Not Owned by Individuals

In the case of Policies issued to a nonnatural taxpayer, or held for the benefit of such an entity, a portion of the taxpayer's otherwise deductible interest expenses may not be deductible as a result of ownership of a Policy even if no loans are taken under the Policy. An exception to this rule is provided for certain life insurance policies which cover the life of an individual who is a 20 percent owner, or an officer, director, or employee, of a trade or business. Entities that are considering purchasing the Policy, or entities that will be beneficiaries under a Policy, should consult a tax advisor.

Policies That Are Not MECs

Tax Treatment of Withdrawals Generally. If the Policy is not a MEC (described below), the amount of any withdrawal from the Policy generally will be treated first as non-taxable recovery of premium and then as income from the Policy. Thus, a withdrawal from a Policy that is not a MEC generally will not be includible in income except to the extent it exceeds the investment in the contract immediately before the withdrawal. It is possible that some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy for these purposes.

Certain Distributions Required by the Tax Law in the First 15 Policy Years. As indicated above, Section 7702 of the Code places limitations on the amount of premiums that may be paid and the Policy Values that can accumulate relative to the Death Benefit. Where cash distributions are required under Section 7702 of the Code in connection with a reduction in benefits during the first 15 years after the Policy is issued (or if withdrawals are made in anticipation of a reduction in benefits, within the meaning of the tax law, during this period), some or all of such amounts may be includible in income notwithstanding the general rule described in the preceding paragraph. A reduction in benefits may result upon a decrease in the Face Amount, if withdrawals are made, and in certain other instances.

Tax Treatment of Loans. If a Policy is not classified as a MEC, a loan received under the Policy generally will be treated as indebtedness of the Owner. As a result, no part of any loan under a Policy will constitute income to the Owner so long as the Policy remains in force. However in those situations where the interest rate credited to the Loan Account is identical (or nearly identical) to the interest rate charged for the loan, it is possible that some or all of the loan proceeds may be includible in income. If a Policy lapses or is surrendered when a loan is outstanding, the amount of the loan outstanding will be treated as the proceeds of a surrender for purposes of determining whether any amounts are includable in the Owner's income. As a result, the amount of your taxable income could increase by some or all of the outstanding loan.

Generally, interest paid on any loans under this Policy will not be tax deductible. The non-deductibility of interest includes interest paid or accrued on indebtedness with respect to one or more life insurance policies owned by a taxpayer covering any individual who is or has been an officer or employee of, or financially interested in, any trade or business carried on by the taxpayer. A limited exception to this rule exists for certain interest paid in connection with certain "key person" insurance. In the case of interest paid in connection with a loan with respect to a Policy covering the life of any key person, interest is deductible only to the extent that the aggregate amount of loans under one or more life insurance policies does not exceed $50,000. Further, even as to such loans up to $50,000, interest would not be deductible if the Policy were deemed for federal tax purposes to be a single premium life insurance policy or, in certain circumstances, if the loans were treated as "systematic borrowing" within the meaning of the tax law. A "key person" is an individual who is either an officer or a 20 percent owner of the taxpayer. The maximum number of


50


individuals who can be treated as key persons may not exceed the greater of (1) 5 individuals or (2) the lesser of 5 percent of the total number of officers and employees of the taxpayer or 20 individuals. Owners should consult a tax advisor regarding the deductibility of interest incurred in connection with this Policy.

Policies That Are MECs

Characterization of a Policy as a MEC. In general, a Policy will be considered a MEC for federal income tax purposes if (1) the Policy is received in exchange for a life insurance contract that was a MEC, or (2) the Policy is entered into on or after June 21, 1988 and premiums are paid into the Policy more rapidly than the rate defined by a "7-Pay Test". This test generally provides that a Policy will fail this test (and thus be considered a MEC) if the accumulated amount paid under the Policy at any time during any 7- Pay period exceeds the cumulative sum of the net level premiums which would have been paid to that time if the Policy provided for paid-up future benefits after the payment of 7 level annual premiums. A material change of the Policy (as defined in the tax law) will generally result in a reapplication of the 7-Pay Test. In addition, any reduction in benefits during the 7-Pay period will affect the application of this test. Protective Life will monitor the Policies and will attempt to notify Owners on a timely basis if a Policy is in jeopardy of becoming a MEC. The Policy Owner may then request that Protective Life take whatever steps are available to avoid treating the Policy as a MEC, if that is desired.

Tax Treatment of Withdrawals, Loans, Assignments and Pledges under MECs. If the Policy is a MEC, withdrawals from the Policy will be treated first as withdrawals of income and then as a recovery of premiums paid. Thus, withdrawals will be includible in income to the extent the Policy Value exceeds the investment in the contract. The amount of any Policy Debt will be treated as a withdrawal for tax purposes. Distributions made within two years before a failure to meet the 7-Pay Test are treated as made under a MEC. See the discussion of interest on loans and of lapses and surrenders while loans are outstanding under the caption "Policies That Are Not MECs" also applies to Policies which are MECs.

If the Owner assigns or pledges any portion of the Policy Value (or agrees to assign or pledge any portion), such portion will be treated as a withdrawal for tax purposes. If the entire Policy Value is assigned or pledged, subsequent increases in the Policy Value are also treated as withdrawals for as long as the assignment or pledge remains in place. The Owner's investment in the contract is increased by the amount includible in income with respect to any assignment, pledge, or loan, though it is not affected by any other aspect of the assignment, pledge, or loan (including its release or repayment). Before assigning, pledging, or requesting a loan under a Policy treated as a MEC, an Owner should consult a tax advisor.

Additional Tax. Generally, proceeds of a surrender or a withdrawal (or the amount of any deemed withdrawal such as a loan, assignment, or pledge) from a MEC are subject to an additional tax equal to 10% of the portion of the proceeds that is includible in income, unless the surrender or withdrawal is made (1) after the Owner attains age 591/2, (2) because the Owner has become disabled (as defined in the tax law), or (3) as substantially equal periodic payments over the life or life expectancy of the Owner (or the joint lives or life expectancies of the Owner and his or her Beneficiary, as defined in the tax law).

Aggregation of Policies. All life insurance contracts which are treated as MECs and which are purchased by the same person from Protective Life or any of its affiliates within the same calendar year will be aggregated and treated as one contract for purposes of determining the tax on withdrawals (including deemed withdrawals). The effects of such aggregation are not always clear; however, it could affect the amount of a surrender or a withdrawal (or a deemed withdrawal) that is taxable and the amount which might be subject to the 10% additional tax described above.

Constructive Receipt Issues

The IRS could determine that an Owner is in constructive receipt of the Cash Value of the Policy if the Cash Value equals the Death Benefit, which can occur in some instances where the Insured is age 95 or older. If the Owner was determined to be in constructive receipt of the Cash Value, an amount equal to the excess of the Cash Value over the investment in the contract could be includible in the Owner's income at that time.

Section 1035 Exchanges

Section 1035 of the Code provides that no gain or loss will be recognized on the exchange of a life insurance policy for another life insurance policy, endowment contract, annuity contract, or long-term care insurance contract, provided that certain requirements are met. If the Policy is being issued in exchange for another life insurance policy, the requirements that must be met to receive tax-free treatment under Section 1035 of the Code, include but are not limited to: (1) the policies must have the same insured, and (2) the exchange must occur through an assignment of your old policy to us or by a direct transfer of the account value of the old policy to us by the issuer of the old policy. If


51


your old policy was a MEC the Policy will also be a MEC. You cannot exchange an endowment, annuity, or long-term care insurance contract for a life insurance policy tax-free. If any money or other property is received in the exchange ("boot"), gain (but not loss) will be recognized equal to the lesser of the gain realized on the exchange or the amount of the boot received. We accept Section 1035 exchanges of life insurance policies with outstanding loans. If the amount of the loan under the policy exchanged is greater than the amount of the loan under the policy issued in the exchange, the difference will be treated as boot and may result in the recognition of gain. Generally, the Policy will have the same investment in the contract as the exchanged policy. However, if boot is received in the exchange the investment in the contract will be adjusted. Special rules and procedures apply to Section 1035 exchanges. These rules can be complex, and if you wish to take advantage of Section 1035, you should consult a tax and/or legal adviser.

Actions to Ensure Compliance with the Tax Law

Protective Life believes that the maximum amount of premiums it has determined for the Policies will comply with the federal tax definition of life insurance. Protective Life will monitor the amount of premiums paid, and, if the premiums paid exceed those permitted by the tax definition of life insurance, Protective Life will immediately refund the excess premiums with interest to the extent required by the Code. Protective Life also reserves the right to increase the Death Benefit (which may result in larger charges under a Policy) or to take any other action deemed necessary to ensure the compliance of the Policy with the federal tax definition of life insurance.

Other Considerations

Changing the Owner, designating an irrevocable beneficiary, exchanging the Policy, increasing the Face Amount, and other changes under the Policy may have tax consequences (other than those discussed herein) depending on the circumstances of such change or withdrawal. In addition, special tax consequences may apply if you sell your Policy.

In the case of an "employer-owned life insurance contract" as defined in the tax law that is issued (or deemed to be issued) after August 17, 2006, the portion of the death benefit excludable from gross income generally will be limited to the premiums paid for the contract. However, this limitation on the death benefit exclusion will not apply if certain notice and consent requirements are satisfied and one of several exceptions is satisfied. These exceptions include circumstances in which the death benefit is payable to certain heirs of the insured or to acquire an ownership interest in a business, or where the contract covers the life of a director or an insured who is "highly compensated" within the meaning of the tax law. These rules, including the definition of an employer-owned life insurance contract, are complex, and you should consult with your advisers for guidance as to their application.

Estate, Gift and Generation-Skipping Transfer Tax Considerations

The transfer of the Policy or designation of a beneficiary may have federal, state, and/or local transfer and inheritance tax consequences, including the imposition of gift, estate, and generation-skipping transfer taxes. For example, the transfer of the Policy to, or the designation as a beneficiary of, or the payment of proceeds to, a person who is assigned to a generation which is two or more generations below the generation assignment of the owner may have generation-skipping transfer tax consequences in addition to gift and estate tax consequences under federal tax law. The individual situation of each Owner or beneficiary will determine the extent, if any, to which federal, state, and local transfer and inheritance taxes may be imposed and how ownership or receipt of Policy proceeds will be treated for purposes of federal, state and local estate, inheritance, generation-skipping and other taxes. If this Policy is used with estate and gift tax planning in mind, you should consult with your tax advisor as to the most up-to-date information as to federal estate, gift and generation skipping tax rules.

Medicare Hospital Insurance Tax

A Medicare hospital insurance tax of 3.8% will apply to some types of investment income. This tax will apply to the taxable portion of (1) any proceeds distributed from the Policy as annuity payments pursuant to a settlement option prior to the death of the Insured, or (2) the proceeds of any sale or disposition of the Policy. This tax only applies to taxpayers with "modified adjusted gross income" above $250,000 in the case of married couples filing jointly or a qualifying widow(er) with dependent child, $125,000 in the case of married couples filing separately, and $200,000 for all others. For more information regarding this tax and whether it may apply to you, please consult your tax advisor.

Federal Income Tax Withholding

In General. Protective Life will withhold and remit to the federal government a part of the taxable portion of a surrender and withdrawal made under a Policy unless the Owner notifies Protective Life in writing and such notice is


52


received at the Home Office at or before the time of the surrender or withdrawal that he or she elects not to have any amounts withheld. Regardless of whether the Owner requests that no taxes be withheld or whether Protective Life withholds a sufficient amount of taxes, the Owner will be responsible for the payment of any taxes including any additional tax that may be due on the amounts received. The Owner may also be required to pay penalties under the estimated tax rules if the Owner's withholding and estimated tax payments are insufficient to satisfy the Owner's tax liability.

Nonresident Aliens and Foreign Corporations

The discussion above provides general information regarding U.S. federal withholding tax consequences to life insurance purchasers that are U.S. citizens or residents. Purchasers or beneficiaries that are not U.S. citizens or residents will generally be subject to U.S. federal withholding tax on taxable distributions (including taxable Death Benefit Proceeds) from life insurance policies at a 30% rate, unless a lower treaty rate applies. Prospective purchasers that are not U.S. citizens or residents are advised to consult with a tax advisor regarding federal tax withholding with respect to distributions from a Policy.

FATCA Withholding

If the payee of a distribution (including the Death Benefit) from the Policy is a foreign financial institution ("FFI") or a non-financial foreign entity ("NFFE") within the meaning of the Code as amended by the Foreign Account Tax Compliance Act ("FATCA"), the distribution could be subject to U.S. federal withholding tax on the taxable amount of the distribution at a 30% rate irrespective of the status of any beneficial owner of the Policy or the nature of the distribution. The rules relating to FATCA are complex, and a tax advisor should be consulted if an FFI or NFFE is or may be designated as a payee with respect to the Policy.

USE OF THE POLICY

Life insurance, including variable life insurance, can be used to provide for many individual and business needs, in addition to providing a death benefit. The primary purpose of this Policy is to provide death benefit protection and to assist with covering qualified long-term care expenses.

As with any investment, using this Policy under these or other applications entails certain risks. For example, if investment performance of Sub-Accounts to which Policy Value is allocated is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate Cash Value or Surrender Value sufficient to adequately fund the application for which the Policy was purchased. Similarly, certain transactions under a Policy entail risks in connection with the application for which the Policy is purchased. Withdrawals, Policy loans and interest paid on Policy loans may significantly affect current and future Policy Value, Cash Value, Surrender Value or Death Benefit Proceeds. If, for example, a Policy loan is taken but not repaid prior to the death of the Insured, the Policy Debt is subtracted from the Death Benefit in computing the Death Benefit Proceeds to be paid to a Beneficiary.

Prior to utilizing this Policy for the above applications, you should consider whether the anticipated duration of the Policy is appropriate for the application for which you intend to purchase it.

In addition, you need to consider the tax implications of using the Policy with these applications. The tax implications of using this Policy with these applications can be complex and generally are not addressed in the discussion of "Tax Considerations" above. Loans and withdrawals will affect the Policy Value and Death Benefit. There may be penalties and taxes if the Policy is surrendered, Lapses, matures or if a withdrawal or a loan is made. Because of these risks, you need to carefully consider how you use this Policy. This Policy may not be suitable for all persons, under any of these applications.

STATE VARIATIONS

The Prospectus and SAI describe all material rights, benefits and obligations under the Policy. Any material state variations in the Policy are covered in this Prospectus and in a state specific policy form for use in that state. If you would like to review a copy of your Policy and its endorsements and riders, if any, contact our Home Office or your sales representative.

SALE OF THE POLICIES

We have entered into an agreement with Investment Distributors, Inc. ("IDI") under which IDI has agreed to distribute the Policies on a "best efforts" basis. Under the agreement, IDI serves as principal underwriter (as defined under Federal securities laws and regulations) for the Policies. IDI is a Tennessee corporation and was established in 1993. IDI, a wholly owned subsidiary of PLC, is an affiliate of Protective Life, and its home office shares the same address


53


as Protective Life. IDI is registered with the SEC under the Securities Exchange Act of 1934 as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority ("FINRA").

IDI does not sell Policies directly to purchasers. IDI, together with Protective Life, enters into distribution agreements with other broker-dealers (collectively, "Selling Broker-Dealers") for the sale of the Policies. Registered representatives of the Selling Broker-Dealers sell the Policies directly to purchasers. Registered representatives of the Selling Broker-Dealers must be licensed as insurance agents by applicable state insurance authorities and appointed as agents of Protective Life in order to sell the Policies.

We pay commissions and additional asset-based compensation to Selling Broker-Dealers through IDI. IDI does not retain any commission payment or other amounts as principal underwriter for the Policies. However, we pay IDI a fee to cover some or all of IDI's operating and other expenses.

We offer the Policies on a continuous basis. While we anticipate continuing to offer the Policies, we reserve the right to discontinue the offering at any time.

We paid the following aggregate dollar amounts to IDI in commissions and additional asset-based compensation relating to sales of our variable life policies, which IDI passed along directly to the Selling Broker-Dealers.

Fiscal Year Ended

 

Amount Paid to IDI

 

December 31, 2023

 

$

44,125,570

   

December 31, 2024

 

$

54,476,984

   

December 31, 2025

 

$

53,943,492

   

Selling Broker-Dealers

We pay commissions to all Selling Broker-Dealers and provide some form of non-cash compensation to some Selling Broker-Dealers in connection with the promotion and sale of the Policies. A portion of any payments made to Selling Broker-Dealers may be passed on to their registered representatives in accordance with their internal compensation programs. We may use any of our corporate assets to pay commissions and other costs of distributing the Policies, including any profit from the mortality and expense risk charge. Commissions and other incentives or payments described below are not charged directly to Policy Owners or the Variable Account. We intend to recoup commissions and other sales expenses through fees and charges deducted under the Policies.

Compensation Paid to All Selling Broker-Dealers. We pay commissions as a percentage of initial and subsequent premium payments at the time we receive them, as a percentage of Policy Value on an ongoing basis, or a combination of both. Registered representatives may be paid commissions by their selling firms on Policies they sell based on premiums paid in amounts up to approximately 120% of a targeted first year premium payment. A targeted first year premium payment is approximately equal to your minimum initial premium on an annual basis. For premiums paid in the first Policy Year which exceed this targeted amount, registered representatives may receive up to 4.5% on premiums in excess of target. For premiums received during Policy Years two through ten, the registered representatives may be paid up to 5.0% on premiums. After the first ten Policy Years registered representatives may be paid up to 1.00% on premiums received and 0.25% on unloaned Policy Value. In the normal course of business, we also provide non-cash compensation in connection with the promotion of the Policies, including conferences and seminars (including travel, lodging and meals in connection therewith), and items of relatively small value, such as promotional gifts, meals, or tickets to sporting or entertainment events, in accordance with all applicable federal and state rules, including FINRA's non-cash compensation rules.

The registered representative who sells you the Policy typically receives a portion of the compensation we pay to his or her Selling Broker-Dealer, depending on the agreement between the Selling Broker-Dealer and your registered representative and the Selling Broker-Dealer's internal compensation program. These programs may include other types of cash and non-cash compensation and other benefits. If you would like information about what your registered representative and the Selling Broker-Dealer for whom he or she works may receive in connection with your purchase of a Policy, please ask your registered representative.

Additional Compensation Paid to Selected Selling Broker-Dealers. In addition to ordinary commissions and non-cash compensation, we may pay additional asset-based compensation in the form of marketing allowances and "revenue sharing" to selected Selling Broker-Dealers. These payments may be made through IDI. These payments may be (1) additional amounts as a percentage of premium payments and/or premiums we receive on our variable insurance products, and (2) additional "trail" commissions, which are periodic payments as a percentage of the contract and policy values or variable account values of our variable insurance products. Some or all of these additional asset-based compensation payments may be conditioned upon the Selling Broker-Dealer producing a specified amount of new premium payments and/or premiums and/or maintaining a specified amount of contract and


54


policy value with us.

The Selling Broker-Dealers to whom we pay additional asset-based compensation provide preferential treatment with respect to our products in their marketing programs. Preferential treatment of our products by a Selling Broker-Dealer may include any or all of the following: (1) enhanced marketing of our products over non-preferred products; (2) increased access to the Selling Broker- Dealer's registered representatives; and (3) payment of higher compensation to registered representatives for selling our products than for selling non-preferred products.

In 2025, we paid additional asset-based compensation to the Selling Broker-Dealers AgencyOne, American Global Wealth, Ameritas, Amplify, Bonsai, Cabot Lodge, Cambridge, Cape Securities, Cetera, Commonwealth, CreativeOne, DMI, DPL, Edward Jones, First Palladium, Halo, IFG, James Boldischar, Lion Street, Lockton Affinity, LPL, Mariner Insurance Resources, Mark W. Maurer, Mitchell K. Smith, MMLIS, Mutual Securities, One Resource Group, Osaic, Pinnacle, Producers Choice, Professional Life Underwriters Services, Purshe Kaplan, Raymond James, RetireOne, RIA Insurance Solutions, Schwab, Stifel, TruChoice, UBS, and Valmark Securities in connection with the sale of our variable insurance products (including the Policies). These payments ranged from $0 to $10,892,261 in total.

These additional asset-based compensation arrangements are not offered to all Selling Broker-Dealers. These arrangements are designed specifically to encourage the sale of our products (and/or our affiliates' products) by such Selling Broker-Dealers. The prospect of receiving, or the receipt of, additional asset-based compensation provides Selling Broker-Dealers and/or their registered representatives with an incentive to favor sales of our variable insurance products (including the Policies) over other variable insurance products (or other investments) with respect to which a Selling Broker-Dealer does not receive additional compensation, or receives lower levels of additional compensation. You may wish to take such payment arrangements into account when considering and evaluating any recommendation relating to the Policies. If you would like information about what your registered representative and the Selling Broker-Dealer for whom he or she works may receive in connection with your purchase of a Policy, please ask your registered representative.

We may also pay to selected Selling Broker-Dealers, including those listed above as well as others, additional compensation in the form of (1) payments for participation in meetings and conferences that include presentations about our products (including the Policies), and (2) payments to help defray the costs of sales conferences and educational seminars for the Selling Broker-Dealers' registered representatives.

LEGAL PROCEEDINGS

Protective Life and its subsidiaries, like other insurance companies, in the ordinary course of business are involved in some class action and other lawsuits, or alternatively in arbitration. In some class action and other lawsuits involving insurance companies, substantial damages have been sought and material payments have been made. Although the outcome of any litigation or arbitration cannot be predicted, Protective Life believes that at the present time there are no pending or threatened lawsuits that are reasonably likely to have a material adverse impact on the Variable Account, the ability of IDI to perform its contract with the Variable Account, or the ability of Protective Life to meet its obligations under the Policies.

FINANCIAL STATEMENTS

The financial statements of the Company and the Variable Account are incorporated by reference in the Statement of Additional Information.


55


APPENDIX:
FUNDS AVAILABLE UNDER THE POLICY

The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund's past performance is not necessarily an indication of future performance.

Asset
Allocation
 

Fund - Investment Adviser;

 

Current

  Average Annual Total Returns
(as of 12/31/2025)
 
Type  

Sub-Adviser(s), as applicable

 

Expenses

 

1 year

 

5 year

 

10 year

 

Allocation

 

American Funds Insurance Series®​ Asset Allocation Fund - Class 1 - Capital Research and Management Company

 

0.29

%

 

16.16

%

 

9.24

%

 

10.05

%

 

International Equity

 

American Funds Insurance Series®​ Global Growth Fund - Class 1 - Capital Research and Management Company(1)

 

0.40

%

 

21.98

%

 

8.51

%

 

12.46

%

 

U.S. Equity

 

American Funds Insurance Series®​ Growth Fund - Class 1 - Capital Research and Management Company

 

0.33

%

 

20.54

%

 

13.66

%

 

18.26

%

 

U.S. Equity

 

American Funds Insurance Series®​ Growth-Income Fund - Class 1 - Capital Research and Management Company

 

0.28

%

 

18.37

%

 

14.19

%

 

14.20

%

 

International Equity

 

American Funds Insurance Series®​ New World Fund®​ - Class 1 - Capital Research and Management Company(1)

 

0.57

%

 

28.60

%

 

5.59

%

 

9.53

%

 

U.S. Equity

 

ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

 

0.81

%

 

9.23

%

 

-0.17

%

 

9.38

%

 

International Equity

 

Dimensional VA International Small Portfolio - Institutional Class

 

0.39

%

 

36.99

%

 

8.89

%

 

8.68

%

 

International Equity

 

Dimensional VA International Value Portfolio - Institutional Class

 

0.27

%

 

45.64

%

 

15.85

%

 

10.46

%

 

U.S. Equity

 

Dimensional VA U.S. Large Value Portfolio - Institutional Class

 

0.21

%

 

15.83

%

 

11.97

%

 

10.51

%

 


56


Asset
Allocation
 

Fund - Investment Adviser;

 

Current

  Average Annual Total Returns
(as of 12/31/2025)
 
Type  

Sub-Adviser(s), as applicable

 

Expenses

 

1 year

 

5 year

 

10 year

 

Taxable Bond

 

Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

 

0.11

%

 

7.55

%

 

1.05

%

 

3.12

%

 

U.S. Equity

  Fidelity®​ VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

0.56

%

 

22.02

%

 

11.31

%

 

19.94

%

 

U.S. Equity

 

Fidelity®​ VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC

 

0.09

%

 

17.78

%

 

14.31

%

 

14.70

%

 

Taxable Bond

  Fidelity®​ VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

0.37

%

 

7.22

%

 

0.06

%

 

2.71

%

 

U.S. Equity

  Fidelity®​ VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

0.55

%

 

11.75

%

 

10.10

%

 

10.59

%

 

U.S. Equity

 

Franklin Growth and Income VIP Fund - Class 1(1)

 

0.59

%

 

16.98

%

 

12.16

%

 

11.39

%

 

Allocation

 

Franklin Income VIP Fund - Class 1

 

0.47

%

 

12.87

%

 

7.92

%

 

7.57

%

 

Taxable Bond

 

Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)

 

0.42

%

 

7.46

%

 

-0.57

%

 

2.11

%

 

U.S. Equity

 

Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)

 

0.81

%

 

9.39

%

 

10.05

%

 

10.02

%

 

U.S. Equity

 

Invesco®​ V.I. Diversified Dividend Fund - Series I

 

0.68

%

 

15.74

%

 

10.81

%

 

9.20

%

 

International Equity

 

Invesco®​ V.I. Global Fund - Series I

 

0.81

%

 

15.32

%

 

7.28

%

 

11.00

%

 

Money Market

 

Invesco®​ V.I. U.S. Government Money Portfolio - Series I

 

0.67

%

 

3.64

%

 

2.80

%

 

1.76

%

 


57


Asset
Allocation
 

Fund - Investment Adviser;

 

Current

  Average Annual Total Returns
(as of 12/31/2025)
 
Type  

Sub-Adviser(s), as applicable

 

Expenses

 

1 year

 

5 year

 

10 year

 

Taxable Bond

 

Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

 

0.98

%

 

8.33

%

 

2.10

%

 

4.72

%

 

U.S. Equity

 

Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC(1)

 

0.99

%

 

15.98

%

 

12.34

%

 

13.06

%

 

Taxable Bond

 

PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class - Pacific Investment Management Company LLC

 

0.94

%

 

4.10

%

 

1.18

%

 

3.04

%

 

Taxable Bond

 

PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC

 

0.50

%

 

4.83

%

 

3.40

%

 

2.91

%

 

Taxable Bond

 

PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Management Company LLC

 

0.58

%

 

9.05

%

 

0.16

%

 

2.51

%

 

U.S. Equity

  Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited  

0.63

%

 

10.99

%

 

10.62

%

 

14.98

%

 

U.S. Equity

 

Royce Capital Small-Cap Portfolio - Investment Class

 

1.18

%

 

8.93

%

 

10.66

%

 

7.88

%

 

International Equity

  Templeton Emerging Markets VIP Fund - Class 1 (formerly, Templeton Developing Markets VIP Fund)  

1.12

%

 

46.64

%

 

5.73

%

 

10.68

%

 

Allocation

  TOPS®​ Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS®​ Aggressive Growth ETF Portfolio)  

0.29

%

 

19.17

%

 

9.69

%

 

10.71

%

 

Allocation

  TOPS®​ Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC  

0.31

%

 

10.39

%

 

4.61

%

 

5.25

%

 

Allocation

  TOPS®​ Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Moderate Growth ETF Portfolio)  

0.29

%

 

15.50

%

 

7.20

%

 

8.26

%

 


58


Asset
Allocation
 

Fund - Investment Adviser;

 

Current

  Average Annual Total Returns
(as of 12/31/2025)
 
Type  

Sub-Adviser(s), as applicable

 

Expenses

 

1 year

 

5 year

 

10 year

 

Allocation

  TOPS®​ Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Growth ETF Portfolio)  

0.29

%

 

18.31

%

 

8.85

%

 

9.80

%

 

U.S. Equity

 

Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

 

0.29

%

 

16.79

%

 

12.59

%

 

11.51

%

 

International Equity

 

Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

 

0.32

%

 

19.96

%

 

0.62

%

 

10.48

%

 

U.S. Equity

 

Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)

 

0.34

%

 

28.97

%

 

13.97

%

 

14.96

%

 

Sector Equity

 

Vanguard Variable Insurance Funds - Real Estate Index Portfolio

 

0.26

%

 

3.11

%

 

4.50

%

 

5.08

%

 

Taxable Bond

 

Vanguard®​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio

 

0.14

%

 

6.85

%

 

2.23

%

 

2.80

%

 

(1)​  These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.


59


APPENDIX:
RIGHT TO CANCEL

RIGHT TO CANCEL (FREE LOOK) TIME PERIODS AND POLICY PROVISION VARIATIONS

States  

Free-look period/Right to cancel language

 

AL, AK, AZ, AR, CO, CT, DE, DC, FL GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA WV, WI, WY

 

THE OWNER HAS THE RIGHT TO RETURN THIS POLICY. The Owner may cancel this Policy after receipt by returning the Policy to the Company's Home Office, or to any Agent of the Company, with a written request for cancellation within thirty (30) days after receipt. Return of this Policy by mail is effective on actual receipt by the Company. The returned Policy will be treated as if it had never been issued. The Company will promptly refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to the Company, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to the Company.

 

CA

  THE OWNER HAS THE RIGHT TO RETURN THIS POLICY. Important. You have purchased a variable life insurance contract. Carefully review it for limitations. This Policy may be returned by the Owner for cancellation by delivering it or mailing it to the Company or to the agent through whom it was purchased, within 30 days from the date you received it. Return of the Policy during the 30 day cancellation period shall entitle the Owner to a refund of Account Value and any Policy Fee paid. The Account Value and Policy Fee shall be refunded within 30 days from the date the Company is notified that the Owner has canceled the Policy.
A return of the Policy after 30 days may result in a substantial penalty, known as a Surrender Charge. Please refer to the "Surrenders and Withdrawals" section of this Policy.
(The above right to cancel period is varied for individual Policy Owners aged 60 years or over as follows)
IMPORTANT! YOU HAVE PURCHASED A VARIABLE LIFE INSURANCE POLICY, REFERRED TO BELOW AS A "POLICY". CAREFULLY REVIEW IT FOR LIMITATIONS.
This Policy may be returned within 30 days from the date you received it. During that 30-day period, your money will be placed in a fixed account or money-market fund, unless you direct that the premium be invested in a stock or bond portfolio underlying the Policy during the 30-day period. If you do not direct that the premium be invested in a stock or bond portfolio, and if you return the Policy within the 30-day period, you will be entitled to a refund of the premium and any policy fee paid. If you direct that the premium be invested in a stock or bond portfolio during the 30-day period, and if you return the Policy during that period, you will be entitled to a refund of the Policy's Account Value on the day the policy is received by the insurance company or agent who sold you this Policy, which could be less than the premium you paid for the Policy, plus any policy fee paid. A return of the Policy after 30 days may result in a substantial penalty, known as a Surrender Charge.
 


60


APPENDIX:
FINANCIAL INTERMEDIARY VARIATIONS

There may be variations in the availability of investment options, benefits, and/or other features described in this prospectus – including restrictions, limitations, and other variations – which may apply depending on the financial intermediary through which this Policy was sold. For example, a financial intermediary may not recommend certain investment options, optional benefits, or other features available under the Policy.

Currently, we are not aware of any variations in the offering of the Policy by any financial intermediary. Variations may be imposed by some financial intermediaries without our knowledge. We do not believe we can obtain information about other financial intermediary variations, restrictions and/or limitations without unreasonable effort or expense. In some cases, if a particular investment option, benefit and/or feature described in this prospectus is of interest to you, you may contact us directly to discuss availability. If we become aware of any variations we will update this appendix.

You should always discuss with your financial professional any limitations, restrictions, or other variations related to the investment options, benefits, and/or other features available to you through your financial professional.


61


To learn more about the Policy, you should read the Statement of Additional Information ("SAI") dated the same date as this Prospectus. The SAI contains more detailed information about the Policy and the Variable Account than is contained in this Prospectus. Personalized illustrations of Death Benefits, Cash Value, and Policy Values are available without charge. For a free copy of the SAI, to receive personalized illustrations, and to request other information about the Policy please contact us toll-free at 1-800-265-1545.

The SAI has been filed with the SEC and is incorporated by reference into this Prospectus. Reports and other information about the Variable Account are available on the SEC's website at http://www.sec.gov. Copies of the information may be obtained, upon payment of a duplicating fee, by electronic request at the following email address: publicinfo@sec.gov.

EDGAR Contract Identifier C000272129


N-6/A 0000948923 false 0000948923 2026-04-24 2026-04-24 0000948923 ck0000948923:WithdrawalChargeMember 2026-04-24 2026-04-24 0000948923 vip:RiskOfLossMember 2026-04-24 2026-04-24 0000948923 vip:NotShortTermInvestmentRiskMember 2026-04-24 2026-04-24 0000948923 vip:InvestmentOptionsRiskMember 2026-04-24 2026-04-24 0000948923 vip:InsuranceCompanyRiskMember 2026-04-24 2026-04-24 0000948923 vip:ContractLapseRiskMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MinimumSurrenderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MaximumSurrenderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MortalityAndExpenseRiskChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MortalityAndExpenseRiskChargeMember ck0000948923:First10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeInitialFaceAmountDuringTheFirst2PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeInitialFaceAmountAfterTheFirst2PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeForFaceAmountIncreasesMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareRiderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareInflationProtectionOptionMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InterestRateMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LapseProtectionEndorsementMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvestmentRiskMember 2026-04-24 2026-04-24 0000948923 ck0000948923:WithdrawalAndSurrenderRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TaxRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LoanRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:SpecializedUsesOfThePolicyMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FundRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:BusinessDisruptionandCyberSecurityRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option1DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option2DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option3DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option4DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareRiderMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TerminalIllnessAcceleratedDeathBenefitEndorsementMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DollarCostAveragingMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PortfolioRebalancingMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PolicyLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:ReservationOfRightsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TelephoneTransfersMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGrowthFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesNewWorldFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:ClearBridgeVariableSmallCapGrowthPortfolioClassIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAInternationalSmallPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAInternationalValuePortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAUSLargeValuePortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPIndex500PortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPInvestmentGradeBondPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPMidCapPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FranklinGrowthAndIncomeVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:FranklinIncomeVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:GoldmanSachsVITMidCapValueFundInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIDiversifiedDividendFundSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIGlobalFundSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIUSGovernmentMoneyPortfolioSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LordAbbettSeriesFundBondDebenturePortfolioClassVCMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LordAbbettSeriesFundDividendGrowthPortfolioClassVCMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITInternationalBondPortfolioUSDollarHedgedInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITShortTermPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITTotalReturnPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PutnamVTSustainableLeadersFundClassIAMember 2026-04-24 2026-04-24 0000948923 ck0000948923:RoyceCapitalSmallCapPortfolioInvestmentClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TempletonEmergingMarketsVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSAggressiveETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSConservativeETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSModerateETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSModeratelyAggressiveETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsEquityIncomePortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsInternationalPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsPRIMECAPPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsShortTermInvestmentGradePortfolioMember 2026-04-24 2026-04-24 iso4217:USD xbrli:pure

 

PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT
(Registrant)

 

PROTECTIVE LIFE INSURANCE COMPANY
(Depositor)

 

2801 Highway 280 South
Birmingham, Alabama 35223
(800) 265-1545

 

STATEMENT OF ADDITIONAL INFORMATION
Individual Flexible Premium Variable and Fixed Life Insurance Policy

 

This Statement of Additional Information ("SAI") contains additional information regarding the individual flexible premium variable and fixed life insurance policy (the "Policy") offered by Protective Life Insurance Company ("Protective Life"). The Policy is issued to individuals. This SAI is not a prospectus and should be read together with the Prospectus for the Policy dated May 1, 2026, and the prospectuses for the Funds. You may obtain a copy of these prospectuses by writing or calling us at our address or phone number shown above. Capitalized terms in this SAI have the same meanings as in the Prospectus for the Policy. 

 

May 1, 2026

 

 

 

 

TABLE OF CONTENTS

 

 

 

Company 3
Variable Account 3
Illustrations 3
CEFLI 3
Other Investors in the Funds 3
Assignment 3
State Regulation 4
Reports to Owners 4
Experts 4
Reinsurance 4
Additional Information 4
Financial Statements 5

 

2

 

 

Company

 

The Policies are issued by Protective Life Insurance Company ("Protective Life" or the "Depositor"). Protective Life is a Nebraska corporation that was founded in 1907. Following its receipt of an Order Approving Redomestication on December 20, 2024, Protective Life redomesticated from Tennessee to Nebraska, and became an insurance company domiciled in the State of Nebraska as of December 31, 2024. Protective Life markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities and extended service contracts. Protective Life is currently licensed to transact life insurance business in 49 states and the District of Columbia. Protective Life is the principal operating subsidiary of Protective Life Corporation (“PLC”), a U.S. insurance holding company of Daiichi Life Group, Inc. ("Daiichi") (formerly Dai-ichi Life Holdings, Inc.). Daiichi’s stock is traded on the Tokyo Stock Exchange.

 

Variable Account

 

Protective Variable Life Separate Account is a separate investment account of Protective Life established under Tennessee law by the board of directors of Protective Life on February 22, 1995. On December 31, 2024, Protective Life changed to a Nebraska corporation and, accordingly, the Variable Account currently operates under the laws and regulations of Nebraska.

 

Illustrations

 

We may provide illustrations for Death Benefit, Policy Value, and Surrender Value based on hypothetical rates of return that are not guaranteed. The illustrations also assume costs of insurance for a hypothetical person. These illustrations are illustrative only and are not a representation of past or future performance. Your rates of return and insurance charges may be higher or lower than these illustrations. The actual return on your policy account value will depend on factors such as the amounts you allocate to particular Funds, the amounts deducted for the Policy's monthly charges, the Funds' expense ratios, and your policy loan and partial withdrawal history.

 

Before you purchase the Policy and upon request thereafter, we will provide illustrations of future benefits under the Policy based upon the proposed insured's age and underwriting class, face amount, planned premiums, and riders requested. We reserve the right to charge a reasonable fee for this service to persons who request more than one illustration during a Policy Year.

 

CEFLI

 

Protective Life is a member of the Compliance & Ethics Forum for Life Insurers ("CEFLI"), and as such may include the CEFLI logo and information about CEFLI membership in Protective advertisements. Companies that belong to CEFLI subscribe to a set of ethical standards covering the various aspects of sales and service for individually sold life insurance and annuities.

 

Other Investors in the Funds

 

Shares of the underlying Funds (a complete list of the Funds is included in the Prospectus under Appendix: Funds Available Under the Policy) are sold to separate accounts of insurance companies, which may or may not be affiliated with Protective Life or each other, a practice known as "shared funding." They may also be sold to separate accounts to serve as the underlying investment for both variable annuity contracts and variable life insurance policies, a practice known as "mixed funding." Shares of some of these Funds may also be sold to certain qualified pension and retirement plans. As a result, there is a possibility that a material conflict may arise among and between the interests of Policy Owners and other of the Fund's various investors. In the event of any such material conflicts, Protective Life will consider what action may be appropriate, including removing the Fund from the Variable Account or replacing the Fund with another Fund. The board of directors (or trustees) of each of the Funds monitors events related to their Funds to identify possible material irreconcilable conflicts among and between the interests of the Fund's various investors. There are certain risks associated with mixed and shared funding and with the sale of shares to qualified pension and retirement plans, as disclosed in each Fund's prospectus. 

 

Assignment

 

The Policy may be assigned in accordance with its terms. An assignment is binding upon Protective Life only if it is in writing and filed at the Home Office. Once Protective Life has received a signed copy of the assignment, the Owner's

 

3

 

 

rights and the interest of any beneficiary (or any other person) will be subject to the assignment. Protective Life assumes no responsibility for the validity or sufficiency of any assignment. An assignment is subject to any Policy Debt and any liens. An assignment may result in certain amounts being subject to income tax and a 10% additional tax. (See "Tax Considerations" in the prospectuses.)

 

State Regulation

 

Protective Life is subject to regulation by the Nebraska Department of Insurance, which periodically examines the financial condition and operations of Protective Life. Protective Life is also subject to the insurance laws and regulations of all jurisdictions where it does business. The Policy has been filed with and, where required, approved by, insurance officials in those jurisdictions where it is sold.

 

Protective Life is required to submit annual statements of operations, including financial statements, to the insurance departments of the various jurisdictions where it does business to determine solvency and compliance with applicable insurance laws and regulations.

 

Reports to Owners

 

Each year you will be sent a report at your last known address showing, as of the end of the current report period: the Death Benefit; Policy Value; Fixed Account Value; Variable Account Value; Loan Account Value; Sub-Account Values; premiums paid since the last report; withdrawals since the last report; any Policy loans and accrued interest; Surrender Value; current Net Premium allocations; charges deducted since the last report; any liens and accrued interest; and any other information required by law. You will also be sent a notice that the annual and a semi-annual reports for each Fund underlying a Sub-Account to which you have allocated Policy Value, as required by the Investment Company Act of 1940, is available online. In addition, when you pay premiums or request any other financial transaction under your Policy you will receive a written confirmation of these transactions.

 

Experts

 

The financial statements of the subaccounts that comprise Protective Variable Life Separate Account as of December 31, 2025, and for each of the years or periods presented, have been incorporated by reference in this Statement of Additional Information in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

 

The financial statements of Protective Life Insurance Company as of December 31, 2025 and 2024, and for each of the years in the three-year period ended December 31, 2025, have been incorporated by reference in this Statement of Additional Information in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. 

 

The audit report covering the December 31, 2025 financial statements includes explanatory language that states that the financial statements are prepared by Protective Life Insurance Company using statutory accounting practices prescribed or permitted by the Nebraska Department of Insurance, which is a basis of accounting other than U.S. generally accepted accounting principles. Accordingly, the audit report states that the financial statements are not intended to be and, therefore, are not presented fairly in accordance with U.S. generally accepted accounting principles and further states that those financial statements are presented fairly, in all material respects, in accordance with statutory accounting practices prescribed or permitted by the Nebraska Department of Insurance.

 

The business address for KPMG LLP is 420 20th Street North, Suite 1800, Birmingham, Alabama 35203

 

Reinsurance

 

The Company may reinsure a portion of the risks assumed under the Policies.

 

Additional Information

 

A registration statement has been filed with the SEC under the Securities Act of 1933, as amended, with respect to the Policies. Not all the information set forth in the registration statement, and the amendments and exhibits thereto, has been

 

4

 

 

included in the prospectuses and this SAI. Statements contained in this SAI concerning the content of the Policies and other legal instruments are intended to be summaries. For a complete statement of the terms of these documents, reference should be made to the instruments filed with the SEC at 100 F Street, N.E., Washington, DC 20549. The instruments may also be accessed using the SEC's website at http://www.sec.gov.

 

Financial Statements

 

The audited statements of assets and liabilities of the subaccounts that comprise Protective Variable Life Separate Account as of December 31, 2025, and the related statements of operations for the year or period then ended, and the statements of changes in net assets for each of the years or periods in the two-year period then ended as well as the Report of Independent Registered Public Accounting Firm are incorporated into the Statement of Additional Information by reference to the Variable Account’s Form N-VPFS, File No. 811-07337, filed with the SEC on April 21, 2026.

 

The audited statutory statements of admitted assets, liabilities, and capital and surplus of Protective Life Insurance Company as of December 31, 2025 and 2024, and the related statutory statements of operations, changes in capital and surplus, and cash flow for each of the years in the three-year period ended December 31, 2025 as well as the Independent Auditors' Report are incorporated into the Statement of Additional Information by reference to the Variable Account’s Form N-VPFS, File No. 811-07337, filed with the SEC on April 6, 2026. Protective Life's audited financial statements should be considered only as bearing on its ability to meet its obligations under the Policies. They should not be considered as bearing on the investment performance of the assets held in the Variable Account.

 

5

 

 

PART C

 

OTHER INFORMATION  

 

Item 30. Exhibits

 

(a) Board of Directors Resolutions

 

(a) (1) Resolution of the Board of Directors of Protective Life Insurance Company establishing Protective Variable Life Separate Account is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on July 19, 2019.

 

(b) Custodial Agreements - Not Applicable.

 

(c) Underwriting Contracts

 

(c) (1) Underwriting Agreement among Protective Life Insurance Company, Investment Distributors, Inc. and Protective Variable Life Separate Account is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

 

(c) (1) (i) Amendment No. 1 dated June 1, 1998 to the Underwriting Agreement (PLICO-IDI-PVLSA) is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on July 19, 2019.

 

(c) (1) (ii) Second Amended Distribution Agreement dated October 24, 2013 (PLICO-IDI) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-190294), filed with the Commission on April 25, 2014.

 

(c) (1) (iii) Revised Second Amended Distribution Agreement dated June 1, 2018 (PLICO-IDI) is incorporated herein by reference to Post-Effective Amendment No. 26 to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on July 20, 2018.

 

(c) (1) (iv) Amendment No. 1 to the Second Amended Distribution Agreement (PLICO-IDI) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on July  27, 2020.

 

(c) (1) (v) Revised Schedule to Second Amended Distribution Agreement between IDI and PLICO is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on November 25, 2020.

 

(c) (2) Distribution Agreement between Investment Distributors, Inc. and broker-dealers is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

 

(d) Contracts

 

(d) (1) Protective VUL Form of Contract

- Filed herein.

 

(d) (2) Long Term Care Rider with Long-Term Care Inflation Protection Option

- Filed herein.

 

(d) (3) Lapse Protection Endorsement

- Filed herein.

 

C-1

 

 

(d) (4) Terminal Illness Accelerated Death Benefit Endorsement is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

 

(e) Applications

 

(e) (1) Form of Variable Universal Individual Life Insurance Application

- Filed herein.

 

(f) Depositor's Certificate of Incorporation and By-Laws

 

(f) (1) 2011 Amended and Restated Charter of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-4 Registration Statement (File No. 333-153041), filed with the Commission on September 16, 2011.

 

(f) (1) (i) 2020 Amended and Restated Charter of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

 

(f) (1) (ii) 2024 Amended and Restated Articles of Incorporation of Protective Life Insurance Company

- Filed herein.

 

(f) (2) 2011 Amended and Restated By-laws of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-4 Registration Statement (File No. 333-153041), filed with the Commission on September 16, 2011.

 

(f) (2) (i) 2020 Amended and Restated By-laws of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

 

(f) (2) (ii) 2024 Amended and Restated Bylaws of Protective Life Insurance Company

- Filed herein.

 

(g) Reinsurance Contracts

 

(g) (1) Automatic and Facultative Yearly Renewable Term Agreement is incorporated herein by reference to Post-Effective Amendment No. 7 to the Form N-6 Registration Statement (File No. 333-52215), filed with the Commission on April 30, 2003.

 

(g) (2) Yearly Renewable Term Reinsurance Agreement is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-6 Registration Statement (333-52215) as filed with the Commission on April 27, 2009.

 

(g) (3) List of Reinsurers is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-6 Registration Statement (333-206951), filed with the Commission on April 25, 2019.

 

(h) Participation Agreements

 

(h) (1) Participation Agreement dated April 11, 2007 (Fidelity Variable Insurance Products) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (1) (i) Rule 22c-2 Shareholder Information Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

 

C-2

 

 

(h) (1) (ii) Amendment dated October 15, 2020 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (1) (iii) Amendment dated October 11, 2021 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-261426), filed with the Commission on November 30, 2021.

 

(h) (1) (iv) Amendment dated March 10, 2022 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

 

(h) (1) (v) Amendment dated December 15, 2022 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 25, 2023.

 

(h) (2) Participation Agreement dated April 30, 2002 (Lord Abbett Series Fund) is incorporated herein by reference to Post-Effective Amendment No. 3 to the Form N-4 Registration Statement (File No. 333-94047), filed with the Commission on April 25, 2002.

 

(h) (2) (i) Rule 22c-2 Shareholder Information Agreement (Lord Abbett Series Fund) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

 

(h) (2) (ii) Amendment dated April 28, 2022 (Lord Abbett Series Fund) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed July 5, 2022.

 

(h) (3) Participation Agreement dated December 19, 2003 (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on February 17, 2004.

 

(h) (3) (i) Rule 22c-2 Shareholder Information Agreement dated April 11, 2007 (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

 

(h) (3) (ii) Amendment dated April 12, 2011 to Participation Agreement re Summary Prospectus (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 19 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 25, 2011.

 

(h) (3) (iii) Amendment dated December 22, 2020 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

 

(h) (3) (iv) Amendment dated April 12, 2021 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

 

(h) (3) (v) Amendment dated March 24, 2022 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

 

(h) (3) (vi) Amendment dated December 15, 2022 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-261426), filed with the Commission on April 20, 2023.

 

C-3

 

 

(h) (3) (vii) Amendment dated April 23, 2024 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 16 to the N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 23, 2025.

 

(h) (4) Participation Agreement dated February 1, 2015 (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 12 to the Form N-4 Registration Statement (File No. 333-190294), as filed with the Commission on April 28, 2021.

 

(h) (4) (i) Rule 22c-2 Shareholder Information Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

 

(h) (4) (ii) Participation Agreement dated November 30, 2020 (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

 

(h) (4) (iii) Addendum dated November 30, 2020 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

 

(h) (4) (iv) Amendment dated March 31, 2021 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

 

(h) (4) (v) Amendment dated April 1, 2022 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed July 5, 2022.

 

(h) (4) (vi)Amendment dated November 1, 2022 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-261426), filed with the Commission on April 20, 2023.

 

(h) (5) Participation Agreement dated November 1, 2009 (Legg Mason) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

 

(h) (5) (i) Amendment dated April 11, 2014 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (5) (ii) Amendment dated September 10, 2019 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (5) (iii) Amendment dated August 11, 2020 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (5) (iv) Amendment dated November 30, 2020 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

 

(h) (5) (v) Amendment dated April 7, 2021 to Participation Agreement (Legg Mason) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

 

C-4

 

 

(h) (5) (vi) Amendment dated October 26, 2022 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on December 15, 2022. 

 

(h) (6) Participation Agreement dated November 1, 2009 (PIMCO Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

 

(h) (6) (i) Novation of and Amendment dated April 25, 2011 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (6) (ii) Amendment dated April 25, 2011 to Participation Agreement re Summary Prospectuses (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (6) (iii) Amendment dated September 1, 2020 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

 

(h) (6) (iv) Amendment dated April 2, 2021 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

 

(h) (6) (v) Amendment dated August 9, 2022 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on September 9, 2022.

 

(h) (7) Participation Agreement dated November 1, 2009 (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

 

(h) (7) (i) Rule 22c-2 Information Sharing Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

 

(h) (7) (ii) Amendment dated November 30, 2020 to Participation Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

 

(h) (7) (iii) Amendment dated August 10, 2022 to Participation Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 26 to the Form N-4 Registration Statement (File No. 333-176657), filed with the Commission on April 20, 2023.

 

(h) (8) Participation Agreement dated February 1, 2015 (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (8) (i) Rule 22c-2 Agreement (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Post-Effective Amendment No. 12 to the Form N-4 Registration Statement (File No. 333-179649), as filed with the Commission on August 24, 2016.

 

(h) (8) (ii) Amendment dated March 22, 2022 to Participation Agreement (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed with the Commission on July 5, 2022.

 

C-5

 

 

(h) (9) Participation Agreement dated June 18, 2015 (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (9) (i) Rule 22c-2 Shareholder Information Agreement (American Funds) is incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 30, 2008.

 

(h) (9) (ii) Amendment dated October 1, 2019 to Participation Agreement (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

 

(h) (9) (iii) Amendment dated November 25, 2020 to Participation Agreement (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

 

(h) (9) (iv) Amendment dated March 22, 2021 to Participation Agreement (American Funds) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File 333-240192), filed with the Commission on April 16, 2021.

 

(h) (9) (v) Amendment dated April 29, 2022 to Participation Agreement (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed July 5, 2022.

 

(h) (9) (vi) Amendment dated August 1, 2022 to Participation Agreement (American Funds) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on September 9, 2022.

 

(h) (10) Participation Agreement dated July 1, 2017 (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 6 to the Form N-6 Registration Statement (File No. 333-206951), as filed with the Commission on July 12, 2017.

 

(h) (10) (i) Amendment dated September 1, 2020 to Participation Agreement (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 6 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on August 6, 2021.

 

(h) (10) (ii) Amendment dated March 22, 2022 to Participation Agreement (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on August 8, 2022.

 

(h) (10) (iii)  Amendment dated September 15, 2022 to Participation Agreement (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 25, 2023.

 

(h) (11) Participation Agreement dated October 15, 2017 (DFA Investment Dimensions Group Inc.) is incorporated herein by reference to Post-Effective Amendment No. 28 to the Form N-6 Registration Statement (File No. 333-52215), filed with the Commission on November 27, 2017.

 

(h) (11) (i) Amendment dated August 20, 2020 to Participation Agreement (DFA Investment Dimensions Group) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on August 24, 2020.

 

(h) (11) (ii) Amendment dated May 1, 2022 to Participation Agreement (DFA Investment Dimensions Group) is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on August 8, 2022.

 

C-6

 

 

(h) (12) Participation Agreement dated April 1, 2017 (Vanguard Variable Insurance Fund) is incorporated herein by reference to Post-Effective Amendment No. 27 to the Form N-6 Registration Statement (File No. 333-52215), as filed with the Commission on April 27, 2017.

 

(h) (12) (i) Amendment dated November 1, 2019 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (333-232740), filed with the Commission on October 29, 2019.

 

(h) (12) (ii) Participation Agreement dated November 23, 2020 (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on April 28, 2021.

 

(h) (12) (iii) Revised Schedule A dated April 30, 2021 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on April 28, 2021.

 

(h) (12) (iv)  Revised Schedule A dated October 13, 2022 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to the Post-Effective Amendment No. 11 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 25, 2023.

 

(h) (13) Participation Agreement dated November 9, 2020 (Putnam Variable Trust) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

 

(h) (13) (i) Rule 22(c)-2 Agreement dated November 9, 2020 (Putnam Variable Trust)is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on April 25, 2022.

 

(h) (13) (ii) Amendment dated March 22, 2022 to Participation Agreement (Putnam Variable Trust) - is incorporated herein by reference to the Post-Effective Amendment 11 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 25, 2023.

 

(h) (13) (iii)  Amendment dated September 21, 2022 to Participation Agreement (Putnam Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on April 25, 2023.

 

(i) Administrative Contracts - Not Applicable.

 

(j) Other Material Contracts - Not Applicable.

 

(k) Legal Opinion

 

(k) (1) Opinion and Consent of Brandon J. Cage, Esq. is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-292264), filed with the Commission on December 19, 2025.

 

(l) Actuarial Opinion - Not Applicable.

 

(m) Calculation - Not Applicable.

 

(n) Other Opinions

 

(n) (1) Consents of KPMG LLP

- Filed herein.

 

(n) (2) Powers of Attorney

- Filed herein.

 

C-7

 

 

(o) Omitted Financial Statements - Not Applicable.

 

(p) Initial Capital Agreements - Not Applicable.

 

(q) Redeemability Exemption

 

(q) (1) Memorandum Pursuant to Rule 6e-3(T)(b)(12)(iii) Describing Issue, Transfer and Redemption Procedures

- Filed herein.

 

(r) Form of Initial Summary Prospectus

- Filed herein.

 

C-8

 

 

Item 31.    Directors and Officers of the Depositor

 

Name and Principal Business Address*   Position and Offices with Depositor
Adams, D. Scott   Executive Vice President, Chief Transformation and Strategy Officer
Bartlett, Malcolm Lee   Senior Vice President, Corporate Tax
Bern, Leigh Bynum   Senior Vice President, Chief Financial Actuary, and Appointed Actuary
Bielen, Richard J.   Chairman of the Board, Chief Executive Officer, and Director
Black, Lance P.   Executive Vice President, Acquisitions and Corporate Development
Byrd, Kenneth   Senior Vice President, Operations
Cramer, Steve   Senior Vice President, and Chief Product Officer
Creutzmann, Scott E.   Senior Vice President, and Chief Compliance Officer
Cropenbaker, John   Senior Vice President, Executive Benefits Markets
Drew, Mark L.   Executive Vice President, and Chief Legal Officer
Evesque, Wendy L.   Executive Vice President, and Chief Human Resources Officer
Goldsmith, Lisa M.   Director
Hardeman, James C.   Senior Vice President, Financial Planning and Analysis
Harrison, Wade V.   Vice Chairman, Chief Operating Officer and Director
Herring, Derry W   Senior Vice President, and Chief Auditor
Karchunas, M. Scott   Senior Vice President, and President, Asset Protection Division
Kohler, Matthew   Senior Vice President, and Chief Information Officer
Kolmin, Russell   Senior Vice President, and Chief Product Officer
Kurtz, Richard J.   Senior Vice President, and Chief Distribution Officer
Lassiter, Frank Q.   Vice President, Head of Treasury, and Treasurer
Lawrence, Mary Pat   Senior Vice President, Government Affairs
Lebel, Dominique   Senior Vice President and Chief Risk Officer
McDonald, Laura Y.   Senior Vice President, and Chief Mortgage and Real Estate Officer
Passafiume, Philip E.   Executive Vice President, Chief Investment Officer and Director
Peeler, Rachelle R.   Senior Vice President, and Senior Human Resources Partner
Peevy, Melinda   Secretary
Pugh, Barbara N.   Senior Vice President, and Chief Accounting Officer
Ray, Webster M.   Senior Vice President, Investments
Seurkamp, Aaron C.   Senior Vice President, and President, Protection and Retirement Division
Wagner, James   Senior Vice President, and Chief Distribution Officer
Wahlheim, Cary T.   Senior Vice President, and Senior Counsel
Wells, Paul R.   President, Chief Financial Officer, and Director
Whitcomb, John   Senior Vice President, Retirement Operations and Strategic Planning
Williams, Doyle J.   Senior Vice President, and Chief Marketing Officer

 

* Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223

 

Item 32.    Persons Controlled by or Under Common Control With the Depositor or Registrant

      

 

The registrant is a segregated asset account of the Company and is therefore owned and controlled by the Company. All of the Company’s outstanding voting common stock is owned by Protective Life Corporation, a subsidiary of Daiichi Life Group, Inc. Protective Life Corporation is described more fully in the prospectus included in this registration statement. 

 

For more information regarding the company structure of Protective Life Corporation and Daiichi Life Group, Inc., please refer to the Organizational Chart filed herein.

 

Item 33.    Indemnification

 

Article XI of the By-laws of Protective Life provides, in substance, that any of Protective Life’s directors and officers, who is a party or is threatened to be made a party to any action, suit or proceeding, other than an action by or in the right of Protective Life, by reason of the fact that he is or was an officer or director, shall be indemnified by

 

C-9

 

 

Protective Life against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such claim, action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. If the claim, action or suit is or was by or in the right of Protective Life to procure a judgment in its favor, such person shall be indemnified by Protective Life against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to Protective Life unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. To the extent that a director or officer has been successful on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, he shall be indemnified by Protective Life against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection therewith, not withstanding that he has not been successful on any other claim issue or matter in any such action, suit or proceeding. Unless ordered by a court, indemnification shall be made by Protective Life only as authorized in the specific case upon a determination that indemnification of the officer or director is proper in the circumstances because he has met the applicable standard of conduct. Such determination shall be made (a) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been successful on the merits or otherwise with respect to, such claim action, suit or proceeding, or (b) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion or (c) by the shareholders.

 

In addition, the executive officers and directors are insured by PLC’s Directors’ and Officers’ Liability Insurance Policy including Company Reimbursement and are indemnified by a written contract with PLC which supplements such coverage.

 

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. 

 

Item 34.    Principal Underwriters

 

(a)  Investment Distributors, Inc. (“IDI”) is the principal underwriter of the Policies as defined in the Investment Company Act of 1940. IDI is also principal underwriter for the Protective Variable Annuity Separate Account, PLICO Variable Annuity Account S, Protective COLI VUL, Protective COLI PPVUL, Variable Annuity Separate Account A of Protective Life, PLAIC Variable Annuity Account S, Protective NY COLI VUL and Protective NY Variable Life Separate Account. The principal underwriter, IDI, is also currently distributing units of interest in the following separate accounts: Variable Annuity-1 Series Account, Variable Annuity-1 Series Account of Great West Life & Annuity Insurance Company of New York, Variable Annuity-2 Series Account, Variable Annuity-2 Series Account [New York], Variable Annuity-3 Series Account, COLI VUL-2 Series Account, COLI VUL-2 Series Account of Great West Life & Annuity Insurance Company of New York, COLI VUL-4 Series Account of Great-West Life & Annuity Insurance Company, Maxim Series Account of Great West Life & Annuity Insurance Company, Prestige Variable Life Account, Pinnacle Series Account of Great West Life & Annuity Insurance Company, Trillium Variable Annuity Account.

 

(b)  The following information is furnished with respect to the officers and directors of IDI:

 

C-10

 

 

Name and Principal
Business Address* 
  Position and Offices with Underwriter
Baggett, Alan   Assistant Financial Officer
Barkson, Carl   Vice President, Head of Corporate Tax
Carlson, Martha H.       Designated Responsible Licensed Producer
Coffman, Benjamin P.    Chief Financial Officer
Collazo, Kimberly B.   Assistant Secretary
Creutzmann, Scott E.   Director
Lane, Jamie L.   Director
Leopard, Mona   Assistant Secretary
McCreless, Kevin L.   Chief Compliance Officer
Morsch, Letitia A.   Assistant Secretary, and Director
Peevy, Melinda   Secretary
Tennent, Rayburn   Assistant Financial Officer
Wagner, James   President, and Director

 

*  Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama, 35223.

 

(c)  The following commissions were received by each principal underwriter, directly or indirectly, from the Registrant during the Registrant’s last fiscal year:

 

(1) Name of Principal
Underwriter
  (2) Net Underwriting
Discounts
  (3) Compensation on
Redemption
  (4) Brokerage
Commissions
  (5) Other
Compensation
Investment Distributors, Inc.   N/A   None   N/A   N/A

 

Item 35.    Location of Accounts and Records.

 

All accounts and records required to be maintained by Section 31(a) of the Investment Company Act of 1940 and the rules thereunder are maintained by Protective Life Insurance Company at 2801 Highway 280 South, Birmingham, Alabama 35223.

 

Item 36.    Management Services.

 

 All management contracts are discussed in the Prospectus or Statement of Additional Information.

 

Item 37.    Fee Representation.

 

Protective Life Insurance Company represents that the fees and charges deducted under the Policy, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by Protective Life Insurance Company.

 

C-11

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this Registration Statement on Form N-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Birmingham, State of Alabama, on April 24, 2026.

 

PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT  
   
By: *  
  Paul R. Wells, President  
  Protective Life Insurance Company  
   
  PROTECTIVE LIFE INSURANCE COMPANY  
   
By: *  
  Paul R. Wells, President  
  Protective Life Insurance Company  
     

As required by the Securities Act of 1933, this Registration Statement on Form N-6 has been signed by the following persons in the capacities and on the dates indicated:

 

Signature   Title   Date
*   Chairman of the Board,   *
Richard J. Bielen   Chief Executive Officer, and Director    
    (Principal Executive Officer)    
         
*   Vice Chairman, Chief Operating Officer   *
Wade V. Harrison   and Director    
         
*   President, Chief Financial Officer,   *
Paul R. Wells   and Director      
    (Principal Accounting and Financial Officer)    
         
*BY: /S/ BRANDON J. CAGE       April 24, 2026
Brandon J. Cage        
Attorney-in-Fact        

 

C-12

 

 

EXHIBIT LIST

 

(d) (1) Protective VUL Form of Contract

 

(d) (2) Long Term Care Rider with Long-Term Care Inflation Protection Option

 

(d) (3) Lapse Protection Endorsement

 

(e) (1) Form of Variable Universal Individual Life Insurance Application

 

(f) (1) (ii) 2024 Amended and Restated Articles of Incorporation of Protective Life Insurance Company

 

(f) (2) (ii) 2024 Amended and Restated Bylaws of Protective Life Insurance Company

 

(n) (1) Consents of KPMG LLP

 

(n) (2) Powers of Attorney

 

(q) (1) Memorandum Pursuant to Rule 6e-3(T)(b)(12)(iii) Describing Issue, Transfer and Redemption Procedures

 

(r) Form of Initial Summary Prospectus

 

Item (32) Organizational Chart of Daiichi Life Group, Inc.

 

C-13

 

EX-99.(D)(1) 2 tm268049d1_ex99-xdx1.htm EXHIBIT 99.(D)(1)

 

Exhibit 99.(d)(1)

 

PROTECTIVE LIFE INSURANCE COMPANY

A Stock Company; Domiciled in [Nebraska]

[www.protective.com]

 

[P. O. Box 2606; Birmingham, Alabama 35202; (800) 866-9933]

 

 

 

VARIABLE LIFE INSURANCE POLICY

 

INSURED: [John Doe]

 

POLICY NUMBER: [PN123456]

 

 

This is a legal contract (the "Policy") between the Owner (also referred to as "you" or "your") and Protective Life Insurance Company (also referred to as "the Company", "we", "us", or "our"). Please read it carefully.

 

This is an Individual Flexible Premium Variable Life Insurance Policy ("Policy"). This Policy provides a Death Benefit.

 

THE OWNER HAS THE RIGHT TO RETURN THIS POLICY. The Owner may cancel this Policy after receipt by returning the Policy to the Company's Home Office, or to any Agent of the Company, with a written request for cancellation within thirty (30) days after receipt. Return of this Policy by mail is effective on actual receipt by the Company. The returned Policy will be treated as if it had never been issued. The Company will promptly refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to the Company, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to the Company.

 

 

[ ]

 

  []
[Paul R. Wells]   [Felicia M. Lee]
[President]   [Secretary]

 

THE POLICY VALUES, THE AMOUNT OF THE DEATH BENEFIT PROVIDED IN THIS CONTRACT, OR THE DURATION OF THE INSURANCE COVERAGE, MAY BE FIXED OR VARIABLE WHEN BASED ON THE INVESTMENT EXPERIENCE OF THE VARIABLE ACCOUNT, MAY INCREASE OR DECREASE IN ACCORDANCE WITH THE FLUCTUATIONS IN THE NET INVESTMENT FACTOR, AND ARE NOT GUARANTEED AS TO DOLLAR AMOUNTS. THERE IS NO GUARANTEED MINIMUM FOR THE PORTION OF THE POLICY VALUE IN THE SUB-ACCOUNTS. PLEASE REFER TO THE VARIABLE ACCOUNT SECTION OF THIS POLICY FOR MORE INFORMATION REGARDING THE VARIABLE ACCOUNT. PLEASE REFER TO THE DEATH BENEFIT SECTION OF THIS POLICY FOR A DESCRIPTION OF THE DEATH BENEFIT.

 

READ THE CONTRACT CAREFULLY

THIS POLICY IS A LEGAL CONTRACT BETWEEN THE OWNER AND THE COMPANY

INDIVIDUAL FLEXIBLE PREMIUM VARIABLE ADJUSTABLE LIFE INSURANCE POLICY

NON-PARTICIPATING - DOES NOT PAY DIVIDENDS

 

ICC25-VUL-18SPage S[1]

 

 

TABLE OF CONTENTS

 

 

POLICY SCHEDULE - GENERAL INFORMATION S1
TERMS USED IN THIS POLICY 1
GENERAL PROVISIONS 2
PREMIUMS 4
DETERMINING FIXED ACCOUNT VALUES 6
DETERMINING VARIABLE ACCOUNT VALUES 6
ADDITIONAL PROVISIONS FOR DETERMINING VALUES 8
ACCESSING POLICY VALUES 10
DEATH BENEFIT 12
CHANGING THIS POLICY 13

 

ICC25-VUL-18SPage S[1]

 

 

POLICY SCHEDULE

 

POLICY NUMBER:  [SPECIMEN] POLICY EFFECTIVE DATE:  [JANUARY 15, 2025]
INSURED:  [JOHN Q. DOE]
POLICY ISSUE DATE:  [JANUARY 15, 2025] AGE:  [35]
INITIAL FACE AMOUNT:  $[100,000] SEX:  [MALE]
INITIAL PREMIUM PAYMENT: $[67.17] MONTHLY ANNIVERSARY DAY: [1]
RATE CLASS: STANDARD UNISMOKE DEATH BENEFIT OPTION: LEVEL
MAXIMUM LAPSE PROTECTION PERIOD: [YY] YEARS
PLANNED PREMIUM PAYMENT: $[67.17] [PAYABLE MONTHLY BY PRE-AUTHORIZED CHECK]
OWNER:  [JOHN Q. DOE]
   
STATE DEPARTMENT OF INSURANCE:      [ALABAMA-WYOMING] PHONE: [###-###-####]

 

[FORM

NUMBER

SCHEDULE OF ADDITIONAL
BENEFITS

MONTHLY CHARGE

DURING FIRST YEAR]

     

 

 

 

 

 

 

 

*************************************************************************************************

THIS POLICY PROVIDES LIFE INSURANCE COVERAGE ON THE INSURED UNTIL TERMINATION, SUBJECT TO THE TERMS OF THIS POLICY. THERE MAY BE LITTLE OR NO SURRENDER VALUE PAYABLE ON CONTRACT TERMINATION.

 

BASIS OF COMPUTATIONS

 

MAXIMUM COST OF INSURANCE RATES ARE BASED ON THE 2017 COMMISSIONER'S STANDARD ORDINARY (CSO) COMPOSITE, MALE OR FEMALE MORTALITY TABLE (AGE NEAREST BIRTHDAY) AND THE RATE CLASS OF THE INSURED.

 

 

GUARANTEED INTEREST RATE FOR FIXED ACCOUNT: 1% ANNUALLY (.0830% MONTHLY) (.0027% DAILY)

 

MAXIMUM LOAN INTEREST RATE: 5% YEARS 1-10 - 3.25% YEARS 11+

 

MAXIMUM CARRY OVER LOAN RATE (Applicable to loan balances transferred under Section 1035 of the Code): 5% YEARS 1-10 - 3.25% YEARS 11+

 

MINIMUM FACE AMOUNT: $50,000

 

ICC25-VUL-18SPage S[1]

 

 

POLICY SCHEDULE (continued)

 

 

 

DEDUCTION FROM PREMIUM PAYMENTS

 

Premium Expense Charge. A maximum Premium Expense Charge of 5.0% will be deducted from each premium payment. The Company reserves the right to charge less than the maximum charge.

 

MONTHLY DEDUCTIONS

 

Beginning as of the Policy Effective Date and continuing on each Monthly Anniversary Day thereafter, the Company will deduct the charges listed below. With the exception of the Mortality and Expense Risk Charge, each charge will reduce the Sub-Account Value(s) and the Fixed Account Value in the proportion that each Sub-Account Value and the Fixed Account Value bears to the Un-loaned Policy Value. The Mortality and Expense Risk Charge will reduce only the Sub-Account Value(s).

 

Administration Charge. The monthly Administration Charge is $9.

 

Administration Charge for Initial Face Amount. The maximum monthly Administration Charge for Initial Face Amount is equal to $[0.70] per every $1,000 of Initial Face Amount.

 

The Company reserves the right to charge less than the maximum charge.

 

Administration Charge for Increase in Face Amount. The monthly Administration Charge for Increase in Face Amount is $[2.57] per every $1,000 of increase in Face Amount. This monthly charge applies during the twelve-month period following the effective date of each increase in Face Amount.

 

 

 

Charge For Benefits Under Riders. The Company will deduct a monthly charge for any riders.

 

Cost of Insurance Charge. The Company will deduct a monthly Cost of Insurance Charge. This charge varies and is calculated in accordance with the policy provisions. See the Cost of Insurance section of this Policy for details. The Maximum Monthly Cost of Insurance Rates are set forth in the table on the following page.

 

Mortality and Expense Risk Charge. The maximum monthly Mortality and Expense Risk Charge is equal to [0.05]% multiplied by the Variable Account Value, which is equivalent to an annual rate of [0.60]% of such amount. The Company reserves the right to charge less than the maximum charge.

 

 

OTHER DEDUCTIONS

 

Withdrawal Charge. A Withdrawal Charge equal to the lesser of: (a) 2% of the amount withdrawn; or (b) $25 is deducted from the Fixed Account and Variable Account Value(s) whenever you make a Withdrawal. See the Surrenders and Withdrawals section of this Policy for additional details.

 

Transfer Fee. A $25 charge may be deducted from the Fixed Account and Variable Account Value(s) being transferred for each transfer request in excess of 12 during a Policy Year. See the Variable Account section of this Policy for additional details.

 

ICC25-VUL-18SPage S[2]

 

 

POLICY SCHEDULE (continued)

 

 

SURRENDER CHARGES

 

If this Policy is surrendered, lapses at the end of a Grace Period, the face amount is reduced due to a Withdrawal, or the Owner elects to decrease the Initial Face Amount during the first ten Policy Years, the Company will deduct a Surrender Charge from the Fixed Account and Variable Account Value(s). The Maximum Surrender Charge on surrender or lapse of this Policy is shown in the table below.

 

 

The partial Surrender Charge imposed for an elected decrease of the Initial Face Amount, or for a face decrease resulting from a Withdrawal, will equal the portion of the Surrender Charge (shown in the table below and reduced by any previous partial Surrender Charge(s)) that corresponds to the percentage by which the Initial Face Amount is reduced. In the event of such a reduction in the Initial Face Amount, the Company will allocate the partial Surrender Charge to each Sub-Account and the Fixed Account based on the proportion that the value of the Fixed Account and the value of the Sub-Account(s) bear to the total unloaned Policy Value.

 

 

Policy Surrender Policy Surrender
Year Charge Year Charge
1 [$3,100] 9 [$2,075]
2 [$3,050] 10 [$1,725]
3 [$3,000] 11 [$1,375]
4 [$2,950] 12 [$1,050]
5 [$2,875] 13 [$700]
6 [$2,825] 14 [$350]
7 [$2,775] 15+ 0
8 [$2,425]    

 

ICC25-VUL-18SPage S[3]

 

 

POLICY SCHEDULE (continued)

 

 

 

GUARANTEED MAXIMUM MONTHLY COST OF INSURANCE RATES

PER $1,000 OF NET AMOUNT AT RISK

 

 

AGE RATE AGE RATE AGE RATE AGE RATE AGE RATE
[0   [25   [50 [0.244 [75 [2.505 [100 [29.34
1   26   51 0.257 76 2.792 101 31.205
2   27   52 0.273 77 3.101 102 33.066
3   28   53 0.291 78 3.437 103 34.888
4   29   54 0.312 79 3.814 104 36.637
5   30   55 0.337 80 4.242 105 38.28
6   31   56 0.365 81 4.735 106 39.785
7   32   57 0.398 82 5.277 107 41.943
8   33   58 0.435 83 5.949 108 44.217
9   34   59 0.478 84 6.719 109 46.615
10   35 [0.114 60 0.527 85 7.605 110 49.143
11   36 0.125 61 0.585 86 8.622 111 51.808
12   37 0.135 62 0.649 87 9.77 112 54.618
13   38 0.146 63 0.721 88 11.048 113 57.58
14   39 0.158 64 0.801 89 12.411 114 60.702
15   40 0.171 65 0.886 90 13.843 115 63.995
16   41 0.184 66 0.977 91 15.295 116 67.465
17   42 0.195 67 1.073 92 16.729 117 71.123
18   43 0.2 68 1.177 93 18.135 118 74.98
19   44 0.205 69 1.294 94 19.442 119 79.046
20   45 0.211 70 1.43 95 20.595 120 83.333
21   46 0.217 71 1.59 96 22.092 121+] 0.000]
22   47 0.222 72 1.778 97 23.701    
23   48 0.228 73 1.995 98 25.469    
24]   49] 0.234] 74] 2.238] 99] 27.36]    

 

ICC25-VUL-18SPage S[4]

 

 

POLICY SCHEDULE (continued)

 

 

TABLE OF DEATH BENEFIT FACTORS

 

 

 

Attained
Age

 

Percentage

Attained
Age

 

Percentage

Attained
Age

 

Percentage

[0 463% [34 245% [68 138%
1 454% 35 241% 69 136%
2 446% 36 237% 70 134%
3 437% 37 233% 71 133%
4 429% 38 229% 72 131%
5 421% 39 225% 73 129%
6 412% 40 221% 74 127%
7 404% 41 217% 75 126%
8 397% 42 213% 76 124%
9 389% 43 210% 77 123%
10 381% 44 206% 78 121%
11 374% 45 202% 79 120%
12 367% 46 199% 80 119%
13 360% 47 196% 81 117%
14 353% 48 192% 82 116%
15 346% 49 189% 83 115%
16 340% 50 186% 84 114%
17 333% 51 182% 85 113%
18 327% 52 179% 86 112%
19 321% 53 176% 87 111%
20 316% 54 173% 88 110%
21 310% 55 170% 89 109%
22 305% 56 167% 90 109%
23 299% 57 165% 91 108%
24 294% 58 162% 92 107%
25 289% 59 159% 93 107%
26 284% 60 157% 94 106%
27 279% 61 154% 95 106%
28 274% 62 152% 96 105%
29 269% 63 149% 97 104%
30 264% 64 147% 98 103%
31 259% 65 145% 99 102%
32 254% 66 143% 100+ 100%]
33 250%] 67 140%]    

 

ICC25-VUL-18SPage S[5]

 

 

POLICY SCHEDULE (continued)

 

 

ALLOCATION OF PREMIUM PAYMENTS:

 

 

[Protective Variable Life Separate Account

 

   Sub-Accounts:  
Fidelity VIP Investment Grade Bond 50.00%
Lord Abbot Series Bond Debenture 20.00%
Goldman Sachs VIT Strategic Growth 30.00%
   
   
Protective Life General Account:  
Fixed Account 0.00%]

 

ICC25-VUL-18

 

 

TERMS USED IN THIS POLICY

 

The terms below have specific meaning associated with them each time they are used in this Policy. Other terms may be defined elsewhere in this Policy and will have that meaning each time they are used in this Policy.

 

Administrative Office: The location where administrative services for this Policy are performed.

 

Age: The Insured's age as of the nearest birthday on the Policy Effective Date plus the number of complete Policy Years since the Policy Effective Date.

 

Beneficiary: The primary Beneficiary(ies) is the person(s) or class of persons designated to receive the Proceeds of this Policy upon the death of the Insured. You may designate a contingent Beneficiary(ies) to receive the Proceeds if there is no primary Beneficiary(ies) living at the time of the Insured's death.

 

There may be one or more than one Beneficiary in a class. If one or more persons in the class die before the Insured, the living members of the class will share the Policy's Death Benefit Proceeds equally unless you instruct us otherwise. By Written Notice, you may change a Beneficiary and may designate an Irrevocable Beneficiary. If you designate an Irrevocable Beneficiary it may limit your ability to change that designation in the future or to make other Policy changes.

 

Cash Value: It is equal to the Policy Value minus any applicable Surrender Charge.

 

Code: The Internal Revenue Code of 1986, as amended, or its successor.

 

Evidence of Insurability: Information that the Insured provides that is the basis for determining whether we will approve or reinstate this Policy or any additional benefit attached thereto. This could include underwriting information such as a medical exam and/or collection of current medical information.

 

Fund: An investment portfolio of Protective Investment Company or any other open-end management investment company or unit investment trust in which a Sub-Account invests.

 

General Account: The assets of the Company other than those allocated to the Variable Account or another separate account.

 

Insured: The person shown on the Policy Schedule upon whose life this Policy is issued.

 

Irrevocable Beneficiary: A Beneficiary whose rights in this Policy are irrevocable unless the irrevocably designated Beneficiary agrees to such change in writing.

 

Issue Age: The Insured's age as of the nearest birthday on the Policy Effective Date.

 

Issue Date: The date the Policy is issued. The Issue Date may be a later date than the Policy Effective Date if the initial premium payment is received at the Administrative Office before the Issue Date.

 

Loan Account Value: The Policy Value in the Loan Account.

 

Monthly Anniversary Day: The same day of the month as the Policy Effective Date. The Monthly Anniversary Day is shown on the Policy Schedule.

 

Net Asset Value Per Share: The value per share of any Fund as computed on any Valuation Day as described in the Fund Prospectus.

 

Net Premium: The amount remaining of each premium payment after deduction of the Premium Expense Charge. The Premium Expense Charge is shown in the Policy Schedule.

 

ICC25-VUL-18

 

 

Owner: The person, persons or entity entitled to all rights in this Policy while the Insured is living. These rights are subject to any assignment and to the rights of any Irrevocable Beneficiary. You may name a contingent Owner who will own this Policy if you die while this Policy is in force. If you die before the Insured, any contingent Owner named in the application, or subsequent endorsement, will become the new Owner. If no contingent Owner is named, your estate becomes the new Owner. You may change the Owner (including a contingent Owner) by Written Notice.

 

Policy Anniversary: The same day in each Policy Year as the Policy Effective Date.

 

Policy Debt: The sum of all outstanding policy loans plus accrued interest.

 

Policy Effective Date: The date shown on the Policy Schedule and on which coverage takes effect. For any increase, decrease, additions, or changes to coverage, the effective date of change shall be the first Monthly Anniversary Day on or following the date the supplemental application is approved by the Company. The Policy Effective Date will never be the 29th, 30th or the 31st of a month.

 

Policy Value: The sum of the Variable Account Value, the Fixed Account Value and the Loan Account Value. The Policy Value on the Policy Effective Date is the initial Net Premium less the Monthly Deduction for the upcoming month.

 

Policy Year: Each period of 12 months commencing with the Policy Effective Date.

 

Proceeds: The amount payable upon claiming a Death Benefit, requesting a full surrender or a Withdrawal.

 

Sub-Account: A separate division of the Variable Account. Each Sub-Account invests in a corresponding Fund.

 

Surrender Value: The Cash Value minus any outstanding Policy Debt at the time of the Surrender.

 

Unit: A unit of measurement used to calculate the Sub-Account Values.

 

Valuation Day: Any day for which the Funds underlying the Sub-Accounts are valued (e.g., Any day the NYSE is open for business).

 

Valuation Period: The period commencing at the close on any day for which the Funds underlying the Sub-Accounts are valued and ending at the close on the next day that the Funds underlying the Sub-Accounts are valued.

 

Written Notice and Request: Any information We receive at our Administrative Office which is written, signed and dated by you and is acceptable to us. No change in this Policy is valid unless it is by Written Notice and, unless otherwise specified, will be effective as of the date it is signed. No agent or other person has the authority to change this Policy. Instructions, requests and assignments are subject to any payment We made and any action We took prior to receiving the Written Notice.

 

 

GENERAL PROVISIONS

 

Commission Standards: This Policy was approved under the authority of the Interstate Insurance Product Regulation Commission ("the Commission") and issued under the Commission standards. Any provision of this Policy, as of the Effective Date, that is in conflict with the applicable Commission's standards for this product type in effect as of the provision's effective date of the Commission policy approval, is hereby amended to conform to the applicable Commission standards in effect as for the provisions Effective Date of Commission policy approval.

 

ICC25-VUL-18

 

 

Entire Contract: This Policy is a legal contract between you and us. We entered into this contract in consideration of a complete application and the payment of premiums. The Policy, including its applications, both initial and supplemental, all endorsements, amendments, riders and Policy Schedule, both initial and supplemental, are consolidated, attached, and constitute the entire agreement between you and us. Any changes made to the Policy and its terms must be made in writing and approved by our Administrative Office.

 

Representations and Contestability: In determining whether to issue this Policy We relied on the statements in the application made by and for the Insured. We acknowledge these statements are representations, not warranties. We have the right to contest the validity of this Policy or resist any claim based on a material misrepresentation in any application We accept and make part of this Policy. However, We cannot bring any legal action to contest the validity of this Policy or to resist a claim after the Policy has been in force for two years during the life of the Insured, except for the non-payment of premium.

 

If We accept an application, requiring evidence of insurability, to change the Policy, add or change a benefit, or reinstate the Policy after it has lapsed and make the application part of this Policy, We cannot bring any legal action to contest the change, addition or reinstatement after such change, addition or reinstatement has been in force for two years during the life of the Insured, except for the non-payment of premium. The contestability period for a reinstated Policy is based only on statements made in the reinstatement application, unless the original contestability period has not yet expired.

 

Error in Age or Sex: Questions in the application concern the Insured's date of birth and sex. If the date of birth or sex given in the application or any application for riders is not correct, the Death Benefit and any benefits provided under any riders to this Policy will be adjusted to those which would be purchased by the most recent deduction for the cost of insurance and the cost of any benefits provided by such riders, at the correct age and sex.

 

Assignment: You may assign your rights under this Policy. However, for this assignment to be binding on the Company, it must be by Written Notice and with the consent of any Irrevocable Beneficiary. However, this Policy may not be assigned where prohibited by law or regulation in the state in which this Policy is delivered. We assume no responsibility for the validity of any assignment and any claim under any assignment shall be subject to proof of interest and the extent of assignment. Once We receive a signed copy of the assignment, the Owner's rights and the interest of any Beneficiary or any other person will be subject to the assignment. An assignment is subject to any Policy Debt. The effective date for the assignment is the date the assignment is signed, unless otherwise specified by the Owner, subject to payments and actions taken prior to receipt of the assignment.

 

Suicide Exclusion: If the Insured commits suicide, while sane or insane, within two years (or any shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) from the Policy Effective Date, our total liability shall be limited to the premium payments made before death, less any Policy Debt and less any Withdrawals. If the Insured commits suicide, while sane or insane, within two years (or any shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) from the effective date of any increase in the Face Amount, our total liability with respect to such increase shall be limited to the sum of the monthly Cost of Insurance Charges deducted for such increase. We reserve the right to obtain and/or request evidence of the manner and cause of the Insured’s death.

 

Termination: All coverage under this Policy shall terminate when any one of the following events occurs:

 

(1)   the Owner requests a full surrender. Surrender will require a return of this Policy.

 

(2)the Insured dies and We settle claims for the Death Benefit Proceeds.

 

(3)the Policy lapses, as described in the sub-section entitled "Grace Period" under "Premiums" and the sub-section entitled "Loan Account" under "Policy Loans".

 

(4)the Death Benefit Proceeds are equal to or less than zero.

 

ICC25-VUL-18

 

 

Annual Report: At least once per year We will send you a report for this Policy showing, as of the end of the report period: (1) the beginning and end dates of the current report period; (2) the current Death Benefit; (3) the current Policy Value and the Policy Value as of the beginning of the reporting period; (4) the current Fixed Account Value; (5) the current Variable Account Value; (6) the current Loan Account Value; (7) the current Sub-Account Values; (8) premium payments made since the last report; (9) any Withdrawals since the last report; (10) any policy loans and accrued interest; (11) the current Surrender Value; (12) the Owner's current premium allocations; (13) charges deducted since the last report; and (14) any other information required by law. A notice will be included in the Annual Report if the Policy's Surrender Value will not maintain the Policy in Force until the end of the next reporting period.

 

In addition, We will provide an illustrative Report for this Policy at any time upon the Owner's Written Request. If you request this information more frequently than annually, We may charge a fee which will not exceed $50.

 

Tax Considerations: In order to receive the tax treatment afforded to life insurance contracts, this Policy must qualify at all times as a life insurance contract under the Code. If necessary to prevent this Policy from failing to qualify under Section 7702 of the Internal Revenue Code as a life insurance contract, we reserve the right to:

 

(1)decline to accept a premium payment; or

 

(2)decline to process a withdrawal; or

 

(3)refund a premium payment, including any earnings thereon, or

 

(4)increase the death benefit.

 

We also reserve the right, with the Owner's written consent, to make changes to this Policy or to any endorsements or to any riders or to make distributions from this Policy to the extent We consider necessary for this Policy to continue to qualify as a life insurance contract. Such changes will apply uniformly to all affected policies, and We will provide you written notification of such changes.

 

 

PREMIUMS

 

Premium Payment(s): Premium payment(s) are payable in advance at the Administrative Office or to any agent of the Company. Premium payment(s) must be made by check payable to Protective Life Insurance Company or by any other method We deem acceptable. The least amount of premium payment(s) that We will accept is $50 if paid by a monthly pre-authorized payment arrangement; or $150 for any other mode of payment accepted by the Company. Upon request, a receipt for premium payment(s) will be sent.

 

We reserve the right to refund a premium payment, including any earnings thereon, which:

 

(a)in the first Policy Year, causes the Death Benefit to exceed the Initial Face Amount shown on the Policy Schedule; or

 

(b)increases the difference between the Death Benefit and the Policy Value.

 

We have the right not to accept any premium payment in the event that We determine that the premium payment will cause this Policy to fail to qualify as a life insurance contract under the Code.

 

If mandated by law, We may reject a premium payment. We may also provide information about an Owner’s account to a government agency.

 

No insurance will take effect until the initial premium payment is paid and the health and other conditions of the Insured are determined to be the same as that described in the application on the date this Policy is delivered.

 

ICC25-VUL-18

 

 

Net Premiums will be allocated to the Sub-Accounts and the Fixed Account according to your instructions contained in the application during the Valuation Period in which We receive them. You may change the allocations in effect at any time by Written Notice. Allocations must be made in whole percentages and the sum of allocations must add up to 100%. We reserve the right to establish a limitation on the number of Sub-Accounts to which Net Premiums may be allocated and/or a minimum allocation requirement for the Sub-Accounts and the Fixed Account.

 

If this Policy is issued in a state where, upon cancellation and within the cancellation period, the Company returns the premium payment(s) made, We reserve the right to allocate the initial premium payment and any additional premium payments made during the cancellation period to the Fixed Account or Money Market Sub-Account. After the cancellation period, allocations will be made in accordance with your instructions.

 

Planned Premium Payments: Planned premium is our understanding of your intention regarding premium payments at any particular time. Your initial planned premium amount and mode was communicated to us on the application and is shown in the Policy Schedule. You may change the amount and/or mode of your planned premium by Written Notice. You may choose periodic reminders for the planned premium on an annual, semiannual or quarterly basis, or may pre-authorize automatic payment of planned premiums from a designated account at your bank or other financial institution.

 

Our acceptance of your planned premium instructions does not in any way imply or guarantee insurance coverage or any other benefit provided by this Policy will continue. If planned premium payments are discontinued and no subsequent premiums are paid, the insurance coverage will continue until the end of the Grace Period.

 

If you stop paying premiums, coverage will continue until the Surrender Value is no longer sufficient to cover the Monthly Deductions, subject to the Grace Period provision and all other provisions of the policy.

 

Additional Premium Payments: Subject to the limits described above, while this Policy is in force, We will accept premium payment(s) other than the planned premium payments. We reserve the right to limit the amount or frequency of any such additional premium payments in accordance with the “Tax Considerations” provision. We also reserve the right to require Evidence of Insurability for any premium payment that would result in an immediate increase in the difference between the Death Benefit and the Policy Value. If Evidence of Insurability is not received, the premium, or any portion of the premium, may be returned. Any additional payment we receive will be applied as premium and not to repay any outstanding loans, unless you submit a Written Request otherwise.

 

Grace Period: If the Surrender Value on a Monthly Anniversary Day is insufficient to cover the Monthly Deductions due on that Monthly Anniversary Day, then this Policy will begin a 61 day Grace Period. The insurance provided by this Policy remains in effect during the Grace Period. Written notification will be sent to the last known address of the owner and any assignee of record at least 31 days prior to the end of the Grace period. If the Owner does not pay sufficient Net Premiums to cover the current and past due Monthly Deductions by the end of the Grace Period, this Policy will terminate without value. You have the entire Grace Period to make the payment, and if the payment is sent by U.S. Mail, it must be postmarked within the Grace Period. If the Insured dies during the Grace Period, the Death Benefit will be reduced by the amount of the unpaid Monthly Deductions and Policy Debt before We pay or settle the Death Benefit Proceeds.

 

Reinstatement: If this Policy has terminated at the end of the Grace Period, you may request that it be reinstated during the life of the Insured. We will reinstate this Policy, if We receive:

 

(1)the Owner's written request within five years after the end of the Grace Period.

 

(2)evidence of insurability, satisfactory to Us,

 

(3)payment of Net Premium equal to all Monthly Deductions that Were due and unpaid during the Grace Period, and payment of premium payments at least sufficient to keep this Policy in force for three months (We may accept premium payments larger than this amount), and

 

(4)payment of or reinstatement of any Policy Debt which existed at the end of the Grace Period.

 

ICC25-VUL-18

 

 

The effective date of the reinstatement of the Policy will be the day We approve the reinstatement and all of the above requirements have been met. The beginning Policy Value, Surrender Charge and Policy Debt, if any, of the reinstated Policy will be determined based on the Policy Value, Surrender Charge and Policy Debt, if any, as of the date the Policy entered the most recent Grace Period.

 

 

DETERMINING FIXED ACCOUNT VALUES

 

Fixed Account: The Fixed Account is part of the Company's General Account to which Policy Value may be transferred or Net Premiums allocated under a Policy.

 

Fixed Account Value: The value of the Fixed Account at any time is equal to:

 

(a)   All Net Premiums allocated to the Fixed Account; plus

 

(b)any Policy Value transferred to the Fixed Account; plus

 

(c)any interest credited to the Fixed Account; less

 

(d)any Withdrawals including any withdrawal charges deducted or transfers from the Fixed Account including any transfer fees deducted from the Fixed Account; less

 

(e)any Surrender Charges deducted from the Fixed Account in the event of a decrease of the Initial Face Amount; less

 

(f)any Policy loans taken from the Fixed Account; less

 

(g)all Monthly Deductions taken from the Fixed Account.

 

Interest Credited: Net Premiums allocated to the Fixed Account or Policy Value transferred to the Fixed Account, the guaranteed interest rate applicable will be the annual effective interest rate in effect on the date We receive the subsequent Net Premium or the date the transfer is made. Such guaranteed interest rate will apply to such amounts for a twelve-month period which begins on the date the Net Premium is allocated or the date the transfer is made.

 

After the guaranteed interest rate expires, We will credit interest on the Fixed Account Value attributable to such Net Premiums and transfers at the current interest rate in effect. New current interest rates are effective for such Fixed Account Value for 12 months from the time they are first applied. The current interest rate the Company will credit is annual effective interest rates of not less than the annual Guaranteed Interest Rate for Fixed Account shown on the Policy Schedule. For purposes of crediting interest, amounts deducted, transferred or withdrawn from the Fixed Account will be accounted for on a "first-in, first-out" (FIFO) basis.

 

Interest shall be credited to the Fixed Account on a daily basis.

 

 

DETERMINING VARIABLE ACCOUNT VALUES

 

Variable Account: The Protective Variable Life Separate Account is a separate investment account of the Company used to fund variable life insurance benefits and to which Policy Value may be transferred or into which Net Premiums may be allocated. The variable benefits under this Policy are provided through the Variable Account. The Variable Account is registered with the Securities and Exchange Commission (the “SEC”) as a unit investment trust under the Investment Company Act of 1940.

 

ICC25-VUL-18

 

 

The portion of the assets of the Variable Account equal to the reserves and other contract liabilities of the Variable Account are not chargeable with the liabilities arising out of any other business the Company may conduct. We have the right to transfer to our General Account any assets of the Variable Account which are in excess of such reserves and other liabilities. The assets of the Variable Account are available to cover the liabilities of the General Account of the Company only to the extent that the assets of the Variable Account exceed the liabilities of the Variable Account arising under the policies supported by the Variable Account.

 

Variable Account Value: The sum of all Sub-Account Values.

 

Sub-Accounts of the Variable Account: The assets of the Variable Account are divided into a series of Sub-Accounts that are listed in the current Prospectus the Owner received. Each Sub-Account invests exclusively in shares of a corresponding Fund. Any amounts of income, dividends, and gains distributed from the shares of a Fund will be reinvested in additional shares of that Fund at its Net Asset Value Per Share.

 

When permitted by law, We may:

 

(1)create new Variable Accounts;

 

(2)combine Variable Accounts;

 

(3)transfer assets of one Variable Account to another Variable Account;

 

(4)add new Sub-Accounts to or remove existing Sub-Accounts from the Variable Account or combine Sub-Accounts;

 

(5)make new Sub-Accounts or other Sub-Accounts available to such classes of policies as We may determine;

 

(6)close certain Sub-Accounts to allocations of premium payments or transfers of Policy Value.

 

(7)add new Funds or remove existing Funds;

 

(8)substitute a different Fund for any existing Fund if shares of a Fund are no longer available for investment or if We determine that investment in a Fund is no longer appropriate in light of the purposes of the Variable Account;

 

(9)deregister the Variable Account under the Investment Company Act of 1940 if such registration is no longer required;

 

(10)operate the Variable Account as a management investment company under the Investment Company Act of 1940 or in any other form permitted by law; and

 

(11)make any changes to the Variable Account or its operations as may be required by the Investment Company Act of 1940 or other applicable law or regulations.

 

The investment policy of the Variable Account will not be changed without approval pursuant to the insurance laws of the Company's state of domicile. If required, approval of or change of investment policy will be filed with the insurance department of the state where this Policy is delivered.

 

The values and benefits of this Policy provided by the Variable Account depend on the investment performance of the Funds in which your selected Sub-Accounts are invested. The Company does not guarantee the investment performance of the Funds. The Owner bears the full investment risk for Net Premiums allocated or Policy Value transferred to the Sub-Accounts.

 

Valuation of Assets: Assets of Funds held by each Sub-Account will be valued at their Net Asset Value Per Share on each Valuation Day. The Prospectus the Owners(s) received for the Funds defines the Net Asset Value Per Share of the Funds and describes each Fund.

 

ICC25-VUL-18

 

 

Sub-Account Values: The Sub-Account Value for any Sub-Account is equal to the number of Units this Policy then has in that Sub-Account, multiplied by the value of such Units at that time. Amounts allocated, transferred or added to a Sub-Account are used to purchase Units of that Sub-Account. Units are redeemed when amounts are deducted, transferred, or withdrawn. The number of Units in a Sub-Account at any time is equal to the number of Units purchased minus the number of Units redeemed up to such time.

 

For each Sub-Account, the Net Premiums allocated to the Sub-Account or Policy Value transferred to the Sub-Account are converted into Units. The number of Units credited is determined by dividing the dollar amount directed to each Sub-Account by the value of the Unit for that Sub-Account for the Valuation Day on which the Net Premiums allocated to or Policy Value transferred are credited to the Sub-Account. The Unit value at the end of every Valuation Day is the Unit value at the end of the previous Valuation Day times the Net Investment Factor, as described below.

 

For each Sub-Account, amounts deducted, transferred, or withdrawn from the Sub-Account are converted into Units. The number of Units debited is determined by dividing the dollar amount directed from each Sub-Account by the value of the Unit for that Sub-Account for the Valuation Day on which the amount deducted, transferred, or withdrawn is debited from the Sub-Account. The Unit value at the end of every Valuation Day is the Unit value at the end of the previous Valuation Day times the Net Investment Factor, as described below.

 

Net Investment Factor: The Unit value for each Sub-Account for any Valuation Period is determined by the Net Investment Factor. The Net Investment Factor is an index applied to measure the investment performance of a Sub-Account from one Valuation Period to the next. The Net Investment Factor for a Sub-Account for any Valuation Period is determined by dividing (1) by (2) where

 

(1)is the result of:

 

a.the Net Asset Value Per Share of the Fund held in the Sub-Account, determined at the end of the current Valuation Period; plus

 

b.the per share amount of any dividend or capital gain distributions made by the Fund to the Sub-Account, if the "ex-dividend" date occurs during the current Valuation Period; plus or minus

 

c.a per share charge or credit for any taxes reserved for, which is determined by the Company to have resulted from the operations of the Sub-Account.

 

(2)is the Net Asset Value Per Share of the Fund held in the Sub-Account, determined at the end of the last Valuation Period.

 

 

ADDITIONAL PROVISIONS FOR DETERMINING VALUES

 

Transfers: On or after the later of thirty days after the Policy Effective Date or six days after the thirty-day cancellation period, or such other period as required by law, you may, by Written Notice, transfer the Fixed Account Value or any Sub-Account Value to other Sub-Accounts and/or the Fixed Account. The transfer will be effected as of the Valuation Period during which We receive your Written Notice.

 

The amount of each transfer must be at least $100, or if the value in an account is less, the entire amount. If, after the transfer, the amount remaining in the Fixed Account or Sub-Account(s) from which the transfer is made is less than $100, We reserve the right to transfer the entire amount instead of the requested amount. We reserve the right to limit the maximum amount which may be transferred from the Fixed Account in any Policy Year. This maximum is currently the greater of $2500 or 25% of the Fixed Account Value.

 

The Policy Value on the effective date of the transfer will not be affected except to the extent of the transfer fee. We reserve the right to limit transfer requests to no more than 12 per Policy Year. For each additional transfer request over 12 during each Policy Year, We reserve the right to charge a transfer fee indicated on the Policy Schedule, which will be deducted from the amount being transferred.

 

ICC25-VUL-18

 

 

We reserve the right, at any time and without prior notice, to terminate, suspend or modify the transfer privileges described above.

 

We reserve the right to provide to a Fund information about Owners and their trading activities involving the Fund’s portfolio(s) that We deem necessary to:

 

(1)deter fraud or violations of our operating rules or the operating rules of a Fund; and

 

(2)as required to comply with applicable state and federal law.

 

Deductions from the Policy Value: Monthly Deductions, Other Deductions and Surrender Charges are described on the Policy Schedule.

 

Net Amount at Risk: The Net Amount at Risk as of any Monthly Anniversary Day is equal to the Death Benefit discounted at one plus the monthly guaranteed interest rate minus the Policy Value (prior to deducting the Cost of Insurance).

 

The cost of insurance charge for each increment of Face Amount is calculated separately to the extent a different cost of insurance rate applies. Because the Net Amount at Risk for Death Benefit Option A is equal to the Death Benefit less Policy Value, the entire Policy Value is applied first to offset the Death Benefit derived from the Initial Face Amount. Only if the Policy Value exceeds the Initial Face Amount is the excess applied to offset the portion of the Death Benefit derived from increases in Face Amount in the order of the increases. If there is a decrease in Face Amount after an increase, the decrease is applied first to decrease any prior increases in Face Amount, starting with the most recent increase.

 

Cost of Insurance Charge: The monthly Cost of Insurance Charge is computed at the beginning of each policy month by multiplying the Net Amount at Risk (divided by $1,000) by the Cost of Insurance Rate. The Cost of Insurance Charge is computed separately for the Initial Face Amount and for each increase in Face Amount.

 

Cost of Insurance Rates: The monthly Cost of Insurance Rate is based on the sex, Issue Age, duration and rate class of the Insured and on the number of years that a Policy has been in force. For each Face Amount increase, We will use the Issue Age, sex, and rate class of the Insured and duration of this Policy at the time of the request. We will determine monthly cost of insurance rates, based on our expectations as to future investment earnings, mortality, persistency, taxes, expenses and other relevant factors.

 

Any change in the monthly Cost of Insurance Rates will be by class and based on expectations of future investment earnings, mortality, persistency, taxes, expenses and other relevant factors. However, the Cost of Insurance Rates will never be greater than those shown in the Guaranteed Maximum Monthly Cost of Insurance Rates Table on the Policy Schedule.

 

Changes in Policy Cost Factors: Changes in non-guaranteed credited rates, Cost of Insurance Charge rates, Mortality and Expense Risk Charge rates, administration charge rates, or expense charge rates, if any, will be by class and will be based upon changes in future expectations of such factors as investment earnings, mortality, persistency, expenses, and taxes.

 

Minimum Values: The values and benefits of this Policy will not be less than the minimum benefits required by the National Association of Insurance Commissioners Variable Life Insurance Regulation, model #270 using Actuarial Guideline XXIV. The method of computing minimum required values has been filed with the Interstate Insurance Product Regulation Commission.

 

Continuation of Insurance: If this Policy is in force on the date that the Insured attains age 121, no additional premium payments will be accepted and the Monthly Deduction will cease. The Policy will remain in force. Interest will continue to accrue on the Policy Value and on the Policy Debt, if any. Your ability to take partial withdrawals or loans and to repay Policy Debt continue.

 

ICC25-VUL-18

 

 

Upon the death of the Insured, We will calculate and pay the Death Benefit Proceeds as described in the "DEATH BENEFIT" section of this Policy.

 

If the Policy remains in force after the date that the Insured attains the Age 121, this Policy may not qualify as life insurance under the Code. If you choose to continue the Policy under this provision, you should consult your personal tax advisor, as there may be adverse tax consequences.

 

 

ACCESSING POLICY VALUES

 

Right to Make Loans/Policy Debt: A loan can be made prior to the Insured's death and while the Policy is in force and the Policy has Surrender Value greater than zero. A loan can be a standard loan or a carryover loan. However, the Policy must be properly assigned to the Company before any policy loan is made. No other collateral is needed. Any policy loan must be for at least a minimum loan amount of $500. The Company may delay making any policy loan from the Fixed Account for up to six months. The Company refers to all outstanding loans plus accrued interest as Policy Debt. The most the Owner can borrow is an amount that equals 90% of the Cash Value of the Policy, and this amount is reduced by any Policy Debt on the date the loan request is received.

 

Carryover Loan: An initial carryover loan is a loan on the Policy the amount of which must (a) be transferred from another policy that is exchanged for the Policy such that the exchange qualifies under Section 1035 of the Internal Revenue Code, as amended, or its successor and (b) be approved by the Company. Additional carryover loans are loans on the Policy made to cover carryover loan interest.

 

Standard Loan: A standard loan is any loan that is not a carryover loan.

 

Interest: The maximum interest charged on standard and carryover loans is at an effective annual rate shown on the Policy Schedule. Interest will accrue daily on any outstanding loan and is considered part of Policy Debt. Interest payments are due for the prior Policy Year on each Policy Anniversary. If interest on a standard loan is not paid when due, it will be added to the standard loan portion of the Policy Debt and will bear interest at the rate payable on a standard loan. If interest on a carryover loan is not paid when due, it will be added to the carryover loan portion of the Policy Debt and will bear interest at the rate payable on a carryover loan. Interest is charged in arrears from the date of the policy loan. The Company will set such rate and may redetermine it at any time. Any change in rate will apply to the Policy Year which follows the date of redetermination.

 

Collateral: When a policy loan is made, an amount sufficient to secure the policy loan is transferred out of the Sub-Account(s) and the Fixed Account and into the Policy's Loan Account. The Owner can specify, on a standard loan, how to allocate the amount to be transferred to the Loan Account as collateral from amount the Sub-Account(s) and the Fixed Account. If an allocation is not specified, the amount will be allocated in the same proportion that the value of the Owner's Fixed Account and the value of the Owner's Sub-Account(s) bear to the total Unloaned Policy Value on the date the policy loan is made. An amount equal to any unpaid policy loan interest will also be transferred on each Policy Anniversary to the Loan Account. The Company will allocate the unpaid interest based on the proportion that the value of the Owner's Fixed Account and the value of the Owner's Sub-Account(s) bear to the total Unloaned Policy Value. The Loan Account Value will be recalculated

 

(1)when Policy Interest is added to the amount of the loan,
(2)when a loan repayment is made, or
(3)when a new policy loan is made.

 

ICC25-VUL-18

 

 

The Company will credit the Loan Account with interest at an effective annual rate of not less than the Guaranteed Interest Rate for the Fixed Account shown on the Policy Schedule. The Company will set such rate and may redetermine it at any time. On each Policy Anniversary, the interest earned on the Loan Account since the preceding Policy Anniversary will be transferred to the Sub-Account(s) and the Fixed Account. The interest will be transferred to the Sub-Account(s) and the Fixed Account in the same proportion that premium payments are allocated. If the Loan Account Value exceeds the Cash Value, the Owner must pay the excess. The Company will send the Owner a notice of the amount the Owner must pay. This amount must be paid within 31 days after the notice is sent, or the Policy will lapse. The Company will send the notice to the owner and any assignee of record.

 

Repaying Policy Debt: Policy Debt can be repaid in part or in full any time prior to the Insured’s death and while the Policy is in force. After the Policy Effective Date, any Policy Debt repayment will first reduce the standard loan portion of the Policy Debt until all standard loan Policy Debt has been repaid. After the standard loan Policy Debt has been repaid, any Policy Debt repayment will reduce the carryover loan portion of the Policy Debt. When a loan repayment is made, Policy Value in the Loan Account in an amount equal to that payment will be transferred to the Sub-Account(s) and the Fixed Account. The Owner may tell the Company how to allocate this transfer among the Sub-Account(s) and the Fixed Account. If no allocation is specified, the Company will allocate that amount among the Sub-Account(s) and the Fixed Account in the same proportion that premium payments are allocated. Any payment not designated as loan repayment will be applied as a premium payment.

 

Surrenders: Prior to the Insured's death, and while this Policy is in force, you may surrender this Policy, by Written Request, for its Surrender Value. The surrender will be effective as of the Valuation Period during which We receive your Written Notice. If you surrender this Policy at any time other than your Policy Anniversary, then the calculation used to determine the Surrender Value will take into account the lapse of time from the preceding Policy Anniversary. If this Policy is surrendered, any applicable Surrender Charge as described on the Policy Schedule will be imposed. Once the surrender is effective, all benefits provided by this Policy cease and this Policy cannot be reinstated.

 

Withdrawals: After the first Policy Year, you may make a Written Request for a Withdrawal, subject to certain restrictions. The minimum Withdrawal request is $500. The maximum Withdrawal request may be for an amount less than the Surrender Value. The Sub-Account Value(s) and Fixed Account Value will be reduced by the amount withdrawn (the amount withdrawn will equal the amount requested plus the partial Surrender and withdrawal charges as described on the Policy Schedule) as of the Valuation Period during which We receive your Written Notice. You may specify how the Withdrawal, partial surrender charge and withdrawal charge are to be deducted from the Sub-Account Value(s) and Fixed Account Value. If you do not specify an allocation, We will allocate the withdrawal, the partial surrender charge and withdrawal charge based on the proportion that the value in the Fixed Account and the value in the Sub-Accounts bear to the un-loaned Policy Value.

 

We reserve the right to reduce the Face Amount of this Policy by the amount of the Withdrawal (excluding the partial surrender charge and withdrawal charge). Face Amount reductions will be effective at the same time as the Withdrawal. The order of Face Amount reductions will be as provided in the provision "Decreasing the Face Amount". There may be a partial Surrender Charge, as described on the Policy Schedule, for a Face Amount reduction resulting from a Withdrawal.

 

We may decline a Withdrawal request if the remaining Face Amount would be below the Minimum Face Amount shown on the Policy Schedule; or We determine that the Withdrawal would cause this Policy to fail to qualify as a life insurance contract under the Code.

 

ICC25-VUL-18

 

 

Suspension or Delay in Payment: We have the right to suspend or delay the date of payment of a Withdrawal, Loan, Surrender, or the variable Death Benefit Proceeds for any period:

 

(1)when the New York Stock Exchange is closed; or

 

(2)when an emergency exists (as determined by the SEC) as a result of which (a) the disposal of securities in the Variable Account is not reasonably practicable; or (b) it is not reasonably practicable to determine fairly the value of the net assets of the Variable Account; or

 

(3)as the SEC may permit by order.

 

However this provision shall not apply to withdrawals and/or loans requested to make premium payments.

 

Pursuant to SEC rules, if the Money Market Fund suspends payment of redemption proceeds in connection with the liquidation of the Fund, We will delay a transfer or payment of any Withdrawal, Surrender or Death Benefit Proceeds from the Money Market Sub-Account until the Fund is liquidated. In addition, pursuant to SEC rules, if the Money Market Fund suspends the payment of redemption proceeds in connection with the implementation of liquidity gates by such Fund, We will delay a transfer or payment of any Withdrawal, Surrender or Death Benefit Proceeds from the Money Market Sub-Account until the removal of such liquidity gates.

 

In addition, We may defer payment, provided such payments are based on Policy Values which do not depend on the investment experiences of the Variable Account of any Withdrawal, Surrender or the making of a Policy loan for up to six (6) months after a Written Request is received. If We delay payment of surrender benefits under this Policy, We will pay interest at the rate specified under applicable state law as required, if any, at the time of the request.

 

If mandated under applicable law, We may be required to block the Owner’s account and thereby refuse to pay any request for transfer, Surrender, Withdrawal, loans or payment of Death Benefit Proceeds or payment under a Settlement Option, until instructions are received from the appropriate regulator. We also may be required to provide information about the Owner and his/her account to government regulators.

 

 

DEATH BENEFIT

 

Death Benefit: A Death Benefit is payable when We receive a properly completed claim form and due proof of the death of the Insured while this Policy was in force. Due proof of death includes a certified copy of the death certificate (or other lawful evidence providing equivalent information) and proof of the interest of the claimant in the Proceeds.

 

The Death Benefit Proceeds will be determined as of the date of the Insured's death and will be equal to the Death Benefit provided by the Death Benefit Option selected plus any additional benefits due under riders attached to this Policy. Policy Debt, and any unpaid Monthly Deductions from a death during a Grace Period, will be deducted from the Death Benefit Proceeds.

 

Death Benefit Option: The Death Benefit Option on the Policy Effective Date is the Level Death Benefit .

 

The Death Benefit will be the greater of:

 

(a)the Face Amount of insurance on the Insured's date of death; or

 

(b)a specified percentage of the Policy Value on the date of the Insured's death as indicated on the Table of Death Benefit Factors, shown on the Policy Schedule.

 

Payment of Death Benefit Proceeds: We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner's estate.

 

ICC25-VUL-18

 

 

Interest on Death Benefit Proceeds: Interest on Death Benefit Proceeds is payable from the date of death at the rate applicable to proceeds of life insurance left on deposit with the Company. Additional interest at an annual rate of 10% will be paid beginning on the 31st calendar day from the latest of the following, to the date the Proceeds are paid:

 

a)The date We receive due proof of death;

 

b)The date We receive sufficient information to determine our liability, the extent of that liability, if any, and to identify the payee legally entitled to the Proceeds; or,

 

c)The date We are provided with sufficient evidence that all legal impediments to the payment of Proceeds dependent on parties other than the Company have been resolved.

 

Settlement Options: Depending on the needs of the Beneficiary, a selection of Settlement Options may be available. Settlement Options are used to distribute Proceeds over a period of time rather than paying them in a lump sum. Proceeds from the Death Benefit and Full Surrenders may be applied to a Settlement Option. You may select or change a Settlement Option from those available while this Policy is in force and prior to the death of the Insured. If you do not select a Settlement Option, the Beneficiary may select a Settlement Option from among those available at that time, or may take the amount due immediately in a lump sum. The amount of payment benefits at the time of their commencement will not be less than those that would be provided by the application of a one sum payment to purchase a single premium immediate annuity contract at purchase rates offered by the Company at the time to the same class of annuitants.

 

 

CHANGING THIS POLICY

 

You may request, by Written Notice, any one of the following changes subject to certain conditions. We will send you a supplemental Policy Schedule or other acknowledgment to amend or endorse the Policy change and shows its effective date.

 

Increasing the Face Amount: On or after the first Policy Anniversary, you may submit a supplemental application for an increase in Face Amount. We reserve the right to require satisfactory proof of insurability. The Insured's current Attained Age must be less than the maximum Issue Age. The amount of any increase must be at least $10,000. Any increase approved by the Company will be effective on the effective date shown on the supplemental Policy Schedule which will be issued and attached to the Policy and will be subject to monthly cost of insurance deductions for the increase from the Policy Value of this Policy.

 

Additional premium payments may be required in connection with an increase in Face Amount. We will notify you if additional premium payments are required and specify the premium payments required on the supplemental Policy Schedule.

 

The cancellation provision on the cover of this Policy applies equally to any increase in Face Amount. However, if an increase is cancelled under this provision and no additional premium payments were required in order to increase the Face Amount, only the first monthly cost of insurance deduction and the administration fee for the increase in Face Amount will be credited back to the Sub-Accounts and Fixed Account in the proportion that each Sub-Account Value and the Fixed Account Value bears to the un-loaned Policy Value.

 

Decreasing the Face Amount: On or after the third Policy Anniversary you may request in writing a decrease in Face Amount subject to the following rules. Any decrease will go into effect on the Monthly Anniversary Day that falls on or next following the date We approve the Written Request for change. The decrease will first be applied against increases in Face Amount in the reverse order in which they occurred. It will then be applied against the Initial Face Amount. We reserve the right to prohibit any elected decrease for the three years following an increase in Face Amount, and for one Policy Year following the last elected decrease in Face Amount.

 

ICC25-VUL-18

 

 

The Face Amount remaining in effect after any decrease cannot be less than the Minimum Face Amount shown on the Policy Schedule. Decreasing the Face Amount may result in lower Monthly Deductions or a refund in premiums and earnings thereon. Decreasing the Initial Face Amount may result in a Surrender Charge, as described in the Policy Schedule. We reserve the right to refuse a decrease in Face Amount if such decrease would cause this Policy to fail to qualify as a life insurance contract under the Code.

 

Change Approval: All changes must be approved by the Administrative Office. No agent has the authority to make any changes or waive any of the terms of this Policy.

 

ICC25-VUL-18

 

 

 

 

 

 

 

 

 

 

THIS PAGE INTENTIONALLY LEFT BLANK

 

 

 

 

 

 

 

 

ICC25-VUL-18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

READ THE CONTRACT CAREFULLY

THIS POLICY IS A LEGAL CONTRACT BETWEEN THE OWNER AND THE COMPANY

INDIVIDUAL FLEXIBLE PREMIUM VARIABLE ADJUSTABLE LIFE INSURANCE POLICY

NON-DIVIDEND PAYING

 

 

 

ICC25-VUL-18

 

EX-99.(D)(2) 3 tm268049d1_ex99-xdx2.htm EXHIBIT 99.(D)(2)

 

Exhibit 99.(d)(2)

 

PROTECTIVE LIFE INSURANCE COMPANY

A Stock Company; Domiciled in [Nebraska]

[www.protective.com]

[P. O. Box 2606; Birmingham, Alabama 35202; (800) 866-9933]

 

 

LONG-TERM CARE RIDER

 

We have issued this rider as part of the Policy to which it is attached to provide for an acceleration of the death benefit under the policy for Long-Term Care Benefits to the Owner or the Owner's estate, during the life of the Insured and while this rider is in force. It is issued in consideration of the application and payment of the rider charges. Unless otherwise stated all Policy provisions not expressly modified by this rider remain in full force and effect. Where the Policy and this rider conflict the terms of this rider will be applied.

 

This is a long-term care rider providing coverage for Qualified Long-Term Care Services.

 

Caution: The issuance of this rider is based on your responses to the questions on your application. A copy of your application is attached to the Policy. If your answers are incorrect or untrue, We have the right to deny benefits or rescind your Policy. The best time to clear up any questions is now, before a claim arises. If, for any reason, any of your answers are incorrect, contact Us.

 

Notice To Buyer: This policy may not cover all the costs associated with long-term care incurred by the buyer during the period of coverage. The buyer is advised to review carefully all policy limitations.

 

TAX CONSEQUENCES: This rider is intended to be a qualified long-term care insurance contract under Section 7702B of the Internal Revenue Code, as amended. Benefits paid under this rider may be taxable. If any changes are necessary to your rider to conform to changes in the requirements of the Internal Revenue Code for tax-qualified riders, you will be given the right to accept or reject the changes. If you reject the changes, the rider may no longer be tax-qualified under the Internal Revenue Code. As with all tax matters, you should consult your personal tax advisor to assess the impact of this benefit.

 

Renewability: This rider is non-cancelable. We cannot change any of the terms of this rider on our own and cannot increase the LTC Monthly Charges shown on the Policy Schedule for this rider that is used to calculate the LTC Monthly Charges. This rider will remain in force for as long as the Policy remains in force, subject to the “Termination” provision of this rider and “Representations and Contestability” and “Termination” provisions of the Policy.

 

This rider is attached to a non-participating policy.

 

YOU HAVE THE RIGHT TO CANCEL THIS RIDER. If you decide not to keep this rider, return it to us or to the agent who sold it to you within thirty (30) days after it is first delivered to you. We will then cancel the rider and the Policy to which it is attached. The returned Policy and rider will be treated as if they had never been issued. The Company will promptly refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to the Company, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to the Company.

 

ICC26-LTC11

 

 

TABLE OF CONTENTS

 

 

DEFINITIONS 3  
LONG-TERM CARE BENEFIT 4  
DETERMINATION OF THE CURRENT LTC BENEFIT POOL 5  
DETERMINATION OF THE MAXIMUM MONTHLY LTC BENEFIT AMOUNT   6  
IMPACT OF POLICY CHANGES ON RIDER BENEFITS 6  
BENEFITS WHILE ON CLAIM 6  
RESIDUAL DEATH BENEFIT   7  
OPTIONAL LONG-TERM CARE INFLATION PROTECTION   7  
CLAIMS   7  
LTC RIDER MONTHLY CHARGE   9  
IMPACT ON POLICY   9  
NONFORFEITURE BENEFIT   10  
GENERAL PROVISIONS   10  

 

ICC26-LTC12

 

 

DEFINITIONS

 

Activities of Daily Living: Means the following six basic human functions necessary for a person to live independently:

 

1.Eating - The ability to feed oneself by getting food into the body from a receptacle (such as a plate, cup or table) or by a feeding tube intravenously.
2.Toileting - The ability to get to and from the toilet, getting on and off the toilet and performing associated personal hygiene.
3.Transferring - The ability to move into or out of a bed, chair or wheelchair.
4.Bathing - The ability to wash oneself by sponge bath; or in either a tub or shower, including the task of getting into or out of the tub or shower.
5.Dressing - The ability to put on and take off all items of clothing and any necessary braces, fasteners or artificial limbs.
6.Continence - The ability to maintain control of bowel and bladder function; or, when unable to maintain control of bowel or bladder function, the ability to perform associated personal hygiene (including caring for a catheter or colostomy bag).

 

Active Claim Status: Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.

 

Assistive Device: Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.

 

Chronically Ill: Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:

 

1.Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity; or
2.Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Severe Cognitive Impairment.

 

The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.

 

Elimination Period: Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and during which the Insured is receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.

 

Family Member: Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.

 

Hands-on Assistance: Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.

 

Home: Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision, or Substantial Assistance with Activities of Daily Living.

 

Insured: Means the person shown on the Policy Schedule upon whose life this Policy is issued.

 

ICC26-LTC13

 

 

Licensed Health Care Practitioner: Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.

 

Plan of Care: Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured’s needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured’s care requirements.

 

Qualified Long-Term Care Services: Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a Chronically Ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

 

Severe Cognitive Impairment: Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:

 

1.The Insured's short or long-term memory;
2.The Insured's orientation as to person (such as who they are), place (such as their location) or time (such as day, date, and year); and
3.The Insured's deductive or abstract reasoning.

 

Standby Assistance: Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.

 

Substantial Assistance: Means Hands-On Assistance or Standby Assistance.

 

Substantial Supervision: Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.

 

Written Certification: Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.

 

 

LONG-TERM CARE BENEFIT

 

Long-Term Care Benefit: While this rider is in force, you may make a claim for a Long-Term Care Benefit (the “LTC Benefit”). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met.

 

If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.

 

ICC26-LTC14

 

 

Eligibility for LTC Benefits: You will become eligible for the LTC Benefit payments during the life of the Insured when each of the following conditions are met:

 

1.We receive Your written request for the LTC Benefit;
2.We receive Written Certification;
3.The Policy and this rider are in force;
4.The Elimination Period has been satisfied;
5.We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy; and
6.The benefit payment is made in respect to a month when the insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

 

The Elimination Period only has to be satisfied once while this Policy is in force.

 

Unless you have requested a decrease in the Policy’s Face Amount or make a Withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown on the Policy Schedule minus the sum of any LTC Benefits paid under this rider. The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown on the Policy Schedule and the monthly benefit will be payable for at least the Initial LTC Benefit Minimum Number of Months shown on the Policy Schedule.

 

 

DETERMINATION OF THE CURRENT LTC BENEFIT POOL

 

The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:

 

1.The Base LTC Benefit Pool;
2.The Protected LTC Benefit Pool; and
3.The Market Value LTC Benefit Pool.

 

On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month’s Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals, or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the “Benefits While on Claim” provision below.

 

Base LTC Benefit Pool: On the Policy Effective Date, the Base LTC Benefit Pool is equal to the Base LTC Benefit Pool shown on the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the “Optional Long-Term Care Inflation Protection”, and “Impact of Policy Changes on Rider Benefits” provisions.

 

Market LTC Benefit Pool: The Market LTC Benefit Pool is equal to the unloaned Policy Value multiplied by the Market Benefit Multiplier shown on the Policy Schedule for this rider. This pool may increase or decrease daily and is adjusted as described in the “Optional Long-Term Care Inflation Protection” provision.

 

Protected LTC Benefit Pool: The Protected LTC Pool on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on the Policy Schedule) multiplied by the unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on the Policy Schedule for this rider.

 

On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:

 

1.The Protected LTC Percentage of the unloaned Policy Value (shown on the Policy Schedule) as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier; and
2.The Protected LTC Pool in effect immediately prior to that Policy Anniversary.

 

The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to Optional Inflation Protection Increases, LTC Benefit payments, Withdrawals, loans, and policy changes.

 

ICC26-LTC15

 

 

DETERMINATION OF THE MAXIMUM MONTHLY LTC BENEFIT AMOUNT

 

The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date.

 

The Maximum Monthly LTC Benefit Amount is equal to:

 

1.The Base Maximum Monthly LTC Benefit Amount plus
2.80% of the result of the following:
a)1/48 of the Current LTC Benefit Pool minus
b)the Base Maximum Monthly LTC Benefit Amount.

 

On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, the Maximum Monthly LTC Benefit Amount may increase and/or decrease as described in the “Benefits While on Claim” provision below.

 

Base Maximum Monthly LTC Benefit Amount: On the Policy Effective Date, the Base Maximum Monthly LTC Benefit Amount is equal to the amount shown on the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the “Optional Long-Term Care Inflation Protection” and “Impact of Policy Changes on Rider Benefits” provisions.

 

 

IMPACT OF POLICY CHANGES ON RIDER BENEFITS

 

Increases in Face Amount: If you request an increase in the Policy’s Face Amount after the Effective Date, the Base LTC Benefit Pool and the Base Maximum Monthly LTC Benefit will be increased proportionally to the increase in the Policy’s Face Amount. The Protected LTC Benefit Pool may be increased.

 

Decreases in Face Amount: If the Policy’s Face Amount decreases either by request or as a result of a Withdrawal under the Policy, the Base LTC Benefit Pool and the Base Maximum Monthly LTC Benefit will be decreased proportionally to the decrease in the Policy’s Face Amount. The Protected LTC Benefit Pool may be decreased.

 

 

BENEFITS WHILE ON CLAIM

 

On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date.

 

Any amount paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.

 

An Optional Inflation Protection increase will increase the Base Monthly LTC Benefit and the Base LTC Benefit Pool and may increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the “Optional Long-Term Care Inflation Protection” provision.

 

An increase and/or decrease in the Policy’s Face Amount or a Withdrawal under the Policy may likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the “Impact of Policy Changes on Rider Benefits” provisions.

 

If Your claim is closed as described in the "Transition Off Claim" provision, the remaining Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any of the remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the “Determination of the Current LTC Benefit Pool” and “Determination of The Maximum Monthly LTC Benefit Amount” provisions, but will be floored at the remaining Current LTC Benefit Pool and the Maximum Monthly LTC Benefit at the time of the transfer.

 

ICC26-LTC16

 

 

RESIDUAL DEATH BENEFIT

 

If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:

 

1.5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment; and
2.$10,000.

 

The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.

 

 

OPTIONAL LONG-TERM CARE INFLATION PROTECTION

 

If You have selected Optional Inflation Protection, a 5% compound Optional Inflation Protection increase will occur on each Policy Anniversary, with no Evidence of Insurability. The Optional Inflation Protection election in effect on the Policy Issue Date is shown on the Policy Schedule for this rider. Every annual Optional Inflation Protection increase will be factored into the calculation of the following values: Base Maximum Monthly LTC Value, Base LTC Limit Value, Current Maximum Monthly LTC Value, Current LTC Limit Value, if any.

 

You may choose to decline the annual Optional Inflation Protection increase at any time during a Policy Year, provided we receive notification no later than five (5) business days before your Policy Anniversary. This decision will take effect on the subsequent Policy Anniversary date. After any declination, no further Optional Inflation Protection increases will occur on any future Policy Anniversary. The Optional Inflation Protection increases under this rider cannot be reinstated once declined.

 

The annual Optional Inflation Protection increases will continue without regard to the Insured’s age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:

 

1.You have not declined an annual Optional Inflation Protection increase;
2.The LTC Benefit Limit is greater than zero; and
3.This rider remains in force.

 

On the Policy Anniversary on which you decline the Optional Inflation Protection increase, the following will occur:

 

1.All future annual Optional Inflation Protection increases will terminate; and
2.You will no longer be charged the Optional Inflation Protection monthly LTC charge.

 

Even if you terminate future Optional Inflation Protection increases, any previously purchased Optional Inflation Protection increases will continue to be included in the calculation of benefits under this rider.

 

 

CLAIMS

 

Notice of Claim: We must receive your intention to file a claim for the LTC Benefit at our Administrative Office via Written Notice and Request or telephone. The request should include at least the Insured's name, the Policy number and the address to which claim forms should be sent.

 

ICC26-LTC17

 

 

Claim Forms: We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you provide Written Certification and Proof of Loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.

 

Proof of Loss: Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Certification from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date proof would otherwise be required.

 

Re-certification: At least once every 12 months after the initial certification, but not more frequently than once every 90 days, you must provide us with a re-certification from a Licensed Health Care Practitioner indicating that the Insured remains Chronically Ill.  The practitioner must either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification.  After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be required or conducted until at least a 90-day period has passed.

 

Physical Examination: We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, Eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agreed upon by the Insured and the Company. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.

 

Transition Off Claim: If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Policy Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the remaining Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.

 

If, on the date your claim is closed, the Policy’s Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any of the remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as described in the “Determination of The Maximum Monthly LTC Benefit Amount” and “Determination of the Current LTC Benefit Pool” provisions, but will be floored at the remaining Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount at the time of the transfer.

 

Extension of LTC Benefits: If the Policy to which this rider is attached terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:

 

1.The death of the Insured;
2.Transition from Active Claim Status has completed; or
3.The Current Maximum LTC Benefit has been exhausted.

 

Any Extension of Benefit is subject to all terms and conditions of this rider including Eligibility for LTC Benefits and Claim requirements. If any LTC Benefit payments have been made under this provision only the Residual Death Benefit will be due upon the death of the Insured.

 

Cross Border Claims: LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issued. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.

 

ICC26-LTC18

 

 

International Claims: According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.

 

 

LTC RIDER MONTHLY CHARGE

 

We will calculate the LTC Monthly Charges for this rider on each Monthly Anniversary Day and the monthly charge for this rider will be added to the Monthly Deduction.

 

For every month the Insured is not on claim, the LTC Monthly Charge is determined by adding 1 and 2 below:

 

1.The result of dividing the Base LTC Benefit Pool on the Monthly Anniversary by 1,000 and then multiplying that result by the LTC Base Monthly Charge shown on the Schedule; and
2.The result of subtracting the Base LTC Benefit Pool from the Current LTC Benefit Pool on the Monthly Anniversary, dividing that result by 1,000 and then multiplying the result by the LTC Excess Monthly Charge shown on the Schedule.

 

For every date the Insured is on claim, as of the date the claim is approved, and for every month the Insured remains on claim the LTC Monthly Charges for this rider will be waived.

 

The LTC Monthly Charges for this rider are shown on the Policy Schedule and will not increase. The charges vary by the Insured’s Issue Age, sex, Rate Class and Optional Inflation Protection (if elected).

 

If any increase in the Policy’s Face Amount is issued at a more favorable Rate Class than the Rate Class shown in the Schedule, the more favorable Rate Class will be used to determine the LTC Monthly Charges for this rider from that date forward.

 

If you do not purchase that year’s Optional Inflation Protection on any Policy Anniversary, the LTC Monthly Charges for this rider will be reduced from that date forward to reflect that change, as described in the “Optional Long-Term Care Inflation Protection” provision.

 

 

IMPACT ON POLICY

 

Account Value Transfer: Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, the Variable Account Value will be transferred to the Fixed Account. The restrictions outlined in the "Transfers" provision of the Policy will not be enforced.

 

While on Active Claim Status Fixed Account Values may not be transferred to any Sub-Account and Net Premiums received will be allocated to the Fixed Account.

 

Impact of LTC Benefit Payments on Face Amount: While the Policy’s Face Amount is greater than zero, benefit payments under this rider will reduce the Policy’s Face Amount dollar for dollar. This change may reduce the Policy’s Face Amount below the minimum as described in the Policy.

 

Impact of Benefit Payments on Policy Values: While the Policy Value is greater than zero, benefit payments under this rider will reduce the Policy Value dollar for dollar.

 

Effect on Monthly Deductions: When this rider is Active Claim Status, Monthly Deductions required to maintain the Policy continue; however, the LTC rider Monthly Charge will be waived.

 

ICC26-LTC19

 

 

Policy Changes, Loans and Withdrawals: When this rider is Active Claim Status, Policy Changes, Loans and Withdrawals are not permitted.

 

Interaction with Terminal Illness Accelerated Death Benefit Endorsement: Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under the Terminal Illness Accelerated Death Benefit Endorsement.

 

 

NONFORFEITURE BENEFIT

 

After the Policy and this rider have been in force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:

 

1.the death of the Insured; or
2.the date the LTC Nonforfeiture Benefit Limit has been reduced to zero.

 

The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:

 

1.one month’s Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates; or
2.an amount equal to the sum of Monthly rider Charges paid for this rider.

 

The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider lapses or terminates and will not change.

 

The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Optional Inflation Protection increases.

 

No benefits are payable under this provision until benefits, if any, under the “Extension of LTC Benefits” provision are no longer in effect. The sum of any benefits paid under the “Extension of LTC Benefits” provision plus any benefits paid under this “Nonforfeiture Benefit” provision will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.

 

 

GENERAL PROVISIONS

 

Commission Standards: This rider was approved under the authority of the Interstate Insurance Product Regulation Commission ("the Commission") and issued under the Commission standards. Any provision of this rider, as of the Effective Date, that is in conflict with the applicable Commission's standards for this product type in effect as of the provision's effective date of the Commission policy approval, is hereby amended to conform to the applicable Commission standards in effect as for the provisions effective date of Commission policy approval.

 

Exclusions: We will not pay Long-Term Care Benefits for any Chronic Illness caused by any of the following:

 

1.Any attempt at suicide or intentionally self-inflicted injury, while sane or insane.
2.Committing or attempting to commit a felony.
3.Alcoholism or drug addiction.
4.Declared or undeclared war or any act of war.
5.Participation in a riot or insurrection.
6.Involvement in an illegal occupation.

 

ICC26-LTC110

 

 

Pre-Existing Condition Limitation: We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by or received from a provider of health care services, within six months preceding the effective date of this rider.

 

Protection Against Unintended Lapse: To protect against unintended lapse, you may designate at least one person other than the Owner to receive notices about potential lapse or termination of the Policy due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the additional person for services provided to the Insured.

 

Termination: This rider will terminate on the earliest of:

 

1.Your written notice to terminate this rider. If you request to terminate this rider, the Policy to which it is attached will also be terminated; We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination;
2.Termination of the Policy to which this rider is attached;
3.Failure to pay sufficient premium to maintain the rider;
4.The death of the Insured;
5.Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness endorsement or rider attached to the Policy;
6.The date that the Current Maximum LTC Benefit is exhausted;
7.The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.

 

Contestability: In determining whether to issue this rider, we relied on the statements in the application made by and for the Insured. We acknowledge these statements are representations, not warranties. We have the right to void and rescind this rider or resist an otherwise valid claim based on a misstatement in any application we accept and make part of the Policy as follows:

 

1.If this rider has been in force for less than 6 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was material to the issuance of this rider.
2.If this rider has been in force for at least 6 months but less than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was material to the issuance of this rider and pertains to the condition for which benefits are sought.
3.If this rider has been in force for more than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the Insured knowingly and intentionally misrepresented relevant facts relating to the Insured's health.

 

Reinstatement: If the Policy to which this rider is attached terminates and is subsequently reinstated, this rider may also be reinstated subject to the following:

 

1.Your request to reinstate must be received by Us within 6 months from the date of lapse;
2.We must receive a reinstatement application from You. However, If We 1) collected a reinstatement application from You; 2) issued a conditional receipt or interim insurance agreement for premium collected; and 3) did not provide written notice of approval or disapproval by the 45th day following the date of conditional receipt or interim insurance agreement, this rider will be automatically reinstated on the 45th day;
3.We must receive: 1) Evidence of Insurability satisfactory to Us; or 2) proof that You were Chronically Ill before the Policy Grace Period expired and the request for reinstatement must be received by Us within 5 months from the date of lapse;
4.You must pay sufficient premium to keep this rider in force from the reinstatement date to the next premium due date; and
5.You must pay past due premiums with interest at the annual rate of 6%.

 

ICC26-LTC111

 

 

If, after the Grace Period ends, We or our agent accepted premium without requiring an application for reinstatement of this rider, this rider shall be automatically reinstated.

 

Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement. The reinstated rider is subject to the Representations and Contestability provision in the Policy beginning on the date of reinstatement.

 

Your rights and Ours under the rider will be the same as they were just before the rider terminated, subject to any provisions attached to the reinstated Policy.

 

 

 

Signed for the Company as of the Effective Date.

 

PROTECTIVE LIFE INSURANCE COMPANY

[]

[Melinda L. Peevy]

[Secretary]

 

ICC26-LTC112

EX-99.(D)(3) 4 tm268049d1_ex99-xdx3.htm EXHIBIT 99.(D)(3)

 

Exhibit 99.(d)(3)

 

PROTECTIVE LIFE INSURANCE COMPANY

A Stock Company; Domiciled in [Nebraska]

[www.protective.com]

 

[P. O. Box 2606; Birmingham, Alabama 35202; (800) 866-9933]

 

 

 

 

LAPSE PROTECTION ENDORSEMENT

 

 

We have issued this endorsement as a part of the Policy to which it is attached to add Lapse Protection provisions to the Policy. All Policy provisions not expressly modified by this endorsement remain in full force and effect.

 

Definition of Month: The period of time that elapses between any two Monthly Anniversary Days.

 

Lapse Protection Guarantee: The Policy will not lapse during the Maximum Lapse Protection Period shown on the current Policy Schedule as long as:

1.the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirements; and
2.the Policy Debt does not exceed the Cash Value.

 

Lapse Protection Net Premium (“LPNP”): The amount after the deduction of the Lapse Protection Premium Expense Charge for that Policy Year, shown on the Policy Schedule, from each Premium payment.

 

Accumulated Net Payments Received ("ANPR"): Accumulated Net Payments Received is calculated as of the last day of the Month. For each Month the ANPR is equal to:

 

1.the ANPR for the prior Month ($0 for the first Month of the first Policy Year); plus
2.the sum of all LPNP received since the beginning of the Month; plus
3.the Lapse Protection Interest for the Month; less
4.the reduction in Policy Value for any Withdrawals taken and any applicable Surrender Charges assessed since the beginning of the Month.

 

Lapse Protection Interest: Lapse Protection Interest is calculated as:

 

1.the lesser of the Accumulated Fund Threshold and the sum of 1 plus 2 of the ANPR provision, multiplied by the Threshold Accumulation Factor, shown on the Policy Schedule; plus
2.the amount of 1 plus 2 of the ANPR provision in excess of the Accumulated Fund Threshold, if any, multiplied by the Excess Accumulation Factor, shown on the Policy Schedule.

 

Accumulated Minimum Monthly Requirements ("AMMR"): The Accumulated Minimum Monthly Requirements each Month is equal to:

 

1.the AMMR as of the prior Month ($0 for the first Month of the first Policy Year) plus the Minimum Monthly Requirement, shown on the Policy Schedule, for the Month; multiplied by
2.one plus the Threshold Accumulation Factor.

 

Accumulated Fund Threshold: For the first Month of a Policy Year the Accumulated Fund Threshold is equal to:

 

1.the Accumulated Fund Threshold for the prior Month ($0 for the first Month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor; plus
2.the Annual Threshold Premium, shown on the Policy Schedule, for that Policy Year.

 

For all other Months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior Month multiplied by one plus the Threshold Accumulation Factor.

 

ICC25-VUL-E54Page 1

 

 

If the Policy is being maintained under the Lapse Protection provision, Monthly Deductions continue.

 

Based on guaranteed assumptions, the Policy Value at the end of the Maximum Lapse Protection Period may not be sufficient to keep the policy in force unless additional premiums are paid. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of the Maximum Lapse Protection Period.

 

Any decrease in Face Amount, including adjustments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.

 

During the Maximum Lapse Protection Period, any change to the benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement along with its/their new Effective Date, will be provided to you on a supplemental Policy Schedule.

 

No Accessible Value: The Lapse Protection provisions of this endorsement do not represent accessible Policy Value available to you, or the beneficiary, for any purpose whatsoever.

 

Termination: This endorsement terminates when the Policy to which it is attached terminates.

 

Reinstatement: If the Policy to which this endorsement is attached is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.

 

 

Signed for the Company as of the Policy Effective Date.

 

PROTECTIVE LIFE INSURANCE COMPANY

[]

[Melinda L. Peevy]

[Secretary]

 

ICC25-VUL-E54Page 2

EX-99.(E)(1) 5 tm268049d1_ex99-xex1.htm EXHIBIT 99.(E)(1)

 

Exhibit 99.(e)(1)

 

 

 

 

Policy Number: ________________________

 

 

 

Protective Life Insurance Company

 

[P.O. Box 830619]

 

[Birmingham, AL 35283-0619]

 

 

INDIVIDUAL LIFE INSURANCE APPLICATION (PART I)

 

1.  Proposed Insured  
  a.    Title  
  b.    First Name  
  c.     Middle Initial  
  d.    Last Name  
  e.    Suffix  
  f.      Gender  
  g.    Birthdate  
  h.    Birth State  
  i.      Birth Country  
  j.      Marital Status  
  k.     Phone Number(s)  
  l.      Driver’s License Number and State  
  m.   Social Security or Tax ID Number  
  n.    Email Address  
  o.    Residential Address  
  p.    Length of Time at Residence  
     
2. Employment Information  
  a.    Employer’s Name  
  b.    Employer’s Address  
  c.     Number of Years Employed  
  d.    Annual Income  
  e.    Net Worth  
     
3. a)   Owner (If other than Proposed Insured)  
  1.    Name  
  2.    Date of Trust  
  3.    Birthdate  
  4.    Relationship to Proposed Insured  
  5.    Social Security or Tax ID Number  
  6.    Email Address  
  7.    Residential Address  
     
  b)  Joint Owner (If applicable)  
  1.    Name  
  2.    Date of Trust  
  3.    Birthdate  
  4.    Relationship to Proposed Insured  
  5.    Social Security or Tax ID Number  
  6.    Email Address  
  7.    Residential Address  

 

ICC23-PL-EA1-P1[ Page 1 of 5 ]10/23

 

 

4. Beneficiary Designations – If multiple beneficiaries are named, shares will be divided equally among the surviving beneficiaries, unless otherwise specified.  
   
  a)   [ Primary Beneficiary(ies):  
1.    Name  
2.    Address  
3.    Phone Number  
4.    Birthdate  
5.    Social Security Number  
6.    Relationship to Insured  
7.    Percentage ]  

 

b) [ Contingent Beneficiary(ies):

 
1.    Name  
2.    Address  
3.    Phone Number  
4.    Birthdate  
5.    Social Security Number  
6.    Relationship to Insured  
7.    Percentage ]  
   
5. Plan of Insurance  
  a.    Product Name:  
  b.    Face Amount:  
  c.     If Term or Alternative to Term, Indicate Years:  
 

d.    Underwriting Class Quoted:

(Protective will issue the best underwriting

class.)

 
  e.    If Applicable, Death Benefit:   [ Level / Increasing ]
  f.      Section 1035:    [ Yes / No ]
  g.    1035 Loan Transfer :    [ Yes / No ]
  h.    If Applicable, Death Benefit Compliance Test: [ Cash Value Accumulation Test / Guideline Premium Test ]
  i.      Is Proposed Insured Requesting Additional Benefits, Riders, or Child Coverage?   [ Yes / No ]
  j.      Premium Payment Mode and Amount:  
             (Cash payment with application, Annual, Quarterly, Semi-Annual Payments; or Monthly Pre-Authorized Withdrawal)  
     
     

 

ICC23-PL-EA1-P1[ Page 2 of 5 ]10/23

 

 

6. Regarding the Proposed Insured:
  a)            Should this application be considered a potential replacement or modification of any existing life insurance or annuity? [ Yes / No ]
  b)            List all life insurance information for any policy(ies) in force on your life, whether owned by you or not.  If None, insert None.  
  1.      [ Company:  
  2.     Policy Number:  
  3.     Replace: [ Yes / No ]
  4.     Amount:  
  5.     Insurance Type:  
  6.     Issue Date: ]  
     

Remarks and Explanations to any Yes answers.

 

 

 

DECLARATIONS
 
I have read or have had read to me the completed Application before signing below.  I represent that all statements and answers made in all parts of this application are full, complete and true, to the best of my knowledge and belief and I have not withheld any material information that may influence the assessment or acceptance of this application.  I agree to inform Protective Life Insurance Company of any material changes before the insurance goes into effect.  It is agreed that:
 
1. All such statements and answers shall be the basis of any insurance issued, and my (our) answers are material to the decision as to whether the risk is accepted by Protective Life.
   
2. No representative or medical examiner can make, alter or discharge any contract, accept risks, or waive Protective Life’s rights or requirements.
   
3. Acceptance of a policy by the Owner shall constitute ratification of any changes made by the Company.  In those states where it is required, changes as to plan, amount, age at issue, classification or benefits will be made only with the Owner’s written consent.
   
4. No insurance shall take effect unless:  (1) a policy is delivered to the Owner; (2) the full first premium is paid while the proposed insured(s) is (are) alive; and (3) there has been no change in health and insurability from that described in this application.  However, if the premium is paid as set forth in the Conditional Receipt Agreement, if any, and the Conditional Receipt Agreement is delivered to the Owner, the terms of the Conditional Receipt Agreement shall apply.  No representative or medical examiner has any authority to waive or to alter these terms and conditions or to bind coverage under any other circumstances.
   
5. I have reviewed the Conditional Receipt Agreement, if any, and understand and agree that it provides a limited amount of life insurance for a limited period of time, and that such coverage is subject to the terms and conditions set forth in the Conditional Receipt Agreement.
   
6. The representative taking this application, if any, has made no statement or representation different from, contrary to or in addition to these Declarations and the terms and conditions of the attached Conditional Receipt Agreement.
 

 

ICC23-PL-EA1-P1[ Page 3 of 5 ]10/23

 

 

IMPORTANT INFORMATION ABOUT IDENTIFICATION VERIFICATION
 
To help the government fight the funding of terrorism and money laundering activities, Federal Law requires all financial institutions to obtain, verify, and record information of its customers.  We may ask for information or identifying documents that will allow us to verify the identity of our customers.
 
Any person who knowingly presents a false statement in an application for insurance may be guilty of a criminal offense and subject to penalties under state law.

 

 

Signatures:

 

 

 
Proposed Insured Signature  
   
   
 
Proposed Insured CityStateDate
   
   
 
Owner Signature (If Owner is other than the Proposed Insured)
   
   
 
Owner CityStateDate
   
   
 
Joint Owner Signature (If applicable)  
   
   
 
Joint Owner CityStateDate
   
   
 
Legal Guardian Signature (If applicable)  
   
   
   
 
Legal Guardian CityStateDate
   

 

ICC23-PL-EA1-P1[ Page 4 of 5 ]10/23

 

 

 

 

 

AGENT / BROKER ATTESTATION:

 

 

 

Will this policy replace or change any existing life insurance policy(ies) or annuity(ies)? [ Yes / No ]

 

 

 

 

What is your relationship to the Proposed Insured? _______________________________________________________________

 

 

 

I hereby certify that my electronic approval was provided and serves as my signature for legal and regulatory purposes for this application.

 

 

 

 

Electronic Signature of _____________________________________________________________________________________

Agent Full Name

 

 

 

 

Was obtained on __________________________________________________________________________________________

Signature Timestamp

 

 

 

________________________________________________________________________________________________________

Agent Number

 

 

 

 

________________________________________________________________________________________________________

Agent Phone Number

 

 

 

 

________________________________________________________________________________________________________

Broker Dealer or Broker General Agent (If applicable)

 

 

 

 

 

ICC23-PL-EA1-P1[ Page 5 of 5 ]10/23

 

EX-99.(F)(1)(II) 6 tm263879d5_ex99-xfx1xii.htm EXHIBIT 99.(F)(1)(II)

 

  NE Sec of State - Robed B. Evnen
  Filing Document #: 2412235205        Pages: 7
  Company Name: PROTECTIVE LIFE INSURANCE COMPANY
  Filing Date and Time: 12/26/2024 04:44 PM

 

   

NEBRASKA DEPT OF INSURANCE

 

DEC 19 2024

 

Tentative Approval

NOT FINAL

 

 

ARTICLES OF DOMESTICATION

OF

PROTECTIVE LIFE INSURANCE COMPANY

 

 

 

For the purpose of its redomestication from the State of Tennessee to the State of Nebraska, pursuant to the applicable provisions of Chapter 44 of the Nebraska Insurance Code and the Nebraska Model Business Corporation Act, the undersigned hereby executes the following Articles of Domestication ("the Articles"):

 

ARTICLE 1

 

The name of the Company immediately before the filing of the Articles is Protective Life Insurance Company.

 

ARTICLE 2

 

The Company was originally incorporated under the laws of Tennessee on July 24, 1907.

 

ARTICLE 3

 

The domestication of the Company in the State of Nebraska was duly authorized as required by the laws of the State of Tennessee.

 

Execution Version

Protective Life Insurance Company

Articles of Domestication

STATE OF NEBRASKA

DEPARTMENT OF INSURANCE

 

JAN 03 2024

 

APPROVED

 

 

 

 

 

IN WITNESS WHEREOF, Protective Life Insurance Company has caused these Articles of Domestication to be executed in duplicate in its corporate name and its corporate seal to be affixed hereto by its duly authorized officers, this 19th day of December, 2024.

 

  Protective Life Insurance Company
   
  By: /s/ Richard J. Bielen
  Richard J. Bielen
  President, Chief Executive Officer, and Chairman of the Board

 

STATE OF ALABAMA )
  )
COUNTY OF JEFFERSON )

 

I HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State and County aforesaid to take acknowledgements, Richard J. Bielen, Charmain of the Board of Protective Life Insurance Company, personally appeared before me and acknowledges the execution of the foregoing Articles of Domestication of Protective Life Insurance Company, and who having been duly sworn, stated that any representations therein contained are true.

 

WITNESS my hand and Notarial Seal in the County and State last aforesaid, the 19th day of December, 2024.

 

  /s/ Vanessa Ricaurte
  NOTARY PUBLIC

 

{SEAL}

 

Execution Version

Protective Life Insurance Company

Articles of Domestication

 

 

 

 

   

NEBRASKA DEPT OF INSURANCE

 

DEC 19 2024

 

Tentative Approval

NOT FINAL

 

 

AMENDED AND RESTATED

ARTICLES OF INCORPORATION

OF

PROTECTIVE LIFE INSURANCE COMPANY

 

 

 

WHEREAS, Protective Life Insurance Company ("the Company") was originally incorporated in 1907 under the laws of Tennessee; and

 

WHEREAS, the Company now desires to amend and restate its Amended and Restated Charter (the "Charter") in connection with the redomestication of the Company from the State of Tennessee to the State of Nebraska pursuant to the Nebraska Model Business Corporation Act and Chapter 44 of the Nebraska Insurance Code, and these Articles of Incorporation amend and restate the provisions of the Charter and all restatements thereof and amendments thereto.

 

WHEREAS, the Company in connection with the redomestication of the Company from the State of Tennessee to the State of Nebraska pursuant to the Nebraska Model Business Corporation Act, the Company has filed Articles of Domestication with the Nebraska Secretary or State.

 

NOW THEREFORE, the Company hereby adopts the following Amended and Restated Articles of Incorporation:

 

ARTICLE 1
NAME

 

The name of the Company shall be Protective Life Insurance Company.

 

ARTICLE 2
DURATION

 

The duration of the Company shall be perpetual.

 

ARTICLE 3

PURPQSES, OBJECTS AND POWERS

 

The purposes, objects and powers of the Company are:

 

a.To engage in any lawful business, act or activity for which a corporation may be organized under the Nebraska Model Business Corporation Act, it being the purpose and intent of this Article 3 to invest the Company with the broadest purposes, objects and powers lawfully permitted a corporation formed under the said Act.

 

 

STATE OF NEBRASKA

DEPARTMENT OF INSURANCE

 

JAN 03 2024

 

APPROVED

 

 

 

 

b.To carry on any and all aspects, ordinary or extraordinary, of any lawful business and to enter into and carry out any transaction, ordinary or extraordinary, permitted by law, having and exercising in connection therewith all powers given to corporations by the laws of the State of Nebraska.

 

c.Without limiting the scope and generality of the foregoing, the Company shall have the following specific purposes, objects and powers:

 

1.To transact the business of life, disability, health and accident insurance and to issue annuities and endowments and every other kind of insurance in such places as may be approved by the Board of Directors subject to applicable regulatory approvals, including without limitation, to transact the business of insuring the lives of individuals and the writing of every kind of insurance pertaining to life, including the granting, selling, purchasing and disposing of annuities and endowments; to accept risks and insure against accidents or sickness; to effect reinsurance; and generally to make all contracts and to do and perform all things whatsoever pertaining to the business of insuring lives and of taking risks against accidents or sickness, or the granting, selling, purchasing and disposing of annuities and endowments; all in a manner not inconsistent with the laws of the State of Nebraska or the provisions hereof.

 

2.To have and to exercise any and all of the powers specifically granted in the insurance laws of the State of Nebraska, none of which shall be deemed to be inconsistent with the nature, character or object of the Company and none of which are denied to it by these Amended and Restated Articles of Incorporation, including, without limitation, the power to accept and execute all legal trusts which may be confided to the Company.

 

ARTICLE 4

CAPITAL STOCK

 

The Company is authorized to issue five million (5,000,000) shares of stock, one dollar ($1.00) par value per share. All such shares are to be of one class and shall be designated as Common Stock. The shareholders of the Company shall not have preemptive rights.

 

ARTICLE 5

REGISTERED AGENT AND REGISTERED OFFICE

 

C T Corporation System shall serve as the registered agent. The business address of the registered agent and the registered office address is 5601 South 59th Street, Suite C, Lincoln, Nebraska 68516.

 

The principal place of business of the Company shall be in Omaha, Nebraska or at such other city within the State of Nebraska as the Board of Directors may determine or at such city as the Board of Directors may determine provided such city complies with applicable law. The

 

 

 

 

Company may establish branches and agencies in any other part of the State of Nebraska, in other states or territories of the United States, or in the District of Columbia.

 

ARTICLE 6

BOARD OF DIRECTORS

 

The business and affairs of the Company shall be managed by the Board of Directors. The number of directors of the Company shall be fixed from time to time in the manner provided in the Bylaws, or, in the absence of a by-law fixing or providing a manner of determining the number of directors. The number of directors shall be determined by the shareholders. The Board of Directors shall consist of at least five (5) or more individuals, with the number specified in or fixed in accordance with the Bylaws, and no decrease in the number of directors shall have the effect of shortening the term of any incumbent director. Any director may be removed in accordance with the provisions of the Bylaws and the laws of the State of Nebraska.

 

To the fullest extent permitted by the Nebraska Model Business Corporation Act as in effect on the date hereof and as hereafter amended from time to time, a director of the Company shall not be liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director. If the Nebraska Model Business Corporation Act or any successor statute is amended after adoption of this provision to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Nebraska Model Business Corporation Act, as so amended from time to time, provided, in no event shall a director be exempt from any obligation imposed by Chapter 44, Nebraska Code Annotated. Any repeal or modification of this Article 7 by the shareholders of the Company shall not adversely affect any right or protection of a director of the Company existing at the time of such repeal or modification or with respect to events occurring prior to such time.

 

In addition to the powers and authorities bereinbefore or by statute expressly conferred upon them, the directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Company; subject, nevertheless, to the provisions of the Code of Nebraska, these Amended and Restated Articles of Incorporation and to any Bylaws from time to time adopted; provided, however, that no Bylaws so adopted shall invalidate any prior act of the directors which would have been valid if such Bylaw had not been adopted.

 

ARTICLE 8

INTERNAL AFFAIRS

 

The following provisions for the regulation of the business and for the conduct of the affairs of the Company, the directors and the shareholders are hereby adopted:

 

 

 

 

The power to alter, amend, or repeal the Bylaws or adopt new Bylaws shall be vested in the Board of Directors and the shareholders, or either of them, which power may be exercised in the manner and to the extent provided in the Bylaws, provided, however, that the Board of Directors may not alter, amend or repeal any Bylaw establishing what constitutes a quorum at such shareholders' meetings, or which was adopted by the shareholders and specifically provides that it cannot be altered, amended or repealed by the Board of Directors. The Bylaws may contain any provisions for the regulation of the business and for the conduct of the affairs of the Company, the directors and shareholders not inconsistent with these Amended and Restated Articles of Incorporation.

 

The Company reserves the right from time to time to amend, alter or repeal each and every provision contained in these Amended and Restated Articles of Incorporation, or to add one or more additional provisions, in the manner now or hereafter prescribed or permitted by the Nebraska Insurance Code or the Nebraska Model Business Corporation Act, and all rights conferred upon shareholders at any time are granted subject to this reservation.

 

IN WITNESS WHEREOF, Protective Life Insurance Company has caused these Amended and Restated Articles of Incorporation to be executed in the duplicate for it by its President and Chairman of the Board and by its Secretary this 19th day of December, 2024.

 

  PROTECTIVE LIFE INSURANCE COMPANY
   
  By: /s/ Richard J. Bielen
  Richard J. Bielen
  President, Chief Executive Officer, and Chairman of the Board
   
  By: /s/ Felicia Malloch Lee
  Felicia Malloch Lee
  Secretary

 

 

 

 

 

STATE OF ALABAMA )
  )
COUNTY OF JEFFERSON )

 

I HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State and County aforesaid to take acknowledgements, Richard J. Bielen, Charmain of the Board of Protective Life Insurance Company, personally appeared before me and acknowledges the execution of the foregoing Amended and Restated Articles of Incorporation of Protective Life Insurance Company, and who having been duly sworn, stated that any representations therein contained are true.

 

WITNESS my hand and Notarial Seal in the County and State last aforesaid, the 19th day of December, 2024.

 

  Vanessa Ricaurte
  NOTARY PUBLIC

 

{SEAL}

 

 

 

EX-99.(F)(2)(II) 7 tm263879d5_ex99-xfx2xii.htm EXHIBIT 99.(F)(2)(II)

 

 STATE OF NEBRASKA
 DEPARTMENT OF INSURANCE
  
 JAN 14 2025
  
 FILED

 

AMENDED AND RESTATED BYLAWS

OF

PROTECTIVE LIFE INSURANCE COMPANY

(herein called the "Company")

 

ARTICLE I
OFFICES

 

The principal place of business and statutory home office of the Company shall be in Omaha, Nebraska. The administrative office of the Company shall be in Birmingham, Jefferson County, Alabama, or at any such other place as the Board of Directors may determine or at such place as the Board of Directors may determine provided such place complies with applicable law.

 

ARTICLE II

SHAREHOLDERS

 

Section 1.     Meetings. The annual meeting of the shareholders for the purpose of electing directors and for the transaction of such other business as may come before the meeting shall be held at such date and time during the calendar year as shall be specified by resolution of the Board of Directors. Special meetings of the shareholders may be called for any purposes by the Board of Directors, the Executive Committee or the chief executive officer.

 

Section 2.     Place of Meeting. The place of meeting shall be the administrative office of the Company in the State of Alabama unless some other place, either within or without the State of Nebraska, is designated by the shareholders or by the Board of Directors.

 

Section 3.     Notice of Meeting. Written or printed notice stating the place, day and hour of the meeting and, in case of a special meeting, the purpose or purposes for which the meeting is called, shall be delivered not less than ten, or, in the case it is proposed to increase the stock or bonded indebtedness of the Company, not less than thirty nor more than sixty days before the date of the meeting, either personally or by mail or e-mail, by or at the direction of the Board of Directors, the chief executive officer, or the Secretary to each shareholder of record entitled to vote at such meeting. If sent by email, such notice shall be deemed to be delivered when sent. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at the address as it appears on the stock transfer books of the Company, with postage thereon prepaid.

 

Section 4.     Fixing of Record Date. For the purpose of determining shareholders entitled to notice of or to vote at any meeting of shareholders or any adjournment thereof, or shareholders entitled to receive payment of any dividend, or in order to make a determination of shareholders for any other purpose, the Board of Directors of the Company may fix in advance a date as the record date for any such determination of shareholders, such date in any case to be not more than seventy days and, in case of a meeting of shareholders, not less than ten days prior to the date on which the particular action, requiring such determination of shareholders, is to be taken. If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of shareholders.

 

Section 5.     Proxies. At all meetings of shareholders, a shareholder may vote by proxy executed in writing by the shareholder or by his duly authorized attorney in fact. Such proxy shall be filed with the

 

 

 

 

Secretary of the Company before or at the time of the meeting. No proxy shall be valid after eleven months from the date of its execution, unless otherwise provided in the proxy.

 

Section 6.     Voting of Shares. Each outstanding share entitled to vote shall be entitled to one vote upon each matter submitted to a vote at a meeting of shareholders.

 

Section 7.     Voting of Shares by Certain Holders. Shares held by another corporation if a majority of the shares entitled to vote for the election of directors of such other corporation is held by the Company shall not be voted at any meeting or counted in determining the total number of outstanding shares at any given time. Treasury shares and shares of stock held by the Company in a fiduciary capacity shall not be voted directly or indirectly, at any meeting, and shall not be counted in determining the total number of outstanding shares at any given time.

 

Section 8.     Informal Action by Shareholders. Any action required to be taken at a meeting of the shareholders, or any other action which may be taken at a meeting of the shareholders, may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the shareholders entitled to vote with respect to the subject matter thereof.

 

ARTICLE III

BOARD OF DIRECTORS

 

Section 1.     General Powers. The business and affairs of the Company shall be managed by its Board of Directors.

 

Section 2.     Number, Tenure and Qualifications. The number of directors of the Company shall be fixed from time to time by resolution of the shareholders; provided that the Board shall consist of a range from at least five (5) persons to no more than twenty (20) persons, and that no decrease in the number of directors shall have the effect of shortening the term of any incumbent director. Each director shall hold office until the next annual meeting of shareholders and until his successor shall have been elected and qualified or until there is a decrease in the number of directors. Directors need not be shareholders or residents of the state of the Company's domicile except as otherwise provided by law or by the shareholders of the Company.

 

Section 3.     Regular Meetings. Regular meetings may be held either within or without the state of the Company's domicile, if permitted by law, without notice.

 

Section 4.     Special Meetings. Special meetings of the Board of Directors of any committee designated thereby may be called by or at the request of the President, the chief executive officer, or any two directors. A special meeting of the Board of Directors or of any committee designated thereby shall be held at the administrative office of the Company, provided that by resolution, or by waiver signed by all directors, it may be held at any other place, either within or without the state of the Company's domicile.

 

Section 5.     Notice. Notice of any special meeting shall be given at least one day previously thereto by written notice giving the date, time and place of the meeting delivered personally or mailed to each director at his business address, or by telegram or e-mail. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail so addressed, with postage thereon prepaid. If notice be given by telegram or e-mail, such notice shall be deemed to be delivered when the telegram is delivered to the telegraph company, or when the e-mail is sent. If sent by facsimile transmission, electronic mail or other electronic transmission, such notice shall be deemed to be delivered when sent. Any director may waive notice of any meeting. The attendance of a director at a meeting shall constitute

 

 

 

 

a waiver of notice of such meeting, except where a director attends a meeting for the express purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened.

 

Section 6.     Quorum. A majority of the number of directors fixed in the manner provided by Section 2 of this Article III shall constitute a quorum for the transaction of business at any meeting of the Board of Directors, but if less than such majority is present at a meeting, a majority of the directors present may adjourn the meeting from time to time without further notice. If a quorum is present when a meeting is convened, the directors present may continue to do business taking action by a vote of a majority of a quorum until adjournment, notwithstanding the withdrawal of enough directors to leave less than a quorum or the refusal of any director present to vote. Notwithstanding the foregoing provisions of this section to the contrary, in the event of an emergency caused by an enemy attack, or a natural or other disaster, or other occurrence that creates an emergency, as declared by the President, the chief executive officer or senior officer on site, at each meeting of the Board during such emergency the presence of one-third of the total number of directors, but in any event not less than two directors, shall constitute a quorum and be sufficient for the transaction of business.

 

Section 7.     Manner of Acting. The act of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. Members of the Board of Directors or of any committee thereof may participate in a meeting of the Board or committee by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other at the same time and participation by such means shall constitute presence in person at a meeting.

 

Section 8.     Vacancies. Any vacancy occurring in the Board of Directors may be filled by the affirmative vote of a majority of the remaining directors, though less than a quorum of the Board of Directors. A director elected to fill a vacancy shall be elected until the next annual meeting of shareholders. Any directorship to be filled by reason of an increase in the number of directors shall be filled by election at an annual meeting or at a special meeting of shareholders called for that purpose.

 

Section 9.     Committees. The Board of Directors may, by resolution or resolutions adopted by a majority of the full Board of Directors, designate one or more committees, each committee to consist of 1 (one) or more of the directors of the Company, which, to the extent provided in such resolution or resolutions, shall have and may during intervals between the meetings of the Board exercise the powers of the Board of Directors in the management of the business and affairs of the Company and may have power to authorize the seal of the Company to be affixed to all papers which may require it; provided, however, that no such committee shall have the authority of the Board of Directors in reference to: authorize distributions, except according to a formula or method prescribed by the Board of Directors; fill vacancies on the Board of Directors or on any of its committees; adopt, amend or repeal the bylaws of the Company; authorize or approve reacquisition of shares, except according to a formula or method prescribed by the Board of Directors; or authorize or approve the issuance or sale or contract for sale of shares or determine the designation and relative rights, preferences, and limitations of a class or series of shares, except that the Board of Director's may authorize a committee (or senior executive officer of the Company) to do so within limits specifically prescribed by the Board of Directors. Such committee or committees shall have such name or names as may be determined from time to time by resolution or resolutions adopted by the Board of Directors. The designation of any such committee or committees and the delegation thereto of authority shall not operate to relieve the Board of Directors, or any member thereof, of any responsibility imposed upon it or him/her by law.

 

Section 10.     Informal Action. Any action required or permitted under the Nebraska corporate or insurance laws, the Articles of Incorporation or these bylaws to be taken at any meeting of the Board of Directors or of

 

 

 

 

any committee thereof may be taken without a meeting, if a written consent setting forth the action so taken is signed by all members of the Board of Directors or of such committee, as the case may be. Such written consent shall be filed with the minutes of proceedings of the Board of Directors or committee.

 

Section 11.     Removal of Directors. At any meeting of shareholders, including a meeting called expressly for that purpose, one or more directors may be removed, with or without cause, by a vote of the holders of a majority of shares then entitled to vote at an election of directors and the shareholders may at such meeting elect a successor director or directors for the unexpired term of the director or directors removed.

 

ARTICLE IV
OFFICERS

 

Section 1.     Number. The officers of the Company shall be a President and a Secretary and, in the discretion of the Board of Directors which may leave one or more offices vacant from time to time, a Chairman of the Board, one or more Executive Vice Presidents, Senior Vice Presidents, Vice Presidents, Second Vice Presidents (the number thereof to be determined by the Board of Directors), a Treasurer, one or more Assistant Secretaries and Assistant Treasurers and such other officers and assistant officers as may be deemed necessary by the Board of Directors. All such officers shall be elected for a term of one year and shall by subject to removal by the Board of Directors at its pleasure. Such officers shall perform such duties and exercise such powers as are conferred by the Board of Directors or as are conferred herein. The Board of Directors may designate one of such elected officers the chief executive officer of the Company. The Board of Directors or the chief executive officer, by and with the consent and approval of the Board of Directors or of the Executive Committee if any, may appoint such other officers and agents as, in its or his discretion, are required for the proper transaction of the Company's business. The same individual may simultaneously hold more than one office in a corporation, except the offices of President and Secretary. The Board of Directors shall be and is hereby authorized to adopt and amend from time-to-time Bylaws to be effective in the event of an emergency caused by an enemy attack, dealing with or making provisions during such emergency for continuity of management, succession to the authority and duties of officers, vacancies in office, alternative offices or other matters deemed necessary or desirable to enable the Company to carry on its business and affairs.

 

Section 2.     Chairman of the Board. Any director may be designated as Chairman of the Board and shall preside, when present, at all meetings of the shareholders and of the Board of Directors. The Chairman of the Board shall perform such other duties as from time to time may be assigned to him/her by the Board of Directors.

 

Section 3.     President. Subject to the control of the Board of Directors, the President shall have general management and control of the affairs and business of the Company, and shall perform all other duties and exercise all other powers commonly incident to his office, or which are or may at any time be authorized or required by law. He/She shall keep the Board of Directors fully informed concerning the affairs and business of the Company. The Board of Directors may by resolution designate the officer of the Company who in the event of the death, unavailability or incapacity of the President shall perform the duties of the President until the Board of Directors shall designate another person to perform such duties.

 

Section 4.     Vice Presidents. Each Vice President shall have powers and perform such duties as shall from time to time be assigned to him/her by these bylaws or by the Board of Directors and shall have and may be assigned to him/her by the chief executive officer.

 

 

 

 

Section 5.     Other Authority of Officers. The Chairman of the Board of Directors and the President may sign and execute all authorized bonds, contracts or other obligations in the name of the Company, and with the Secretary or an Assistant Secretary, may sign all certificates of shares of the capital stock of the Company, and do and perform such other acts and things as may from time to time be assigned to each of them by the Board of Directors. The chief executive officer, the President, the Treasurer or such other officers as are authorized by the Board of Directors may enter into contracts in the name of the Company or sell and convey any real estate or securities now or hereafter belonging to the Company and execute any deeds or written instruments of transfer necessary to convey good title thereto and each of the foregoing officers, or the Secretary or the Treasurer of the Company, is authorized and empowered to satisfy and discharge of record any mortgage or deed of trust now or hereafter of record in which the Company is a grantee or of which it is the owner, and any such satisfaction and discharge heretofore or hereafter so entered by any such officer shall be valid and in all respects binding on the Company.

 

Section 6.     Secretary. The Secretary shall attend all meetings of the shareholders, and record all votes and the minutes of all proceedings in a book to be kept for that purpose, and shall perform like duties for the Board and its committees as required. He/She shall give or cause to be given, notice of all meetings of the shareholders and of the Board of Directors. He/She shall record all transfers of stock, and cancel and preserve all certificates of stock transferred, and shall keep a record, alphabetically arranged, of all persons who are shareholders of the Company, showing their places of residence and the number of shares of stock held by them respectively. The Secretary shall also be the transfer agent of the Company for the transfer of all certificates of stock ordered by the Board of Directors, and shall affix the seal of the Company to all certificates of stock or other instruments requiring the seal. He/She shall keep such other books and perform such other duties as may be assigned to him/her from time to time. The Board of Directors may designate a bank or trust company as transfer agent of the Company stock, in which case such transfer agent shall perform all duties above set forth relative to transfers of such stock.

 

Section 7.     Treasurer. The Treasurer shall have custody of all the funds and securities of the Company, and shall perform such duties as may from time to time be assigned to him/her by the Board of Directors or the chief executive officer.

 

Section 8.     Assistant Secretaries and Assistant Treasurers. The Assistant Secretaries may sign with the President certificates for shares of the Company the issuance of which shall have been authorized by a resolution of the Board of Directors. The Assistant Treasurers shall, respectively, if required by the Board of Directors, give bonds for the faithful discharge of their duties in such sums and with such sureties as the Board of Directors shall determine. The Assistant Secretaries and Assistant Treasurers, in general, shall perform such duties as shall be assigned to them by the Secretary or the Treasurer, respectively, or by the President or the Board of Directors.

 

Section 9.     Election and Term of Office. The officers of the Company to be elected by the Board of Directors shall be elected annually by the Board of Directors at the first meeting of the Board of Directors held after each annual meeting of the shareholders. If the election of officers shall not be held at such meeting, such election shall be held as soon thereafter as conveniently may be. Each officer shall hold office until his successor shall have been duly elected and shall have qualified or until his death or until he/she shall resign or shall have been removed in the manner hereinafter provided.

 

Section 10.     Removal. The Chief Executive Officer, Chairman of the Board, or President may be removed, with or without cause, at any time by action of the Board of Directors. Any other officer elected by the Board of Directors may be removed, with or without cause, at any time, by action of the Board of Directors or the Executive Committee, if any. Any other officer, agent or employee, including

 

 

 

 

any officer, agent or employee appointed by the Board of Directors, may be removed, with or without cause, at any time by the Board of Directors, the Chief Executive Officer, the Executive Committee, if any, or the superior officer to whom authority to so remove has been delegated by these bylaws or by the Chief Executive Officer.

 

Section 11.     Vacancies. A vacancy in any office elected or appointed by the Board of Directors because of death, resignation, removal, disqualification or otherwise, may be filled by the Board of Directors for the unexpired portion of the term. A vacancy in any other office for any reason shall be filled by the Board of Directors, or any committee, or superior officer to whom authority in the premises may have been delegated by these bylaws or by resolution of the Board of Directors.

 

ARTICLE V

CONTRACTS, LOANS, CHECKS AND DEPOSITS

 

Section 1.     Contracts. The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of and on behalf of the Company, and such authority may be general or confined to specific instances.

 

Section 2.     Loans. No loans shall be contracted on behalf of the Company and no evidence of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances. Notwithstanding anything herein to the contrary, any loans to directors who are not also employees of the Company or a subsidiary thereof, or the use of the credit of the Company to assist same, shall require authorization in the particular case by shareholders of the Company, and any loans to employees, whether or not directors, of the Company or of any subsidiary shall be made only in compliance with the applicable law of the domiciliary state.

 

Section 3.     Checks, Drafts, etc. All checks, drafts or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the Company shall be signed by such officer or officers, agent or agents of the Company and in such manner as shall from time to time be determined by resolution of the Board of Directors.

 

Section 4.     Deposits. All funds of the Company not otherwise employed shall be deposited from time to time to the credit of the Company in such banks, trust companies or other depositaries as the Board of Directors may select.

 

Section 5.     Proxies. Unless otherwise provided by resolution of the Board of Directors, the Chief Executive Officer may from time to time appoint an attorney or agent of the Company, in the name and on behalf of the Company, to cast the votes which the Company may be entitled to cast as the holder of stock or other securities in any other corporation any of whose stock or securities may be held by the Company, at meetings of the holders of the stock or other securities of such other corporation, or to consent in writing, in the name and on behalf of the Company as such holder, to any action by such other corporation, and may instruct the person or persons so appointed as to the manner of casting such votes or giving such consent, and may execute or cause to be executed, in the name and on behalf of the Company and under its corporate seal or otherwise, all such written proxies or other instruments as he/she may deem necessary or proper in the premises.

 

ARTICLE VI

CERTIFICATES FOR SHARES AND THEIR TRANSFER

 

Section 1.     Certificates of Shares. Certificates may be issued for whole or fractional shares. Certificates representing shares of the Company shall be in such form as shall be determined by the

 

 

 

 

Board of Directors. Such certificates shall be signed in the manner provided by the Model Business Corporation Act of the domiciliary state and any act amendatory thereof, supplementary thereto or substituted therefore. All certificates for shares shall be consecutively numbered or otherwise identified. The name and address of the person to whom the shares represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Company. All certificates surrendered to the Company for transfer shall be canceled and no new certificate shall be issued until the former certificate for a like number of shares shall have been surrendered and canceled, except that in case of a lost, destroyed or mutilated certificate a new one may be issued therefore upon such terms and indemnity to the Company as the Board of Directors may prescribe.

 

Section 2.     Transfer of Shares. Transfer of shares of the Company shall be made only on the stock transfer books of the Company by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney thereunto authorized by power of attorney duly executed and filed with the Secretary of the Company, and on surrender for cancellation of the certificate for such shares. The person in whose name shares stand on the books of the Company shall be deemed by the Company to be the owner thereof for all purposes.

 

ARTICLE VII
FISCAL YEAR

 

The fiscal year of the Company shall begin on the first day of January and end on the 31st day of December in each year.

 

ARTICLE VIII
DIVIDENDS

 

The Board of Directors may from time to time declare, and the Company may pay, dividends on its outstanding shares in the manner and upon the terms and conditions provided by law and the Articles of Incorporation.

 

ARTICLE IX

SEAL

 

The corporate seal shall have inscribed thereon the name of the Company and the words "Corporate Seal," including the name of the state of domicile. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or otherwise reproduced.

 

ARTICLE X

WAIVER OF NOTICE

 

Whenever any notice is required to be given to any shareholder or director of the Company under the provisions of these by-laws, the Articles of Incorporation, the provisions of the Nebraska Model Business Corporation Act of the domiciliary state or the domiciliary state Insurance Code and any act amendatory thereof, supplementary thereto or substituted therefore, or the domiciliary state Constitution, a waiver thereof in writing, signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice.

 

 

 

 

ARTICLE XI

INDEMNIFICATION

 

In amplification and not in limitation of applicable provisions of the Insurance Code of the state of domicile and the Model Business Corporation Act of the state of domicile:

 

(a)            The Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed claim, action, suit or proceeding, whether civil, criminal, administrative or investigative, including appeals (other than an action by or in the right of the Company), by reason of the fact that he/she is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him/her in connection with such claim, action, suit or proceeding if he/she acted in good faith and in a manner he/she reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any claim, action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he/she reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful.

 

(b)            The Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed claim, action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that he/she is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him/her in connection with the defense or settlement of such action or suit if he/she acted in good faith and in a manner he/she reasonably believed to be in or not opposed to the best interests of the Company and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to the Company unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.

 

(c)            To the extent that a director, officer, employee or agent of the Company has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b), or in defense of any claim, issue or matter therein, he/she shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by him/her in connection therewith, notwithstanding that he/she has not been successful on any other claim, issue or matter in any such action, suit or proceeding.

 

(d)           Any indemnification under subsections (a) and (b) (unless ordered by a court) shall be made by the Company only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because he/she has met the applicable standard of conduct set forth in subsections (a) and (b).

 

 

 

 

Such determination shall be made (1) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been wholly successful on the merits or otherwise with respect to, such claim, action, suit or proceeding, or (2) if such a quorum is not obtainable, or even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (3) by the shareholders.

 

(e)            Expenses (including attorneys' fees) incurred in defending a civil or criminal claim, action, suit or proceeding may be paid by the Company in advance of the final disposition of such claim, action, suit or proceeding as authorized in the manner provided in subsection (d) upon receipt of an undertaking by or on behalf of the director, officer, employee or agent to repay such amount if and to the extent that it shall ultimately be determined that he/she is not entitled to be indemnified by the Company as authorized in this Section.

 

(f)            The indemnification authorized by this Section shall not be deemed exclusive of and shall be in addition to any other riots to which those indemnified may be entitled under any statute, rule of law, provision of articles of incorporation, bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

 

(g)           The Company shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him/her and incurred by him/her in any such capacity or arising out of his status as such, whether or not the Company would have the power to indemnify him/her against such liability under the provisions of this Section.

 

ARTICLE XII
AMENDMENTS

 

Section 1.     Power of Directors to Amend. The Board of Directors shall have power to alter, amend and repeal the bylaws of the Company or adopt new bylaws for the Company at any regular or special meeting of the Board, provided that the Board of Directors may not alter, amend or repeal any bylaw which establishes what constitutes a quorum at such shareholders' meetings, or which was adopted by the shareholders and specifically provides that it cannot be altered, amended or repealed by the Board of Directors.

 

Section 2.     Power of Shareholders to Amend. The shareholders may alter, amend, or repeal the bylaws of the Company or adopt new bylaws for the Company at any annual meeting or at a special meeting, and all bylaws made by the directors may be altered or repealed by the shareholders.

 

 

 

 

The foregoing are hereby certified by the undersigned officer of Protective Life Insurance Company to be a true and accurate copy of the Amended and Restated Bylaws of Protective Life Insurance Company and to be in full force and effect this date.

 

Given under my hand and the seal of the Company this 26 day of December, 2024.

 

  
 President

 

[CORPORATE SEAL]

 

 

 

EX-99.(N)(1) 8 tm268049d1_ex99-xnx1.htm EXHIBIT 99.(N)(1)

 

Exhibit (n)(1)

 

Consent of Independent Registered Public Accounting Firm

 

 

We consent to the use of our report dated April 1, 2026, with respect to the financial statements of Protective Life Insurance Company, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the Statement of Additional Information.

 

/s/ KPMG LLP

 

Birmingham, Alabama

April 23, 2026

 

 

 

Consent of Independent Registered Public Accounting Firm

 

 

We consent to the use of our report dated April 20, 2026, with respect to the financial statements of the subaccounts that comprise Protective Variable Life Separate Account, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the Statement of Additional Information.

 

/s/ KPMG LLP

 

Birmingham, Alabama

April 23, 2026

 

 

EX-99.(N)(2) 9 tm263879d5_ex99-xnx2.htm EXHIBIT 99.(N)(2)

 

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

 

 

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned Directors of Protective Life Insurance Company, a Nebraska corporation (the “Company’), by his or her execution hereof or upon an identical counterpart hereof, does hereby constitute and appoint Richard J. Bielen, Bradford D. Rodgers, Bradley A. Strickling, Lindsay A. Thorpe, and Brandon J. Cage and each of them (with full power to each of them to act alone), as my true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for me and in my name, place and stead, in any and all capacities to execute (either in writing or electronically) on behalf of the Company or its separate accounts relating to annuity contracts and life insurance policies registered under the Securities Act of 1933 and/or the Investment Company Act of 1940, the “Registration Statements,” as defined below, and any and all amendments thereto, together with all exhibits, instruments, and other documents necessary or appropriate in connection therewith, and to file the same with the Securities and Exchange Commission or any other federal or state regulatory authority as may be necessary or desirable, hereby ratifying and confirming all and every act and thing requisite to all intents and purposes that said attorney-in-fact and agent or his or her substitute, may lawfully do or cause to be done by virtue hereof. This Power of Attorney does not revoke any prior power of attorney. This Power of Attorney shall not be revoked by any subsequent power of attorney I may execute, unless such subsequent power of attorney specifically revokes this Power of Attorney or specifically states that the instrument is intended to revoke all prior powers of attorney.

 

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

 

Contract Name

Registration
Statement
Securities Act

File Number

Separate Account Name

Separate Account
Investment
Company Act

File Number

Aspirations 333-261426 Protective Variable Annuity Separate Account 811-8108
Dimensions 333-176657 Protective Variable Annuity Separate Account 811-8108
Dimensions IV 333-233415 Protective Variable Annuity Separate Account 811-8108
Dimensions V 333-267354 Protective Variable Annuity Separate Account 811-8108
Investors Series 333-190294 Protective Variable Annuity Separate Account 811-8108
Premiere II-III 333-52215 Protective Variable Life Separate Account 811-7337
Protective DualCare VUL 333-292264 Protective Variable Life Separate Account 811-7337
Protective Executive Benefits Registered VUL 333-248236 Protective COLI VUL 811-23604
Protective Investors Benefit Advisory 333-237747 Protective Variable Annuity Separate Account 811-8108
Protective Investors Benefit Advisory VUL 333-267465 Protective Variable Life Separate Account 811-7337
Protective Variable Annuity II B Series 333-201919 Protective Variable Annuity Separate Account 811-8108
Protective Market Defender Annuity 333-278664 N/A N/A

 

 

 

 

Protective Market Defender II Annuity 333-271426 N/A N/A
PVA B Series, C Series, L Series 333-179649 Protective Variable Annuity Separate Account 811-8108
Schwab Genesis Variable Annuity 333-240192 PLICO Variable Annuity Account S 811-23593
Schwab Genesis Advisory Variable Annuity 333-240102 PLICO Variable Annuity Account S 811-23593
Strategic Objectives II VUL 333-232740 Protective Variable Life Separate Account 811-7337
Values 333-112892 Protective Variable Annuity Separate Account 811-8108
Values Advantage 333-113070 Protective Variable Annuity Separate Account 811-8108

 

IN WITNESS WHEREOF, I have hereunto set my hand this 10th day of March, 2026.

 

/s/ Richard J. Bielen  
Richard J. Bielen  
   
WITNESS TO ALL SIGNATURES:  
   
   
/s/ Brandon J. Cage  
Brandon J. Cage  
Vice President and Managing Counsel  
Attorney-in-Fact  
Protective Life Insurance Company  

 

 

 

 

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

 

 

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned Directors of Protective Life Insurance Company, a Nebraska corporation (the “Company’), by his or her execution hereof or upon an identical counterpart hereof, does hereby constitute and appoint Richard J. Bielen, Bradford D. Rodgers, Bradley A. Strickling, Lindsay A. Thorpe, and Brandon J. Cage and each of them (with full power to each of them to act alone), as my true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for me and in my name, place and stead, in any and all capacities to execute (either in writing or electronically) on behalf of the Company or its separate accounts relating to annuity contracts and life insurance policies registered under the Securities Act of 1933 and/or the Investment Company Act of 1940, the “Registration Statements,” as defined below, and any and all amendments thereto, together with all exhibits, instruments, and other documents necessary or appropriate in connection therewith, and to file the same with the Securities and Exchange Commission or any other federal or state regulatory authority as may be necessary or desirable, hereby ratifying and confirming all and every act and thing requisite to all intents and purposes that said attorney-in-fact and agent or his or her substitute, may lawfully do or cause to be done by virtue hereof. This Power of Attorney does not revoke any prior power of attorney. This Power of Attorney shall not be revoked by any subsequent power of attorney I may execute, unless such subsequent power of attorney specifically revokes this Power of Attorney or specifically states that the instrument is intended to revoke all prior powers of attorney.

 

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

 

Contract Name

Registration
Statement
Securities Act

File Number

Separate Account Name

Separate Account
Investment
Company Act

File Number

Aspirations 333-261426 Protective Variable Annuity Separate Account 811-8108
Dimensions 333-176657 Protective Variable Annuity Separate Account 811-8108
Dimensions IV 333-233415 Protective Variable Annuity Separate Account 811-8108
Dimensions V 333-267354 Protective Variable Annuity Separate Account 811-8108
Investors Series 333-190294 Protective Variable Annuity Separate Account 811-8108
Premiere II-III 333-52215 Protective Variable Life Separate Account 811-7337
Protective DualCare VUL 333-292264 Protective Variable Life Separate Account 811-7337
Protective Executive Benefits Registered VUL 333-248236 Protective COLI VUL 811-23604
Protective Investors Benefit Advisory 333-237747 Protective Variable Annuity Separate Account 811-8108
Protective Investors Benefit Advisory VUL 333-267465 Protective Variable Life Separate Account 811-7337
Protective Variable Annuity II B Series 333-201919 Protective Variable Annuity Separate Account 811-8108
Protective Market Defender Annuity 333-278664 N/A N/A

 

 

 

 

Protective Market Defender II Annuity 333-271426 N/A N/A
PVA B Series, C Series, L Series 333-179649 Protective Variable Annuity Separate Account 811-8108
Schwab Genesis Variable Annuity 333-240192 PLICO Variable Annuity Account S 811-23593
Schwab Genesis Advisory Variable Annuity 333-240102 PLICO Variable Annuity Account S 811-23593
Strategic Objectives II VUL 333-232740 Protective Variable Life Separate Account 811-7337
Values 333-112892 Protective Variable Annuity Separate Account 811-8108
Values Advantage 333-113070 Protective Variable Annuity Separate Account 811-8108

 

IN WITNESS WHEREOF, I have hereunto set my hand this 10th day of March, 2026.

 

 

/s/ Wade V. Harrison  
Wade V. Harrison  
   
WITNESS TO ALL SIGNATURES:  
   
   
/s/ Brandon J. Cage  
Brandon J. Cage  
Vice President and Managing Counsel  
Attorney-in-Fact  
Protective Life Insurance Company  

 

 

 

 

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

 

 

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned Directors of Protective Life Insurance Company, a Nebraska corporation (the “Company’), by his or her execution hereof or upon an identical counterpart hereof, does hereby constitute and appoint Richard J. Bielen, Bradford D. Rodgers, Bradley A. Strickling, Lindsay A. Thorpe, and Brandon J. Cage and each of them (with full power to each of them to act alone), as my true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for me and in my name, place and stead, in any and all capacities to execute (either in writing or electronically) on behalf of the Company or its separate accounts relating to annuity contracts and life insurance policies registered under the Securities Act of 1933 and/or the Investment Company Act of 1940, the “Registration Statements,” as defined below, and any and all amendments thereto, together with all exhibits, instruments, and other documents necessary or appropriate in connection therewith, and to file the same with the Securities and Exchange Commission or any other federal or state regulatory authority as may be necessary or desirable, hereby ratifying and confirming all and every act and thing requisite to all intents and purposes that said attorney-in-fact and agent or his or her substitute, may lawfully do or cause to be done by virtue hereof. This Power of Attorney does not revoke any prior power of attorney. This Power of Attorney shall not be revoked by any subsequent power of attorney I may execute, unless such subsequent power of attorney specifically revokes this Power of Attorney or specifically states that the instrument is intended to revoke all prior powers of attorney.

 

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

 

Contract Name

Registration
Statement
Securities Act

File Number

Separate Account Name

Separate Account
Investment
Company Act

File Number

Aspirations 333-261426 Protective Variable Annuity Separate Account 811-8108
Dimensions 333-176657 Protective Variable Annuity Separate Account 811-8108
Dimensions IV 333-233415 Protective Variable Annuity Separate Account 811-8108
Dimensions V 333-267354 Protective Variable Annuity Separate Account 811-8108
Investors Series 333-190294 Protective Variable Annuity Separate Account 811-8108
Premiere II-III 333-52215 Protective Variable Life Separate Account 811-7337
Protective DualCare VUL 333-292264 Protective Variable Life Separate Account 811-7337
Protective Executive Benefits Registered VUL 333-248236 Protective COLI VUL 811-23604
Protective Investors Benefit Advisory 333-237747 Protective Variable Annuity Separate Account 811-8108
Protective Investors Benefit Advisory VUL 333-267465 Protective Variable Life Separate Account 811-7337
Protective Variable Annuity II B Series 333-201919 Protective Variable Annuity Separate Account 811-8108
Protective Market Defender Annuity 333-278664 N/A N/A

 

 

 

 

Protective Market Defender II Annuity 333-271426 N/A N/A
PVA B Series, C Series, L Series 333-179649 Protective Variable Annuity Separate Account 811-8108
Schwab Genesis Variable Annuity 333-240192 PLICO Variable Annuity Account S 811-23593
Schwab Genesis Advisory Variable Annuity 333-240102 PLICO Variable Annuity Account S 811-23593
Strategic Objectives II VUL 333-232740 Protective Variable Life Separate Account 811-7337
Values 333-112892 Protective Variable Annuity Separate Account 811-8108
Values Advantage 333-113070 Protective Variable Annuity Separate Account 811-8108

 

IN WITNESS WHEREOF, I have hereunto set my hand this 10th day of March, 2026.

 

 

/s/ Paul R. Wells  
Paul R. Wells  
   
   
WITNESS TO ALL SIGNATURES:  
   
   
/s/ Brandon J. Cage  
Brandon J. Cage  
Vice President and Managing Counsel  
Attorney-in-Fact  
Protective Life Insurance Company  

 

 

 

EX-99.(Q)(1) 10 tm268049d1_ex99-xqx1.htm EXHIBIT 99.(Q)(1)

 

Exhibit 99.(q)(1)

 

PROTECTIVE LIFE LIFE INSURANCE COMPANY

 

DESCRIPTION OF ISSUANCE, TRANSFER, AND REDEMPTION PROCEDURES FOR
FLEXIBLE PREMIUM VARIABLE AND FIXED LIFE INSURANCE POLICIES

 

Pursuant to Rule 6e-3(T)(b)(12)(iii)

 

This document sets forth the administrative procedures that will be followed by Protective Life Insurance Company (“Protective Life” or the “Company”) concerning the issuance of an individual Flexible Premium Variable and Fixed Life Insurance Policy (the “Policy”), the transfer of assets held thereunder, and the redemption by Owners of their interests in such Policy.

 

I. PROCEDURES RELATING TO ISSUANCE AND PURCHASE OF POLICIES

 

A. Application and Underwriting

 

Upon receipt of a completed application, the Company will follow underwriting (e.g., evaluation of risks) procedures designed to determine whether the applicant is insurable. The underwriting policies of the Company are established by management. The Company uses information from the application and, in some cases, inspection reports, attending physician statements, or medical examinations to determine whether a Policy should be issued as applied for, rated, or rejected. Medical examinations of applicants are required for Policies in excess of certain prescribed amounts and for most insurance applied for by applicants over age 40. Medical examinations are requested of any applicant, regardless of age and amount of requested coverage, if an examination is deemed necessary to underwrite the risk. Substandard risks may be referred to reinsurers for full or partial reinsurance of the substandard risk.

 

The Company requires blood samples to be drawn for applications of coverage over $50,000 (ages 16-70) and all amounts ages 71 and greater. Blood samples are tested for a wide range of chemical values and are screened for antibodies to the HIV virus. Applications also contain questions permitted by law regarding the HIV virus which must be answered by the proposed Insureds. The Company will not issue a Policy until the underwriting procedures have been completed.

 

Insurance coverage under a Policy will begin as of the Policy Effective Date, which is generally the Issue Date. If, an initial minimum premium is received with an application, the Policy Effective Date will be the later of the date that the application is signed or any required medical examination is completed. Temporary life insurance coverage (including various types of conditional receipt) may be provided under the terms of the temporary life insurance (or conditional receipt) agreement. In accordance with the terms of the such agreements, temporary life insurance coverage may not exceed $500,000 (including any life insurance and accidental death benefits then in force or applied for with the Company) and may not be in effect for more than 60 days.

 

In order to obtain a more favorable Issue Age, the Company may permit Owners to “backdate” a Policy by electing a Policy Effective Date which is up to six months prior to the date of the original application; state restrictions may apply. Charges for the Monthly Deductions for the backdated period are deducted as of the new Policy Effective Date.

 

B. Initial Premium Processing and Premium Payments

 

Premiums for the Policies will not be the same for all Owners. The Company requires that the initial premium payment for a Policy be at least equal to the minimum required for the mode of premium selected. For example, the initial premium payment must be at least $150. Premiums paid on a preauthorized checking withdrawal basis must be at least $50.

 

For Policies issued in states where, upon cancellation during the Cancellation Period, the Company returns at least the Owner’s premium payments, the Company reserves the right to allocate the initial Net Premium Payment (and any subsequent Net Premium Payments made during the Cancellation Period) to the available money market Sub-Account or the Fixed Account until the expiration of the number of days in the Cancellation Period plus six

 

 

 

days starting from the date the Policy is mailed from the Home Office. Upon expiration of this period, the Policy Value in the applicable money market Sub-Account or the Fixed Account and all Net Premium Payments will be allocated according to the Owner’s allocation instructions then in effect. In all other states, the Company will allocate the initial Net Premium Payment (and any subsequent Net Premium Payments made during the Cancellation Period) in accordance with the Owner’s instructions.

 

Following the initial premium, the Owner may pay planned premiums on a quarterly, semi-annual, or annual basis, or other period under a pre-authorized payment arrangement. For the first Policy Year, the amount of the planned premiums can be no less than the minimum initial premium payment calculated on an annual basis. The minimum initial premium payment required depends on a number of factors, including the age, sex, and rate class of the proposed Insured, the initial face amount, any supplemental benefits and/or riders and the Planned Periodic Premiums selected. If the Owner fails to pay the planned premiums, the Policy may lapse.

 

An Owner may make unscheduled premium payments, at any time. Unless a Policy is otherwise protected by the lapse protection provision, a Policy will remain in force while the cash surrender value is sufficient to pay the Monthly Deductions. The amount of premium, if any, which must be paid to keep the Policy in force, depends upon the cash surrender value of the Policy, which in turn depends on such factors as the investment experience and the amount of Monthly Deductions which includes cost of insurance. While not every Insured is subject to the same cost of insurance rate, there will be a single “rate” for every Insured in a given actuarial category.

 

The cost of insurance rate for a Policy is based on and varies with the Issue Age, duration, sex and rate class of the Insured, Face Amount, and on the number of years that a Policy has been in force. Protective Life currently places Insureds in the following rate class based on underwriting: Standard Unismoke (30-70).

 

Protective Life will determine a cost of insurance rate for increments of Face Amount above the Initial Face Amount based on the Issue Age, duration, sex and rate class of the Insured at the time of the request for an increase. The following rules will apply for purposes of determining the Net Amount at Risk for each rate.

 

Protective Life places the Insured in a rate class when the Policy is issued, based on Protective Life’s underwriting of the application. This original rate class applies to the Initial Face Amount. When an increase in Face Amount is requested, Protective Life conducts underwriting before approving the increase to determine whether a different rate class will apply to the increase. If the rate class for the increase has lower cost of insurance rates than the original rate class, the rate class for the increase also will be applied to the Initial Face Amount.

 

Protective Life does not conduct underwriting for an increase in Face Amount if the increase is requested as part of an exercise of a guaranteed option to increase the Face Amount without underwriting.

 

However, in no event may the total of all premiums paid in any Policy year exceed the current maximum premium limitations for that year established by Federal tax laws or by the Company. If the Owner pays a premium that would result in total premiums exceeding the current maximum premium limitations, the Company will only accept that portion of the premium that will make total premiums equal the maximum. Any premium in excess of that amount will be returned or applied as otherwise agreed and no further premiums will be accepted until allowed by the current maximum premium limitations prescribed by Federal tax law.

 

If any premium payment would cause an increase in the Policy’s death benefit exceeding the premium received, the Company may require additional evidence of insurability before accepting any premium payment.

 

C. Lapse and Reinstatement Procedures

 

The Company offers lapse protection to Owners of Policies for a specified period of time from the policy effective date. The specified period for this lapse protection is established based on the age of the Insured as of the Policy Effective Date. This provision offers continued life insurance coverage for the requested initial face amount provided the Owner of the Policy continues to pay the minimum monthly guarantee premium throughout the Lapse Protection Period. The amount of premiums required will be net of any loans and withdrawals on the Policy.

 

 

 

The Policy’s lapse protection provision will be threatened if the Company does not receive an amount equal to the minimum monthly guarantee premium specified in the Policy (net of loans and withdrawals) for each month the policy has been in force.

 

During the first 14 Policy Years, a surrender charge will be deducted if the Policy lapses.

 

The Policy may be reinstated within five years after lapse and while the Insured is still living unless the Policy has been surrendered. A Policy will be reinstated upon receipt by the Company of: (1) a written application for reinstatement; (2) evidence of insurability satisfactory to the Company; (3) payment of net premiums equal to (a) all monthly deductions due but unpaid during the grace period and (b) an amount at least sufficient to keep the Reinstated Policy in force for three months; and (4) the Owner repays or reinstates any outstanding policy debt or liens (including accrued interest) as of the date of lapse.

 

The amount of cash value in the Policy on the date the Policy is approved for reinstatement will be equal to the amount of any Policy Debt reinstated or repaid at the time of reinstatement plus the Net Premiums paid at reinstatement. The effective date of reinstatement will be the date the Company approves the application for reinstatement. A full monthly deduction will be charged for the month of reinstatement.

 

II. REDEMPTION PROCEDURES: SURRENDER AND RELATED TRANSACTIONS

 

The principal policy provisions and administrative procedures regarding “redemption” transactions are summarized below. Due to the insurance nature of the Policies, the procedures that will be followed may be different from the redemption procedures for mutual funds and contractual plans.

 

A. Surrenders and Withdrawals

 

An Owner of a Policy may submit a written request to the Company to surrender the Policy at any time while the Insured is living and while the Policy is in effect. The amount available for surrender is the surrender value as of the end of the valuation period on or next following the date the written surrender request, the Policy and any other required documents are submitted and received by the Company. If the Policy itself isn’t returned to the Company, the request must be accompanied by a completed affidavit of lost policy. Amounts payable upon surrender or a partial withdrawal will be paid within seven calendar days of receipt of the written request.

 

Upon surrender, the Company will pay in a lump sum the surrender value that is equal to the cash value as of the valuation day less any outstanding Policy Debt which includes accrued interest less any applicable surrender charges. Coverage under a Policy will end as of the date of surrender.

 

If the Policy is surrendered, if the Policy lapses, or if the initial face amount is reduced, during the first 14 Policy Years, a surrender charge will be deducted from the Policy Value for the initial face amount (or the reduction thereof). The surrender charge will be deducted before any surrender value is paid.

 

The surrender charge varies depending on issue-age, sex and rate class of the Insured and is set forth in your Policy. Representative surrender charges, per $1,000 of initial face amount in the first Policy Year, for an Insured male non-tobacco at each specified issue age are set forth below. The surrender charge decreases over the 14 year period.

 

 

After the 14th Policy Year, there is no surrender charge for the initial face amount. If the initial face amount is decreased at any time during the first 14 Policy Years, a Surrender Charge will be imposed which will be equal to the stated surrender charge for such Policy Year per $1,000 of decrease. In the event of a decrease in the initial face amount, the pro-rated surrender charge will be allocated to each Sub-Account and to the Fixed Account based on the proportion of Policy Value in each Sub-Account and in the Fixed Account. A surrender charge imposed in connection with a reduction in the initial face amount reduces the remaining surrender charge that may be imposed in connection with a surrender of the Policy.

 

 

 

After the first Policy Year, the Owner may also request a withdrawal (partial surrender) by sending a written request to the Company. An Owner may make a withdrawal of an amount equal to or greater than $500. The request must be submitted in writing to the Company. The Company will withdraw the amount requested, plus a withdrawal charge, as of the date the request is received in the Home Office. Requests received at or after 3:00 P.M Central Time are processed as of the next Valuation Day. The Owner may elect to deduct the amount of the withdrawal from any Sub-Account or the Fixed Account. If the Owner does not specify an allocation, or if the Sub-Account value or Fixed Account value is insufficient to carry out the request, the withdrawal will be based on the proportion that such Sub-Account value(s) and Fixed Account value, bear to the total unloaned Policy Value on the valuation day immediately prior to the withdrawal. No withdrawal amounts will be processed if the withdrawal would result in there being insufficient surrender value to pay any surrender charges applicable upon a full surrender.

 

The Company will deduct a withdrawal charge for each withdrawal. This charge is the lesser of 2% of the amount withdrawn or $25. This withdrawal charge will be deducted from the Policy Value in addition to the amount requested to be withdrawn and will be considered to be part of the withdrawal amount. The withdrawal charge will be allocated in the manner described above for the requested amount.

 

The death benefit will be affected by withdrawals. The face amount after a partial withdrawal may not be less than the minimum amount for which the Policy would be issued under the Company’s current rules. If the withdrawal causes the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by the Company, it will not be processed. If the Face Amount at the time of withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the initial Face Amount for which a surrender charge will be deducted.

 

B. Changes in Face Amount

 

An Owner may increase the face amount of the Policy after the first Policy Anniversary by submitting a written request to the Company. A supplemental application is required for an increase in face amount. The Company reserves the right to require satisfactory evidence of insurability for the requested increase portion. Face Amount increases and decreases are subject to the following rules:

 

1.For increases in face amount, the Insured’s attained age must be less than the maximum current issue age for the Policies, as determined by the Company from time to time.

 

2.The amount of the requested increase must be at least $10,000.

 

3.Any increase in face amount will become effective as of the date shown on the supplemental Policy specifications page sent to the owner.

 

4.If the lapse protection provision is in effect, the minimum monthly premium amount required to keep the Policy in force will generally increase and additional premium payments may be required. An increase in coverage does not extend the Lapse Protection provision.

 

5.The monthly cost of insurance charge will be adjusted as of the next monthly anniversary day following the approval of the written request.

 

6.There will be an administrative charge assessed based on a rate per $1,000 of increased coverage. This administrative charge will be deducted from the Policy Value monthly on the effective date of the increase and during the 11th month period following the effective date of the increase. This administrative charge is based on the original issue age, duration, sex, and rate class of the Insured.

 

7.A decrease in face amount will not be accepted by the Company, if the amount requested would decrease the face amount below $100,000.

 

 

 

8.A proportionate Surrender Charge will be imposed for decreases in initial face amount (please note previous section on “Surrenders and Withdrawals”).

 

The Company reserves the right to not process any decrease in Face Amount, if compliance with guideline premium limitations (or other tax compliance test) under current tax law resulting from such a decrease, would result in immediate termination of the Policy, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the guideline premium limitations, and the amount of such payments would exceed the Surrender Value of the Policy. In addition, the Company reserves the right to prohibit any decrease in Face Amount (i) for the first three Policy Years, (ii) for three years following an increase in Face Amount, and (ii) for one Policy Year following the last decrease in Face Amount.

 

C. Death Benefit Claims

 

While the Policy remains in force, the Company will pay a death benefit to the named beneficiary. The Company will pay the death benefit within seven calendar days after receipt in its home office of all necessary proof of death of the Insured. Payment of a death benefit may be postponed under certain circumstances, such as the New York Stock Exchange being closed for reasons other than customary weekend and holiday closings. The death benefit proceeds will be determined as of the date of the Insured’s death and will be equal to:

 

1. the death benefit; plus

2. any additional benefits due under any supplemental riders and/or benefits attached to this Policy; less

3. any policy debt; less

4. any liens for payments made under an accelerated death benefit rider or endorsement, plus accrued interest; less

5. any unpaid monthly deductions if the Insured dies during the grace period.

 

The death benefit proceeds will be determined based on the death benefit option selected by the Owner on the application for insurance, or any request for change in death benefits, and the selected Federal Tax Compliance test applicable to the Policy.

 

The minimum death benefit is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time.

 

E. Policy Loans

 

The Owner may obtain two types of loans under a Policy, a standard loan and/or a carry-over loan. A carry-over loan is a loan which is transferred from another policy that is exchanged for the Policy under Section 1035 of the Internal Revenue Code. A carry-over loan must be approved by Protective Life and can only be executed at the time of issue. A standard loan is any loan that is not a carry-over loan. After the first Policy Year, while the Policy has Cash Value and the Insured is still living, the Owner may take a standard loan. Generally, the minimum loan amount is $500 and the maximum loan amount is 99% of the Policy’s Cash Value. This maximum is reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day the loan request is received. The Owner must submit a written request for a Policy loan. Any amount due an Owner under a loan will generally be paid within seven calendar days after the Company receives a loan request. Requests received at or after 3:00 P.M Central Time are processed as of the next Valuation Day.

 

When a Policy loan is made, an amount equal to the loan is transferred out of the Sub-Account(s) and the Fixed Account and into the Policy’s loan account. The Owner can specify the Sub-Accounts and Fixed Account from which collateral is transferred to the loan account. If no allocation is specified, collateral is transferred from each Sub-Account and from the Fixed Account in the same proportion that each Sub-Account value and the Fixed Account value bears to the total unloaned Policy value on the date that the loan is made.

 

Like the Fixed Account, a Policy’s loan account is part of Protective Life’s General Account. The Company charges interest daily on any outstanding loan at the following effective annual rates:

 

 

 

Loan Interest Rates

 

    Current
Standard
Charge
  Guaranteed
Standard
Charge
  Current
Carry-Over
Loan Charge
  Guaranteed
Carry-Over Loan
Charge
 
Policy Years 1-10   5.0 % 5.0 % 4.0 % 5.0 %
Policy Years 11 and greater   3.0 % 3.25 % 3.0 % 3.25 %

 

Interest is due and payable at the end of each Policy Year while a loan is outstanding. If interest is not paid when due, the amount of the interest is added to the loan and becomes part of the Policy Debt.

 

The loan account is credited with interest at an effective annual rate of not less than 1.0% (3.0% current).

 

The difference between the rate of interest charged on borrowed money and the rate credited on the Loan Account is the net cost of the loan. The net cost of the loans is set forth in the table below.

 

Net Cost of Loans

 

    Current
Standard
Charge
  Guaranteed
Standard
Charge
  Current
Carry-Over
Loan Charge
  Guaranteed
Carry-Over Loan
Charge
 
Policy Years 1-10   2.0 % 2.0 % 1.0 % 2.0 %
Policy Years 11 and greater   0.0 % 0.25 % 0.0 % 0.25 %

 

The current net cost of a standard loan is 2.0% per year during Policy Years 1 through 10 (4% guaranteed), and 0.0% thereafter (2.25% guaranteed). The current net cost of a carry-over loan is 1.0% per year during Policy Years 1 through 10 (4.0% guaranteed) and 0.0% thereafter (2.25% guaranteed).  On each Policy anniversary, an amount of Policy Value equal to any due and unpaid loan interest (explained below), is also transferred to the Loan Account. Such interest is transferred from each Sub-Account and the Fixed Account in the same proportion that each Sub-Account Value and the Fixed Account Value bears to the total unloaned Policy Value.

 

Since interest credited on the Loan Account is transferred to the Sub-Accounts and Fixed Account, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan balance and will increase Policy Debt. If the Insured dies while a loan is outstanding, the Policy debt is deducted from the death benefit in calculating the death benefit proceeds.

 

A Policy loan may be repaid in whole or in part at any time while the Insured is living and the Policy is in force. Loan repayments will be credited as of the date they are received in the Home Office. Payments received at or after 3:00 P.M Central Time are processed as of the next Valuation Day. When a loan repayment is made, Policy Value in the loan account in an amount equal to the repayment will be transferred from the loan account to the Sub-Accounts and/or the Fixed Account in the same proportion that premium payments are allocated. Amounts paid while a Policy loan is outstanding will be treated as premiums unless the Owner requests in writing that these payments be treated as repayment of indebtedness.

 

F. Endorsements

 

Lapse Protection Endorsement The endorsement guarantees that the Policy will not lapse during the maximum Lapse Protection Period set forth on your Policy Schedule, if for each month that the Policy has been inforce, the total accumulated net premiums paid (less any Policy loans) is equal to, or greater than, the accumulated minimum monthly requirement and the Policy Debt does not exceed the Cash Value. The endorsement terminates when the Policy terminates.

 

III. TRANSFERS

 

 

 

You may transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below.

 

Upon receipt of written notice or a telephone request from the Owner, or Registered Representative if applicable, the Company will accept transfer requests subject to the limitations described below. Transfer requests will be accepted at any time on or after the later of the following: (1) thirty days after the Policy effective date, or (2) six days after the expiration of the cancellation period. Transfers (including telephone transfers) are processed as of the date the request is received by the Company. Requests received at or after 3:00 P.M Central Time are processed as of the next Valuation Day. The minimum amount of Policy value that may be transferred is the lesser of: (1) $100; or (2) the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account is less than $100, the Company reserves the right to transfer the entire amount instead of the requested amount. The Company also reserves the right to limit transfers to 12 per Policy year and to charge a transfer fee for each additional transfer over 12 in any Policy year. If the fee is imposed, it will be deducted from the amount requested to be transferred. If an amount is being transferred from more than one Sub-Account or the Fixed Account, the transfer fee will be deducted proportionately from the amount being transferred from each.

 

Protective Life reserves the right to restrict the maximum amount that may be transferred from the Fixed Account, in any Policy Year, this is currently the greater of: (1) $2,500; or (2) 25% of the Fixed Account Value.

 

Transfers may be made upon instructions given by telephone; provided the appropriate election has been made on the application or written authorization is provided. We require a form of personal identification before acting on these telephone instructions. All transfer requests made by telephone instruction will be recorded as a method of documenting authenticity. A confirmation of all instructions received by telephone will be mailed to the Owner.

 

The Company currently intends to allow transfers for the foreseeable future, although the Prospectus provides that the Company may at any time, for any class of Policies, modify, restrict, suspend, or eliminate the transfer privilege (including telephone transfers). The Company may also restrict or refuse to honor excessive transfers, including “market timing” transfers.

 

The Owner may direct the Company to systematically and automatically transfer on a periodic basis, Policy value among specified Sub-Accounts. This is known as the portfolio rebalancing method of investment and is done to achieve a particular percentage allocation among such Sub-Accounts. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one time, an Owner may be less susceptible to the impact of market fluctuations in Sub-Account unit values. The Fixed Account value will not be considered in the automatic transfer process. The Company makes no guarantee that the portfolio rebalancing method will result in a profit or protect against loss. The Company reserves the right to assess a processing fee for this service. The Company reserves the right to stop offering portfolio rebalancing upon 30 days written notice. A minimum Variable Account Value of $100 is required for portfolio rebalancing.

 

 No dollar cost averaging transfers may be made into the Fixed Account. Dollar-cost averaging transfers may commence on any day of the month that the Owner requests, except the 29th, 30th, or 31st. The default transfer date will be the modal anniversary day. The Applicant/Owner can elect dollar cost averaging at the time of application or any time thereafter by submitting a written request to the Company. This can also be requested by telephone if the Owner previously authorized us to take telephone instructions.

 

The Company will continue to process dollar cost averaging transfers until the earlier of the following:

 

·the designated number of transfers has been completed;
·the source Sub-Account value or the Fixed Account value is depleted;
·the Owner, by written notice or by telephone, instructs the Company to cease the automatic transfers;
·a grace period begins under the Policy; or
·the maximum amount of Policy value has been transferred under a dollar cost averaging election.

 

 

 

IV. REFUNDS

 

The right to examine and cancel the Policy is as defined in the Policy. The Owner may cancel a Policy for a refund during the Cancellation Period by returning it to the Company’s home office or to the sales representative who sold it along with a written cancellation request. The Cancellation Period is a 30-day period beginning when the Owner receives the Policy or a 60-day period in the case of a replacement policy, also beginning when the Owner receives the Policy. Return of the Policy by mail is effective when it is received at the home office.

 

Within seven calendar days after receiving the returned Policy, the Company will refund an amount equal to the greater of (i) all the Premium Payments paid or (b) the total value of amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy was returned to the Company and the total value of amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to the Company. This amount may be more or less than the aggregate Premium Payments. In states where required, the Company will refund Premium Payments to the Owner of the Policy.

 

An increase in Face Amount may also be cancelled by the Owner in accordance with the Policy’s cancellation period provisions. The amount refunded will be calculated in accordance with the provisions described above. If no additional Premium Payments are required in connection with the Face Amount increase, the amount refunded is limited to that portion of the first monthly deduction following the increase and will be reallocated to the Sub-Account(s) and the Fixed Account in the same proportion that each Sub-Account value and the Fixed Account value bears to the total unloaned Policy Value as of the effective date of the cancellation. The effective date of this cancellation will be equal to the effective date of the face increase.

 

 

V. GENERAL PROVISIONS

 

A. Suicide

 

If the Insured dies by suicide, while sane or insane, within two years (unless a shorter period as required by state law) from the Policy Effective Date, the death benefit will be limited to the premiums paid before death, less any Policy debt and less any withdrawals. If the Insured dies by suicide, while sane or insane, within two years (unless a shorter period as required by state law) after an increase in face amount, the death benefit with respect to such increase shall be limited to the sum of the monthly cost of insurance charges deducted for such increase.

 

B. Representations and Contestability

 

The Company cannot contest the Policy or any supplemental benefit and/or rider after the Policy or rider has been in force during the Insured’s lifetime for two years from the Policy Effective Date or the effective date of the rider, unless fraud is involved. The Company has the right to contest the validity of any policy change based on material misstatements made in any application for that change and any reinstatement of benefits within two years during the lifetime of the Insured after the reinstatement has been approved.

 

C. Misstatement of Age or Sex

 

Questions in the application concern the Insured’s date of birth and sex. If the date of birth or sex given in the application or any application for supplemental benefits and/or riders is not correct, the death benefit and any benefits provided under any riders to this Policy will be adjusted to those that would have been purchased by the most recent cost of insurance charge and the cost of any such supplemental benefits provided by such riders, at the correct age and sex.

 

 

EX-99.(R) 11 tm268049d1_ex99-xr.htm EXHIBIT 99.(R)

 

Exhibit 99.(r)

 

SUMMARY PROSPECTUS FOR NEW INVESTORS

May 1, 2026

 

Protective DualCare VUL An Individual Flexible Premium Variable and Fixed Life Insurance Policy  

Issued by Protective Variable Life Separate Account and

Protective Life Insurance Company

2801 Highway 280 South Birmingham, Alabama 35223Telephone: (800) 265-1545

 

 

This Summary Prospectus summarizes key features of Protective DualCare VUL, an individual flexible premium variable and fixed life insurance policy (the “Policy”) issued by Protective Life Insurance Company (the “Company”, “we”, “our” and “us”) with variable investment options offered under the Company’s Protective Variable Life Separate Account (the “Variable Account”).

 

Before you invest, you should review the prospectus for the Policy (the “Prospectus”), which contains more information about the Policy’s features, benefits, and risks. You can find this document and other information about the Policy online at www.protective.com/productprospectus. You can also obtain this information at no cost by calling (800) 265-1545 or by sending an email request to prospectus@protective.com.

 

You may cancel your Policy within 10 days of receiving it without paying fees or penalties. In some states, this Cancellation Period may be longer. Upon cancellation, we will refund the full amount you paid with your application or the total Policy Value plus any charges that were deducted less any outstanding loan and accrued loan interest. You should review the Prospectus, or consult with your investment professional, for additional information about the specific cancellation terms that apply.

 

Additional general information about certain investment products, including variable life insurance, has been prepared by the U.S. Securities and Exchange Commission’s (“SEC”) staff and is available at Investor.gov.

 

Neither the SEC nor any state securities authority has approved or disapproved of these securities, nor have they determined if this Summary Prospectus is accurate or complete. Any representation otherwise is a criminal offense. This Summary Prospectus does not constitute an offering in any jurisdiction where such offering may not lawfully be made. Interests in the Variable Account, the Fixed Account and the Funds are not deposits, obligations of, or insured or guaranteed by, the U.S. Government, any bank or other depository institution including the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other agency or entity or person. We do not authorize any representations about this offering other than as contained in this Summary Prospectus or its supplements or in our authorized supplemental sales material. 

 

PRO.DualCare.0526

 

 

 

 

TABLE OF CONTENTS

 

SPECIAL TERMS 3
IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY 5
OVERVIEW OF THE PROTECTIVE DUALCARE VUL POLICY 7
STANDARD DEATH BENEFITS 8
OTHER BENEFITS AVAILABLE UNDER THE POLICY 10
BUYING THE POLICY 13
HOW YOUR POLICY CAN LAPSE 14
MAKING WITHDRAWALS: ACCESSING THE MONEY IN YOUR POLICY 15
FEE TABLE 16
APPENDIX: FUNDS AVAILABLE UNDER THE POLICY 21

 

 

 

 

SPECIAL TERMS

 

“We”, “us”, “our”, “Protective Life”, and “Company”  Refer to Protective Life Insurance Company. “You”, “your” and “Owner” refer to the person(s) who have been issued a Policy.

 

Attained Age The Insured’s age as of the nearest birthday on the Policy Effective Date, plus the number of complete Policy Years since the Policy Effective Date.

 

Beneficiary The person, persons or entity whom the Owner designates to receive the proceeds of the Policy upon the death of the Insured. The Owner may designate a primary Beneficiary or Beneficiaries, as well as a contingent Beneficiary or Beneficiaries to receive the proceeds if there is no primary Beneficiary(ies) living at the time of the Insured’s death. A Beneficiary may also be designated as irrevocable which may limit the Owner’s ability to alter that designation or make future Policy changes.

 

Cash Value Policy Value minus any applicable Surrender Charge.

 

Code (the “Code”) The Internal Revenue Code of 1986, as amended (the “Code”).

 

Death Benefit The amount of insurance provided under the Policy used to determine the Death Benefit Proceeds.

 

Death Benefit Proceeds The amount payable to the Beneficiary if the Insured dies while the Policy is in force. It is equal to the Death Benefit plus any Death Benefit under any rider or endorsement to the Policy less (1) any Policy Debt (2) any liens and (3) less any unpaid Monthly Deductions if the Insured dies during a grace period.

 

Due Proof of Death Receipt at our Home Office of a certified death certificate or judicial order from a court of competent jurisdiction or similar tribunal.

 

Evidence of Insurability Information about an Insured which is used to approve or reinstate this Policy or any additional benefit.

 

Face Amount A dollar amount selected by the Owner and shown in the Policy on the Policy Specifications Page or Supplemental Policy Specifications Page. The minimum Face Amount permitted under the Policy is $50,000 and the maximum is $500,000 (which may increase due to market performance).

 

Fixed Account Part of Protective Life’s General Account to or from which Policy Value may be transferred and into which Net Premiums may be allocated under a Policy.

 

Fixed Account Value The Policy Value in the Fixed Account.

 

Fund A separate investment portfolio of an open-end management investment company or unit investment trust in which a Sub-Account invests. Also referred to as an “Investment Option”.

 

General Account All of the Company’s assets other than those allocated to the Variable Account or any other separate account. The Company has complete ownership and control of the assets in the General Account.

 

Good Order  A Request or transaction generally is considered in “Good Order” if we receive it at our Home Office within the time limits, if any, we prescribe for a particular transaction or instruction, it includes all information necessary for us to execute the requested instruction or transaction, and is signed by the individual or individuals authorized to provide the instruction or engage in the transaction. A Request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet as described above) along with all forms, information and supporting legal documentation we require to affect the instruction or transaction. This information and documentation generally includes, to the extent applicable: the completed application or instruction form; Evidence of Insurability; your Policy number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Funds affected by the requested transaction; the signatures of the Policy Owner (exactly as indicated on the Policy), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that we may require, including any consents. With respect to premium payments, Good Order also generally includes receipt by us of sufficient funds to affect the purchase. We may, in our sole discretion, determine whether any particular transaction Request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have questions, you should contact us or your financial professional before submitting the form or Request.

 

Home Office 2801 Highway 280 South, Birmingham, Alabama 35223. The mailing address for the Home Office is P.O. Box 292 Birmingham, AL 35201-0292. The Home Office is referred to as the “Administrative Office” in the Policy.

 

Initial Face Amount The Face Amount on the Policy Effective Date.

 

Insured The person whose life is covered by the Policy.

 

3

 

 

Issue Age The Insured’s age as of the nearest birthday on the Policy Effective Date.

 

Lapse Termination of the Policy at the expiration of the grace period while the Insured is still living.

 

Loan Account An account within Protective Life’s General Account to which Fixed Account Value and/or Variable Account Value plus interest credited on the portion of the Policy Value being used as collateral for the outstanding Policy loans is transferred as collateral for Policy loans.

 

Loan Account Value The Policy Value in the Loan Account.

 

Monthly Anniversary Day The same day in each month as the Policy Effective Date.

 

Monthly Deduction The fees and charges deducted monthly from the Fixed Account Value and/or Variable Account Value as described on the Policy Specifications Page of the Policy Schedule.

 

Net Amount at Risk The Net Amount at Risk as of any Monthly Anniversary Day is equal to: (a) the Death Benefit discounted at one plus the monthly guaranteed interest rate (the minimum interest rate that may be credited to Fixed Account Value) minus the Policy Value (prior to deducting the Cost of Insurance)..

 

Net Premium A premium payment minus the applicable premium expense charges.

 

Owner The person, or persons, or entity entitled to all rights in this Policy while the Insured is living including designation as a Beneficiary. These rights are subject to any assignment and to the rights of any irrevocable Beneficiary. The Owner may name a contingent Owner who will own this Policy if the Owner dies while this Policy is in force. If the Owner dies before the Insured, any contingent Owner named in the application, or subsequent endorsement, will become the new Owner. If no contingent Owner is named, the Owner’s estate becomes the new Owner. The Owner may change the Owner (including a contingent Owner) by Written Notice.

 

Policy Anniversary The same day and month in each Policy Year as the Policy Effective Date.

 

Policy Debt The sum of all outstanding Policy loans plus accrued interest.

 

Policy Effective Date The date shown in the Policy as of which coverage under the Policy begins.

 

Policy Value The sum of the Variable Account Value, the Fixed Account Value, and the Loan Account Value.

 

Policy Year Each period of twelve months commencing with the Policy Effective Date and each Policy Anniversary thereafter.

 

Request Any written, telephoned, electronic or computerized instruction in a form satisfactory to the Company and received at the Home or Administrative Office from the Owner or an assignee of record, as specified in a form acceptable to the Company and which may be required in writing, or the Beneficiary (as applicable) as required by any provision of the Policy or as required by the Company. In addition, subject to the Company’s administrative requirements as they may exist from time to time and to any requirements that may be imposed by the Funds or other investments, the Company reserves the right to require advance Written Notice from the Owner.

 

Settlement Option The proceeds of the policy are distributed over a period rather than paying them in a lump sum. If a Settlement Option is not selected, the Beneficiary may select a Settlement Option from among those available at that time, or may take the amount due immediately in a lump sum.

 

Sub-Account A separate division of the Variable Account established to invest in a particular Fund.

 

Sub-Account Value The sum of the values of the Sub-Accounts credited to the Owner as Policy Value.

 

Surrender Charge A charge deducted from the Policy Value if the Policy is surrendered, Lapses, or the Initial Face Amount is decreased during the applicable surrender charge period.

 

Surrender Value The Cash Value minus any outstanding Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement plus accrued interest.

 

Valuation Day Each day the New York Stock Exchange and the Home Office are open for business except for a day that a Sub-Account’s corresponding Fund does not value its shares.

 

Valuation Period The period commencing with the close of regular trading on the New York Stock Exchange on any Valuation Date and ending at the close of regular trading on the New York Stock Exchange on the next succeeding Valuation Date.

 

Variable Account Protective Variable Life Separate Account, a separate investment account of Protective Life to and from which Policy Value may be transferred and into which Net Premiums may be allocated.

 

Variable Account Value The sum of all Sub-Account Values.

 

Written Notice A notice or Request submitted in writing in a form satisfactory to Protective Life and received at the Home Office via U.S. postal service or nationally recognized overnight delivery service.

 

4

 

 

IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY

 

FEES AND EXPENSES
Charges for Early Withdrawals  

If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.

 

If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.75% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,750.

 

For additional information about charges for surrenders and early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.

 

 

Transaction Charges  

In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy’s Face Amount and transfer fees.

 

For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.

 

 

Ongoing Fees and Expenses (annual charges)  

In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance (“COI”) under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.

 

You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:

 

 

    Annual Fee   Minimum   Maximum
    Fund Options (Fund fees and expenses) (1)   0.09%   1.18%

 

 
 
(1)As a percentage of Fund assets.
   
 For additional information about ongoing fees and expenses, see “CHARGES AND DEDUCTIONS” in the Prospectus.

 

RISKS
Risk of Loss  

You can lose money by investing in this Policy, including loss of principal.

 

For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.

 

Not a Short-Term Investment  

The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.

 

For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY” and “TAX CONSIDERATIONS--Taxation of Insurance Polices” in the Prospectus.

 

 

5

 

 

Risks Associated with Investment Options  

An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.

 

For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.

 

Insurance Company Risks  

An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.

 

For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.

 

Policy Lapse  

Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.

 

For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.

 

RESTRICTIONS
Investments  

While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing polices described in the Prospectus.

 

We reserve the right to remove or substitute Funds as investment options.

 

For additional information about Investment Options, see “TRANSFERS” and “ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS” in the Prospectus.

 

 

Optional Benefits  

Optional benefits, including Policy loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy’s Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.

 

For additional information about the optional benefits, see “OTHER BENEFITS AVAILABLE UNDER THE POLICY” and “SUPPLEMENTAL RIDERS AND ENDORSEMENTS” in the Prospectus.

 

 

TAXES
Tax Implications  

You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.

 

For additional information about tax implications, see “TAX CONSIDERATIONS” in the Prospectus.

 

CONFLICTS OF INTEREST

 

6

 

 

Investment Professional Compensation  

Some investment professionals have and may receive compensation for selling the Policy to investors, which may include commissions, revenue sharing, and compensation from affiliates and third parties. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment.

 

For additional information about compensation, see “SALE OF THE POLICIES” in the Prospectus.

 

Exchanges  

Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy.

 

For additional information about exchanges, see “EXCHANGE PRIVILEGE” and “TAX CONSIDERATIONS--Section 1035 Exchanges” in the Prospectus.

 

 

 

 

OVERVIEW OF THE PROTECTIVE DUALCARE VUL POLICY

 

Q: What is the Policy, and what is it designed to do?

 

A: The Policy is an individual flexible premium variable and fixed life insurance policy the primary purpose of which is to provide a Death Benefit which is paid upon the death of the Insured person and help cover qualified long-term care expenses. The Owner of the Policy is the person, persons, or entity entitled to all rights in this Policy while the Insured (the person whose life is covered by the Policy) is living, including designation of a Beneficiary.

 

Your Policy is a “flexible premium” policy because you have considerable flexibility in determining when and how much premium you want to pay. Your Policy is “variable” because the Death Benefit and Policy Value vary according to the investment performance of the Sub-Accounts to which you have allocated your premiums and Policy Value. The Policy provides you with an opportunity to take advantage of any increase in your Policy Value but you also bear the risk of any decrease.

 

Because the Policy is designed to provide benefits on a long-term basis and is not intended for short-term investing, the Policy may not be appropriate for those who have a short-term investment horizon.

 

Q: What are the Premiums for this Policy?

 

A: The Policy is designed to be flexible to meet your specific life insurance needs. You have the flexibility to choose the investment options and premiums you pay.

 

Premium is an amount you pay to the Company to establish and maintain life insurance coverage. The minimum initial premium will vary based on various factors, including the age of the Insured. Thereafter, you have the flexibility to choose the amount and timing of premium payments, within certain limits. Before your premiums are allocated to a Sub-Account, we deduct a premium expense charge.

 

You may establish a planned periodic premium. You are not required to pay the planned periodic premium and we will not terminate your Policy merely because you did not. However, payment of insufficient premiums may result in a Lapse of the Policy. Your Policy could Lapse if the value of your Policy becomes too low to support the Policy’s monthly charges.

 

You may allocate premium to your choice of numerous different investment options available in the Sub-Accounts, as well as a Fixed Account, within your Policy. The Sub-Accounts are separate divisions of the Variable Account (Protective Variable Life Separate Account) that invest in a particular Fund (an underlying mutual fund).

 

ADDITIONAL INFORMATION ABOUT EACH FUND IS PROVIDED IN AN APPENDIX TO THIS PROSPECTUS. See FUND APPENDIX – Funds Available Under the Policy.

 

The Fixed Account is part of the Company’s General Account, which holds all of the Company’s assets other than those held in the Variable Account or other separate accounts.

 

Q: What are the primary features and options that this Policy offers?

 

Death Benefit. Upon the death of the Insured and while the Policy is in force, we will pay a Death Benefit to your Beneficiary. The Death Benefit is the Face Amount on the Insured’s date of death or the minimum death benefit on the date of death.

 

Transfers. At any time after the Cancellation Period (period during which the Owner may return the Policy for a refund), you may transfer Policy Value among the Sub-Accounts and the Fixed Account, subject to restrictions on the

 

7

 

 

amount and frequency of transfers. The Company also may restrict or refuse to honor frequent transfers, including “market timing” transfers.

 

Withdrawals. You may Request a partial withdrawal of your Policy at any time after the first Policy Year. The amount of any partial withdrawal must be at least $500. We will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals. Withdrawals may have tax consequences.

 

Surrender Benefit. The Owner may surrender this Policy for the surrender benefit. The surrender benefit is the Surrender Value on the date of surrender. The Surrender Value is the Cash Value minus Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement, plus accrued interest. All coverage will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of surrender of the Policy. Surrenders may have tax consequences.

 

Loans. While the Policy is in force, the Owner may obtain a loan on the security of the Policy. Policy loan amounts will be withdrawn first on a pro rata basis from the Sub-Accounts and/or Fixed Account unless the Owner specifies otherwise.

 

Loans may be treated as taxable income if your Policy is a “modified endowment contract” (“MEC”) for federal income tax purposes. See “Tax Considerations”.

 

Additional Benefits. The following additional benefits are available:

 

Long-Term Care Rider (Automatically included): This endorsement provides for a monthly benefit payment to the Owner if the Insured has qualifying long term care expenses and all the terms and conditions of the endorsement are met.

 

Terminal Illness Accelerated Death Benefit Endorsement (Automatically included): This endorsement provides for an accelerated Death Benefit payment to the Owner if the Insured has a qualifying terminal illness and all the terms and conditions of the endorsement are met.

 

Lapse Protection Endorsement (Automatically included): This rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule as long as all of the terms and conditions of this rider are met.

 

Long-Term Care Inflation Protection Option: This provides a 5% compound increase on each Policy Anniversary with no Evidence of Insurability on each Policy Anniversary. The increase purchased on each Policy Anniversary will be factored into the calculation of certain benefit values under the Long-Term Care Rider. The increase must be elected each Policy Anniversary. There is an additional monthly charge for this optional benefit rider.

 

Dollar Cost Averaging: This program allows for the systematic and automatic transfer, on a monthly or quarterly basis, of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub- Accounts.

 

Portfolio Rebalancing: This program allows for the automatic transfer, on a quarterly, semi-annual or annual basis, of Variable Account Value among specified Sub-Accounts to maintain a particular percentage allocation of Variable Account Value.

 

See “OTHER BENEFITS AVAILABLE UNDER THE POLICY” and “SUPPLEMENTAL RIDERS AND ENDORSEMENTS” in the Prospectus for details on obtaining optional benefits.

 

 

 

STANDARD DEATH BENEFITS

 

As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner’s estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment of the Death Benefit Proceeds may have tax consequences. See “Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds” in the Prospectus.

 

Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.

 

Calculation of Death Benefit Proceeds

 

The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured’s death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for

 

8

 

 

payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.

 

Federal Tax Compliance Tests. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test. This Policy will only be issued using the Cash Value Accumulation Test.

 

The Cash Value Accumulation Test (“CVAT”) does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy’s cash value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.

 

Under this Policy, which provides a level Death Benefit, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater than the Face Amount under the Policy.

 

The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured’s death and are moved to the General Account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.

 

Cash Value Accumulation Test. This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) the minimum death benefit described below.

 

The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

 

For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

 

Changing the Face Amount

 

On or after the first Policy Anniversary, the Owner may Request an increase in the Face Amount. The Request must be received in writing in Good Order at the Home Office.

 

Settlement Options

 

The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured’s lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner’s estate.

 

9

 

 

OTHER BENEFITS AVAILABLE UNDER THE POLICY

 

In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.

 

Name of Benefit   Purpose   Is Benefit Standard
or Optional?
  Brief Description of
Restrictions/Limitations
Long-Term Care Rider   Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.   Standard  

·         Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.

·         Additional cost applies.

·         Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.

·         Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).

·         Benefit payments are made monthly and may not cover all long-term care expenses incurred.

·        If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.

·         If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.

 

10

 

 

Name of Benefit   Purpose   Is Benefit Standard
or Optional?
  Brief Description of
Restrictions/Limitations
Long-Term Care Inflation Protection Option   On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.   Optional  

·         This rider must be elected at Policy issue.

·         Additional cost applies.

·         On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.

·         If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.

             
             
             
             
             
Terminal Illness Accelerated Death Benefit Endorsement (Automatically included at Policy Issue)   Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.   Standard  

·   Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

 

·   The lesser of 60% of the current face amount of the Policy or $1,000,000; minus

 

·   Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

 

·   Minimum acceleration permitted is $15,000

 

·   The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.

 

·   Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.

 

11

 

 

Name of Benefit   Purpose   Is Benefit Standard
or Optional?
  Brief Description of
Restrictions/Limitations
Lapse Protection Endorsement (Automatically issued with this Policy)   Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.   Standard  

 

·    The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.

 

·    Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.

 

 

 

 

 

 

 

Dollar-Cost Averaging   Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts.   Optional  

·    No transfers may be made into the Fixed Account.

 

·    Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.

             
Portfolio Rebalancing  

Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.

 

  Optional  

·    Rebalancing transfers cannot be made into Fixed Account.

 

·    Minimum Variable Account Value of $100 required.

Policy Loans   Allows Owner to borrow from Policy’s Cash Value.   Standard  

·   Not available during the first Policy Year.

 

·   Maximum loan amount is 99% of Cash Value.

 

·   Minimum loan amount is $500.

 

·   Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.

·  If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.

 

12

 

 

BUYING THE POLICY

 

Purchasing a Policy

 

For insurance coverage to take effect under a Policy, you must submit a completed application and at least the minimum initial premium payment through a licensed representative of Protective Life who is also a registered representative of a broker-dealer having a distribution agreement with Investment Distributors, Inc. Protective Life requires satisfactory Evidence of Insurability, which may include a medical examination of the Insured. Generally, Protective Life will issue a Policy covering an Insured up to age 70 if Evidence of Insurability satisfies Protective Life’s underwriting rules. Minimum age requirements may apply. Acceptance of an application depends on Protective Life’s underwriting rules, and Protective Life may reject an application for any reason. With your consent, a Policy may be issued on a basis other than that applied for (e.g., on a higher premium class basis due to increased risk factors). A Policy is issued after Protective Life approves the application. Payment of Premium is not a requirement to issue a Policy but your insurance will not take effect until you pay your minimum initial premium. Premium may be collected at the time of Policy delivery.

 

Insurance coverage under a Policy begins on the Policy Effective Date. Temporary life insurance coverage also may be provided under the terms of a temporary insurance agreement. Under such agreements, the total amount of insurance which may become effective prior to the Policy Effective Date may not exceed $500,000 (including the amount of any life insurance and accidental death benefits then in force or applied for with the Company), may be dependent on satisfactory underwriting and other conditions and may not be in effect for more than 60 days. In addition, such agreement may not be issued on proposed Insureds under 15 days of age.

 

In order to obtain a more favorable Issue Age, Protective Life may permit the Owner to “backdate” a Policy by electing a Policy Effective Date up to six months prior to the date of the original application, subject to state requirements (3 months in Ohio, not allowed in Montana). Charges for the Monthly Deduction for the backdated period are deducted as of the Policy Effective Date and the calculation of the Policy’s lapse protection will include the Minimum Monthly Premiums for the backdated period.

 

The Owner of the Policy may exercise all rights provided under the Policy. The Insured is the Owner, unless a different person or entity is named as Owner in the application. By Written Notice received by Protective Life at the Home Office while the Insured is living, the Owner may name a contingent Owner or a new Owner. If there are joint Owners, all Owners must authorize the exercise of any right under the Policy. Unless the Owner provides otherwise, in the event of one joint Owner’s death, ownership passes to any surviving joint Owner(s). Unless a contingent Owner has been named, ownership of the Policy passes to the estate of the last surviving Owner upon his or her death. A change in Owner may have tax consequences. See “Tax Considerations — Other Considerations” in the Prospectus.

 

Fees, charges and benefits available under the Policy may vary depending on the state in which the Policy is issued.

 

Minimum Initial Premium. The minimum initial premium required depends on a number of factors, including the age, sex and rate class of the proposed Insured, the Initial Face Amount requested by the applicant, any supplemental riders requested by the applicant and the planned periodic premiums that the applicant selects. Consult your sales representative for information about the initial premium required for the coverage you desire.

 

Planned Periodic Premiums. In the application the Owner selects a plan for paying level premiums at specified intervals (i.e., quarterly, semi-annually or annually). At the Owner’s election, we will also arrange for payment of planned periodic premiums on a monthly basis (on any day except the 29th, 30th, or 31st of a month) under a pre-authorized payment arrangement. You are not required to pay premiums in accordance with these plans. You can pay more or less than planned or skip a planned periodic premium entirely. See “Lapse and Reinstatement.” Subject to the limits described below, you can change the amount and frequency of planned periodic premiums at any time by Written Notice to Protective Life at the Home Office. Additional premiums may be required to maintain the Policy, depending on a number of factors including past premiums paid, investment experience and loans and/or withdrawals on the Policy.

 

Unless you have arranged to pay planned periodic premiums by pre-authorized payment arrangement or have otherwise requested, you will be sent reminder notices for planned periodic premiums.

 

Unscheduled Premiums. Subject to the limitations described below, additional unscheduled premiums may be paid in any amount and at any time. By Written Notice to Protective Life at the Home Office, the Owner may specify that all unscheduled premiums are to be applied as repayments of Policy Debt, if any, otherwise any unscheduled premiums are allocated to the Sub-Accounts based on the most recent allocation instructions we have on file.

 

Premium Limitations. Premiums are accepted until Attained Age of 121. Premiums may be paid by any method acceptable to Protective Life. If by check, the check must be from an Owner (or the Owner’s designee other than a sales representative), payable to Protective Life, and be dated prior to its receipt at the Home Office.

 

Additional limitations apply to premiums. Premium payments must be at least $150 ($50 if paid monthly by a pre-authorized payment arrangement) and must be remitted to the Home Office. Protective Life also reserves the right to limit the amount and frequency of any premium payment. In addition, at any point in time aggregate premiums paid

 

13

 

 

under a Policy may not exceed limitations for life insurance policies as set forth in the Internal Revenue Code. See “Tax Considerations” in the Prospectus and the discussion of Cash Value Accumulation Test under “Calculation of Death Benefit Proceeds.” Protective Life will immediately refund any portion of any premium payment, with interest thereon, that is determined to be in excess of the limits established by law to qualify a Policy as a contract for life insurance. Protective Life will also monitor Policies and will attempt to notify the Owner on a timely basis if his or her Policy is in jeopardy of becoming a modified endowment contract under the Internal Revenue Code, if applicable. See “Tax Considerations” in the Prospectus.

 

Premium Payments Upon Increase in Face Amount. Depending on the Policy Value at the time of an increase in the Face Amount and the amount of the increase requested, an additional premium payment may be necessary to keep the Policy in force or a change in the amount of planned periodic premiums may be advisable. You will be notified if a premium payment is necessary or a change is appropriate.

 

Net Premium Allocations

 

You must indicate in the application how Net Premiums are to be allocated to the Sub-Accounts and/or to the Fixed Account. These allocation instructions apply to both initial and subsequent Net Premiums. You may change the allocation instructions in effect at any time by Written Notice to Protective Life at the Home Office or by telephone, facsimile, automated telephone system, or via the Internet at www.protective.com. Whole percentages must be used. The sum of the allocations to the Sub-Accounts and the Fixed Account must be equal to 100% of any Net Premiums. Protective Life reserves the right to establish (i) a limitation on the number of Sub-Accounts to which Net Premiums may be allocated and/or (ii) a minimum allocation requirement for the Sub-Accounts and the Fixed Account.

 

For Policies issued in states where, upon cancellation during the Cancellation Period, Protective Life returns at least your premiums, Protective Life reserves the right to allocate your initial Net Premium (and any subsequent Net Premiums paid during the Cancellation Period) to the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account until the expiration of the number of days in the Cancellation Period plus 6 days starting from the date that the Policy is mailed from the Home Office. Thereafter, the Policy Value in the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account and all Net Premiums will be allocated according to your allocation instructions then in effect.

 

If Protective Life receives a premium payment at the Home Office before 3:00 P.M. Central Time, Protective Life will process the payment as of the Valuation Day it is received. Protective Life processes premium payments received at the Home Office at or after 3:00 P.M. Central Time as of the next Valuation Day. However, premium will not be accepted in connection with an increase in Face Amount until underwriting has been completed. When approved, Net Premium received will be allocated in accordance to your allocation instructions then in effect.

 

Unless designated by the Owner as a loan repayment, premiums received from Owners (other than planned periodic premiums) are treated as unscheduled premiums.

 

Protective Life reserves the right to limit the amount and frequency of planned periodic premiums and additional unscheduled premiums (each an “additional premium”) under the Policy or the amount and frequency of Net Premiums that may be allocated to the Fixed Account at any time. Protective Life also reserves the right to refuse to accept such additional premium under the Policy or allocate additional Net Premium to the Fixed Account at any time without prior notice. In all cases, Protective Life will accept additional premium necessary to prevent the Policy from lapsing. Protective Life will attempt to notify the Owner that a premium payment may result in a Policy becoming a Modified Endowment Contract (“MEC”), and will accept the premium payment unless otherwise instructed by the Owner. If a premium payment would cause the Policy to no longer qualify as life insurance under the Internal Revenue Code, the Company will refuse to accept the premium payment.

 

If mandated by law, we may reject a premium payment. We may also provide information about you and your account to a government regulator.

 

 

 

 

HOW YOUR POLICY CAN LAPSE

 

Lapse

 

Failure to pay planned periodic premiums will not necessarily cause a Policy to Lapse (terminate without value). Paying all planned periodic premiums will not necessarily prevent a Policy from lapsing. Except when the Lapse Protection Endorsement is in effect, a Policy will Lapse if its Policy Value less the Surrender Charge and Policy Debt is insufficient to cover the Monthly Deduction on the Monthly Anniversary Day. Absent any lapse protection, if the Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. This could happen if investment experience has been sufficiently unfavorable that it has resulted in a decrease in Surrender Value or the Surrender Value has decreased because you have not paid sufficient Net Premiums to offset prior Monthly Deductions.

 

14

 

 

You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions. Protective Life will send you, at your last known address and the last known address of any assignee of record, notice of the premium required to prevent Lapse. A Policy will remain in effect during the grace period. If the Insured should die during the grace period, the Death Benefit Proceeds payable to the Beneficiary will reflect a reduction for the Monthly Deductions due on or before the date of the Insured’s death as well as any unpaid Policy Debt or liens (including accrued interest). See “Calculation of Death Benefit Proceeds.” Unless the premium stated in the notice is paid before the grace period ends, the Policy will Lapse. A Policy Lapse may have tax consequences. See “Tax Considerations” in the Prospectus.

 

Age 121. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse and the Death Benefit will remain in effect, regardless of your Surrender Value.

 

Lapse Protection.Lapse protection is provided by the Lapse Protection Endorsement that is automatically added to the Policy on the Issue Date. For additional information about the Lapse Protection Endorsement, see “OTHER BENEFITS AVAILABLE UNDER THE POLICY” and “SUPPLEMENTAL RIDERS AND ENDORSEMENTS” in the Prospectus.

 

Reinstatement

 

An Owner may reinstate a Policy within 5 years of its Lapse provided that: (1) a request for reinstatement is made by Written Notice received by Protective Life at the Home Office, (2) the Insured is still living, (3) the Owner pays Net Premiums equal to (a) all Monthly Deductions that were due but unpaid during the grace period, and (b) which are at least sufficient to keep the reinstated Policy in force for three months, (4) the Insured provides Protective Life with satisfactory Evidence of Insurability, (5) the Owner repays or reinstates any Policy Debt and/or lien (including accrued interest) which existed at the end of the grace period; and (6) the Policy has not been surrendered. The “Approval Date” of a reinstated Policy is the date that Protective Life approves the Owner’s request for reinstatement and requirements 1-6 above have been met.

 

 

 

 

MAKING WITHDRAWALS: ACCESSING THE MONEY IN YOUR POLICY

Surrender Privileges

 

At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. A Surrender Charge may apply. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See “Tax Considerations.”).

 

Withdrawal Privileges

 

At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge and, if applicable, a Surrender Charge, from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.

 

Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.

 

The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.

 

Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life’s then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as

 

15

 

 

interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See “Tax Considerations.”

 

 

 

FEE TABLE

 

The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).

 

The first table describes the fees and expenses that you will pay at the time that you pay premiums, surrender the Policy, allow the Policy to Lapse, decrease the Initial Face Amount, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals.

 

Transaction Fees
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge

Premium Expense

Charge:

  Upon receipt of each premium payment   5% of each premium payment   3.5% of each premium payment
             
             
             
Surrender Charge:(1)
Minimum and Maximum Charge   At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years   $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable   $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable
             
             
Charge for a 49 year old male in the standard unismoke class during the first Policy Year   At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years   $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable   $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

 

 

 

(1)The Surrender Charge varies based on individual characteristics such as the Insured’s Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

 

 

Transaction Fees
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
Transfer Fee:(2)  

Upon each transfer in excess of 12 in a Policy Year 

 

  $25 per transfer   $0 per transfer

 

16

 

 

Withdrawal Charge:   At the time of each withdrawal of Policy Value   The lesser of 2.0% of the amount withdrawn or $25   The lesser of 2.0% of the amount withdrawn or $25

 

 

(2)Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

 

 

The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds’ fees and expenses.

 

Periodic Charges Other Than Fund Operating Expenses
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
Base Contract Charge:
Cost of Insurance:(1)(2)
Minimum and Maximum Charge   On the Policy Effective Date and each Monthly Anniversary Day   $0.01-$83.33 per $1,000 of Net Amount at Risk (2)   $0.00-$70.46 per $1,000 of Net Amount at Risk (2)
Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.   On the Policy Effective Date and each Monthly Anniversary Day   $0.23 per $1,000 of Net Amount at Risk   $0.03 per $1,000 of Net Amount at Risk

 

 

(1)Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.
(2)See definition of Net Amount at Risk in the Special Terms.

 

 

Periodic Charges Other Than Fund Operating Expenses
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
Mortality and Expense Risk Charge:   On the Policy Effective Date and each Monthly Anniversary Day   0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount   0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.
             
Standard Administrative Fee:  

On the Policy Effective Date and each Monthly Anniversary Day

 

  $9.00   $9.00
             
             
Administrative Charge:(3)

 

17

 

 

Minimum and Maximum Charge   On the Policy Effective Date and each Monthly Anniversary Day   $0.36-$3.89 per $1,000 of Initial Face Amount   $0.29-$2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16-$1.46 per $1,000 of Initial Face Amount thereafter
Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.   On the Policy Effective Date and each Monthly Anniversary Day $1.11 per $1,000 of Initial Face Amount   $0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter

 

 

(3)We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

 

 

Periodic Charges Other Than Fund Operating Expenses
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
Administrative Charge For Face Amount Increases:(4)
 
Minimum and Maximum Charge   On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days   $1.95 – $4.95 per $1,000 of any increase in Face Amount   $1.95 – $4.95 per $1,000 of any increase in Face Amount
Charge for a 49 year old male in the standard unismoke rate class   On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days   $3.45 per $1,000 of any increase in Face Amount   $3.45 per $1,000 of any increase in Face Amount
             
Long-Term Care Rider Charge (5)            
Minimum and Maximum Charge   On each Monthly Anniversary Day starting from the Effective Date   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 -$2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 - $2.07   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 -$2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 - $2.07
Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000   On each Monthly Anniversary Day starting from the Effective Date   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

 

 

(4)The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
(5)The charge for the Long-Term Care Rider varies based on the Insured’s Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.

 

18

 

 

Periodic Charges Other Than Fund Operating Expenses
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
Optional Benefit Charges:
Long-Term Care Inflation Protection Option (#)   On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 -$0.50   The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 -$0.50
             
             
Net Cost of Loans(6)   On each Policy Anniversary, as applicable (7)   2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.   2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter
             
             

 

 

(6)The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).
(7)As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

 

 

Periodic Charges Other Than Series Fund Operating Expenses
Charge   When Charge is Deducted   Amount Deducted —
Maximum Guaranteed Charge
  Amount Deducted —
Current Charge
 
Lapse Protection Endorsement
Minimum and Maximum Charge   Upon receipt of each premium payment   1% of each premium payment   1% of each premium payment

 

19

 

 

ANNUAL FUND EXPENSES

 

The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “FUND APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.

 

Annual Fund Expenses
         
         
         
         
         
         
         
      Minimum           Maximum      
                                                                                                                                                                         
Total Annual Fund Expenses 0.09 % 1.18 % (1)  
         
(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)        
 
       
(1)       The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.        

  

20

 

 

APPENDIX: FUNDS AVAILABLE UNDER THE POLICY

 

The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

 

The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.

Asset
Allocation
Type
  Fund - Investment Adviser;
Sub-Adviser(s), as applicable
  Current
Expenses
  Average Annual Total Returns
(as of 12/31/2025)
 
1 Year   5 Year   10 Year  
Allocation   American Funds Insurance Series® Asset Allocation Fund - Class 1 - Capital Research and Management Company   0.29%   16.16%   9.24%   10.05%  
International Equity   American Funds Insurance Series® Global Growth Fund - Class 1 - Capital Research and Management Company (1)   0.40%   21.98%   8.51%   12.46%  
U.S. Equity   American Funds Insurance Series® Growth Fund - Class 1 - Capital Research and Management Company   0.33%   20.54%   13.66%   18.26%  
U.S. Equity   American Funds Insurance Series® Growth-Income Fund - Class 1 - Capital Research and Management Company   0.28%   18.37%   14.19%   14.20%  
International Equity   American Funds Insurance Series® New World Fund® - Class 1 - Capital Research and Management Company (1)   0.57%   28.60%   5.59%   9.53%  
U.S. Equity   ClearBridge Variable Small Cap Growth Portfolio - Class I – Franklin Templeton Fund Adviser, LLC   0.81%   9.23%   -0.17%   9.38%  
International Equity   Dimensional VA International Small Portfolio - Institutional Class   0.39%   36.99%   8.89%   8.68%  
International Equity  

Dimensional VA International Value Portfolio - Institutional Class

 

  0.27%   45.64%   15.85%   10.46%  
U.S. Equity   Dimensional VA U.S. Large Value Portfolio - Institutional Class   0.21%   15.83%   11.97%   10.51%  
Taxable Bond  

Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

 

  0.11%   7.55%   1.05%   3.12%  
U.S. Equity   Fidelity® VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd   0.56%   22.02%   11.31%   19.94%  
U.S. Equity   Fidelity® VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC   0.09%   17.78%   14.31%   14.70%  
Taxable Bond   Fidelity® VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd   0.37%   7.22%   0.06%   2.71%  
U.S. Equity   Fidelity® VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd   0.55%   11.75%   10.10%   10.59%  
U.S. Equity   Franklin Growth and Income VIP Fund - Class 1(1)   0.59%   16.98%   12.16%   11.39%  
Allocation   Franklin Income VIP Fund - Class 1   0.47%   12.87%   7.92%   7.57%  
Taxable Bond   Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)   0.42%   7.46%   -0.57%   2.11%  

 

21

 

 

U.S. Equity   Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)   0.81%   9.39%   10.05%   10.02%  
U.S. Equity   Invesco® V.I. Diversified Dividend Fund - Series I   0.68%   15.74%   10.81%   9.20%  
International Equity   Invesco® V.I. Global Fund - Series I   0.81%   15.32%   7.28%   11.00%  
Money Market   Invesco® V.I. U.S. Government Money Portfolio - Series I   0.67%   3.64%   2.80%   1.76%  
Taxable Bond   Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC   0.98%   8.33%   2.10%   4.72%  
U.S. Equity   Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC(1)   0.99%   15.98%   12.34%   13.06%  
Taxable Bond   PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class – Pacific Investment Management Company LLC   0.94%   4.10%   1.18%   3.04%  
Taxable Bond   PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC   0.50%   4.83%   3.40%   2.91%  
Taxable Bond   PIMCO VIT Total Return Portfolio – Institutional Class - Pacific Investment Management Company LLC   0.58%   9.05%   0.16%   2.51%  
U.S. Equity   Putnam VT Sustainable Leaders Fund - Class IA – Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited   0.63%   10.99%   10.62%   14.98%  
U.S. Equity   Royce Capital Small-Cap Portfolio - Investment Class   1.18%   8.93%   10.66%   7.88%  
International Equity   Templeton Emerging Markets VIP Fund - Class 1 (formerly, Templeton Developing Markets VIP Fund)   1.12%   46.64%   5.73%   10.68%  
Allocation   TOPS® Aggressive ETF Portfolio - Class 1 – Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Aggressive Growth ETF Portfolio)   0.29%   19.17%   9.69%   10.71%  
Allocation   TOPS® Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC   0.31%   10.39%   4.61%   5.25%  
Allocation   TOPS® Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS® Moderate Growth ETF Portfolio)   0.29%   15.50%   7.20%   8.26%  
Allocation   TOPS® Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS® Growth ETF Portfolio)   0.29%   18.31%   8.85%   9,80%  
U.S. Equity   Vanguard Variable Insurance Funds - Equity Income Portfolio – Wellington Management Company, LLP and Vanguard Portfolio Management, LLC   0.29%   16.79%   12.59%   11.51%  
International Equity   Vanguard Variable Insurance Funds - International Portfolio – Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.   0.32%   19.96%   0.62%   10.48%  
U.S. Equity   Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds – Capital Growth Portfolio)   0.34%   28.97%   13.97%   14.96%  
Sector Equity   Vanguard Variable Insurance Funds - Real Estate Index Portfolio   0.26%   3.11%   4.50%   5.08%  
Taxable Bond   Vanguard® Variable Insurance Funds - Short-Term Investment-Grade Portfolio   0.14%   6.85%   2.23%   2.80%  

 

(1)These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

 

22

 

 

SUMMARY PROSPECTUS BACK COVER

 

This Summary Prospectus incorporates by reference the prospectus for the Policy and the Statement of Additional Information (“SAI”), both dated May 1, 2026, as amended or supplemented. The SAI may be obtained, free of charge, in the same manner as the statutory prospectus.

 

EDGAR Contract Identifier C000272129

 

 

 

EX-99.32 12 tm263879d1_ex99-32.htm EXHIBIT 99.32

GRAPHIC

1 Except as otherwise indicated, chart does not reflect less than 50% ownership interests 2 Insurance company 3 Pages 6-9 contain a list of Protective Life Corporation’s subsidiaries 4 The voting rights pertaining to The Dai-ichi Life Research Institute Inc. are split among other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● DAI-ICHI SEIMEI CARD SERVICE Co., LTD. – 9.58% ● Nihon Bussan Co., Ltd. – 8.75% As such, the Dai-ichi group owns 100% of the voting rights pertaining to The Dai-ichi Life Research Institute Inc. 5 The voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● Nihon Bussan Co., Ltd. – 20% As such, the Dai-ichi group owns 95% of the voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Dai-ichi Life Holdings, Inc.* (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life International Holdings LLC (Japan) TAL Life Limited2 (Australia) Asset Management One Co., Ltd. (Japan) TAL Direct Pty Ltd. (Australia) TAL Services Limited (Australia) Asset Management One USA Inc. (USA) Dai-ichi Life Vietnam Fund Management Company Limited (Vietnam) The Dai-ichi Life Insurance Company, Limited2 (Japan) 1 49% Dai-ichi Life Insurance Company of Vietnam, Limited 2 (Vietnam) 81.67% International Life Solutions Proprietary Limited (South Africa) The Neo First Life Insurance Company, Limited 2 (Japan) Dai-ichi Life International (Europe) Limited (UK) Daiichi Life Asia Pacific Pte. Ltd. (Singapore) The Dai-ichi Life Research Institute Inc.4 (Japan) Star Union Dai-ichi Life Insurance Company Limited 2 (India) 36.84% 47.42% Lifebroker Pty Limited (Australia) DLI North America Inc. (USA) QOLead, Limited (Japan) Dai-ichi Life International Limited (Japan) Effissimo Capital Management Pte Ltd. (“Effissimo”) and Effissimo’s controlling persons Takashi Kousaka, Hisaaki Sato, and Yoichiro Imai are considered by the New York State Department of Financial Services, for New York insurance regulatory purposes only, to be controlling persons of MONY Life Insurance Company and Protective Life and Annuity Insurance Company. Based on the Statement of Changes to Large-Volume Holdings available on Electronic Disclosure for Investors’ Network (EDINET) as of April 10, 2025, Effissimo, a non-affiliated asset management company, may be deemed the beneficial owner of 10.99% of the common stock of Dai-ichi Life Holdings, Inc. * 99.9988% Daiichi Life Insurance (Cambodia) PLC.2 (Cambodia) The Dai-ichi Life Techno Cross Co., Ltd. (Japan) TAL Daiichi Life Australia Pty Ltd (Australia) National Financial Solutions Pty Limited (Australia) TAL Australia Distribution Limited (Australia) Vertex Investment Solutions Co., Ltd. (Japan) TAL Life Insurance Services Limited2 (Australia) YuLife Holdings Ltd. (United Kingdom) 10.49% Partners Group Holdings Limited (New Zealand) Protective Life Corporation3 (USA) PT Panin Internasional (Indonesia) ipet Insurance Co., Ltd.2 (Japan) Topaz Capital, Inc. (Japan) 73.1670% Panin Dai-ichi Life2 (Indonesia) 95% Dai-ichi Life Reinsurance Bermuda Ltd. (Bermuda) The Dai-ichi Frontier Life Insurance Co., Ltd.2 (Japan) 49% 5% Benefit One Inc. (Japan) DL – Canyon Investments LLC (USA) 100% 0.0012% DAI-ICHI SEIMEI CARD SERVICE Co., LTD.5 (Japan) 75% Daiichi Life Insurance Myanmar Ltd.2 (Myanmar) Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) 50% Subsidiaries shown on subsequent pages. Challenger Limited (Australia) 19.9% Dai-ichi Mekong Shared Service Center Company Limited (Vietnam) Nihon Bussan Co., Ltd. (Japan) 1 Except as otherwise indicated, chart does not reflect less than 50% ownership interests 2 Insurance company 3 Pages 6-9 contain a list of Protective Life Corporation’s subsidiaries 4 The voting rights pertaining to The Dai-ichi Life Research Institute Inc. are split among other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● DAI-ICHI SEIMEI CARD SERVICE Co., LTD. – 9.58% ● Nihon Bussan Co., Ltd. – 8.75% As such, the Dai-ichi group owns 100% of the voting rights pertaining to The Dai-ichi Life Research Institute Inc. 5 The voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● Nihon Bussan Co., Ltd. – 20% As such, the Dai-ichi group owns 95% of the voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Dai-ichi Life Holdings, Inc.* (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life International Holdings LLC (Japan) TAL Life Limited2 (Australia) Asset Management One Co., Ltd. (Japan) TAL Direct Pty Ltd. (Australia) TAL Services Limited (Australia) Asset Management One USA Inc. (USA) Dai-ichi Life Vietnam Fund Management Company Limited (Vietnam) The Dai-ichi Life Insurance Company, Limited2 (Japan) 1 49% Dai-ichi Life Insurance Company of Vietnam, Limited 2 (Vietnam) 81.67% International Life Solutions Proprietary Limited (South Africa) The Neo First Life Insurance Company, Limited 2 (Japan) Dai-ichi Life International (Europe) Limited (UK) Daiichi Life Asia Pacific Pte. Ltd. (Singapore) The Dai-ichi Life Research Institute Inc.4 (Japan) Star Union Dai-ichi Life Insurance Company Limited 2 (India) 36.84% 47.42% Lifebroker Pty Limited (Australia) DLI North America Inc. (USA) QOLead, Limited (Japan) Dai-ichi Life International Limited (Japan) Effissimo Capital Management Pte Ltd. (“Effissimo”) and Effissimo’s controlling persons Takashi Kousaka, Hisaaki Sato, and Yoichiro Imai are considered by the New York State Department of Financial Services, for New York insurance regulatory purposes only, to be controlling persons of MONY Life Insurance Company and Protective Life and Annuity Insurance Company. Based on the Statement of Changes to Large-Volume Holdings available on Electronic Disclosure for Investors’ Network (EDINET) as of April 10, 2025, Effissimo, a non-affiliated asset management company, may be deemed the beneficial owner of 10.99% of the common stock of Dai-ichi Life Holdings, Inc. * 99.9988% Daiichi Life Insurance (Cambodia) PLC.2 (Cambodia) The Dai-ichi Life Techno Cross Co., Ltd. (Japan) TAL Daiichi Life Australia Pty Ltd (Australia) National Financial Solutions Pty Limited (Australia) TAL Australia Distribution Limited (Australia) Vertex Investment Solutions Co., Ltd. (Japan) TAL Life Insurance Services Limited2 (Australia) YuLife Holdings Ltd. (United Kingdom) 10.49% Partners Group Holdings Limited (New Zealand) Protective Life Corporation3 (USA) PT Panin Internasional (Indonesia) ipet Insurance Co., Ltd.2 (Japan) Topaz Capital, Inc. (Japan) 73.1670% Panin Dai-ichi Life2 (Indonesia) 95% Dai-ichi Life Reinsurance Bermuda Ltd. (Bermuda) The Dai-ichi Frontier Life Insurance Co., Ltd.2 (Japan) 49% 5% Benefit One Inc. (Japan) DL – Canyon Investments LLC (USA) 100% 0.0012% DAI-ICHI SEIMEI CARD SERVICE Co., LTD.5 (Japan) 75% Daiichi Life Insurance Myanmar Ltd.2 (Myanmar) Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) 50% Subsidiaries shown on subsequent pages. Challenger Limited (Australia) 19.9% Dai-ichi Mekong Shared Service Center Company Limited (Vietnam) Nihon Bussan Co., Ltd. (Japan)

GRAPHIC

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Partners Life Limited1 (New Zealand) Dai-ichi Life International Holdings LLC (Japan) Evince Limited (New Zealand) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Partners Group Nominee Limited (New Zealand) Partners Group Holdings Limited (New Zealand) 1 insurance company Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 100%

GRAPHIC

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life Challenged Co., Ltd. (Japan) 49% 80% 1 The voting rights pertaining to Corporate-pension Business Service Co., Ltd. are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● The Dai-ichi Life Techno Cross Co., Ltd. – 1% As such, the Dai-ichi group owns 50% of the voting rights pertaining to Corporate-pension Business Service Co., Ltd. The Dai-ichi Life Insurance Company, Limited (Japan) A.F. BUILDING MANAGEMENT CO., LTD. (Japan) Dai-ichi Life Business Service Co., Ltd. (Japan) 100% Alpha Consulting Co., Ltd. (Japan) 100% Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Smart Small-amount and Short-term Insurance Company, Limited (Japan) 100% 100% Corporate-pension Business Service Co., Ltd. 1 (Japan)

GRAPHIC

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Benefit One Inc. (Japan) BENEFIT ONE USA, INC. (USA) BENEFIT ONE INTERNATIONAL PTE. LTD. (Singapore) PT. BENEFIT ONE INDONESIA (Indonesia) REWARDZ BENEFITS SDN. BHD. (Malaysia) FLABULESS FZ LLC (UAE) REWARDZ PRIVATE LIMITED (Singapore) BENEFITONE ENGAGEMENT TECHNOLOGIES PRIVATE LIMITED (India) Rouken Publishing Co. Ltd. (Japan) BENEFIT ONE CONSULTING (SHANGHAI) INC. (China) 1% 61.5% 70% 99% 38.5% Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Benefit One Inc. (Japan) BENEFIT ONE USA, INC. (USA) BENEFIT ONE INTERNATIONAL PTE. LTD. (Singapore) PT. BENEFIT ONE INDONESIA (Indonesia) REWARDZ BENEFITS SDN. BHD. (Malaysia) FLABULESS FZ LLC (UAE) REWARDZ PRIVATE LIMITED (Singapore) BENEFITONE ENGAGEMENT TECHNOLOGIES PRIVATE LIMITED (India) Rouken Publishing Co. Ltd. (Japan) BENEFIT ONE CONSULTING (SHANGHAI) INC. (China) 1% 61.5% 70% 99% 38.5%

GRAPHIC

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) THE DAI-ICHI BUILDING CO., LTD. (Japan) Marubeni Asset Management Co., Ltd. (Japan) O.M. Building Management Inc.3 (Japan) 50% SOHGO HOUSING CO., LTD.2 (Japan) Dai-Ichi Life Realty Asset Management Co., Ltd.1 (Japan) Marubeni REIT Advisors Co., Ltd. (Japan) Marubeni Real Estate Development Co., Ltd. (Japan) Marubeni Real Estate Management Co., Ltd. (Japan) 85.5% 40% 70% 1 The shares of Dai-ichi Life Realty Asset Management Co., Ltd. are held 70% by Daiichi Life Marubeni Real Estate Co., Ltd. and 30% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd., and therefore the percentage of voting rights in Dai-ichi Life Realty Asset Management Co., Ltd. held by the Dai-ichi group is 50%. 2 The shares of SOHGO HOUSING CO., Ltd. are held 85.5% by Daiichi Life Marubeni Real Estate Co., Ltd. and 14.5% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. and therefore the percentage of voting rights in SOHGO HOUSING CO., Ltd. held by the Dai-ichi group is 50%. 3 The shares of O.M. Building Management Inc. are held 40% by THE DAI-ICHI BUILDING CO., LTD. and 10% by The Dai-ichi Life Insurance Company, Limited. Since Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. the percentage of voting rights in O.M. Building Management Inc. held by the Dai-ichi group is 30%. Marubeni Real Estate Agency Co., Ltd. (Japan) Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) THE DAI-ICHI BUILDING CO., LTD. (Japan) Marubeni Asset Management Co., Ltd. (Japan) O.M. Building Management Inc.3 (Japan) 50% SOHGO HOUSING CO., LTD.2 (Japan) Dai-Ichi Life Realty Asset Management Co., Ltd.1 (Japan) Marubeni REIT Advisors Co., Ltd. (Japan) Marubeni Real Estate Development Co., Ltd. (Japan) Marubeni Real Estate Management Co., Ltd. (Japan) 85.5% 40% 70% 1 The shares of Dai-ichi Life Realty Asset Management Co., Ltd. are held 70% by Daiichi Life Marubeni Real Estate Co., Ltd. and 30% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd., and therefore the percentage of voting rights in Dai-ichi Life Realty Asset Management Co., Ltd. held by the Dai-ichi group is 50%. 2 The shares of SOHGO HOUSING CO., Ltd. are held 85.5% by Daiichi Life Marubeni Real Estate Co., Ltd. and 14.5% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. and therefore the percentage of voting rights in SOHGO HOUSING CO., Ltd. held by the Dai-ichi group is 50%. 3 The shares of O.M. Building Management Inc. are held 40% by THE DAI-ICHI BUILDING CO., LTD. and 10% by The Dai-ichi Life Insurance Company, Limited. Since Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. the percentage of voting rights in O.M. Building Management Inc. held by the Dai-ichi group is 30%. Marubeni Real Estate Agency Co., Ltd. (Japan)

GRAPHIC

Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 1 insurance company 2 special purpose financial insurance company Protective Life and Annuity Insurance Company1 (AL) (commercially domiciled – NY) PLC owns 100% of non-voting preferred stock PLICO owns 100% of voting stock TIN 63-0761690 NAIC 88536 MONY Life Insurance Company1 (NY) PLICO owns 100% of stock TIN 13-1632487 NAIC 66370 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) ShelterPoint Group, Inc. (NY) PLICO owns 100% of stock TIN 11-2284016 ShelterPoint Life Insurance Company1 (NY) TIN 11-2284118 NAIC 81434 ShelterPoint Insurance Company.1 (FL) TIN 86-0367818 NAIC 89958 Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 100% 100% Protective ML Holdings 1, LLC (DE) PLICO owns 100% of membership interests TIN 33-4524758 Magnolia Re, Inc. (VT)2 PLICO owns 100% of stock TIN 39-2280797 NAIC17815

GRAPHIC

Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 Protective Property & Casualty Insurance Company 1 (MO) PLICO owns 100% of stock TIN 43-1139865 NAIC 35769 Protective Asset Protection, Inc. (MO) (formerly Lyndon Insurance Group, Inc.) PLICO owns 100% of stock TIN 43-1802403 Asset Protection Financial, Inc. (MO) (formerly Lyndon Financial Corporation) PPCIC owns 100% of stock TIN 43-1819865 Western General Dealer Services, Inc. (CA) PAP owns 100% of stock TIN 47-0939814 Western General Warranty Corporation2 (FL) PAP owns 100% of stock TIN 59-3126230 First Protection Company (MN) PAP owns 100% of stock TIN 41-1703034 First Protection Corporation of Florida2 (FL) FPC owns 100% of stock TIN 41-1637611 Protective Administrative Services, Inc. (MO) PAP owns 100% of stock TIN 43-1724227 1 insurance company 2 specialty insurer USWC Holding Company (USWC) (FL) PLICO owns 100% of stock TIN 20-8645816 New World Warranty Corp.2 (FL) USWC owns 100% of stock TIN 20-8639268 USWC Installment Program, Inc. (FL) USWC owns 100% of stock TIN 20-8646196 United States Warranty Corp.2 (FL) USWC owns 100% of stock TIN 59-1651866 Western Diversified Services, Inc. (IL) PLICO owns 100% of stock TIN 36-2600350 The Advantage Warranty Corporation2 (FL) WDS owns 100% of stock TIN 36-3445516 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Atlas Peak Insurance Company, Ltd.1 (Turks & Caicos) PLICO owns 100% of stock TIN 98-0137725 A.U.L. Corp. (NV) PLICO owns 100% of stock TIN 68-0300949 Wisconsin A.U.L., Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0440623 AUL Insurance Agency, Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0406407 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Life Reinsurance Bermuda Ltd. (Bermuda) PLICO owns 100% of stock TIN 98-1512479 Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 Protective Property & Casualty Insurance Company 1 (MO) PLICO owns 100% of stock TIN 43-1139865 NAIC 35769 Protective Asset Protection, Inc. (MO) (formerly Lyndon Insurance Group, Inc.) PLICO owns 100% of stock TIN 43-1802403 Asset Protection Financial, Inc. (MO) (formerly Lyndon Financial Corporation) PPCIC owns 100% of stock TIN 43-1819865 Western General Dealer Services, Inc. (CA) PAP owns 100% of stock TIN 47-0939814 Western General Warranty Corporation2 (FL) PAP owns 100% of stock TIN 59-3126230 First Protection Company (MN) PAP owns 100% of stock TIN 41-1703034 First Protection Corporation of Florida2 (FL) FPC owns 100% of stock TIN 41-1637611 Protective Administrative Services, Inc. (MO) PAP owns 100% of stock TIN 43-1724227 1 insurance company 2 specialty insurer USWC Holding Company (USWC) (FL) PLICO owns 100% of stock TIN 20-8645816 New World Warranty Corp.2 (FL) USWC owns 100% of stock TIN 20-8639268 USWC Installment Program, Inc. (FL) USWC owns 100% of stock TIN 20-8646196 United States Warranty Corp.2 (FL) USWC owns 100% of stock TIN 59-1651866 Western Diversified Services, Inc. (IL) PLICO owns 100% of stock TIN 36-2600350 The Advantage Warranty Corporation2 (FL) WDS owns 100% of stock TIN 36-3445516 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Atlas Peak Insurance Company, Ltd.1 (Turks & Caicos) PLICO owns 100% of stock TIN 98-0137725 A.U.L. Corp. (NV) PLICO owns 100% of stock TIN 68-0300949 Wisconsin A.U.L., Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0440623 AUL Insurance Agency, Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0406407 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Life Reinsurance Bermuda Ltd. (Bermuda) PLICO owns 100% of stock TIN 98-1512479

GRAPHIC

Protective Life Corporation (DE) TIN 95-2492236 1 specialty insurer 2 special purpose financial insurance company Investment Distributors, Inc. (TN) PLC owns 100% of stock TIN 63-1100710 Warranty Topco, Inc. (DE) PLC owns 100% of stock TIN 26-3854933 Empower Financial Resources, Inc. (DE) (formerly Financial Leadership Alliance, Inc.) PLC owns 100% of stock TIN 46-5331907 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 National Warranty Corp. (OR) Warranty Topco, Inc. owns 100% of stock TIN 93-1198148 Interstate National Dealer Services, Inc. (DE) Warranty Topco, Inc. owns 100% of stock TIN 11-3078398 PIPCO Reinsurance Company, Ltd. (Turks & Caicos) Warranty Topco, Inc. owns 100% of stock TIN 98-0159153 Interstate National Dealer Services of Florida, Inc.1 (FL) INDS owns 100% of stock TIN 11-3284019 Interstate Administrative Services, Inc. (DE) INDS owns 100% of stock TIN 20-1549705 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Golden Gate Captive Insurance Company2 (VT) PLC owns 100% of stock TIN 63-1191165 NAIC 60234 Concourse Distributors, Inc. (AL) PLC owns 100% of stock TIN 33-1396088 Chesterfield International Reinsurance Limited (Nevis) PLC owns 100% of stock TIN 98-0458684 Dealer Services Reinsurance, Ltd. (Bermuda) PLC owns 100% of stock TIN 98-0199455 First Protection Corporation (MN) PLC owns 100% of stock TIN 41-1368934 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Foundation, LLC (AL) PLC owns 100% of membership interests TIN 41-5073717 Protective Life Corporation (DE) TIN 95-2492236 1 specialty insurer 2 special purpose financial insurance company Investment Distributors, Inc. (TN) PLC owns 100% of stock TIN 63-1100710 Warranty Topco, Inc. (DE) PLC owns 100% of stock TIN 26-3854933 Empower Financial Resources, Inc. (DE) (formerly Financial Leadership Alliance, Inc.) PLC owns 100% of stock TIN 46-5331907 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 National Warranty Corp. (OR) Warranty Topco, Inc. owns 100% of stock TIN 93-1198148 Interstate National Dealer Services, Inc. (DE) Warranty Topco, Inc. owns 100% of stock TIN 11-3078398 PIPCO Reinsurance Company, Ltd. (Turks & Caicos) Warranty Topco, Inc. owns 100% of stock TIN 98-0159153 Interstate National Dealer Services of Florida, Inc.1 (FL) INDS owns 100% of stock TIN 11-3284019 Interstate Administrative Services, Inc. (DE) INDS owns 100% of stock TIN 20-1549705 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Golden Gate Captive Insurance Company2 (VT) PLC owns 100% of stock TIN 63-1191165 NAIC 60234 Concourse Distributors, Inc. (AL) PLC owns 100% of stock TIN 33-1396088 Chesterfield International Reinsurance Limited (Nevis) PLC owns 100% of stock TIN 98-0458684 Dealer Services Reinsurance, Ltd. (Bermuda) PLC owns 100% of stock TIN 98-0199455 First Protection Corporation (MN) PLC owns 100% of stock TIN 41-1368934 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Foundation, LLC (AL) PLC owns 100% of membership interests TIN 41-5073717

GRAPHIC

Organizational Chart of Protective Life Corporation as of March 31, 2026 Protective Life Corporation (DE)1 TIN 95-2492236 Turbo Topco, Inc. (DE) TIN 84-2855430 Turbo Buyer, Inc. (DE) TIN 84-2774149 PGM Holdings Corporation (DE) TIN - 90-0919323 Piston Acquisition Company, Inc. (DE) TIN 81-2921633 Portfolio Holding, Inc. (DE) “PHI” TIN 46-1625561 Turbo Intermediate, Inc. (DE) TIN 84-2888092 Folio Protection Company, Inc. (TX) TIN 84-2790842 Portfolio Services Limited, Inc. (TX) TIN 99-0380279 Express Systems, Inc. (CA) TIN 33-0620692 Portfolio SE, Inc. (TX)4 TIN 30-0964112 Standard Group Insurance, Ltd. (TCI) TIN 04-3160317 Express Performance RE, Ltd. (TCI) TIN 98-0596201 SGR Ltd. (TCI) TIN None Portfolio Captive Insurance Company (TX)3 TIN 81-1383985 PRO Consulting, LLC (WA) TIN 91-1914078 National Automotive Experts LLC (OH) TIN 20-4752011 Veritas Insurance Ltd. (TCI) TIN 98-0698837 ALDS Holdings, Inc. (DE) TIN 92-1647133 Finance Concepts LLC (CA) TIN 45-0980182 Sean Moore Holdings, Inc. (DE) TIN 93-3532764 New Global Administrators, LLC (MA) TIN 37-2027711 New RMG LLC (CT) TIN 35-2741013 New AIG LLC (MA) TIN 38-4206540 NWAN, Inc. (OH) TIN 46-1273738 Villa Mani Reinsurance Company, Ltd. (TCI) TIN 98-1437144 Imprise Captive Insurance Co. (OH)3 TIN 36-4812450 Automotive Platform Holdings LLC (DE) 2 TIN 86-2884016 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 1 Unless otherwise indicated, all ownership interests are 100% 2 PHI owns 50%; New AIG owns 50% 3 captive insurance company 4 specialty insurer Organizational Chart of Protective Life Corporation as of March 31, 2026 Protective Life Corporation (DE)1 TIN 95-2492236 Turbo Topco, Inc. (DE) TIN 84-2855430 Turbo Buyer, Inc. (DE) TIN 84-2774149 PGM Holdings Corporation (DE) TIN - 90-0919323 Piston Acquisition Company, Inc. (DE) TIN 81-2921633 Portfolio Holding, Inc. (DE) “PHI” TIN 46-1625561 Turbo Intermediate, Inc. (DE) TIN 84-2888092 Folio Protection Company, Inc. (TX) TIN 84-2790842 Portfolio Services Limited, Inc. (TX) TIN 99-0380279 Express Systems, Inc. (CA) TIN 33-0620692 Portfolio SE, Inc. (TX)4 TIN 30-0964112 Standard Group Insurance, Ltd. (TCI) TIN 04-3160317 Express Performance RE, Ltd. (TCI) TIN 98-0596201 SGR Ltd. (TCI) TIN None Portfolio Captive Insurance Company (TX)3 TIN 81-1383985 PRO Consulting, LLC (WA) TIN 91-1914078 National Automotive Experts LLC (OH) TIN 20-4752011 Veritas Insurance Ltd. (TCI) TIN 98-0698837 ALDS Holdings, Inc. (DE) TIN 92-1647133 Finance Concepts LLC (CA) TIN 45-0980182 Sean Moore Holdings, Inc. (DE) TIN 93-3532764 New Global Administrators, LLC (MA) TIN 37-2027711 New RMG LLC (CT) TIN 35-2741013 New AIG LLC (MA) TIN 38-4206540 NWAN, Inc. (OH) TIN 46-1273738 Villa Mani Reinsurance Company, Ltd. (TCI) TIN 98-1437144 Imprise Captive Insurance Co. (OH)3 TIN 36-4812450 Automotive Platform Holdings LLC (DE) 2 TIN 86-2884016 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 1 Unless otherwise indicated, all ownership interests are 100% 2 PHI owns 50%; New AIG owns 50% 3 captive insurance company 4 specialty insurer

EX-101.SCH 15 ck0000948923-20260424.xsd XBRL TAXONOMY EXTENSION SCHEMA EX-101.DEF 16 ck0000948923-20260424_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 17 ck0000948923-20260424_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 18 ck0000948923-20260424_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 19 tm263879d1_2025q4orgchrt1.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt1.jpg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�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

@4I2@Y%W6RTO.UY6"?;@:2+91LH8GV10,40W!_&'>'\85&D]%;56*\6D M(X'LA()F+(.@763!R8PHF4-M!3!-QFZ0X#NVX#O',\I05J7ATL)-919.+?(+ M&$G+51FGR9VX$YNTB!BK *! !=4-B6TN#B&,=*]2V@MAKQA(XT"4K-,XJ)II MNER8?W4^#FR8,]!# 8\\AP\6BLY=N&+9>/7?+B=X;M:ZQ%4SN4 MW*Z94SJ"1,%%$B"82E#ID [ZL^E I2E I2E!3F@7]_&O'W=A^1(FKCJG- O[ M^->/N[#\B1-7'0*4I0*4I0*4I0*4I09[XPOVD?OGPG]?6A*JWB#T9?ZTVW;S M2)N;V)3,#/-+@821F!7Q"KM]^TIT1.3<4=X_L@^"HK[57$!Y?(7T 2^N4%^5 MB;B'M]U?^HFM$5*1\U("VB;;1BTH5F5ZX2CSN5%7*Q6A@'M2?/2+S40 14*D M!?BJW?:JX@/+Y"^@"7URO";0W6X\XG,FUNMT99-N9H1][7:/.!$Q@,9/?VS. MT3%*..[(9H,[6X^U-T]82T;;$%<=F6B9:2T)")NYO&> U M2LBXX:20/>2<+,72T8RL3,08))J-/6%'>\5%1L58ABN$2)[]Q2 )1*("(CGI MZHQ>JK[B1>:RQ-IOEK=LN5:6ZV:D%R62>QABB215;,0;F!P0RCHJA5>8'1F M@4P5<_M5<0'E\A?0!+ZY3VJN(#R^0OH E]G-\QS!E=)FBS!: M8/$.[8;."R\DI.N4A%<%&8G6,#5-%8"YR "0WV&T*GZVJFN;>TRBN.IJMTO' M149IHC:*:,=#B+M0N&CDK!=51/DD+XZ:#OH8#"8IAJ^O:JX@/+Y"^@"7URGM M5<0'E\A?0!+ZY05?PZW/?4WJ=I2^NY"0;WE)VO.HW0C(LQ:+BU;2)"QRRJ7* M2\;QS@4W+)N YQ R(5LRLZI:&ZWH33B73UNMTDJX1(V5>AIVCSCI$$QB$$_ M;,B4!.<0#NR8?CKW>U5Q >7R%] $OKE!?E9[X/?V[?OGSG]37H]JKB \OD+Z M )?7*E7#YHR_T6MNX6DMN*Y7EQ(C)@HDP AW]_3N#NXXI_CT?\ ]TK0: I6?\<4_P >C_\ NE:8XI_C MT?\ ]TK0: J)W?IQ&WC<=ISRZJ[25MIXHZ9N&XER8BB1DED3@8!RFC_^Z5ICBG^/1_\ W2M!85NZ Z9VBM,*PFG]M11YA$[>0[)% M()@Z1-]FD< +@2&'J)/L1'J(5ZK7T4T\L=VV=6Y85L6^Z:G.H@O%P[=L=(YR M;#F(8A $HF* %$0[P# ]*K/'%/\ 'H__ +I6F.*?X]'_ /=*T%BM-%[88:F) M7NU8I-)))!R0C=L@DDCVAR<@N79@*4#'74*DD0RAA$=I,?"-3NL_XXI_CT?_ M -TK3'%/\>C_ /NE:#0%*S_CBG^/1_\ W2M,<4_QZ/\ ^Z5H- 57W$-^L#J9 M]S$G\E4J 8XI_CT?_P!TK7$O>U>*"^;+G[;=+Z1MVLQ'N(Y59$)3>0BJ9DS& M+GID ,(AF@MOAZ_6"TT^YF,^2IU8%1S3BU#V)IY:]M*."O%(:*:QQG!2[05% M%$J8F ,C@!VYQGX:D=!2#;W[$C][UK^4G%7?517MI%=S_5XE_P!G7C$6^\/! M$@G+.9@%))-0A7!UBJ$%-VW$HY.(" [@Q\5?9[%=;_*58_H([_2]!;-*J;V* MZW^4JQ_01W^EZ>Q76_RE6/Z"._TO06S2JF]BNM_E*L?T$=_I>GL5UO\ *58_ MH([_ $O06S2JF]BNM_E*L?T$=_I>GL5UO\I5C^@CO]+T%LTJIO8KK?Y2K']! M'?Z7I[%=;_*58_H([_2]!;-*J;V*ZW^4JQ_01W^EZ>Q76_RE6/Z"._TO06S2 MJF]BNM_E*L?T$=_I>GL5UO\ *58_H([_ $O06S5(.??L1WWO7/Y20KK>Q76_ MRE6/Z"._TO7UV1I%=S#5X]_WC>,1<#PD$>";,X: 4C4TR&<$6,H<5';@3FR0 M VACXZ"W:B6KOZT]Z_R(]_H#U+:Y5UP);IM>8A3K"W)(LUF9EBEW"0%""3 M< ?#C.<4''TC_6HLO^1&7] 2I;5*VYISK1;%O1<.VU-LM1M'M4FB1U;%="GL5U MO\I5C^@CO]+T%LUS9*WF$M)1D@Y0WO(U0ZK58IA*9,3D$A@Z#U 2CU*.0Z / M> 8KCV*ZW^4JQ_01W^EZ>Q76_P I5C^@CO\ 2]!:Z:9$2 1,I2$#N*4, %@MFE5-[%=;_*58_H([_2] M/8KK?Y2K']!'?Z7H+9I53>Q76_RE6/Z"._TO3V*ZW^4JQ_01W^EZ"6:N_K3W MK_(CW^@/7*X=O>_:9?@LFX(%G<\,[BI JIV;HFQ0$%SH*8[\E M4()3$$! ! Q1 0$.@UXK/LJ)L2-691"2Y$UUSNEUG;I5TNNL;&XZBJIC'.80 M R(C@ P %0/V*ZW^4JQ_01W^EZ>Q76_RE6/Z"._TO06- VW&VP@Z1C&W M9DG3M9\L7>8^Y94XG4-XPCC)A$Q76_RE6/Z"._TO3V*ZW^4J MQ_01W^EZ"QY2WF$T]C'3U#GJQJXN6NXP[2*B0Q-^W.!$"G, 9SC.0ZUTJJ;V M*ZW^4JQ_01W^EZ>Q76_RE6/Z"._TO06S2JF]BNM_E*L?T$=_I>GL5UO\I5C^ M@CO]+T%LU4W#Y^V5]VLG_5T]BNM_E*L?T$=_I>N[H]IW)Z6E MW,NZ>,X\S%#>L(>(1$RJHE * =3F$>H_P 5!4'^$O\ YHO^LUINLR?X2_\ MFB_ZS6FZ!2E*#/?![^W;]\^<_J:T)6?KK-U7&W>F"I)!(#%#8&/$ >^N][#-=O*M9/H"X_2U!<=*ISV&:[>5:R?0 M%Q^EJ>PS7;RK63Z N/TM06/.65#W'.0,P^:2#DZAE#KJ F5,O4PC@I2$*4"A@ QT#J.>Y5.>PS7;RK63Z N/TM3V&:[>5 M:R?0%Q^EJ"XZ53GL,UV\JUD^@+C]+4]AFNWE6LGT!WBQ$-&3CF+>J.01?SK^&41,9!1( MJR+AID0.43]2G(8!*)@#:.!JE[LX([I?HVU+Q$TQ3O:.CFBDE.*2;M)66E"F M0(NJ)MB@( **1\+)DYAU#$.8,IE-6SJ4&?;8CIF(XDM/&-Q2"QH** & Z&, CW!W]P=U:"JM]0-%BWO>L3=C"\;CLV=CX]Q%E<0/8 MC LW6425,0Y739_OS7.]I*Z/+GJ'^ @OT906S2JF]I*Z/+GJ' M^ @OT93VDKH\N>H?X""_1E!;-*J;VDKH\N>H?X""_1E/:2NCRYZA_@(+]&4% MLTJIO:2NCRYZA_@(+]&4]I*Z/+GJ'^ @OT906S2JF]I*Z/+GJ'^ @OT93VDK MH\N>H?X""_1E!;-*J;VDKH\N>H?X""_1E/:2NCRYZA_@(+]&4%LTJIO:2NCR MYZA_@(+]&4]I*Z/+GJ'^ @OT90>70+^_C7C[NP_(D35QU!=*=*$-*FUQ 6X) MBYW\_*FF'\E."WYZBPMT&X -T44RE!-LD !,YR(B.:G5 I2E I2E I2E I M2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I M2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I M2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E!F3_"7_P T M7_6:TW69/\)?_-%_UFM-T"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E* M4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E* M4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E* M4"E*4"E*4"E*4"OBHH1%,RBABD3( F,8PX #O$1KY55G%9[UW6'[C9CY$M0 M2CVV+(^W*W_.B'SZ>VQ9'VY6_P"=$/GU1.@?"-HG.:%:6W&N' M#IQ#H'464.U3,\1J>>!EH/Y'[+\R-_FT$Z]MBR/MRM_SHA\ M^GML61]N5O\ G1#Y]07P,M!_(_9?F1O\VG@9:#^1^R_,C?YM!.O;8LC[VQ9'VY6_YT0^?4%\#+0?R/V7YD;_-IX&6@_D?LOS(W^;03KVV M+(^W*W_.B'SZ>VQ9'VY6_P"=$/GU!? RT'\C]E^9&_S:>!EH/Y'[+\R-_FT$ MZ]MBR/MRM_SHA\^OY[;=C;]GLTM[?C.WUU0SCX_LZ@W@9:#^1^R_,C?YM4 M MPM:2)\?#.W/:UM?V-+:9KR'K5ZU(]F[62523YW+VXW[%-N[&<=*#7/ML61]N M5O\ G1#Y]/;8LC[V MQ9'VY6_YT0^?3VV+(^W*W_.B'SZ@O@9:#^1^R_,C?YM/ RT'\C]E^9&_S:"= M>VQ9'VY6_P"=$/GT]MBR/MRM_P Z(?/J"^!EH/Y'[+\R-_FT\#+0?R/V7YD; M_-H)U[;%D?;E;_G1#Y]/;8LC[EO")1P8 E4.@XSU\?^,* M@W@9:#^1^R_,C?YM4+H1PN:03G$!Q#1DAII:SV.B)J+1CVB\4B=)H0\:BHVQ9'VY6_YT0^?3VV+(^W*W_.B'SZ@O@9:#^1^R M_,C?YM/ RT'\C]E^9&_S:"=>VQ9'VY6_YT0^?3VV+(^W*W_.B'SZ@O@9:#^1 M^R_,C?YM/ RT'\C]E^9&_P V@G7ML61]N5O^=$/GT]MBR/MRM_SHA\^H+X&6 M@_D?LOS(W^;3P,M!_(_9?F1O\V@G7ML61]N5O^=$/GT]MBR/MRM_SHA\^H+X M&6@_D?LOS(W^;3P,M!_(_9?F1O\ -H)U[;%D?;E;_G1#Y]?P^K=C)EW'O2WB ME^,TJ@ ?^.H-X&6@_D?LOS(W^;6?>/CA?TBL;A1O.;MW36UX28;KQA47S"+1 M163 \DU3.!3E* ADAS%'XP,(4&O/;8LC[!EH/Y'[+\R-_FT$Z]MBR/MRM_SHA\^GML61]N5O^=$ M/GU!? RT'\C]E^9&_P VG@9:#^1^R_,C?YM!.O;8LC[VQ9'VY M6_YT0^?4%\#+0?R/V7YD;_-IX&6@_D?LOS(W^;050.HUIAZHZ$B-SPP1XZ4= MG!WZX)UK: M_L;]K#US]:O6I'LW:O77E\_E[<;]GB[L9QTK0G@9:#^1^R_,C?YM!.O;8LC[ MVQ9'VY6_YT0^?4%\#+0?R/V7YD;_-IX&6@_D?LOS(W^;0 M3KVV+(^W*W_.B'SZ[4)<<3.CD2HH);XP3GVD* M&3&,8<=XB(T&LJ4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I M0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I M0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*JSBL]Z[K#] MQLQ\B6JTZJSBL]Z[K#]QLQ\B6H/;PW^]WTM^Y6+^2)58U5SPW^]WTM^Y6+^2 M)58U I2E I2E I2E I2E I2E K-]Z",5Q]Z9.?L0E;(FH_/^-RG+1;%:0K-> MMKCLW&QPS '3M#*ZT1'X_P"U&IP#_P#PH-*4I2@4I2@4I2@4I2@4I2@4I2@5 MG#AS]\KQ._R_$?DI"M'UG#AS]\KQ._R_$?DI"@T?2E*!2E*!2E*!2E*!2E*! M69_5(O>:7W_K$1^56E:8K,_JD7O-+[_UB(_*K2@TQ2E*!2E*!2J?XF^(Z,X; M+"]?'$:I<$NX.)&,*W6!)1P!<&54$^TVQ-,F3&-M'J)2]Y@JNISC@"%NV%8&;RP&D'K^/9BY.068)9324 !(10#G$1$HB0 ,%!J6E9PT+XR8 MW62Z&,"X8Q< ]42<HVJ5M:3Q3&1N=\LR;OGI( MYJ5LR7=JKN#E,8J9$D"'.81*F<>A>XHU+*I+B3_OAT.^^"U_)[^@ZGA16%_E M5Z%S7U2GA16%_E5Z%S7U2K9I05-X45A?Y5>AA&@.ID#$-KJ=RTK;$FQ9M_8=,$YJRK50B9=QFH%#)C &1$ #/40 MJY8[5>'E+ MA5OP$M;\RVFDY9^RC#-F;QL99BNZ()TR."BJ&TP Y*43&R M [0-@:E45J=%2^I\_8B*+LLQ"L&LBX6.0H(&3<&4*0"& VX3 *1L@)0#J&!' MX BGA16%_E5Z%S7U2GA16%_E5Z%S7U2H\VXT=/5[ZBK5.LHT>O&[]XNX'>%! O"BL+_*KT+FOJE/"BL+_ "J]"YKZI5LTH(OIYJ9; MFJL&O+VR^4?,D':K%;G-%FJJ*Z8X43.DL0AR& 1#H)0[ZX%V<0ECV7=;NVI% M])KS;-!%RY:1<$_D!035W M^AUL_P!0M[^B=T'1\**PO\JO0N:^J4\**PO\JO0N:^J5;-*"IO"BL+_*KT+F MOJE/"BL+_*KT+FOJE>2[.)1*T]6X_3T^GEZ2,G(E.JS?L4&0LUT2L0#FV M)P#'7KN+\(@%!]WA16%_E5Z%S7U2J(UBU?@;BXG^'RZXYA=3B$MM:?+*NO8A M+%[.5S'[$?%,V Q]QR 'B@..\M;@/%%87^57H7-?5*D]H:L6]? M=Q/XJ"=IR1&K!I)%?M7*"S=PBXW\LR>Q03X]S-U,4I1_8B;KCB1O$AIZY:Q1 MY&Y8RWG,J]<,&+*5D6Q%G*B*YD#; (J+0>/PHK"_RJ]"Y MKZI3PHK"_P JO0N:^J5S8;B_TWG[6N.792Z9WL 5VH^@5';5*0(FW7,@+G32!CG$A)O;ACF#Z3*LW=-;/F%$EB"&2F(8&@@8HAU 0Z M#5R53W!U[U#1_P"Y2-^3$H/1X45A?Y5>AA[3M&J2J!3)%*.XC@X9/SBB4._!3".W'4)%X45A?Y5>AAYR3874VBKAF8UQ&./8A+'[01 M..13..TK43%P)/3QB26(PN:,GWT2Z09OH^,D&QEVYU5R MH )@.H0 %#8'KG(" )L%&0W3JC!676;XNM*8/V, M.%;OC%X2X%':*$Z@\1%@@HV(4ZA%E1.&TP@8H (B(_!WU+H+5J"N3V5GCS MF=-[=!,Z[A!9!8C@AVY7!3);%##@2'#&\"9[PR40$0C?A16%_E5Z%S7U2GA1 M6%_E5Z%S7U2O6CQ"6PIIG9M]J%=,X*Z5&Q&IGAT$#H N43E,KO5 N HB($$ MYOB U<+2_C!TRU0@H:32GV=O^O;Q5G$LYJ0:)N7XD.!-Z:::QQ #&$ IMIL MB "4,AD.EX45A?Y5>AA?@&HAX45A?Y5>AAA@T"XCXT$+PC+P.]3;':-I1E:4VDY;)F,4Q@(/9!(.1*'V13!_%7'MZ&T3 MMW6)KJ$F\OIT]8F,=@Q<6/(F(U,+?L_]W".!PH0J>0(FHJ8I!,80#J&-ETH, M8.+=T/=7_&7FM)ZCJSK23-+.%CVG*"#];M*;A,%O_)V0*F9%(I 3$GB)E*(F M"M2Z=:GVWJO#.Y2V'RKYHT>*1[@'#-=HJ@X3 !.F=)8A#E, &*/4H=X5*JI# MAC_5'6?[X4A\G:4$3_PE_P#-%_UFM-UF3_"7_P T7_6:TW0*C+C4ZSFBZB"] MV0:*R1A(=-221*8A@' @(";H(#\%2:LN<'NANF\[PQZ=2$EI_:T@_=11%5W3 MJ%;*JJG$QA$QSF((F$1[Q$:"^O;5LG[<(#SFA\ZGMJV3]N$!YS0^=7'\'C2K MR9V=Y@:?1T\'C2KR9V=Y@:?1T'8]M6R?MP@/.:'SJ>VK9/VX0'G-#YU- M*O)G9WF!I]'3P>-*O)G9WF!I]'0=CVU;)^W" \YH?.K.&A&H5JM.+_B?=KW+ M#HM';BVA;KJ/TBIK;8O!MAA-@V!Z#CN&KW\'C2KR9V=Y@:?1U\"\.>DY#G.7 M3"S"G/C<8+?:9-CNS[GUH.W[:MD_;A >3. MSO,#3Z.G@\:5>3.SO,#3Z.@S]QB:4L.(L(IY;^LMMPKB*3(5K%2#ANHT%47" M9U'&\!,8BG+)M 0*/3)?% YQJ*6[H/#OM:>WW;>]I/-/&;J;=I1*=RD62>'D M4^6IAL*91;B(&4.?W=4-XAR@3 1K5G@\:5>3.SO,#3Z.G@\:5>3.SO,#3Z.@ MROIOHX[TTU8A+CA-5K2AX)=Z9W-Q+2YE%""F"J^U I3A_;8&2.EE1-*O)G M9WF!I]'57W7II:%A\3^B*ULVK"6ZLX).D64B8Y%J94H-"" &%,H9 !ZX&@TC M2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*! M2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*! M2E*!2E*!2E*!5)<2?]\.AWWP6OY/?U=M4EQ)_P!\.AWWP6OY/?T%VTI2@JW7 M?2"7U70M!> N9M:TQ;4VG--G3R+&014.5)1/89(%D1Q[J(YW?!W51M\\ DO> M=MJQQM45DW,JO)/9Y<\6J5%ZZ=F3'G)H(NDP*"8)%*5-0RI,"(B&[ U&^-J: MU 3UF4:6@I<3UI'6*O+K1T)=3N'%(Y78D%T":!1!R8A1SRS8W X$1P \Z'X MO[Y+>$+9S62B;FC B&27K@)2(NY=-6.,LK)I&[414 *H7&TB!@#:?<:MQI,PL=?C(EM3+%-)\DYMXJSP7)(P& '26,MA-,0*538!=X" E!0 $:K33 M#BDU*(/&SIR]=#*( *A^TG<"("0W4!,4XFSU'X_)9G'= M>2S6>5N!S;9O6R8BB/'3-L46+!BX?"W7$ZY'9Q*8I SAG.Y^DEG]$;T3UPEM0K1 MOR*@DY>/91SV,D[<._$Q&YU# )%2NTMHFYI@ZD'& [ZI"'XO[^NZ537BG=N- M[>:,KBF7;H(M=VHY9Q[T$4BHE(N7QCIF 1-USW@ 9KC:9<9>IFH\8"X&IGP>\3=Y:\71<+*XV46DU:LR MNQ38E336C%Q<*)BS6*5RL83 4@&RH1$^0-XF!*-!JFE*4%(\+W=JU]\*7_YI M5]FFGOH=;/\ 4+>_HG=?7PO=VK7WPI?_ )I5]FFGOH=;/]0M[^B=T%U4I2@@ M%P:5>ONLUI7]ZZ8E-42JW?*NF':GK*'58LC,FI%2D:@BB\*L "*QCB8' "(@ "&W(#6UY\4> MK;B-N?<7-[V M0W>+LIV+F4W9;>06NAP858]MS8M9LP^2"+C8XIX-9S"K99G<&*8RJ#@3&*<'&!3$<>)D2W>#>; MLB=1DK>OQBDHY(Y:R825NE=@HV5DE'Y00*9;:FH453)B8X*%$,&V@(!7OX<- M:]1]9M0)8DVE!0EOQ,/%N7$8W:J*.E7+QH"PB5?FB0$RB!A -HB(& ,],C4I MN**-A]$]']RV[<9\;OR7NK4[%MV)DW;[M_* M3*GNQC. QG%?G3)<0^I>D4M>\R>XFTB64N]W$D?3/,,QBTFK$BZ2!$W$@D@0 M53' N2B4X[#C[H8Q2EW[I[/OKJL.W9J38EC)&0CT'3EF0^XJ*ATRF,0!^$ $ M1 !H)!5+\:/O3M6/N=>?T8U=%4OQH^].U8^YUY_1C0715/<'7O4-'_N4C?DQ M*N&J;X0$@7X2M(TQ,8H'M*-*)B&$I@RV)W"'4!_CH+#U#M/V>V#:F8F_;D-V-V<9#..\*IB\^$0EX0L6P-=!6XL;">N[[,,=:8-.SVAA^(*ZHB?NRZ7-FRC*-BV5Q7$]D635!P@V M,JLJBJN!3\L53J;C&+@ QN*&1#[HGC/O:01MM.5GK.M!DX(_63N.29&=-9X4 M'2:*;=L1LZ4*50Y#F,()J+#DOB@(4%JZ-\'/M3:KFNL]TC,1Z"KYTQ8J(."* MHK.P)SQ$1%UG=7^@2QKEN1KBT>A)MUU'+1 M2.,95$HK"MXR778"0$+M* 8&I$\XL-1H-1[#3TO:4,8)>*;+7BXBUDXZ*;/( M\SOW9(SGJ('*"13F5*4=X"(9Z4'5;\ $ZU148234Q95VXE3E4=F M;F*9,ZZP\M,AFX>XE#:(&$ V_#'K[UCO*\>#RV[T4%Y;*TE(LTYZ2@"*IJMX MOM?+7>-_LE$RG2 % -U,0A\@/3-1ZW=7'L:YMBW=%[W?W7"W%=+F/+-7N5Q+ M(H)),1<'(R7,H11,RM2@4O.,;*8%W"8YCF-G&2@ 8Z^B_#9[4-L73#^R/UV]?&+%ESNP\ MGD]FCDF6[',-NW<>M[-8*P90'<"+%ZLX1DC^MZ0N7IT MGA4,-4@D-BQ-IOLFJK@PFZ@3:&*"Z;4X4;UC+0L&U)S4N*E[>LN0CWT>DSM8 M[1P?LNX (HH+U0!W%-C(%# ]<#W5&S^I_ 'L12+>YE6D9&(1,HDHS<)@]11> MF=D,F5)V0I#;C"4>:"Q>@& $*Z?%5=S6*U3M%E?%XS]A:7KPCUP,G!OW$<* MTH4Z?*1471P8!!,3F(F(@!S!C!L8J'R/%9=EGS-O0D7))NVR#"#,PB[OCCDN M"[2O%.6LHF)#D!,Z)?&-A(_4!$^ &@VY5-WW[ZG2/[G[D_\ '%U.[:U1M.\9 M08V$GV4F_!%5P+=NIN/RTUC(*&Q\152F(/\ & U!+[]]3I']S]R?^.+H/)Q. M?JEHO]\*/^3.Z^'%WQ /N'_3AF_@DXAQ==7Y+0QL"HJ90VXN"E3( M;]D'C"7XZ^?$Y^J6B_WPH_Y,[JPKJTHM*^;CAYVX8-M-2,0DLDQ%[N511!7: M"@\D1Y8F$"%#<)1, =PAD:"ET^.JT.=IFB,6^6+>\>V?(/0<-6[9$53\L4@, MNL055"'W 8B8&, !G Y *\1/5!+&*SO%=S"RK%2WG2;/LKIRQ3<.%3N.SD*9 M(7 &;@)\#N7 A=H[L_!4[4X/M*#=C(G;KELS:N#.@CF\P]39J&%<7&U1 %N6 M<@+")RD,42E$>@ '2HM]A2NJD&V@+?6FX.=%G;I5DEQ(Z9)"L M+M1< 5 3'3*CWD$H9.7(5KVV- [+L^X(.W=*2KI4ZJ*QQ44! M?>H//$3B)\J[A W4!# 5'+MX5M')1Q+3]P6PVWJED'#U^XD7"12E=E+VLYC< MT (!BIAD0P!0 =NW(Y"(7-QTVE9E[RUKRD-(J/(R+29VBJ4NX0'X.M?R4XYK?AK5G)5_:$Y&/(IVT;'C)%W'MU%".6XN$5"G M,YY8[DP'Q ,)\X#;\71F=!N'Y[)R4W)*1XFDF#J87!2Z'";86;A$&[EV1(' M)D343,4IEBE !':.[( -?-?2WA^U+MU[>;:1BG\*@JDXPXQEL7&[AGZ\.S6F 3;%09.)(I3M MTE2BL"@B!#@)C$*8H=V1$:XT)ZH;8UQH+FB[?G9%G.F^$"SXZ[[#&)DBH*%5.04F.#(" M+LSP$3D, E#FJI*' OBE.!1JW8'A9TPADBBQA'"C8'C:1;)*2[Q9%L=!45D0 M0(982I)E4,8_+( $$1ZE$,!05JW]4$M%*%?2L1)!E:-Q2YTF3]_((QZC%4&*3)5- M-P85>TMJC)>$RSQ===LZ.51P514Z MHG.8YB%'>([@Q@! .E!]&A^N#[5^Y]0V*MN+0\=;NX# ',X8_U1UG^^%(?)VE6!9FE%M:?3<[*P+-=BYFS(J/B M"]6414.DF"1#E2.<2$-L*4HF* ";:&(1W"+IP[O!;8D!,(G((NN8J"JAGRAEP!P!E *8><)@R ?!TH*_OCU1 M*W8V-O1.U[<>SH" ]:#->G_J@[KV MJ[AO2]K<;O9R-BMDG#QF5VW(8O.YG4AL"($$"B'4>H#7PU"T1X= MK):QK&[%XJSR.W9E&975SKQAW"AFR;0Z9#=H(8Q#(IIIF3 =H@ 9 1$1&;QW M#)IBR8H(-K;*+4CMG()E,_M!6-O\?MIW M0X?1\9:\V_G22+.-8Q;-TP<"^4<\WE[5B.11)@$%1,!S@)< '41I'>J#V%(3 MMO1AH>99+2:A47 .SM$U&!SO56:8'2Y^]7*J!Q'D@IL*(&-BO=>' Y9/L0,P MLO-LR1%F2I)"5=OY(I$FICF12+EVFHB4H*' ID54S% < ..E?/1[A?TOM*Q[ M/F1ED+A5BB"@8ZUZT_5 ]/UG%XE2CI99 M&WF;UZ51$[50STC14$EP(D583I"!C!M!8J>\ $0[JG4CP[:/("VMU[$-45I1 MB_CF\>K+."+.FZRX.G9$RBL!C>Z8.(EZE#H E+TKTDX5-,B$N-'UAL32SP6P$6."BP(IN5CSYQS;J$PY0;"R5>H;]Y V.#*@7W,V#&3 /C M$*G"?$'I8O#RPQT%3L7!Q,SCW!EDT%"+.U"[C[A#*8$(7J()]1"@NEQQ5:-M1. M5;5&TDC)I\TQ3S" "4N0#(AN_P"T'3^.I234:RCKG;DN*%,JJ\19&3*[2$3N M5D@522'KU.=/!RAWB7J'2J0DN"I"0D9!T%TII=J?7&\ GK4 [/75L5 "YYO7 MD@7.>F_NP3OKG-N"20;3\<8+]1]CJ#^*E'#'UF'M*[AFP!D.U?M&$R'(4#8Y M9A*;X1#O"QD^+[29:ZI6&3O**40BX_UP>S!'R!F" "XY (F4 ^>:)Q#!<=0$ M,"/=4CNW7"TK.TO;WXBZ]?;764;)-W,&9-\0Q M6=TN JZ&S1@DAJHW;&BXEI L>R02K43LF[KGE(X41>%4.8P")3&2.D(X 0QU M ;"\$QRAPL-='FUWII.6CDCI&>4BQ4*!B/NUE S<5\F#( 4?=>O?_%061>NM M]BZ?WW;UK7'-LXN%[ MNU:^^%+_ /-*OGIJ..*#6P?BC[>_HG=?#A>[M6OOA2__ #2KYZ;!GB@UL#XX M^WOZ)W0>ZU.*W3"YX*!D%[KCK<7FQ$&47.O$&SP_NZB!1Y>\>AE$C@40$<_Y M^E2%/7K3=9_-LB7U;YG<((!)(A(I;FGN@)^Z!N\7QS 0?B,( /7I5#QW 21A M:C^&&]BJG=0[6)*Y&'P*?)E59#F '/Z[N:">W(8V[LCG:'TRG C(R4A?QD[_ M "1L9<:*_9X]E&K BFNH[3!A$V1H-"3NMNG]L+E1 ME[U@HU8SXT85-U())F,[*!!,@ ";(J "J8B7O#>7XZY:7$;I,]CWDF34.UE& M4 B)A'=@<8R,.L/@)D+7GF,S-:C!.NF\G$2*IU M8Q83..P'7,4#'6>*B!E 7Z[<$*)?%( #@ T$OK[IH@WMU96_+=(C,&[Q>G[+IW]*Z5LZDV5>TM+0,!<<--2,0;EOXYBZ364:B XPXP*%$ VT! ,=CA\X2@T,OA_.'N4TZV(VIYYB8F*H* MH%*)1**HIR]1'TFRM>ZX>X7<8?EO4(UZFN=N.1#QP*(XZ@(9 M[L@(? -59!<,L_;-Q.VT3J6]CM/'4PZFE;:;1I"N3*N-YE41>;\B@)SF/LY> M[N#?@*Y>E7"M<>F$DQ>M[^8+O(6%1MN'.2 V G'%<@L<')>T#SECE+L!0-A2 M]3;!$1"@N+5C4F'TFLM:XYULY=QR3ELV,DT3(HH)UER)$'!C%# &.41Z] < M9'I7AO372R-/;X@+3N&>:Q4S-MW#MJ1TH5,G*1+N4.-ML[0IVCQ%,F"$%XIM4(=(#;A$P& 1#:'?067 MI_Q VAJ\ZO!K9DF$R2W"(^J8U+N MJY+SX"=5I.Z2O22)XB3(F62A5HET"(%'E\UNJ4-IA#KXN2X$ QA 1&?Z1: MW=II<\U/.[ZBY)[.N8\\DDTMT6J1V[5J= $DP%R<2&-E,PG$1QM$-N#!M]O& MC[T[5C[G7G]&-!=%4]P=>]0T?^Y2-^3$JX:I[@Z]ZAH_]RD;\F)07 ( 8! 0 MR ]X#7P[,EM3+RB;4Q 2!M#!1#NQ\5?92@5\5$R+$,10I3D-T$I@R U\J_FX M $ R&1^"@AT+JG#3=^7A:22;EN_M9%HN_77*4K<2.$S*$$A@,(C@I!W9 ,?! MFJV?\<6CC+34UZDNYF[8F[0#:/2<)%?.Q1/L.5)$YRB(YP( (AD#%^.O>OHA M>L7K?0MP[Q02-B"3":Y7:8$$P&-U%,V,AT''6GW/ # M.&MR1A6NHT>W;2,6Y@W*BMN&6/V([XSQ+9ET %5*HHYE]T^SZ!XWP=?CKX]E1 J1>2GM2ZIAM#!/\ -\5>""92S/UQ]=I-"3YK MQ15IR&G9^SMQQL1-XYN88O7)_%SG[$,5TP,!@ 0$! >X0H/[7Q,F0QRG,0HG M+G:80ZAGOQ7RI0>'UD8^O?KOVX,53? M?OJ=(_N?N3_QQ=7)5-WW[ZG2/[G[D_\ '%T'DXG/U2T7^^%'_)G=7?5(<3GZ MI:+_ 'PH_P"3.ZN^@5BW6+1B^G$[K=#Q^FR5ZEU)!OZUW09ZT33B0*W(CL< MJ<%2@B8HJDY13Y$>F!K:5*#$;7037&'DW0GVJ3UU<1CLP9'C1+' MJ V%82%#M0%,&";RCU, %3#A]TFU*2T1U(MV\3R;-S.,SLXUE..^TG04,SY M2R@*=L=CL.J(FZJ!UW& A -M#5E0'4BZI&*N6RX*,6%JI,.W!UUP(4P\ENW. MJ*89 0RW=C ]0#)1-$]2;[ME9M-Z6N69(73E"S_6Y[.M43RCHCMNJ8 M[59%10" !4-Q#*@4!,)0$,9KSM]"-9[ITXGK-);)6,3<]S-'#I]=YXXKXT<@ MB4ZA9#UO, +\Q5--(HDR?9NWB 8JX7>M-U!IEI9*)7$P924Y;S][(/9!),K? MGI,=Y55=I?$(182B;: !\ ACI7'7UJN^R[S,;(3;&3<2EP(I'=7 M$*K)!@I'&+'"#;G&3* .MHAM)O*/40 H5;-AZU2MPP6FDDZ45!T^E7%LSS!= MH+=0'A$53 MHZ8?R,E_S&KMJDN"CWJ.F'\C)?\ ,:"[:I3BJT]GK]M*UUX&&2NA6W[C93;F MW5EDT@E$$1-N1 R@@GN#.R=).(IOJ1IP\N![. MV8LHMD"1RI55#&%4JY@W(* H7=R\G\3[$>E19SIGK#':QLW[2*E4T MVLG'+LWL3/E2@6D,DT*5U&@R,L7)S*@8"F%$?LB&WEVXJ2H\5LM;$#&&?QB- MQK&>+@_<$.LFH@@:679H>*BU.D3!"!@RQT@/L$ $1R(=4G%;)MX]LX?6M'(F ME$USQ!$)99P984GQ&AB*D3:F.4XBH4Q2I%5,;!BX 0H+4MV]Y*['TM"O;6?0 M+QM%-72@N5T52 JN53F)/&'.!W%$!$!S623:6ZG3_!ZPTFE-)[@C MY6!!FY*Z1GH\B;X47Q%#IHB@\W@84A.)>9M+DH=0-MJV(?BYF)EH=ZC934K- M@D124%646252S)*L1!%,[4#'$!2YF% 2' [1P-6_IA=#Z<7NZ,D5A=.8&;68 M%X'"SM] MH0N<8R8/CH+[I5(^&EHY]MQ_-+[Z&GAI:.?;$%ZJ58RY1:J"V#D F8J2BZ I%, ! MO$HA7=^JEFL;@;F"Z)H$6LZSBGB,!VE== MT4R L%#@@W H!M,L!3B4J9MO7(U&;EGM2_9>C-+(7H\GXM&9(5DUMX.Q,DSF M2(U4;K]E,"IS)^.("*PY _N>0 @VYX:6CGVW'\TOOH:>&EHY]MQ_-+[Z&@A6 MGUQWK)RUFKW(21";3N]Y'-5)%J9%5Q$&CQ5.(B9LV$Y 4*3QA1)U(4!#(9'4 M=42IQ@:(JOT7Q[E*=Z@F=))P:&>BH4ZR(X&*F+XE7K!PX;*(=I0,8A2J%*H4IA*(E M, #CX!J-JZO6KHQQ/:IJ7F^<0J4Q&P:D>J:/^ M@TY2J1\-+1S[;C^:7WT-/#2T<^VX_FE]]#07=5:ZW*JBA9;4^?6EW>1XP-$9=H=J]N4KML<2B9)> M&>G*(@(&*.!0[P$ $/B$ H(3=E[W3+W?&EHY]MQ_-+[Z&O.3C T13D%7 MY;E*5ZJF5%1P$,]YAB%$1*43'G M4&V;BHX64+M(0ON/>(B 4&O:I[@Z]ZAH_\ 86CK!>DG+1TI)(LH^*;-$XMF M=VJ@U646YRX)$ 3F*"A0W[ ,;"9>@XKZO#2T<^VX_FE]]#7G-Q@:(FD2/QN4 MHOB)"@5SZS/>8"8B B3=R,X$0 JUFQ5AQ4/%7,R:($CU7+88LY MD5$EWQQ<;P[$J(&(B8!,!UT#$Z"!3=:^RV=5M4I>QXV1CWMX3J+]FU%\^/ E M0[&Z,N("#8Q&*@J(BD [CD1<;?$$!+N,(6^/&CHV(?WW'\TOOH:\T;Q?Z(0S M!!C'W(FQ9(% B39M"/$TTRAW 4I4 _B"@@5D7-K9+1[:5E'5R-%V(Q:9HU M2%2*F^ \HX1@ ACO$:"]J52/AI:.?;KEK:S<4.G;BSGZ\RWA[?GNWK P<(D;\U M2.!(#&43*&3"F? ?]D:"3<3GZI:+_?"C_DSNKOJA.+N70MF+TON!^5P6(A[Y MCWD@Y;ME%^S(M5T1 #%-L,0Y1R M Y*8ASE$/B'I@0 :JSPTM'/MN/YI??0T\-+1S[;C^:7WT-!8<-I195NRDA)1 M5I0D=(2!3D=N6L>DFHN4XY.4Y@+D0,/40'H(]1R-?VW=*;)M!1)2"LZ A3I+ M"X3-'1:#<2*B02"@&'X@Q)ZI' MPTM'/MN/YI??0T\-+1S[;C^:7WT-!=U*I'PTM'/MN/YI??0T\-+1S[;C^:7W MT-!=U4APQ_JCK/\ ?"D/D[2O[X:6CGVW'\TOOH:\7")+(7+%ZGW P*X-$3%\ MR#R/HZ8?R,E_S&KMK,V@,IJ9I#HU:=F26C,Z^?0C(&:KEE,Q(HJB M4P^,3>[*; A@>H -!IFE5-[;=_>0^Y_/,-]0^Y_/,-]2>(4 M!ZX# 9ZURK7X?K M:WW40G:T3(H/5#*/5I"/;JJO3"J94!6'EAS-IC#MW ., M!\/6N5[;=_>0^Y_/,-]0^Y_/,-].:]5J6DSM%H]2:G565>O%G[EPN("HJLH; M(B. , &TH!CH4I0^"H#[;=_>0^Y_/,-]0^Y_/,-]VW?W MD/N?SS#?7*>VW?WD/N?SS#?7*"V:I'5?WS&A/^:>^1DKJ^VW?WD/N?SS#?7* MC!T+ZU'UXTUGW^G4E:,);24H=V[DY)@MO,X0(FF0A&ZZAA'("(B( '?0: MI2E I2E I2E I2E I2E I2E I2LI:2W'K7JYI[$7@&I,%"$ERJ+DCDK3!8K< MO-.4I .9T FP!0ZCWU7+*,>91=-6TJ@?8WK7Y78;T-+];J,7OJ!J3H6,!B'48\314$P)J@DX3(8Q#"4V#%R'3 X'I4A? MW]!1E[Q-H.7W+N&5:+OF;/DJ#S441("IMX%V!@5"=!$!'/0!P-:I2"E?0]=D M8,UW2I5#)()F4,5%(RIQ R.TA0$QAZ= * B/< "-1JX=4;;M*SV%T33MQ%P M[Y5J@BHZ8KD5!1RH1-$AT1)S$S"=0H"!R@)1'QL8&@EE*YMOS[6YHLD@S3>) M('.<@%?LEF:N2'$@Y26(4X!DHX$0P8,"&0$!%(3[6,E(N/63>'7D3G(B9!DL MLD42$$X\U4A!(B& Z"H)0,/0,B.*#I4I2@4J/*W_ *-_M[*.^QF:"14I2@4I2@4KFW)<4;:%O2G M,/$MX9*XEW\TBU3AUW MTWYCHK%! RH&**8'$=@G 0$H&SD,9J:>#1+>6_4O M\+$_H^ODQX7P"XH"4E]4+[N5*&D$Y-".E%X\&QUDP,!!."+-,X@&X1P!@K'' MPY1-JZ6H%TZK3MX77H2ZNF$DY.XW3>#2)5D%C#O/@!P'W!PCZD)QD(UF-,3W-<:9[04C[E"68@ M$ V8HH%>M! ZX'#!TUC81*@#(0(=(X';(F.??M.H7&"V.;@YU$;Q\=(6_;S>V M[V>3EX.W\^5XW*X3([;.DXY0ZI#B<0RJ3:!-PI[S")2CFOT+I0?F-;?!CJ0R ML.68J69<39%8D-SHDK^WTTW+E YQ47[$0#-7I2=,]K52.N!O&P)0&KQ/H3?4 MCP.M-/Y2TCISS>0*HRTNU4$D'V,B;B-,(+"X,.WF("D"8 MI&$V_?\ #7Z+4H/S*LC@TUU&\H0;F;E- NU4(N;($BW.3UOAR(&BS[04$1[0 MHF?( B7<(G N:NWA+X8[BT1O33Z1-:R5OM_8 I'7.LW=(&%>6[6FH3G 0XB MJ<"

BCRCD*DGR]P&P(C5Z<+O#[*Z):B.%F]N(V[;CVR85L\*V72$ MB\RB*H.3G(0XB93!BY5$,&S]D-:@I0?F6KPA:MHMK_;0]B"@23:G5YTM(QXN MW2R8@8< <=N-P9$"Y_16E!^:3?A#UJBI^QGI( M-23N>.91#=2?D)!D\:,^4)P-RUA52>M#-RGQM1!=)P)0$Y<9"N79O!;K)%VE M.M?6.4:2B\&FUETEY6+:M[B4+()++(@=J(JKBJD58 <.S)G %13')1$0_4&E M!^<.D]@W#&ZZ3ESV5I4[CHZT+Z<*.;(9OH]%PU2@WAO7J"E#O4F<>G%J1LE$9@5$W:BBQ1=+&.LWZFYV]F505 M -L,'P!^J:+)NV575102257,!U3D( &4, "80[QP !D?@ *^Z@_.2\.""\ M)*VG"["QVAKGE9:\CRCM1VUYCEJ[0<>MH*&%3QB"KV6;QA @Y&K#XC[ M6+&\/O#I;LAI\=8J%WPK)W915&A!6$K9P51#)5>SB!A 1P*@$-G!A#(XVQ7T MN6;=X*(KH)KBBH"J8J$ VPX9P8N>X0R/4/CH/R\U#X0M9IVW)&.8Z:H%8J-I M%6W&@.F#Q>!*N^4518 =P]*BT A 3."S5-0_C[.8!2AB/7W;LE-Z@-K:(U:N M=:'FHY ;WH28:JO&*'8?$:J)%5%T4K

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end GRAPHIC 20 tm263879d1_2025q4orgchrt2.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt2.jpg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end GRAPHIC 21 tm263879d1_2025q4orgchrt3.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt3.jpg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end GRAPHIC 22 tm263879d1_2025q4orgchrt4.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt4.jpg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end GRAPHIC 23 tm263879d1_2025q4orgchrt5.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt5.jpg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end GRAPHIC 24 tm263879d1_2025q4orgchrt6.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt6.jpg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

GRAPHIC 25 tm263879d1_2025q4orgchrt7.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt7.jpg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Ń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end GRAPHIC 26 tm263879d1_2025q4orgchrt8.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt8.jpg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end GRAPHIC 27 tm263879d1_2025q4orgchrt9.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt9.jpg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

OK 2*HR#)K63E%K8:EKQF/B]ZU3> R(,1<60VE+& MZY.[9.FY(-PS3T;C9%SHV2>QDK'X_KU;9#KO9T:Y<^+A]J]+H:>3XG<0PS.C M((S>1+4UT3IN**4DDQ>27$9-Q6WEECM5;Y) ;:;;O)T!EE)3WV5-R3;+9*G6UJ;6I)?(1J09E_ 9#QSPDL@I)%@:RY[+DY#:ELO$.O_P ^=-NYEA^M@$[X]?\ )\/'\L>-_P#J?'4PX@XLZ;5&/9:! MNYIDN(V]4C5K'#;CT./2H#Y/=*X1*-QV<^DT\IKW3R$9F9'S%L9'V^ #E?17 MAETJU)QK(=)%[.;1S*/U[(0E)?P)(=4"2<+_VL M[7\E]$DM$V@EZ?]6QGU[9G6#!>%;1G M3.ISZPTPH;W&;27'B19=!7L2263Q*-+I&:TI-LB29F9&9[?(8^3/ 3:U6/1J MZIU+7$=;A5,%U15CS2)# M<#TIGY(4B%C,ME]V=XOV\-;03J3;Z,W3Z,S)W[+F5MR^KKZ@FU#4\(5UD^H% M0_I[C=)'PEV.S97%M"88@NK>-1()ESG,UGS)-)[I3Z1;%N-G=TUX.&5TZ'*W M3)M=PAIRO2IZ,1RD.*4AM39VAX $TN&SZ)6<)D+D MT\2I1*\3F1MDS:.3^?8Y!F?-TA-[FSN1IZ+*;B9 M:KGJK^8F"?F%)-HVNE]/;;DWYBWWWV+U#0[?@"@5[=G%P?)(^(TZKR+DE;4M M5KB6X4UMI;3I=+'D,NFRXE>Y(2I!MJ+T5;'R@/[(TXX28%A.:GX?@E;6Q8L. M6FYE+AIAR$2B<-DFU=*:C,R:6>ZDD1_L35L>WL+2S@^4[CS94^FQKR%)+J4D MY'/PU)KY"-KTO2W61I+_ -XC+U]0_N-\"L7&[/'I+.6)4Q52*.2<8ZU2B=57 MKDK41*4^HR)U4H]M^;DY"^SWZO!+X%)[GC$3HI+_3N&PE'1QW" M;D*WWVV;69)4?[$SV,8ZFTSX.LBN:VIJZK36PL[)HWH<6,XPMR0@N;K01*Z_ ML%GU>LDF?R#'V? 9974*WK)6H4;Q,["NX%>PBA/I8Z+&4B2M3KAR=G30I)I( MB2@C(R]1^O8\EX.K#(=:JG-/AR3%-52XDR)1'7NJ2QT493"FTD?-Z/_Q=7KZAY#X#29QN ME@1&MON-]-Z2%*+E4UN1[&9\^X^S*."6WSC*ZW M(;W.XDB8\RW'O(\*H>A1I+;17!='.*;29>#XO78LJSJ[YJ;XK:Z$I*$(B*0EPBZE$E766_J,=/ MB*ZE_&BT4_!^0_T40!:AS%]34^);@7\8M_SM,'3HYB^IJ?$MP+^,6_YVF .G M0 '/?\ G O]F'_-1T(.3M2=6L-T>X[(MIFV1P,8KI>F_@S$JQ=Z-MQW MQH:N0C/Y>4C/;[A .L0$.\^+0+M:Q?\ GZ0\^+0+M:Q?^?I 7$!#O/BT"[6L M7_GZ0\^+0+M:Q?\ GZ0%Q 0[SXM NUK%_P"?I#SXM NUK%_Y^D!<0$.\^+0+ MM:Q?^?I&P8)Q1:2ZG9(QC^*:@T-]=R$K6U A2TK=<2A)J4:4_+L1&9_P$8"H M@ B'!/\5K3[^).?T[@MXB'!/\ %:T^_B3G].X MMX )_J;KOA>D%C45^46,V//MDNKA18%3,L'7DMLR+UB@ M#F_BBX?9IPDK09_]E22/^ >Q%C$<2LTR MF5$V9$LR<(^7?U;_ '-QR/D?"MFUUJ[AF?J@8G$CX]7182; MZWW&B-QZ/SET"G$J4K=9J4@S+:2:5<$.9YCI+4IL:+'L,;ETM9!FUCBI#4FT MZ*R;E.O3VS82:'DM(4TE/IF?,>ZDIV(@_1-JQB/K-+4IEQ1-D[RH<(SY#]2O M]7\(^'CB!X&B7X=&\%6HDI?Z9/(HS/8B)6^QGN.);#@(R M1LRF5SE''QNP9 ML$5Q-2O!7"8D1$QVJ]Q#43I$L-\O5M(4DB2@TM$>^^&G<">H,[1J%C3C&*.3 M8-Y)L8,,Y;*6XS;L9+)&ZLJSH)*N8C4HE1$J-)[$X2MU&'9NIFKV+:0U\&7D M\Y^,4]_P:''A09$V3)<))K-+;+"%N*V2DU&9)V(BW/89+#<^Q[4'%X&1X]:Q M[*EG-$\Q+;,TDI)F9%N2B(TGN1D9*(C(R,C+/8C52K*XN8=? M!BNML/O.NELVXM1(0@]NLE*4HB(O6>XRR;"*I3R4R634R1&X1.%NC?K+F^YO M_"."'^ 7-7(FH,1,3#G*^V>9EPXDQ[P@Y;[=BF5NMXX276D&UTB#2XN2?,L] ME$GJ/[XO 3G2FM1VG;"BCNW]?81(TEJ9LF5X5*0\A$E*(2'.5E*.1)J<>]1< MJ4$9D [O9LHDA9(:E,N+,E&24.$9F23V5\OR'U']P?.)-CSV2>C/M2&C,RZ1 MI9*3N7K+? 3,KT>0F*;T=95\FJ\%1&W::2:2Z7>15$.T;788^^W&LVG$*;*.XMHG4ES*(DJW0 MHE;I,R+?KZQG53HR7F652&B=>(U--FLN99%ZS27R_P#@.4VYEREOOOU#$:;\(F;8%D^'SK& MNPG+EUU73PCM+63).12+A=)TA02)DC43O.1D9K;V,CYDJ+8@'7=]D$#&8!3+ M%_H&%.ML),DFM2W'%DA"$I21F9FI1$1$7RC5(.N&&V.3MT+%E(5+=EN0&9*J MZ2F$])1S<[#AW4V8 M^I^0VM3KC32XY,;-KYW$DITG%^BDS))FK8@H$+6'#[*%?2XMRV_&HK#Q79.I M:2\N9O<6713H-_P!>O!6QSU:ZL81I?Q79L>99EC^)%-PS'BB^ M/;1B%X1R3;KGZ/I5IYN7G1OMOMS%OZR ="@)5YV.B';)I_WH@^U#SL=$.V33 M_O1!]J JHY=^J;_$>U)_\M_.<44WSL=$.V33_O1!]J.(GXOVI MWXKV?]4=&5TC^U1A?X$A?T"!BN(GXOVIWXKV?]4=&5TC^U1A?X$A?T" &V@ M "4TW%)IA?91-H(N3I1.B)E+4]*A2(\1THV_A/127&TLN]%L?/T:U M;;'OZC%6'$B^"W/;S*,FB2)]'B>-7,>W9L9./6VV])ASJZ5 ?;;*XTDR7%Z1XE)(-PE6DA"V6R-#IM*(R6DE?9D:2ZN ML_5ON0R-]J'CN,V=%7V5HW'FWDM,*O9)"EF\\IM;B4^B1\I&AM9\RMB]'U[C ME4N&75FPX;+W1VXJ\!E5:DR'Z^R*WE/../G-\);)QE<(DMEL:DFI*E&75L1C MZHG"#G%9J[79? IL%:<@Y >0LSES'TS&VSKSCHJRY8NW@[3G+RJ)1%R=9-I, MMC#KW(\GKL3@-R[)Y;33KR(S26FEO..NK/9*$(01J49_<(CZB,_41C1Z[B.P M2SCW3Z9EO#CTQ\D]ZQQVQAH9<]#9KF>CH(W3Z1O9I.ZU:)WD^ES9,: M77ILK#*XV3U275KZ$S8**:&GS)&Z24J.HC-)*V)1&6YEL VVJUSPZW=0PU.F M1IRIB(!5\^KEQ)9/+:6\A)L.M)<22D-K4E1I))\ID1F?4-OHKR#DM-"M:V0F M5 F-)>8>21D2DF6Y'L?67^H^LOE$KL,3S_,+O'KO)&:"GB4MVU9(K*Z4]+6E ME$60VX9O&RCI'%+>3L@D$1)2?I&9[#9-"J.=0::0&;%AR)(DR)<\HCI;+C-O MR77D-*+Y#2EQ)&7R&1D W\ 231;[96O/XY1O^'Z@5L231;[96O/ MXY1O^'Z@!6Q!=#_C)<2'X7I/S-&%Z$%T/^,EQ(?A>D_,T8!>@ $FX3?BUZ< M?@6/_P"D5D =Z(/M0\Z_1'MCP#O1!]J JH" M5>=?HCVQX!WH@^U#SK]$>V/ .]$'VH"J@)5YU^B/;'@'>B#[4/.OT1[8\ [T M0?:@/@K0?FQR)5>//\AE3V3=-X)]ESONO=!MS]6W2[<^_P"QWY>O8L-A?"_$ MPC,\$R*%?NDYC]5XNGQ$Q22U:.IC] U),N<^B<2@S(]N;F3RD?V!&,YYU^B/ M;'@'>B#[4/.OT1[8\ [T0?:@,)=\+<*9FUADM;D]E#?GQ+)I^'.0B?&6]+Z+ MTU-N>BI"29271*(R,B26Z220]^+\.\6*FWD7UHZN=932F.,8P[*I8"=F&V22 M<=I\R=(TMD:B=-9&9GU$0]GG7Z(]L> =Z(/M0\Z_1'MCP#O1!]J TX^%ZW?J MXJ)N4ULVRK(L"MJY!U+S*68L7I>0U&W*2Z3RNE/=QIQO[';EV4HCQM9P71:F M34M,WD)R#&**;DAVIWL63:4M;K<.03NT=EXW%\[?*OJ4LMSYNJA^=?HCVQX! MWH@^U#SK]$>V/ .]$'VH#SX!H=8XQ#L&[?(H]L^J@8QF"[&KSCDQ#9)SD4X1 MNKZ1TS =Z(/M0\Z_1'MCP#O1!]J ^[2'2W),"M;RRR7)JO M++&V42W[%FF=ARE&2CY$&M4IU)-(29I2VA""+ =Z(/ MM0\Z_1'MCP#O1!]J JH"5>=?HCVQX!WH@^U#SK]$>V/ .]$'VH"J@)5YU^B/ M;'@'>B#[4/.OT1[8\ [T0?:@*J E7G7Z(]L> =Z(/M0\Z_1'MCP#O1!]J QF M!?&QU@_%W&?Z2U%H'/6B.=XUJ+Q,ZPVV*9#59/5%0XVPQO^E=' M3H ))PO_ &L[7\CQ2Z>? M8U$-5M 9NK2IYBE0JQ3Z2E/-J21J0:4>M:2W21F9;;;BW XA3K] T^QN&QI MWJ/+E89:9#(AJSK40WK.MK";A]*3,>0XXVM]#CAA1L:QU+Q8VR_"L*J0^M3EFXZT;A'X0@TH3R)<2DRW,E$1J+UCNMUM+K M:D+0EQ)_L5EN1B&6.OF8T#VH2[;"*-N%AL1,F4Y#R5YYR1SLFZVE"%04%UD1 M$HS5U?(2@'.-QQT:A5==")^TPZNLF*6;.\'EUSQJO)D:U=AE%C)*01MK>0V2 MB+ZX9'OL1EZOLE<>^<%D>I3,)%&_%IZ2TGP(LJ$33T23$D-M=$\E$M;BB,EJ M,^D0RI6Q*2GE/KMU/K7BUOJC=W$C$7(>;5UG&Q%A]ZZ^,X#FTJI53QW*V#XN.SGNSR8>2@8Z,^FV4 MGTC-:-B]7,9; .>LGXOM4]-UY FXA461MUUNO'FWJRL?8-1:P6F+M]YEE_IG6D%,CI2VV4E!LFHD*) MTDDK=*MS&ZPM4:6@SG42/,H)-$S418ME+MY*B-5D:^D93T;9&:MBZ D)(]C4 M9^BGK(U!S?:\4[5SP^:0R,+U7IUW\:RH(V5277TS76D.IY7"E*-U)H)3B=E& MI1&9[EN6YC[]!^*6US'6=-SF^:T\*E9Q&?)GT,$G8[5')*UC,(9EI4ZLE/I2 M9$2S2A6SA^CLHC.R6_$O,AZ2U.=R,,:CUDE*2I<^'3>()5@I-?.>AN/O&\TT7UUE: M5ER)4H^I1=;A'\A"'4*O$.F^*3K?+,DA8[:Y7/@9#,TQ:YR6E-=(E2K3G+H&GFU,D<8D[>FO ME?0I761)(TEUF9[!((U[7V>05E1B>=9!9XN[6Y%R6,BS=?0E;:8AH4S),^9] M#2EKY7%*69&:T\QD6Q7S3#(9F6Z;XK=V#70SK&KC2WT$6Q$XMI*E=7R=9F,O M=T4+(:2743FC54'$%HK*P_%XN76W@>0)*OEVI5R.4VXFZNE-MSU? ML=)B*ZE_&BT4_!^0_T40!C_*GK_V#47?]'N0UWZFNTZQP88(T^@FWT2;A M+B$JYB2HK:9N1'\O7\HZ<'-WU.[XHV(_Q^[_ #Q- =(@ M #GO6GXV_#A_\ U)_4&QT(.>]:?C;\.'_]2?U!L!T( M "(<$_Q6M/OXDY_3N"WB(<$_Q6M/OXDY_3N +> #Z)T-NQ MA2(KJG4-/MJ;4IAY;+A$9;&:5H,E)/[BDF1EZR,ARI5Q)6,8]=V$+(:/8]DEO M:6\._ES;.%;O.K5X2P4&6IV'(5^R4TZ3:T;1:76Z&W"SBU M;0MZ5%NZZ+8/.3(#?B]:T+8KC;-LV45"4H3N9[)+8A\3CM&A:#:0:%F9J3RELHS M]>_W0''#&JD"Z>T[K6,_L*O.)46'(*/;9,3,1F*B2LC<-!FWXU,R)530HK,SE/LV<>O/-)<^\?0U2S')*TN)4XE7-"(S(VU-MF MWL2"VY#/F'=Y%L0^'0-&EQ/1HY7/LRY2V5\G7]T!P['U/R4I6-JB7EE/LWE5 M\>ECEDBE(<05F\S)=4THTJGM/,IW0X:'32A)&I2#+I%5K03-J?,]65'L;XIWV)?P#Y@ D%#&9D<5^H72M(=VPO&]N=)'M_CUX*^))C?QK] M0_Q+QO\ KUX J7BV)^Y6/R9?V!XMB?N5C\F7]@]( /-XMB?N5C\F7]@Y]X^H M,9KA+SI2([2%%X!L:4$1E_C\<=%CGOC]^*3G?_Y#^OQP'0@ ">\1/Q?M3OQ M7L_ZHZ,KI']JC"_P)"_H$#%<1/Q?M3OQ7L_ZHZ,KI']JC"_P)"_H$ -M M 2[B3FWU%I'D%_CN3V&-651$3>0XAF^[)GOH<0YT++:22M"$-[I21I(N M8O2W,^F[2JA7E?(@6,-BP@R$&V]%E-)<:=2?K2I*B,C+^ QY)F*4EC8(GRJ: MODSD=%RR7HJ%NIZ)1K:V49;ER*4I2?\ LF9F6QF AV):[VN=83K->0GW(#V/ M1U)APY##?2UDI%>EQYEPN7TE(?Y]^;1L,S$0FG-XAF2CC MGNG_ "1FE)\GV.Z2ZNH!$;CB@R&L59QF\,K9$^CCVLBW1X\6EE*8)QS7X.YX M,9N&M,A.Q*2C925$9]6XS6G/$E(U!U&50MXI)ATKLF=#C6JUO;F[%,R7SI4R MEO91DK;HW5F7H\Q%S=5.AZ<8G7UR*^+B]-&@(C.PT16:]E#26'3(W6B22=B0 MLR(U)VV49%N1C[*[ <8J,AD7T#'*F%>24=&]9QX+3+8G[E8_)E_8'BV)^Y6/R9?V"-^>EHQ\]6_H^7[(//2T8^>K M?T?+]D LGBV)^Y6/R9?V!XMB?N5C\F7]@C?GI:,?/5OZ/E^R#STM&/GJW]'R M_9 +)XMB?N5C\F7]@>+8G[E8_)E_8(WYZ6C'SU;^CY?L@\]+1CYZM_1\OV0" MR>+8G[E8_)E_8'BV)^Y6/R9?V"-^>EHQ\]6_H^7[(//2T8^>K?T?+]D LGBV M)^Y6/R9?V!XMB?N5C\F7]@C?GI:,?/5OZ/E^R#STM&/GJW]'R_9 +)XMB?N5 MC\F7]@>+8G[E8_)E_8(WYZ6C'SU;^CY?L@\]+1CYZM_1\OV0"R>+8G[E8_)E M_8'BV)^Y6/R9?V"-^>EHQ\]6_H^7[(//2T8^>K?T?+]D LGBV)^Y6/R9?V!X MMB?N5C\F7]@C?GI:,?/5OZ/E^R#STM&/GJW]'R_9 +)XMB?N5C\F7]@>+8G[ ME8_)E_8(WYZ6C'SU;^CY?L@\]+1CYZM_1\OV0"R>+8G[E8_)E_8'BV)^Y6/R M9?V"-^>EHQ\]6_H^7[(//2T8^>K?T?+]D LGBV)^Y6/R9?V!XMB?N5C\F7]@ MC?GI:,?/5OZ/E^R#STM&/GJW]'R_9 +2RPU'2:6FT-D9[F2$D0^P:-IGK=@^ ML9VB<.R&/=N59MIFM-H6VY'Z0E&V:D+2E1$HD*V/;8^4_N&-Y <4:W%F25$7,I2C49[=9F9_* KP"*^9AH MIV>UG^\[^F'F8:*=GM9_O._I@+4-#O\ 1NER-C.FI,J>A.8QVHT\VG$$;26V MNB2;6Z#V/EZSYN;K_P#D-1\S#13L]K/]YW],/,PT4[/:S_>=_3 92QX;,3M' M:A]YVQ*959(K)XTIMY"7"?4\EY;)F2-E,*4A&Z#+?T4GS;D1E[<_T)I-2,NK M;RXF2UHA=#_B!-QU-+Z-SI$[.*:4ZV1JVYB;<02R2DE;EZ]>\S#13L]K/]YW M],/,PT4[/:S_ 'G?TP'JQ_A_-^Q3L1;=>F^9AHIV>UG^\[^F'F8:*=GM9_O._I@/O1PPT==A*,3I
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end GRAPHIC 28 tm263879d5_bylawsimg01.jpg GRAPHIC begin 644 tm263879d5_bylawsimg01.jpg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tm263879d5_resartofincimg01.jpg GRAPHIC begin 644 tm263879d5_resartofincimg01.jpg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tm263879d5_resartofincimg02.jpg GRAPHIC begin 644 tm263879d5_resartofincimg02.jpg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end GRAPHIC 31 tm268049d1_ex99-xdx1img001.jpg GRAPHIC begin 644 tm268049d1_ex99-xdx1img001.jpg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end GRAPHIC 32 tm268049d1_ex99-xdx1img002.jpg GRAPHIC begin 644 tm268049d1_ex99-xdx1img002.jpg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tm268049d1_ex99-xdx2img001.jpg GRAPHIC begin 644 tm268049d1_ex99-xdx2img001.jpg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end GRAPHIC 34 tm268049d1_ex99-xdx3img001.jpg GRAPHIC begin 644 tm268049d1_ex99-xdx3img001.jpg M_]C_X 02D9)1@ ! 0$ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" !' 14# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBB@D#D MG ]30 455>YBP^V3YHV0, K\NP++'D+RS#G:N2 02 ",_&MM^WC^SEJG[2C^,M5U;XF3ZQJ?A#[;IGA?7[OX:P?$C0_!UU\0]8^%#_$N*P;PE-\4;#P M'8WGBR]\&VNI7-]8:9:RPWWV35#]A(!]J45GSZE9VD8EN[BWM8B8E$MQ,D,3 M/-(D,2+)(41I)9I8XHHU)>25UCC#.=HT* "BBHI)XHB1(^W"-(>&("+]YV(! M"J.Y.!0!+135=7&5.X$9R,XYZ8.,'\^*8)XBVP.-V2H!R 2,Y"DC#8*L#M)P M4<'E& ):*0$'.#G!(/U'44M !15>:=40E2&((&%Y.2=H .0H); !
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�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end GRAPHIC 35 tm268049d1_plicoaccelimg001.jpg GRAPHIC begin 644 tm268049d1_plicoaccelimg001.jpg M_]C_X 02D9)1@ ! 0$ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" \ 0D# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MOS>_X*^^,O'G@#_@F7^VGXJ^&UQ?67BRQ^!OB6S@U'3#(FHZ3HFNS6&@>+]9 MLIX2)K2YT?P?JFO:G%>PLDMB]HMY$Z/ KCU,BRJIGV?9'D-*M2PU7.\XRO** M>)K7]CAYYGF&"P$:]5)Q;A1>,]K**E%SY%3C*,JD6ML-1>)Q%##QDH.O6I45 M*7PQ=6I"FI/;2//=JZO:UU>Z^1?C7_P<0_\ !/SX2?$;Q7\.?"]K\??VC)?A M_-=P_$'QM^SC\+]/\=?#CP6-/NYK/4KS5/&&O>,/!UCJNCZ?<031S^(_"D?B M+P[,TIZ->66H MW/XX_P#!L5X'\ :%_P $SX?$GAW3-)7Q1X^^-OQ6F^)-]#!!)J%YJ/AO4K3P MIX:TG49]K3?8-,\$Z?H4^FZ7*PM;9=8O;^&!9M8O9KG\Z/\ @A-N^%__ 6O M_P""G7P$^%*C1_V?[&+]I1K;PGHC;?">FR?";]JWPWX1^$GV5(=]JO\ PCOA M;QGXX\/Z#'$R&72;N\\HO!883^@.(_#3@&>&\8."VM+6W MBEGN+B=TAAAC>61U1&8?RF?![_@H%_P5+_X+ _&;XX/_ ,$Y/'_P?_8]_95^ M!^I66EZ3\2_B?\.M/^(/CSXC7>LK>OX8BUBR\3^'O%VF66H>)-.TJ;Q1?Z!H M?A_1V^'>@ZGI>GZQXA\5:S=V;W/Y!PEP+FO%V&SO,Z&-R;),@X;H82MGO$?$ M.-JX')\NEF&(>%R["RGA<#F>-Q>/Q]>,X87!8' 8FO*%.K7J>QH4I5'X>"R^ MMC8XBK&I0P^&PL82Q&*Q,Y4Z--U9 [F]^V^$_"FL>')# MXD_H7KBXOX0SK@C./[&SN&$E5JX' YKE^.R[%PQ^5YOD^:4%BLMS;*\=3ITH MXK XV@^>G-TJ-6G.-2AB*%&O2J4S/&X*O@*_L*_(W*G3K4ZE*:J4JU&K%3I5 MJ51*/-3G%W3<8R33C*,9)H****^7.0_!?_@KS_P6A\0_\$OOB7\&OA]HO[.6 MC?&V/XK^!O$WC";5=4^+-]\.7T)_#_B"RT,:?'9VGPV\+.;>WMM:\3?\$Z#%X5N)%4Z_I?[1VNI9E&F-OFTO=3 M_9SAT>\D$ZM"L?\ :ELIG'V=I(Y 0/'/^#L?_DX_]D$?]42^)/\ ZGNBU_0# M_P $0?"WAKQS_P $;OV5?!OC30-'\5^$_%'@/XJ:#XC\,^(M.M-8T/7M$U+X MS?$ZTU#2=7TJ_BGL[_3[RUD>"YM+F&2&6)F1T*DBO[$I$W!_@-X<>(/$G MAM3XNS3B;,JF59K5CQ+GF2XFSQ?$4_KM"6%Q-3">WHX7*J5"E0>%H4)R4)U: MBO4D_N%A+;6%IM3F\*IHD#ZH/V K_+:_P"" M=5Q+\.?^"O7[+UA\*=4N_P"RM&_;7L_ 7AW4+&X:YEO_ (::KX]UCP%JJO=CM^=?ZX_VI_^#B?X=?LC?MU>/OV1?B9^S9XC MG\$_#/Q?X0\/>+_CCH?Q+AO[RTT;Q1X$\+^-;GQ'8_"J+X=/>ZB^CKXGBL'T M:#QF+B_2SEO(+F.26.P'C>+GT=\7EG'&#RCPIRO,LYP6;<'3XT>2XG'8:IF& M483#9A3R[%4J=;'UL'7QM.=7%8-X7"OVV8QJSK82^)]G2JOFSGAJ=/,(4S2V/A(]32R)OOH;_ (*0_P#!?W]GS]A? MXDZA^S_\/?A[K_[37[0.BS:?9>*_"OAKQ!;^%?!/@76-7BADT[PWXB\9_P!C M^*+_ %/QK+'>Z?/_ ,(?X4\+ZS/ ;R'3M8U30]6E6S'Y3B/!'Q2PW$^"X-GP MGB*G$>/RB.>PR_#X[*\3'"Y2\14PLL;F6-HXUY?E=.EB:-3#U5C\91E"M'V< M8UIM1/(ED.;1Q=/ O"2>)J45B%3A4I34*+DX.=6I&HZ5)1E%QE[2HK25ES-I M'[\45_)>[TC6OM_C+0?%EQH5 MC+;1:IJOAKP9\6_AK\/[+QVNE-?6']I6^F^+]':Q6[@\QC-*_#&A^%O#'PLNM?TO7)=-UD^);/6M M7OX+#P'XXUO3+[P7KWAB\\,>*O#NI>&K._T;Q&EWHNK2Z;J5C+:R<^<>#OB+ MD6+R'"YAD-'V?$^-679%FF$SSA_'Y!C\>U7D\&N(<'G%;(\-B(QPN(E*&-S' M!I*A5M4E[.I&G-?(\SP\\/"IAXVQ=3V6'K4\1AJN&J5&I/D^LTZ\J$96A*ZJ M58+W9:NS2WO"/_!7K_@G=\0/V@/#?[+W@/\ :+T_QE\#_#W@ M'XJ7EF_B?18M7GUC3KOQBW@B'P+9MIRZ%J:SR7'B5$:2WV0^ ?VH=$^#/BSXE^)_#?QX^(7Q&M/@1H%UJ,7C'6=3\4+XY% MQX,M+NR\*:]J9U;0CXBG:\>/P=/-I]8\6_#[ MX8V^C>'_ _;QW,6JWL\-WI]I%:S7MWJ5M&CHOZ3XX> :9OD%3'TL^S''PP=+!Y?E.$KX7,\5A92J1ITZN!RO,J*J2BYXUN M<8OU,_X=>5JC5PWM*N'="E[>=6MAW-8FI-05.G1A*-64'=6<*557:O-W2/U# MHK^6_P &_ ?BWQ/IG@>YO+S3H-.\4>.KWP7<2SWUE9W/AZUNK^UCD^@/ MV#/^"^OP\_:5_: '[(O[3WP&\7_L:_M*W>NOX1\/^&O&>KW6I^&]>\;10K-_ MP@6J3:_X:\$>*/ /C[4PR+X;\->)/#LUCXCD:VL=,\1R:[JFC:)J/P..\#O% M/+U+2?#VC MZMJME_,SIO\ P<_?'?XK^+-=@_9O_P""9?C?XI^$/#3)/K$>E>-_&GC#QC9: M1#_";Q X M\R[%YQPWD*KY-@JLL/B,YS',\IR+*5B8^S4\-2S#.\?EV&KUX2JTH5(4:DU2 MG6HTZM6G5JTZ,LL#DV99C3G6PN'YJ%-N,J]6K1P]'F5KP52O4IPE)72:BW9R MBG)-J)_877YJ7G_!7S_@G=:?M"Z5^RK!^T5I^L?'S6/BQ:_!&V\!:!X ^*FM M?9_B9<^*?^$-?PSJ?BK3_ \W@G2KBR\0[[#4+C4?$MO:VC132O,8T9J^-_AI M_P %S;;XS?L,?'']K#X6_L7?'#Q+\2_V>/B3X!^%?Q _9O%_++K5UXH\9^(- M!TV_7PEXK\.^#?$^M:O;^$=)UO\ MO7[?5?AIX?UJR%H;34=(TR*XCU$?Q$: M%^T=XBL/^"FEI^UM;_!7Q9>^+8OVV;KX_P 7[/$5UJ+^.I?$$_QAN/' ^$2W MD7A-]6?Q1'?R_P#"+&9?!/V]]2C9AX:CG;[ OZ[X6_1QS+BFIQ_1XTPN99+B M>%,MQ='+<)@SE'#-3%O,8XZ-6C+"4YPI0IU\*G/%J,IQIU4ZE5JDXRHR51@^*O"7A M75] \4->>$/"'[O3M6L(KG2-;A_M:"6UT.XT_3UUOV#]EG_@J MYXT_:<_9L_;A^-'Q5_80^)/P TS]E7X1ZIX_3P'\5-#;?3;6*#P)%HFJ7(T?Q7;1IXGMIKRQ6.)+74/@7_@AS^WO^R- M\?/VD/C-\)OV4_\ @FE\./V0/%^K?!#Q-\8->\9^'OB99:__ ,)6/"GC7P)X M=T[P!,MM\*M$O/#'AJZU3X@QZHD>C3S:'I#:>8BCFL<1A\91Q,Y9; M#.%*%;^SZZP%7#5JL>:AECHY?G2Q.6SK8K">P4<73Q>']E@N:$*KYXPQ$E6Y MHS4FZ2K74O9R]FXMG]6%%?S%?LK?\'(>B?'C]L'X9_LC?%+]C[6OV>]:\=?$ MW5O@UK7B;6?C?9>,)?!'Q.M!K>B:3X4U/PS'\*?"TEY?:O\ $73=/^'IVZU9 MM9:IJ\-V8[I;=K6;]Y_VO/VDO"G['_[,WQJ_:7\:6,FK:#\'_ FJ^*O[ AOD MTRX\4:VIAT[PIX0M-2EM;V/3KWQ=XJO]&\,V5])9WB6EUJT-PUI*P&/CFD,?CJ6781X3%9?B\7@ZGML97 MHTK?64X1K4JU3EH5(59>7BLJQ^#Q%#"XC#RA6Q2@\/!3I5%552HJ4'"=*I.# MYIRBOC5E)2=HM2?T=17Y.?LY_P#!5OX??$+_ ()XW7_!1S]I#P$/V6/A(VJ> M+HM"T6^\;?\ "S-;\4:/X=\2R^!M)N=$6R\(^#KZ^\1>-?'&G:UH'A3PK:Z- M&/$)TFYM]2E\,6WBGQAJ-K8 M31:B[-:2AU];*O!OQ&SC$Y[A\+D-"C3X9S2IDF=YCF6>\/Y3DN#SFE.%*>5Q MSS,\VP64XS'1JU(4GA\#B\7*-62I3E"I:F]J.1YG7GB8PP\8K"570KU:N(PU M&A"NFDZ7MZM:%&=3F?+RTYS?-[K:>A_6%17X_P#_ 2[_P""R/P!_P""FMKX MB\*^'O#>M?!WX\>#-''B7Q-\'O$^L67B(7WA9KZWTY_%O@/QA8V6DP^+_#^G MWU]ING:X;O0?#FN:'J.I6$=_H:6&H:9J5_\ L!7QW$G#.?\ !^ST:17/>+O#?AGQEX4\3^$/ M&FDZ9KW@[Q5X>UKPWXLT/6H8KC1M:\-:YIMSI>NZ3J]O/^XGTS4=+NKNSOX9 MOW,MK-*DGR,:Z&OX9/\ @H+^W3^T7_P6,_;HT;_@F9^Q1XYN?"7[-DGC74_! M?B/Q1H=["X[V]^)GQ7^(.KZ/>07.L?!7P59:7JI\!^!+74;?1OB' MJ%KI6LZI_;&M^(_ EAX3^K\,_#K-/$+-\9'#9AA^'\EX;P%3/^)N*\_#SXJ>(OAOK=Q9P>'[V;P_XM@UC7X[; MQ9I^F6-EH:^)4T_P/XR;2]#\.:?XHU?6]2\.66N5^X'_ 1M_8@_8Z_9$^#/ MBW6/V:/C[X4_:T\)-=U2G_@ES\)/A[IG M@[Q+\!%^-WB9=-CM/$?Q)^*7BOQA<^(_$%]M87%]9:5X=U_0?"G@V$.[1V%I MX/T/2)+:U2V6[O-1OXY-2N/PV_X*??\ !-WQW_P1D\7>$O\ @HC_ ,$R?B!\ M0?AK\.;3Q7I7A3XG^ KG7-5\6Z?\/9M>OXX/"\.LW6M37EU\1/@9XQU86?A# M6?#/Q.O/$6L:!XSU'PU=Z9XBOI=?TZ7P3^]5<\X9\798OPZR7Q/XHP>?<05< M+".:\3<"<$Y!EGB/FN3TI1R;"\3YUPK.'%$ZU589+*IY\\9&>(]A/&T,1F/) M&?T(Q+@E6Q>7X'#TLSK4$U0ABJ^$MBN9J/[EXAS3ERN<9 M5+)_V;?&[X?W'Q8^#/Q<^%EIJ*:/=?$KX8>/OA_;:M(LC)I=QXR\*:OX+- N+C3-6O9_$OB6\T'P=HW@?7+F"'7?"=[K7BI]9[9YX[II) MO+X$\/N.,IX6X\X$XYX-S/*>#^(\VROVN?UN(.#>%L5EW$G">,Q4,/B:^67Y;F%'"9AE^88*I1P6*K4KXF M6)P.$E3Q6#G)0E1ECJ]*EB:4XN<6HZ2BXU*<[7-+]B^X7_@H-_P<=?&K]M7X M!P7NM?LU? R&<:I\4(K.[M-!UZXT_P#9XT[]GKPS9V5[);JES>^//$D'B'Q; MX9L9_(N;WX>>'+C69H[<_9X)_P"SROY.OV8O^"\'P$_9"UO0?V5?VH_^";_C MG_@F7I,8M]2M+#PCX/N'\'V2ZG<+87'C?7?A^WP\^''CF31KPV<:77B_POHW MQ,N]6DLGFGFE,1*?U-^"/''@_P")?A#PW\0/A]XHT'QKX'\8Z-I_B+PIXN\+ MZK9ZWX>\1:%JL"W6G:MH^K:?+/97]A>6TB2P7%O-(CJQY!!%?#>.^%XHCF_# M=?-.$\;PYPKE7"F2\)<%XFKF.6<08?,\GR'#SC'%U.),@Q&-R',,QQ=6MB,9 MB:. Q,:>&A.%*C2J4:,ZZ\[B&&+5?#.K@YX;"4<)0P>!FZE+$1JT,/%VF\3A MYU,/4JS)_L<_#O_@X=^+?[$'PT^'/[)>L2>&OV-/%'ASQ=HWP]UC2?&7[,7@/ M6AX:O_&?BF#Q:D'BJ>ZC^.VBM+XJE\30M>E[/7+>)@VCW$-F+&0>S_\ !V9< MV\'[1_[('GSPPY^"7Q)QYLJ1YSX]T;&-[+G.UL?[I]#7]$G_ 02D27_ ()( M?L;O&Z2(WACXD;71@ZG'QN^)H.&4D'!!!P>"".HK^\L7QE7X%^BSX/YUA^'> M%N(JT\\JX:AA^+ P=98OC'%4\?A,-.M1IT\PHSP\84J\G54:4ZD'2?, MFOT6ICI8#A+):\<-A,3+ZQ*"AC*"Q%.$E+&352$'**56+BDI.]HR:Y=4S\Y? M^"./_!O_ .*OV,_C'HG[57[6'C+P+XH^*_@S3=5M_A-\,?AO/JFN^%/ FJ>( MM>34O&/BCQ9KFD:!)K_BVUT+5-6T31]%TC1%T#07O[W64U[Q#J#:3+HO\ M.G_P61@MKK_@MC^T7:7EK:7]G=?&_P#9[MKRPO[:&\L+^TN?A=\$H;JROK.Y M5[>\L[R%Y+:[M+B.2"YMY989XWCD93_IAU_F"P&"P^:X:I2PN PE"4XX:C"I5J5I2]K4KU<14EB*V(J5G&5//A MG,L7F>(=8T;1;*WTOX>^"-8U/1_#^F6<%C86UCX4\/75Q8:1IEE:QQ6]C: M16MC'86EM:Q10V]OL@A1(U5!_G%_\$'=)7]H7_@KW\"O'7Q8>+QEX@N=1^-7 M[0FOW>O*=2DU[XG_ /"%>+/$UKXFN6N&D>76+#QYXAB\;V5ZS27,&MZ5:7RM MYL0P1W5G?6T]I=VTRAHKBVN8GAG@D4\-'+$[QNIX*L0:_ MS>C\._B9_P $!_\ @J_\.O'_ ,2? GBCQ#\#/!GQ"\80_#_Q98VQ%C\6OV>/ M'>AZWX0O9/"^K7D^FZ'J'Q0\#^#_ !1!>:SX)U#5M/,/CSP[:V]Y>6_A?6-( M\3W?Q?T:L12S'A7QQX1R^M3CQSQ3P;67#E.6(A1QN:PHY=GU+%X' UJM:E.I MB?K6-A7JTX5G5G''+$U+TZ=>O1X>%I1JX3/L'3:^OXO!2^K)R4:E9*EB(SIT MY2:;ESU%*45*[Y^=W2E*/]4__!R1\./#OC;_ ()8?%'Q1K%G;SZQ\(?B/\&? M'_A"\D0&XT[6M2^(>C?#/47M7/S*;WPK\0O$.G3H#M>"Y8D;XXV3\^_^#3+X MF^)-4^$O[8WP&_%&A>*8;5F),%O> M?\*PT&_-I'L@6^FO[T(+C4+J27YE_P""VG_!;S]FK]M3]F+PY^R;^R!-X[\< MZC\4O'G@C6?B)K6L^ O$?A-;+2/"VIIKF@_#[P]HNMVUIK_B;QKK_CF#PRS- MHVFZAHL6FZ5>65G?:EJ.K6?V/]E?^#>[_@G]\0_V(_V2/$OBGXW>'[[P?\:_ MVE/%FF^/O$/@C5%$&L^ O ?A[1SH_P -_"?B:R&\V/BQHK[Q+XNU[39I([[0 MI/%UKX7U>RL=<\/ZG .['Y=CN!/HHYMPUQW@ZV3Y_P 1\=PQ?"?#^:J-+-J5 M'#8[**V*S"G@*E2IB,+AX0P69UJE9PIQ4<914Y1GCZ5*MI4I5,OX0JX7,(2H MXC%9ASX/#5DE6C&%2C*514W)RC%*G5DW9)*I&[O4BI?R1_\ !-=F_P"'Y_P5 M;<=S?ME_&_+9.3N7XQ!LGJ=P)#9ZY.>M?UQ?\'(_Q6\2_#3_ ()=_$#1O#5S M<6+?&/XF?"[X1:_>VKM'/'X4U?5[WQ;XCL?,4@BT\0:=X+D\,:G$.=9\7_P!B^-O!UKJESIEIK,&J^"O%T'B;04DO[*UU"ZMVT:ZO;"Z6\%K_ M %L_&'XL? 3_ (.$/^">?[6?PJ_9.E\6V7C#X;>(_"NWR:9/;6%O/=?HGC% MA91\2O ?Q-Q.7UL9X<9/E'!4\YXFITJ>(R7 K$YSA*F#J8RM&K/DC"KB\!C% M^XJIPPM9Z2PU6%/TL[A;-.'\UG3=3+*-# ^VQ22E0I\U>#@YR3=K.=.I;EEI M"3^PTOYR/^"+/_!3F#_@GC\-?CIIFD?L5_&O]I#Q'\5OB!X:U'6?'GPK%U_9 MVD:%X2\+_9/#?@O5FMO"'B(_;=.U+7?%GB"%9+N$F#Q/N6V7+2S?.7_!37]H M'XS?MS_MC:+^UQ\$?V-/VDO@7XQT[P/\,M,AT^?X?^-/$WB34_BK\-/$7B#4 M?#7CNVU'1/!&FHU\FFS^!="TRW:">]1O"=M^_:&2UM[?Z0_X)"?\%0;[_@CY M\4OCQ^SE^U[\(?BAI/@OQGKVE:QXL\,6.AVUI\4_A)\3_#NG2:,VHS^#/$FI M>'H==\->,- .DVVIW5KJRS1PZ!H&L^&UUNQO[E9?Z'O '_!QY^S'\?/VC_@' M^S;^S+\#?C]\5=?^,7Q0\)^"?$'B;6-!T[PEI7@#POK^IVMAK'CLZ+IE[XT\ M5:]8>$[>X;5=?%YH_A?1-+T6UU#6;[Q+!;6)2?Z3BS$<1<&^*'$W'G#'@;4X MJ6/R3$XNKX@1XZS%\/9IPY7R'!U<>\9@ZE6>182C0P>5/#QPD'6A4A3HU,!+ M$/-(N?5C98K!9KB\PPF1/%^UP\Y/,OK]7ZM5PTL-"51SIMO#P484;*"NFE%T M^;VUS\:O^#K3XI^*=9_:I_9H^#]W<7-OX0\"_L_7WQ*L]&\P?9O^$P^)7CK7 MO#VM7TQB;RKRXM-&^&VBZ?9SL&^QI<:HMJZ)J5T)/ZAO^"-_P3\%? O_ ()I M_LBZ%X-TK3K"3QS\'O"'QC\9ZE9VMO#>>)_'OQ9T2P\;>(]=UJ[BB2?4[^-M M5M=!LKB^DGGL/#NAZ%H-O(FFZ/86\'XZ?\'-W_!/?XG_ !P\+?"S]L[X+>%= M:\=ZI\$_#&N?#WXU>$_#EE%/$.H6OSU_P2V_X.,OV:O@%^R#\,?V>/VJO M#?Q5@\6_ _PZG@3PKXX^'7A_1_&WASQMX"T1I%\&1WT#>(=%U7P[XGT/1'M/ M"U[;SVNHZ/J4>C6WB(:_:3ZM=:-I/Y+FV29SXC_1B\,/UG'4L?3G-2E.CC(XR@J\:&(EA/'K4*^ M:<*951RN$J\L+B)1QN&HV=15/W]ISI\T7)<]2-1-W;C-3CSWNM7O;6SM[>[U6YM;*WTZUN-2N8HTFOI[:PM;:QMYKIY9( M;.W@M8V6&&.-?\T[P>S-_P '!^ELS%F/_!6[4BS$DL2?VI+XDDGDDYR2>3FO M[?O^":O_ 5&^''_ 4X@^._B/X2?"GXE> O /P?\4^$O#>B^*OB)'I<,OQ M;Q+I6KW]Y/96N@3:OH.EW?A^XTDV^I:/:^+/$.H6UMJ6CWVIKI9U.UM7_AW_ M &ND\0?L!_\ !?W%-?\%1_V8O^"D?[!7_!3[_AG5?B%%#\%/V1?B['XNG^(7AK3?"IN#X^ M^!_QJ0:E<7]KIT<<_V<6;7L4C3)_.3_ ,&J=W:3 M_P#!13XI)!,R_'T71Q6&^L9%E.)H>VIJ=90]KAZM*M"]1WIU(O2[BC M*\/7PO#O%%#$TJE&M35+GI5(\LX,HR6NS7HO/?^#A7]F?7_V0 M/^"D:_M ?#..3PMH?[0[:/\ M%> -&_BM>SAE\S4?B#(82#!*L7Z>_\%J?VV+[]N?\ 8[_X)G?LZ?L^O!<>.?\ M@HWXE^'WQ&U3P]IM[YD6B)H]QH7A*P\#>(0Q,RV,'QR\72&>Y>)A!=?!O73< M/&+22*?],?\ @XK_ &2X_P!I#_@G;XT^(FB::+OXA_LGZDOQZ\/SPP W)J&F>&O&_P 8_$?CV3P=H&E6TS21 M0:9;CQ#\=_'TBVH,]CXKNM*OR\?VBW%?:\)<1Y%Q/X.\%^*^?5:-;B'Z/D,_ MR^=&NO:2S3'1R-8#@G#XAM\TH5\PQG#>81YV_:SR7&Q@_:*4X]N#Q.'Q>2X' M.,0XRQ/#BQ%-QDE+VU14/9X"$MG:4YX6HKO5T*EM=5[W_P '*^G6_P"SI\%_ M^":/[#7P]FN[/X0?##X=^,-1M[(#[+#K^J_"WP]\/OAAX1US6((28+O7+;2] M?\8W]U>.9+B74/%FJWMQ+<3WC3"Q_P $V?\ @MHW[&/[%WP6_9]\-?\ !.;] MH_XGP>$+'Q1?:E\3/ L%U!X:\?Z[XG\:^(O$>J^(;"2U^'^II=+Y^I_V29I- M1O)8TTI+-IRMHB)^J/\ P<:_\$]?B9^V'^SM\./C+\"_#.I^.OBQ^S%JWBO4 M+OX>Z!9-?^)?&_PK\C#QG!X4TZ!'OM<\6>&-3\*^&_$.E^&[ -?Z]H\?B M:PT:TU3Q))H6E7WY0?\ !'[_ (. /@E^Q]^S+HG[)7[6/@WXCPP?"'5?$MG\ M./'OPZT&P\3-)X:UWQ%JWB2\\)>/O#-]K>AZ[HVO^%M?U;5+'3M0TV#5+6^T M66PT[4;'1;_0YKO6>?AF>!X[^CAD&&P/!,_%/.,AXOS7'<6<+X3B7'Y#G,,U MS7,L^QLN(JZRN4,9F4L5'-:-:%.K%T:M.KB:^'G5KY=5P]"<*Z>8<,X>%/ O M-J]#&U:F-PD,54PU=5JM7$S>)?LFIU>=5HR2DK-.4HMRI.,?D#_@G+=?&?Q3 M_P %SOAU^T5X!_9N^,_PE\#_ !>_:3^-GC'4_#>M?#OQ=;:3X*^'WQ@T+XC: MCXGTC6]8;PUI?A^+2M'&O2SH_EVFFVEQ9Z7_HI5^)?[!G_!;?X1 M?\%%OVI?$GP&^ 'P.^,EK\//"7PMUGQQKGQL\<66G:?86OB6QU[PYIFD^$KW MPYX9F\666@VWB#3]4UJ_TG6/$WB[1]2O[G0I=/L_#4QDFN;?]M*_GOQ]XBXA MS[BC(*/$W!*X$S+(^#\GRFED]3-9YQCYY7&=>ME5;,L34E.M3Q4<)25'ZOBI M/&1IQ5;$_O,5%R^:XBQ.)Q&+P\<7@5E]7#X*C1C0=9UZGL=94I59MN2FH)1Y M9OG2UEK/7\R_^"Q7[2NH?LI?\$X?VG_BEX=U-M(\;ZCX'7X7_#W4+>XDM]2T M[QK\7M4L?AOI&O:.\;*_]J^$8O$E[XSM"-RHWAUI94>&*13_ #J_\&F7P(TZ MZ\8_M;_M)7MB1=>%?#?@#X!>#+T >7%;^)[RY^(/Q%LUR0R2*OA;X4OD [HY M'3* ,)?L_P#X.N/'-UH7[%'[/_@Q"\.G^-OVG]*O=4NV5DLQ!X1^&'Q&O;2S MGNB%ACGN=1U*TN;6VED#7"V%Q-$CFT=HNU_X-7] L[#_ ()X_$?Q' D37'BW M]JKXB7#W4;*_VBTT3P#\*M#M5+J2&$-Q:7ZKSP'(P.I_0,DPZX8^B!Q9G&'7 ML\=Q]QQ@\GQ6(@DJDLLP.8X7!0PSFE?V3IY;C)2I-K_>:DG#WU)^GAXK"<%X MRM'2IF&/A1E)6O[*G5A!1OO:U&=U?[>UG=_TM5_*G_PIZO:VVLV?PL^%=QJ45_HFG6=E*7MH?B3XYU M#2$O=%N[M)+GP9X7L)?$]M;6FMZYX)UJS_J)\8>+-!\!^$_$_CCQ5?II?ACP M=X=UOQ5XCU256:+3="\.Z9=:QJ]_*J!G,=GI]G<7#A5+%8R "<"O\U3]A;0? M$?\ P5?_ ."Q_@/QG\8;-M3T_P"+/QL\1_M&?%31KUI-4TW3?AO\-[6Y\<:+ M\-IQ(G='H6H6ZL05>0_._1OX-R?,LXXC\2>*(2J\,^% M.5/B6I0C*4%C<\H4L5C\JHJ3J*-7&5,IIU4Z/M85N7A? T:E M;%9IBTWATQ$8SJ4H]+^S5+VEKJ\W13]U23]<_X-QM$^ 7B[_@H] MHWA#XW_#/PK\1=7U7X4^-=<^!]SXNT]==L/"7Q6\%3Z/XH_MFST*]\[1+G6/ M^$&LO%][I&L:E87=YX>U#2+:^T*73]2D%T/]'*O\R3]B[4IOV>O^"Z7PQTC1 M_P#1(/"W_!0[Q_\ !&."!?)B71O&'Q5\;_!![58T"(MLFG>(UV1*%C18HR$ M55'^FW7T7TPJ$Y\><*YY#$8FI@>(N!,JQ^$PU;$5ZM'".CB)TZRPM&I4E0PR MQ%/,,#6Q"P]*BJ^)A*O5]I4<91Z>-8MYA@\0I3=/$Y?2J0C*4G&#C)J2A%OE MCS*I3E+D2YI+F=[JWY4_\%G/V3/AU^U;_P $_/VA;7Q9H>E3>-_@W\,?'GQL M^$'C">U3^V?!_C?X<^&KWQ;Y.FZBN+FTTKQEI^AS^$/%-H&EM+W1]4>>:UEO MM/TR>U_!#_@U-_:S\87FO_'K]BC7]2O]5\%:;X-'[1'PKL[N;S;?P=.GBG1/ M"7Q2T73C)EK73/$NJ>,?!OB:'2[=ELX-!_%=O/H7CS M5/'&LZ3+=Z?I?C.^\,W.JZ'X6\&_;8_$UIJ&J6GBC4[*ST:PM_[6_+S_ (-> M_@CX[\/^*OVO?VWK?P9XB\2^%/A[\%]4^"7@C0-%M4_M#XE^.=1U3PW\4_%' MAKPI-=>3:7&L:'I_@;P7I;)YVP7GCRQ@(DDCEC3U^$>'LUP7T4_$>/&N&K8/ M+LQSG*\=X>X3.(RPM>&9U:^486CC,MIX]T*F$P^9YG6Q'L9VPM'%4*>9XVWU M*5;%UM\%AJU/A',UCX2A2JUZ53+H5_.?BKX!^#6G:1K3^+_ ![XSN?"%A#K8*K7H_6*-.LHJ52A[65'VL5&,?A=\,_'US97GCOX=^!?&MW MI\$UKI]UXM\(^'_$ES8VT\B336]G/K.G7LMK#-*B2RQ0.D M'= \*:-8^'_"^AZ/X;T+34E33M$T#2[+1](L$FN);J9;+3-.@MK.U2:YFFN9 M5@AC$D\TLSYDD=CM45QNM7E3A1E7KRH4W>G0E6K2H4WKK3HRK2HP?O2UA1@_ M>EK[TN:74FX1INM0E*+C*5"M6H2E%N[C*5"M1E*+:3<92E%M M7<6]0A4G3;<)S@VK-PG*#:WLW"4&UY-M>05RGC7P-X)^(WAV^\)?$/P?X6\> M>$]3$:ZGX8\9^'])\4>'=16-P\:WVBZW9WVFW81\,@GM9-K#*@&NKHJ85*E* M<*M&I4HU:) M_$7PQ^#'PX\!:ZT=S$\-S$VK>%?#>E:@8[B&22&=#<%9HI'CD#*Q!^A***WQ M6-QN/K/$9AC<;F&(<8P>(Q^,QF.Q#A"_)!XC'8O&UW"-WRP=?DC=\L(W=ZG4 MJ59"/B,FCF9E>;^RU\8:'K T_SF56F^R"'S&52^2H(ZSX>_#/X M;?"?P^GA3X6?#WP/\-/"T,S7$/AKX?\ A/0?!N@13NB(TT>C^'=/TW3DF9(X MT:1;8.51%+%57'=44Y8_,)X6G@*F88^IE]*;J4LOGC\=/ 4IMRDYTL#/&SP- M*;E*M"7,+7=GX3T?2+>Y:+>_EF:.39N?:5W$5ZO13>8YF\&LN>9YD\M4N=9: M\QS!Y]_X?M/ M9[Z_P]]=]0KYB\5_L3_L:>/O%%UXX\=?LD_LQ^-?&UW=R7UWXP\6_ 7X5^(_ M%-U>R2&:2\N?$&L>$[S5I[MY297N)+MY6D)\ZKA?44*M6DVZ52I2;5FZ M=2I3;79NG4IMKR;:\C)T/0]%\-Z/I^@>'=(TS0-"TJUBLM*T71=/L]*TG3+* M$8AL]/TVPA@L[.UB7Y8X+>&.)%X5!TKSOXL? /X%_'JPTS2OCE\%OA+\9]*T M6:YN-(TSXL?#GP?\1=/TFXNQ +J?3++Q?HVL6]C/WUJBHHXK%X:O'%X;%XO#8R$Y5(8S#XK%8?%PJ3YU.I#%8?$X?%0J34YJ=2. M*C.?//GG/GGSD:E2$_:1G.-2[?/&T'2=/ MTB]@N;.66UGAN;26.6VD>"16B!_AE\/?!NKSV,NFS: MIX4\%^&_#NHS:=-/;7,MA+>Z1IMG=264MQ:6EQ+:O*T$D]K;S-&9(8V7T:BG M4QF.K2KRK8[&UI8J7/BY5<9C*LL7-I)SQ4JN,J2Q,[)+GQ,L3)I).5DDFZU5 M\]ZM5^T_B7JU'[1[7J7J/G=E;W^?0K7EI::A:75A?VMO>V-[;3VE[9WD$5S: M7=I*OB_^R_\ L[?%;Q.Q MBW>(_B3\%/AKXYUYC#&D<6[6/$_AG5-0/E1QQQQYN#Y:(JKA5 'T516^%QN. MP%7ZQE^.QN7XCEE#V^ QN,P%?V<["K\DN5LFFVF5K31="LK#3;9I"J^8T-LA[&?#WBW1'G@NI-&\3:+INOZ M4]S;/OMKA]/U6VN[1I[=R7@F,)DB;+1LI.:;X4\'^$O!&DC0_!?A?P[X0T47 M,]X-'\+Z)IF@:6+NY*FXNAI^DVMI:"YG*(9I_*\V4HI=VVC'2T4>UK>S]C[: MK[#G]I[#VM7V'M/^?GL?:^QY_P"_['G_ +X^>?)[/FER.9(T>3P=^R[/X IK998V1Q;W=U"OB1XL$^B75O::A'JWPXT&X^(_ATI-=V=_;_9F\0^$]*74( M'M7^U:>UW;(\$DRW$7\HO_!IO5%?UKX6XJA#Z+7CS2PZE''PS# _7:G(XJ>#Q>&X$:B?O MM4J6-C*%DH*:3_M&V'[/,&B_ R3_@HG?_ !]M/B?JGQ@^!AL(OAC#^T1- M\2XO%#^%M*^)6I_$/S;[P[&+BRT,>#_[>6]N;:SU'3;!Q=M;?9G_ 7Q_P"" M8_\ P4)_;*_:M\ ^._V6_ FI_$KX.W_P+\/>!O%VE1_&KP+X%T#0_%V@>-/' M.I74VO\ @[Q[X\\)PZK#JNB^)-'^SZGH.E>(I91I]S:ZA':-:V27?]=%%?"_ M\3'<<_ZR\)<4O+.$YX_@WA;%\)970J97C:N#K9?C*65TJF*QL*N:3KSS&G_8 M^#J4*^&KX2G2J>W<::C6:CYW^L^/^M8/%^RP?M,#A)X*E%TIN$J +>6VNKWX<_ M!*^E\:_$G6;=)U^TZ-=>+=5T/3? O@8RQJ=NK:1:_$IV5FCCL[*8I=1?V;_" M3]GGX*_ GX*>'?V=?A7\.?#/A7X+>%O#5UX3TSP!%8IJ.B7.BZBMT=:CJ&HWMQ-[117QWB'XO\?\ MB?7PT^*LY53!X&L\1@,HRS#QRS*<'B&N58J&%P]:+KWA3ES4Z-**I482Z34(MN51+15)SG-+2+A=WYJP\&^ M$=,;39--\*^&]/?1ULETIK+0]+M&TL:;I6HZ%IPTYK>TC:R%AHNKZMH]D+9H MA:Z5JFHZ?!LM+VYADZ6BBOS-RG)WG.4WKK.4I/5N3UG*;UDW)ZZR;D[R;D_* 4;;U;;?=MMZN[U;;U>KUU>N^I_]D! end XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 39 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} ZIP 44 0001104659-26-048545-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-26-048545-xbrl.zip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

  •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tm268049d6_n6a_htm.xml IDEA: XBRL DOCUMENT 0000948923 2026-04-24 2026-04-24 0000948923 ck0000948923:WithdrawalChargeMember 2026-04-24 2026-04-24 0000948923 vip:RiskOfLossMember 2026-04-24 2026-04-24 0000948923 vip:NotShortTermInvestmentRiskMember 2026-04-24 2026-04-24 0000948923 vip:InvestmentOptionsRiskMember 2026-04-24 2026-04-24 0000948923 vip:InsuranceCompanyRiskMember 2026-04-24 2026-04-24 0000948923 vip:ContractLapseRiskMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MinimumSurrenderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MaximumSurrenderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MortalityAndExpenseRiskChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:MortalityAndExpenseRiskChargeMember ck0000948923:First10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeInitialFaceAmountDuringTheFirst2PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeInitialFaceAmountAfterTheFirst2PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AdministrativeChargeForFaceAmountIncreasesMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareRiderChargeMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareInflationProtectionOptionMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InterestRateMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LapseProtectionEndorsementMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvestmentRiskMember 2026-04-24 2026-04-24 0000948923 ck0000948923:WithdrawalAndSurrenderRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TaxRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LoanRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:SpecializedUsesOfThePolicyMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FundRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:BusinessDisruptionandCyberSecurityRisksMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option1DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option2DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option3DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:Option4DeathBenefitMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LongTermCareRiderMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TerminalIllnessAcceleratedDeathBenefitEndorsementMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DollarCostAveragingMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PortfolioRebalancingMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PolicyLoansMember 2026-04-24 2026-04-24 0000948923 ck0000948923:ReservationOfRightsMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TelephoneTransfersMember 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGrowthFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:AmericanFundsInsuranceSeriesNewWorldFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:ClearBridgeVariableSmallCapGrowthPortfolioClassIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAInternationalSmallPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAInternationalValuePortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVAUSLargeValuePortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPIndex500PortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPInvestmentGradeBondPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FidelityVIPMidCapPortfolioInitialClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:FranklinGrowthAndIncomeVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:FranklinIncomeVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:GoldmanSachsVITMidCapValueFundInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIDiversifiedDividendFundSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIGlobalFundSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:InvescoVIUSGovernmentMoneyPortfolioSeriesIMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LordAbbettSeriesFundBondDebenturePortfolioClassVCMember 2026-04-24 2026-04-24 0000948923 ck0000948923:LordAbbettSeriesFundDividendGrowthPortfolioClassVCMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITInternationalBondPortfolioUSDollarHedgedInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITShortTermPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PIMCOVITTotalReturnPortfolioInstitutionalClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:PutnamVTSustainableLeadersFundClassIAMember 2026-04-24 2026-04-24 0000948923 ck0000948923:RoyceCapitalSmallCapPortfolioInvestmentClassMember 2026-04-24 2026-04-24 0000948923 ck0000948923:TempletonEmergingMarketsVIPFundClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSAggressiveETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSConservativeETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSModerateETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:TOPSModeratelyAggressiveETFPortfolioClass1Member 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsEquityIncomePortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsInternationalPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsPRIMECAPPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember 2026-04-24 2026-04-24 0000948923 ck0000948923:VanguardVariableInsuranceFundsShortTermInvestmentGradePortfolioMember 2026-04-24 2026-04-24 iso4217:USD pure 2026-04-24 N-6 Protective Variable Life Separate Account <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 2pt 0pt; width: 123px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>FEES AND EXPENSES</b></span></p></td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Charges for Early Withdrawals</b></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="-keep: true"> <span style="font-size:10pt; font-family: Arial, Helvetica;">If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.<br/>If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.80% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,800.<br/>For additional information about charges for surrenders and early withdrawals, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span> </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Transaction Charges</b></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="-keep: true"> <span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy's Face Amount and transfer fees.<br/>For additional information about transaction charges, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span> </span> </td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Ongoing Fees and Expenses (annual<br/>charges)</b></span> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance ("COI") under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.<br/>You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; width: 150px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 470px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Annual Fee</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 378px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Minimum</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 379px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Maximum</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 470px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fund Options <br/>(Fund fees and expenses)<sup>(1)</sup>​</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 378px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><br/>0.09%</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 379px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><br/>1.18%</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​ As a percentage of Fund assets.</i></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 150px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="11" style="padding:4pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">For additional information about ongoing fees and expenses, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span></p> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Charges for Early Withdrawals</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.<br/>If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.80% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,800.<br/>For additional information about charges for surrenders and early withdrawals, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span> 25 14 0.058 5800 <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Transaction Charges</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy's Face Amount and transfer fees.<br/>For additional information about transaction charges, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Ongoing Fees and Expenses (annual<br/>charges)</b></span> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance ("COI") under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.<br/>You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; width: 150px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 470px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Annual Fee</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 378px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Minimum</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:2.5pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 379px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Maximum</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 470px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fund Options <br/>(Fund fees and expenses)<sup>(1)</sup>​</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 378px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><br/>0.09%</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 379px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><br/>1.18%</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 150px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>           </b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​ As a percentage of Fund assets.</i></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:4pt .7pt 6pt 0pt; width: 150px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="11" style="padding:4pt .7pt 6pt 0pt; width: 1227px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">For additional information about ongoing fees and expenses, see "CHARGES AND DEDUCTIONS" in the Prospectus.</span></p> </td> <td colspan="1"> </td> </tr> </table> 0.0009 0.0118 As a percentage of Fund assets. <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="7" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1608px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>RISKS</b></span></p></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risk of Loss</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">You can lose money by investing in this Policy, including loss of principal.<br/>For additional information about the risk of loss, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Not a Short-Term Investment</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.<br/>For additional information about the investment profile of the Policy, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "CHARGES AND DEDUCTIONS," "USE OF THE POLICY" and "TAX CONSIDERATIONS — Taxation of Insurance Polices" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risks Associated with Investment<br/>Options</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.<br/>For additional information about the risks associated with Investment Options, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "THE COMPANY AND THE FIXED ACCOUNT," "THE VARIABLE ACCOUNT AND THE FUNDS" and "FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Insurance Company Risks</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.<br/>For additional information about Company risks, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" and "THE COMPANY AND THE FIXED ACCOUNT" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Policy Lapse</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy could terminate if the value of your Policy becomes too low to support the Policy's monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.<br/>For additional information about Policy Lapse, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "PREMIUMS," "LOANS," and "LAPSE AND REINSTATEMENT" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risk of Loss</b></span>  <span style="font-size:10pt; font-family: Arial, Helvetica;">You can lose money by investing in this Policy, including loss of principal.<br/>For additional information about the risk of loss, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" in the Prospectus.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Not a Short-Term Investment</b></span>  <span style="font-size:10pt; font-family: Arial, Helvetica;">The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.<br/>For additional information about the investment profile of the Policy, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "CHARGES AND DEDUCTIONS," "USE OF THE POLICY" and "TAX CONSIDERATIONS — Taxation of Insurance Polices" in the Prospectus.</span> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risks Associated with Investment<br/>Options</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.<br/>For additional information about the risks associated with Investment Options, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "THE COMPANY AND THE FIXED ACCOUNT," "THE VARIABLE ACCOUNT AND THE FUNDS" and "FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Insurance Company Risks</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.<br/>For additional information about Company risks, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" and "THE COMPANY AND THE FIXED ACCOUNT" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 176px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Policy Lapse</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:3pt .7pt 6pt 0pt; width: 1432px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy could terminate if the value of your Policy becomes too low to support the Policy's monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.<br/>For additional information about Policy Lapse, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "PREMIUMS," "LOANS," and "LAPSE AND REINSTATEMENT" in the Prospectus.</span></td> <td colspan="1"> </td> </tr> </table> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investments</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing polices described in the Prospectus.<br/>We reserve the right to remove or substitute Funds as investment options.<br/>For additional information about Investment Options, see "TRANSFERS" and "ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS" in the Prospectus.</span> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Optional Benefits</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">Optional benefits, including Policy loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy's Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.<br/>For additional information about the optional benefits, see "OTHER BENEFITS AVAILABLE UNDER THE POLICY" and "SUPPLEMENTAL RIDERS AND ENDORSEMENTS" in the Prospectus.</span> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Tax Implications</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.<br/>For additional information about tax implications, see "TAX CONSIDERATIONS" in the Prospectus.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Professional<br/>Compensation</b></span>   <span style="font-size:10pt; font-family: Arial, Helvetica;">Some investment professionals have and may receive compensation for selling the Policy to investors, which may include commissions, revenue sharing, and compensation from affiliates and third parties. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment.<br/>For additional information about compensation, see "SALE OF THE POLICIES" in the Prospectus.</span> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Exchanges</b></span></p>   <span style="font-size:10pt; font-family: Arial, Helvetica;">Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy.<br/>For additional information about exchanges, see "TAX CONSIDERATIONS — Section 1035 Exchanges" in the Prospectus.</span> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>FEE TABLE</b></span></p> <p style="margin:0pt 0pt 5pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).</b></span></p> <p style="margin:0pt 0pt 5pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The first table describes the fees and expenses that you will pay at the time that you pay premiums, surrender the Policy, allow the Policy to Lapse, decrease the Initial Face Amount, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals.</b></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Premium Expense Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">5% of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.5% of each premium payment</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Surrender Charge:<sup>(1)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> </tr> </table><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke class during the first Policy Year</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Transfer Fee:<sup>(2)</sup>​</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon each transfer in excess of 12 in a Policy Year</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$25 per transfer</span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$0 per transfer</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal Charge:</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of each withdrawal of Policy Value</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The lesser of 2.0% of the amount withdrawn or $25</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The lesser of 2.0% of the amount withdrawn or $25</span></p></td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(2)</sup>​  Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.</i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds' fees and expenses.</b></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Base Contract Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Cost of Insurance:<sup>(1)(2)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.01 – $83.33 per $1,000 of Net Amount at Risk<sup>(2)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.00 – $70.46 per $1,000 of Net Amount at Risk<sup>(2)</sup>​</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.23 per $1,000 of Net Amount at Risk</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.03 per $1,000 of Net Amount at Risk</span></p> </div> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges </i></span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".</i></span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(2)</sup>​  See definition of Net Amount at Risk in the Special Terms.</i></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Mortality and Expense Risk Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Standard Administrative Fee:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$9.00</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$9.00</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Administrative Charge:<sup>(3)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.36 – $3.89 per $1,000 of Initial Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.29 – $2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16 – $1.46 per $1,000 of Initial Face Amount thereafter</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.11 per $1,000 of Initial Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter</span></p> </div> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(3)</sup>​  We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Administrative Charge For Face Amount Increases:<sup>(4)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.95 – $4.95 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.95 – $4.95 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p> </div> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Rider Charge:<sup>(5)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p> </div> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(4)</sup>​  The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p> <p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(5)  </sup>​The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.</i></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Optional Benefit Charges:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Inflation Protection Option<sup>(#)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50</span></p> </td> <td colspan="1"> </td> </tr> </table> </div><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Net Cost of Loans<sup>(6)</sup>​</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Policy Anniversary, as applicable<sup>(7)</sup>​</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter</span></p></td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(6)</sup>​  The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).</i></span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(7)</sup>​  As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.</i></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Series Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Lapse Protection Endorsement</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">1% of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">1% of each premium payment</span></p> </td> <td colspan="1"> </td> </tr> </table> <p style="margin:12pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL FUND EXPENSES</b></span></p> <p style="margin:0pt 0pt 5pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See "FUND APPENDIX — FUNDS AVAILABLE UNDER THE POLICY".</b></span></p> <p style="margin:4pt 0pt 0pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL FUND EXPENSES</b></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 83px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Minimum</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 42px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Maximum</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px; background-color: #cceeff; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Total Annual Fund Expenses<br/>(expenses that are deducted from Fund assets, <br/>including management fees, distribution and/or <br/>service 12b-1 fees, and other expenses)</span> </td> <td colspan="1" style="background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 51px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.09</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 26px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">—</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 36px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%<sup>(1)</sup>​</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> </tr> </table> <p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.</i></span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Premium Expense Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">5% of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.5% of each premium payment</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Surrender Charge:<sup>(1)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke class during the first Policy Year</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable</span></p> </td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Transaction Fees</b></span></p></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Transfer Fee:<sup>(2)</sup>​</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon each transfer in excess of 12 in a Policy Year</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$25 per transfer</span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$0 per transfer</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal Charge:</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of each withdrawal of Policy Value</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The lesser of 2.0% of the amount withdrawn or $25</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The lesser of 2.0% of the amount withdrawn or $25</span></p></td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(2)</sup>​  Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.</i></span></p> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Premium Expense Charge:</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span> 0.05 0.035 Surrender Charge: <span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years</span> 3 57.75 3 57.75 The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. Transfer Fee: <span style="font-size:10pt; font-family: Arial, Helvetica;">Upon each transfer in excess of 12 in a Policy Year</span> 25 0 <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal Charge:</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of each withdrawal of Policy Value</span> 0.02 25 0.02 25 Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus. <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Base Contract Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Cost of Insurance:<sup>(1)(2)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.01 – $83.33 per $1,000 of Net Amount at Risk<sup>(2)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.00 – $70.46 per $1,000 of Net Amount at Risk<sup>(2)</sup>​</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.23 per $1,000 of Net Amount at Risk</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.03 per $1,000 of Net Amount at Risk</span></p> </div> </td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges </i></span></p><p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".</i></span></p><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(2)</sup>​  See definition of Net Amount at Risk in the Special Terms.</i></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Mortality and Expense Risk Charge:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Standard Administrative Fee:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$9.00</span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">$9.00</span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Administrative Charge:<sup>(3)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.36 – $3.89 per $1,000 of Initial Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.29 – $2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16 – $1.46 per $1,000 of Initial Face Amount thereafter</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.11 per $1,000 of Initial Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter</span></p> </div> </td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(3)</sup>​  We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Administrative Charge For Face Amount Increases:<sup>(4)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.95 – $4.95 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.95 – $4.95 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p> </div> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Rider Charge:<sup>(5)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07</span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000</i></span></p> </div> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <div style="-keep: true"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p> </div> </td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(4)</sup>​  The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</i></span></p><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(5)  </sup>​The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.</i></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Optional Benefit Charges:</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Inflation Protection Option<sup>(#)</sup>​</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50</span></p> </td> <td colspan="1"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Fund Operating Expenses</b></span></p></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Net Cost of Loans<sup>(6)</sup>​</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Policy Anniversary, as applicable<sup>(7)</sup>​</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter</span></p></td> <td colspan="1"> </td> </tr> </table><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(6)</sup>​  The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).</i></span></p><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(7)</sup>​  As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.</i></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="15" style="padding:0pt .7pt 9pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 3268px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Periodic Charges Other Than Series Fund Operating Expenses</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 510px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Charge</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 689px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>When Charge <br/>is Deducted</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 944px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Maximum Guaranteed <br/>Charge</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 1125px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Amount Deducted — <br/>Current Charge</b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 510px; text-align: left;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Lapse Protection Endorsement</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 689px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 944px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 3pt 0pt; width: 1125px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 510px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Minimum and Maximum Charge</i></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 689px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 944px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">1% of each premium payment</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 1125px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">1% of each premium payment</span></p> </td> <td colspan="1"> </td> </tr> </table> Cost of Insurance: <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span> 0.01 83.33 70.46 <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.</i></span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.23 per $1,000 of Net Amount at Risk</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.03 per $1,000 of Net Amount at Risk</span></p> Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges <p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".</i></span></p> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Mortality and Expense Risk Charge:</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span> 0.006 0.00204 0.00096 <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Standard Administrative Fee:</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span> 9 9 Administrative Charge: <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span> 0.36 3.89 0.29 2.72 0.16 1.46 <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.</i></span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$1.11 per $1,000 of Initial Face Amount</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter</span></p> We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. Administrative Charge For Face Amount Increases: <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span> 1.95 4.95 1.95 4.95 <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class</i></span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">$3.45 per $1,000 of any increase in Face Amount</span></p> Long-Term Care Rider Charge: <span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span> 0.05 2.07 0.05 2.07 <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000</i></span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Monthly Anniversary Day starting from the Effective Date</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p>   <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19</span></p> Long-Term Care Inflation Protection Option <span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected</span> 0 0.5 0 0.5 Net Cost of Loans On each Policy Anniversary, as applicable 0.02 0.0025 0.02 0.01 0 0.05 0.04 0.05 0.03 0.0325 0.03 0.03 As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death. <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Lapse Protection Endorsement</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Upon receipt of each premium payment</span> 0.01 0.01 <p style="margin:12pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL FUND EXPENSES</b></span></p><p style="margin:0pt 0pt 5pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See "FUND APPENDIX — FUNDS AVAILABLE UNDER THE POLICY".</b></span></p><p style="margin:4pt 0pt 0pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL FUND EXPENSES</b></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 83px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Minimum</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 42px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Maximum</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px; background-color: #cceeff; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Total Annual Fund Expenses<br/>(expenses that are deducted from Fund assets, <br/>including management fees, distribution and/or <br/>service 12b-1 fees, and other expenses)</span> </td> <td colspan="1" style="background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 51px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.09</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 26px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">—</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 36px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%<sup>(1)</sup>​</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> </tr> </table><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.</i></span></p> <p style="margin:4pt 0pt 0pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL FUND EXPENSES</b></span></p><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 83px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Minimum</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 42px;" valign="bottom"> <span style="-keep: true">   </span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Maximum</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 228px; background-color: #cceeff; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Total Annual Fund Expenses<br/>(expenses that are deducted from Fund assets, <br/>including management fees, distribution and/or <br/>service 12b-1 fees, and other expenses)</span> </td> <td colspan="1" style="background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 51px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.09</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 26px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">—</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 36px; background-color: #cceeff; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%<sup>(1)</sup>​</span></p> </td> <td colspan="1" style="width: 8px; background-color: #cceeff;"> </td> </tr> </table><p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.</i></span></p> 0.0009 0.0118 The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses. <p style="margin:12pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>PRINCIPAL RISKS OF INVESTING IN THE POLICY</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Risk</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. <b><i>You could lose everything you invest.</i></b> If you allocate Policy Value to the </span></p><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See "The Variable Account and The Funds."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risk of Lapse</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Surrender Charge, Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See "Lapse and Reinstatement — Lapse" and "Lapse Protection."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal and Surrender Risks.</b> The Surrender Charge under the Policy applies during the first 14 Policy Years. The Surrender Value of the Policy is generally the Policy Value less the Surrender Charge and Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. <b>The Policy is not suitable as a short-term investment.</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Even if you do not ask to surrender your Policy, Surrender Charges may play a role in determining whether your Policy will Lapse (terminate without value), because Surrender Charges decrease the Surrender Value.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A surrender or withdrawal may have tax consequences. See "Tax Considerations."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Tax Risks</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59</span><span style="font-size:5pt; font-family: Arial, Helvetica;"><sup>1</sup>​</span><span style="font-size:10pt; font-family: Arial, Helvetica;">/</span><span style="font-size:5pt; font-family: Arial, Helvetica;"><sub>2</sub></span><span style="font-size:10pt; font-family: Arial, Helvetica;"> at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">See "Tax Considerations." <i>You should consult a qualified tax adviser for assistance in all Policy related tax matters.</i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Loan Risks</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "Policy Loans" and "Tax Considerations — Tax Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>If a Policy Loan is taken from the Policy while the Long-Term Care Rider is on Active Claim Status, the Long-Term Care Rider will terminate.</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Specialized Uses of the Policy</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See "Tax Considerations — Other Considerations."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Fund Risks</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Business Disruption and Cyber Security Risks</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure <i>(e.g.,</i> hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds' ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.</span></p> <p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Risk</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. <b><i>You could lose everything you invest.</i></b> If you allocate Policy Value to the </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See "The Variable Account and The Funds."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risk of Lapse</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Surrender Charge, Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See "Lapse and Reinstatement — Lapse" and "Lapse Protection."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal and Surrender Risks.</b> The Surrender Charge under the Policy applies during the first 14 Policy Years. The Surrender Value of the Policy is generally the Policy Value less the Surrender Charge and Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. <b>The Policy is not suitable as a short-term investment.</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Even if you do not ask to surrender your Policy, Surrender Charges may play a role in determining whether your Policy will Lapse (terminate without value), because Surrender Charges decrease the Surrender Value.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A surrender or withdrawal may have tax consequences. See "Tax Considerations."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Tax Risks</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59</span><span style="font-size:5pt; font-family: Arial, Helvetica;"><sup>1</sup>​</span><span style="font-size:10pt; font-family: Arial, Helvetica;">/</span><span style="font-size:5pt; font-family: Arial, Helvetica;"><sub>2</sub></span><span style="font-size:10pt; font-family: Arial, Helvetica;"> at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">See "Tax Considerations." <i>You should consult a qualified tax adviser for assistance in all Policy related tax matters.</i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Loan Risks</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "Policy Loans" and "Tax Considerations — Tax Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>If a Policy Loan is taken from the Policy while the Long-Term Care Rider is on Active Claim Status, the Long-Term Care Rider will terminate.</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Specialized Uses of the Policy</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See "Tax Considerations — Other Considerations."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Fund Risks</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Business Disruption and Cyber Security Risks</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure <i>(e.g.,</i> hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds' ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.</span></p><p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>STANDARD DEATH BENEFITS</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner's estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment </span></p><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">of the Death Benefit Proceeds may have tax consequences. See "Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds" in the Prospectus.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Limits on Policy Rights</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Incontestability.</i></b> Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider accept as stated below, after the Policy or rider has been in force during the Insured's lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We have the right to void and rescind the Long-Term Care rider or resist an otherwise valid claim based on a misstatement in any application we accept and make part of the Policy as follows:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  If this rider has been in force for less than 6 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was material to the issuance of this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  If this rider has been in force for at least 6 months but less than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was materials to the issuance of this rider and pertains to the condition for which benefits are sought.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  If this rider has been in force for more than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the Insured knowingly and intentionally misrepresented relevant facts relating to the Insured's health.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Suicide Exclusion.</i></b> If the Insured dies by suicide, while sane or insane, within two years (or shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide, while sane or insane, within two years (or any shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Misstatement of Age or Sex.</i></b> If the Insured's age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Calculation of Death Benefit Proceeds</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured's death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Federal Tax Compliance Tests.</i> Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test. This Policy will only be issued using the Cash Value Accumulation Test.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Cash Value Accumulation Test ("CVAT") does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy's cash value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Under this Policy, which provides a level Death Benefit, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater than the Face Amount under the Policy.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured's death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Cash Value Accumulation Test.</i></b> This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured's death, or (2) the minimum death benefit described below.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Changing the Face Amount</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>On or after the first Policy Anniversary, the Owner may request an increase in the Face Amount. The request must be received in writing in Good Order at the Home Office.</i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Increasing the Face Amount.</i></b> Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. The maximum Face Amount is $500,000. In addition, the Insured's current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See "Premiums Upon Increase in Face Amount." The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy's lapse protection is in effect, the Policy's Minimum Monthly Premium amount will also generally be increased.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">An administrative fee will be charged on the Effective Date of the increase and the subsequent eleven (11) Monthly Anniversary Days following an increase in the Face Amount.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (<i>i.e.</i>, credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "Tax Considerations — Other Considerations." Please consult your tax advisor.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>On or after the third Policy Anniversary, the Owner may request a decrease in the Face Amount. The request must be received in writing in Good Order at the Home Office.</i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Decreasing the Face Amount.</i></b> If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See "Tax Considerations — Policies which are MECs."</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. <b>However, if the initial Face Amount is decreased during the first 14 Policy Years, a Surrender Charge will apply.</b> Decreasing the Face Amount also may have tax consequences. See "Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years."</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Settlement Options</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The following settlement options may be elected.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 1 — Payment for a Fixed Period.</i></b><i>  </i>Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 2 — Life Income with Payments for a Guaranteed Period.</i></b><i>  </i>Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 3 — Interest Income.</i></b><i>  </i>Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 4 — Payments for a Fixed Amount.</i></b><i>  </i>Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Minimum Amounts.</i></b> Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life's option.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Other Requirements.</i></b> Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured's lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner's estate.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Escheatment of Death Benefit</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely </span></p> </div><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This "escheatment" is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Cash Value Accumulation Test.</i></b> This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured's death, or (2) the minimum death benefit described below.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.</span></p><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Changing the Face Amount</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>On or after the first Policy Anniversary, the Owner may request an increase in the Face Amount. The request must be received in writing in Good Order at the Home Office.</i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Increasing the Face Amount.</i></b> Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. The maximum Face Amount is $500,000. In addition, the Insured's current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See "Premiums Upon Increase in Face Amount." The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy's lapse protection is in effect, the Policy's Minimum Monthly Premium amount will also generally be increased.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">An administrative fee will be charged on the Effective Date of the increase and the subsequent eleven (11) Monthly Anniversary Days following an increase in the Face Amount.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (<i>i.e.</i>, credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "Tax Considerations — Other Considerations." Please consult your tax advisor.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>On or after the third Policy Anniversary, the Owner may request a decrease in the Face Amount. The request must be received in writing in Good Order at the Home Office.</i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Decreasing the Face Amount.</i></b> If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See "Tax Considerations — Policies which are MECs."</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. <b>However, if the initial Face Amount is decreased during the first 14 Policy Years, a Surrender Charge will apply.</b> Decreasing the Face Amount also may have tax consequences. See "Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years."</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 1 — Payment for a Fixed Period.</i></b><i>  </i>Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 2 — Life Income with Payments for a Guaranteed Period.</i></b><i>  </i>Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 3 — Interest Income.</i></b><i>  </i>Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Option 4 — Payments for a Fixed Amount.</i></b><i>  </i>Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>OTHER BENEFITS AVAILABLE UNDER THE POLICY</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.</span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:8pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 475px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name of Benefit</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:8pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 609px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Purpose</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:8pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 56px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Is Benefit <br/>Standard<br/>or <br/>Optional?</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:8pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 621px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Brief Description of<br/>Restrictions/Limitations</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Rider</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.<br/>• Additional cost applies.<br/>• Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.<br/>• Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).<br/>• Benefit payments are made monthly and may not cover all long-term care expenses incurred.<br/>• If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.<br/>• If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.</span></td> <td colspan="1"> </td> </tr> </table><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 475px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name of Benefit</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 609px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Purpose</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 56px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Is Benefit <br/>Standard<br/>or <br/>Optional?</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 621px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Brief Description of<br/>Restrictions/Limitations</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Inflation Protection Option</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• This rider must be elected at Policy issue.<br/>• Additional cost applies.<br/>• On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.<br/>• If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Terminal Illness Accelerated Death Benefit Endorsement (Automatically included at Policy Issue)</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:<br/>• The lesser of 60% of the current face amount of the Policy or $1,000,000; minus<br/>• Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.<br/>• Minimum acceleration permitted is $15,000<br/>• The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.<br/>• Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Lapse Protection Endorsement (Automatically issued with this Policy)</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.<br/>• Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.</span></td> <td colspan="1"> </td> </tr> </table> </div><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 475px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name of Benefit</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 609px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Purpose</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 56px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Is Benefit <br/>Standard<br/>or <br/>Optional?</b></span></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 621px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Brief Description of<br/>Restrictions/Limitations</b></span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Dollar-Cost Averaging</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allows for the systematic transfer of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub-Accounts.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• No transfers may be made into the Fixed Account.<br/>• Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Portfolio Rebalancing</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Rebalancing transfers cannot be made into Fixed Account.<br/>• Minimum Variable Account Value of $100 required.</span></td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 475px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Policy Loans</b></span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 609px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allows Owner to borrow from Policy's Cash Value.</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 56px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span></p></td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 621px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Not available during the first Policy Year.<br/>• Maximum loan amount is 99% of Cash Value.<br/>• Minimum loan amount is $500.<br/>• Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.<br/>• If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.</span></td> <td colspan="1"> </td> </tr> </table> <p style="margin:6pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>SUPPLEMENTAL RIDERS AND ENDORSEMENTS</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See "Monthly Deduction." Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The Long-Term Care Rider, the Terminal Illness Accelerated Death Benefit Endorsement, and the Lapse Protection Endorsement are automatically added to all Policies at the time of issue. Also, this Policy will not be issued without the Long-Term Care Rider. The Long-Term Care Inflation Protection Option must be purchased at the time the Policy is issued. Please ask your Protective Life agent for further information or contact the Home Office.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Long-Term Care Rider.</i></b> This rider is automatically issued with the Policy. This rider provides an acceleration of the death benefits and extended benefits under the Policy for long-term care benefits for Qualified Long-Term Care Services incurred for Home Health Care Services, Adult Day Care Services, Assisted Living Facility Services, and Nursing Home Services. You may make a claim for a Long-Term Care Benefit (the "LTC Benefit"). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met. If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">30-Day Right to Cancel</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">You have 30 days after the rider is first delivered to you to examine and return to us or to the financial professional who sold it to you, if you decide not to keep this rider. <b>We will cancel the rider and the Policy.</b> The returned Policy and rider will be treated if they had never been issued. We will refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to us, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to us.</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Rider Terms</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Activities of Daily Living:</b> Means the six basic human functions necessary for a person to live independently are:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Eating</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Toileting</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Transferring oneself into or out of bed, chair, wheelchair</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Bathing</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Dressing</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Continence</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider attached to your Policy contains more detailed information about these self-care functions.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Active Claim Status:</b> Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Assistive Device:</b> Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Chronically Ill:</b> Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity, or</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Sever Cognitive Impairment.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Elimination Period:</b> Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Family Member:</b> Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Hands-on Assistance:</b> Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Home:</b> Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision or Substantial Assistance with Activities of Daily Living.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Insured:</b> Means the person shown on the Policy Schedule upon whose life the Policy insures.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Licensed Health Care Practitioner:</b> Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Plan of Care:</b> Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured's needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured's care requirements.</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Qualified Long-Term Care Services:</b> Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a chronically ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Severe Cognitive Impairment:</b> Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's short or long-term memory,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's orientation as to person (such as who they are), place (such as their location), or time (such as day, date, and year), and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's deductive or abstract reasoning.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Standby Assistance:</b> Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Substantial Assistance:</b> Means Hands-On Assistance or Standby Assistance.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Substantial Supervision:</b> Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Written Certification:</b> Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Eligibility, Limitations, and Exclusions</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">To become eligible for the LTC Benefit payments, the following conditions must be met:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  We receive your written request for the LTC Benefit,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  A Licensed Health Care Practitioner certifies that the Insured is Chronically Ill and prescribes a Plan of Care,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Policy and this rider are in force,</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The applicable Elimination Period has been satisfied,</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy, and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The benefit payment is made in respect to a month when the Insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by, received from, a provider of health care services, within six months preceding the effective date of this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider will not pay benefits for any Chronic Illness caused by:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Any attempt at suicide or intentionally self-inflicted injury, while sane or insane,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Committing or attempting to commit or participating in a riot, insurrection, or involvement in an illegal occupation,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Alcoholism or drug addiction, or</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Declared or undeclared war or any act of war.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Maximum Monthly LTC Benefit Amount</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Base Maximum Monthly LTC Benefit Amount</b> on the Policy Effective Date, is equal to the amount shown in the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the "Long-Term Care Inflation Protection Option" section and "Impact on Your Policy" section.</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date and is equal to:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Base Maximum Monthly LTC Benefit Amount, plus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  80% of the result of the following:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">a)  1/48 of the Current LTC Benefit Pool minus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">b)  the Base Maximum Monthly LTC Benefit Amount</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, that amount may increase and/or decrease as described in the "Benefits While on Claim" section below.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown in the Policy Schedule.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Current LTC Benefit Pool</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Base LTC Benefit Pool,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Market Value LTC Benefit Pool, and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Benefit Pool.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the "Benefits While on Claim" provision below.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Unless you have requested a decrease in the Policy's Face Amount or make a withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown in the Policy Schedule minus the sum of any LTC Benefits paid under this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Base LTC Benefit Pool</b> on the Policy Effective Date, is equal to the Base LTC Benefit Pool shown in the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the "Long-Term Care Inflation Protection Option", and "Impact on Your Policy" sections.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Market Value LTC Benefit Pool</b> is equal to the Unloaned Policy Value multiplied by the Market Benefit Multiplier shown on your Policy schedule. This pool may increase or decrease daily and is adjusted as described in the "Long-Term Care Inflation Protection Option" section.</span></p> </div> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Protected LTC Benefit Pool</b> on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on your Policy schedule) multiplied by the Unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on your Policy schedule.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Percentage (shown on the Policy schedule) multiplied by the Unloaned Policy Value as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier, and</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Pool in effect immediately prior to that Policy Anniversary.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to the Long-Term Care Inflation Protection Option Increases, LTC Benefit payments, withdrawals, loans, and Policy changes.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Claims Provisions</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We prefer that either you or the Insured notify us as soon as the Insured first becomes eligible and may soon need care covered by this rider. We must receive your intent to file a claim for the LTC Benefit at our Administrative Office via written request or by telephone. The Request should include at least the Insured's name, Policy number and the address to which claim forms should be sent.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">provide Written Certification and proof of loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Confirmation from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date of proof would otherwise by required.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A licensed Health Care Practitioner must re-certify that the Insured is Chronically Ill and prescribe a Plan of Care at least once every 12 months. We reserve the right to request a re-certification that the Insured remains Chronically Ill, but not more often than every 90 days, following an initial certification. The practitioner should either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification. After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be conducted until the 90-day period has passed.</span></p> </div> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agree upon by the Insured and us. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Accumulation Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If, on the date your claim is closed, the Policy's Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as in the Maximum Monthly LTC Benefit Amount and Current LTC Benefit Pool section above, but will be floored at the amounts during claim.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issues. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Extension of LTC Benefits</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The death of the Insured,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Transition from Active Claim Status has completed, or</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Maximum LTC Benefit Pool has been exhausted.</span></p> </div> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any extension of benefit is subject to all terms and conditions of this rider including eligibility for LTC Benefits and claim requirements. If the current maximum LTC benefit pool has been exhausted, no death benefit will be due upon the death of the Insured.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Benefits While on Claim</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date. Also, on the date a claim under this rider is approved, </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">we will automatically transfer out any Variable Account Value and transfer to the Fixed Account. See "Impact on Your Policy" below for additional information.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any amounts paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If purchased, the Long-term Care Inflation Protection Option increase will increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Long-Term Care Inflation Protection Option" section.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">An increase and/or decrease in the Policy's Face Amount or a Withdrawal under the Policy will likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Impact on Your Policy" section.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If your claim is closed, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the "Current LTC Benefit Pool" and "Maximum Monthly LTC Benefit Amount" sections, but will be floored at the amounts during claim.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Impact on Your Policy</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Automatic Transfer to Fixed Account.</i> On the date a claim under this rider is approved, we will automatically transfer any Variable Account Value out of the Sub-Accounts and transfer into the Fixed Account. While this rider is in Active Claim Status, no transfers out of the Fixed Account into Sub-Accounts will be permitted. In addition, Net Premiums received during this period will be allocated to the Fixed Account.</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>LTC Benefit Payments.</i> While Policy Value is greater than zero, LTC Benefit payments will reduce the Policy Value dollar for dollar and will be taken from the Fixed Account.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>LTC Benefit Payments on Face Amount.</i> While the Policy's Face Amount is greater than zero, benefit payments under this rider will reduce the Policy's Face Amount dollar for dollar. This may reduce the Policy's Face Amount below the minimum.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Monthly Deductions.</i> When this rider is in Active Claim Status, Monthly Deductions required to maintain the Policy continue, however the LTC Rider Monthly Charge is waived.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Policy Changes, Loans, and Withdrawals.</i> When the rider is in Active Claim Status, Policy Changes, Loans, and withdrawals are not permitted.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Interaction with Terminal Illness Accelerated Death Benefit Endorsement.</i> Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under this endorsement.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Residual Death Benefit.</i> If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment, or</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  $10,000.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Protection Against Unintended Lapse</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">To protect against unintended lapse, you may designate at least one person, other than the Owner, to receive notices about potential lapse or Policy termination due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the third-party for services provided to the Insured.</span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Termination</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider will terminate on the earliest of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your written notice to terminate this rider. If you request to terminate this rider the Policy to which it is attached will also be terminated. We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Policy termination,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Failure to pay sufficient premium to maintain the rider,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Death of the Insured,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness or rider attached to the Policy,</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date that the Maximum LTC Benefit is exhausted, and</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Reinstatement</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy terminates and is subsequently reinstated, this rider may also be reinstated subject to the terms and conditions for reinstatement in the Policy. Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We will reinstate the Policy and this rider without evidence of insurability, if we receive:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Owner's written request within 5 months after the end of the Grace Period,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Due proof that is satisfactory to us that the Insured was Chronically Ill at the end of the Grace Period outlined in the Policy, and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Payment of overdue premium and/or charges for this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Rider LTC Nonforfeiture Benefit</span></i></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">After the Policy and this rider have been In Force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The death of the Insured, or</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date the LTC Nonforfeiture Benefit Limit has been reduced to zero.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  One month's Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates, or</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  An amount equal to the sum of Monthly rider Charges paid for this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider Lapses or terminates, and will not change.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Long-Term Care Inflation Protection Option increases.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">No benefits are payable under this provision until benefits, if any, under the "Extension of LTC Benefits" section are no longer in effect. The sum of any benefits paid under the "Extension of LTC Benefits" section plus any benefits paid under this Rider LTC Nonforfeiture Benefit" section will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Long-Term Care Inflation Protection Option.</i></b> If you selected optional inflation protection, you can purchase a 5% compound inflation protection increase on each Policy Anniversary, with no evidence of insurability. The right to purchase the inflation protection increase in effect on the date the Policy is issued is shown on the Schedule Page. </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Every annual inflation protection increase purchased by you will be factored into the calculation of the following values: Base Maximum Monthly LTC Benefit Value, Base LTC Benefit Pool, Current Maximum Monthly LTC Benefit Value, Current LTC Benefit Pool, if any.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Starting with the first Policy Anniversary, and for as long as you continue to purchase each year's inflation protection increase, we will send you written notification regarding that year's right to purchase. You must return your request to purchase that year's inflation protection increase within the timeframe stated in the notification.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you decline to purchase any annual inflation protection increase, you will no longer have the right to purchase an inflation protection increase on any future Policy Anniversary. The right to purchase inflation protection under this rider cannot be reinstated once terminated.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The right to purchase annual inflation protection increases will continue without regard to the Insured's Attained Age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  You continue to purchase each year's inflation protection increase,</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The LTC Benefit Limit is greater than zero, and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  This rider remains in force.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Anniversary on which you do not purchase that year's inflation protection increase, the following will occur:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your right to purchase any future annual inflation protection increase will terminate, and</span></p> <div style="-keep: true"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  You will no longer be charged the optional Inflation Protection monthly LTC charge.</span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Even if your right to purchase this rider is terminated, any previously purchased increases will continue to be included in the calculation of benefits under this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Terminal Illness Accelerated Death Benefit Endorsement.</i></b> This endorsement is automatically issued with the Policy. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest. <b>If a claim is filed under this endorsement, the LTC Rider will terminate and when the benefits under the LTC Rider are being utilized (claim is filed under the LTC Rider) no claims under the Terminal Illness Accelerated Death Benefit are allowed.</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the lesser of 60% of the current face amount of the Policy or $1,000,000; minus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Lapse Protection Endorsement.</i></b> The rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule, as long as the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirement and the Policy Debt does not exceed the Cash Value.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For the Maximum Lapse Protection Period, the Policy Value at the end of this period may not be sufficient to keep the Policy in force unless additional premiums are made. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of this period. In addition, during this period any change to the </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement, will be provided to you on a supplemental Policy Schedule, along with any applicable effective date.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Minimum Monthly Requirement each month is equal to the Minimum Monthly Requirement for a given month plus the Accumulated Minimum Monthly Requirement as of the prior month ($0 for the first month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor shown in the Policy Schedule.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Net Payments Received (calculated as of the last day of the month) for each month is equal to:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year), plus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the sum of all the Lapse Protection Net Premium received since the beginning of the month, Plus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Lapse Protection Interest for the month, less</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the reduction in Policy Value for any Withdrawal taken and any applicable Surrender Charges assessed since the beginning of the month.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Lapse Protection Net Premium is the amount after deducting the Lapse Protection Premium Expense Charge for that Policy Year, as shown on the Policy Schedule, for each premium payment.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Lapse Protection Interest is calculated as:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the lesser of the Accumulated Fund Threshold and the sum of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year) PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, MULTIPLIED by the Threshold Accumulation Factor, shown in the Policy Schedule, plus</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the amount of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, in excess of the Accumulated Fund Threshold, if any, MULTIPLIED by the Excess Accumulation Factor, shown on the Policy Schedule.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Fund Threshold for the first month of a Policy Year is equal to:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Accumulated Fund Threshold for the prior month ($0 for the first month of the first Policy Year) multiplied by 1 plus the Threshold Accumulation Factor, PLUS</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Annual Threshold Premium, as shown on the Policy Schedule, for that Policy Year.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For all other months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior month multiplied buy 1 plus the Threshold Accumulation Factor.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any adjustments made due to a decrease in Face Amount, including payments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy is maintained under this endorsement, Monthly Deductions will continue.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">This endorsement terminates when the Policy terminates. If the Policy is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $250,000 Face Amount. The Policy Schedule indicates a Lapse Protection Premium Expense Charge of 1.00%, the initial Minimum Monthly Requirement is $161.88, the Threshold Accumulation Factor is 0.446150%, the Excess Accumulation Factor is 0.105844%, and an initial Threshold Premium of $5,980.25. The owner makes an initial premium payment of $200, which is an Lapse Protection Net Premium Received of $198 ($200 less 1.00%, the Lapse Protection Premium Expense Charge).</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">In the first Policy month, the Accumulated Fund Threshold ($5,980.25) is equal to the initial Threshold Premium. The Accumulated Minimum Monthly Requirement is $162.60 which is $161.88 (the initial Minimum Monthly Requirement) multiplied by 1.00446150 (one plus the Threshold Accumulation Factor). The Accumulated Net Payments Received ($198.00) is less than the Accumulated Fund Threshold ($5,980.25), so the Threshold Accumulation Factor is applied to the entire Accumulated Net Payments Received value. The Accumulated Net Payments Received in the first Policy </span></p> </div><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">month, after accumulation, is $198.88 ($198.00 multiplied by 1.00446150). Because the Accumulated Net Payments Received of $198.88 equals or exceeds the Accumulated Minimum Monthly Requirement $162.60, the conditions have been met for the first month for the rider to remain in effect guaranteeing the Policy remains in force.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Assume on each of the 23 subsequent monthly anniversaries, the owner has made premium payments of the same amount and taken no partial surrenders or Policy Loans. The total premiums paid for the Policy equals $4,800.00. The Accumulated Net Payments Received at the end of Policy month 24 is $5,026.30 and the Accumulated Minimum Monthly Requirement is $4,109.26. Because the Accumulated Net Payments Received equals or exceeds the Accumulated Minimum Monthly Requirement, the conditions have been met on this monthly anniversary day. Since the rider remains in effect, the Policy is guaranteed to remain in force. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $250,000.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Assume that starting with the 24th monthly anniversary, the owner misses the next six anticipated monthly premium payments. At the end of Policy month 30, the Accumulated Net Payments Received has accumulated to $5,162.36 while the Accumulated Minimum Monthly Requirement has accumulated to $5,207.02. Also assume that the Cash Value of the Policy is zero. Because the Accumulated Net Payments Received is less than the Accumulated Minimum Monthly Requirement, the owner must pay additional premiums within the 60-day grace period to keep the rider in effect and the Policy in force. Under these circumstances, if the insured dies outside of the 60-day grace period without having made the necessary additional premium payments, the death benefit will be $0.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Dollar-Cost Averaging</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account ("Source Sub-Account") or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29<sup>th</sup>​, 30<sup>th</sup>​, or 31<sup>st</sup>​. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate Source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Portfolio Rebalancing</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29<sup>th</sup>​, 30<sup>th</sup>​ or 31<sup>st</sup>​. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.</span></p> </div><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.</i></b></span></p><p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>TRANSFERS</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On or after the later of thirty days after the Policy Effective Date or 6 days after the 30-day cancellation period, you may, upon receipt of Written Notice in Good Order to Protective Life at the Home Office transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See "Suspension or Delay of Payments." The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Limitations on frequent transfers, including "market timing" transfers.</i></b> Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund's portfolio securities and the reflection of that change in the Fund's share price. This strategy, sometimes referred to as "market timing," involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Increased brokerage trading and transaction costs;</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Disruption of planned investment strategies;</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Forced and unplanned liquidation and portfolio turnover;</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Lost opportunity costs; and</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Large asset swings that decrease the Fund's ability to provide maximum investment return to all Policy Owners.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">In order to try to protect our Policy Owners and the Funds from the potential adverse effects of frequent transfer activity, the Company has implemented certain market timing policies and procedures (the "Market Timing Procedures"). Our Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners' beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.</span></p><div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds' policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund's investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund's refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner's transfer request. Some Funds also may impose redemption fees on short-term trading (<i>i.e.</i>, redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or tranfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Reservation of Rights</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Telephone Transfers</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.</span></p> </div><p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>SURRENDERS AND WITHDRAWALS</b></span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Surrender Privileges</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. A Surrender Charge may apply. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See "Tax Considerations.").</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Withdrawal Privileges</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge and, if applicable, a Surrender Charge, from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life's then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See "Tax Considerations."</span></p> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Rider</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.<br/>• Additional cost applies.<br/>• Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.<br/>• Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).<br/>• Benefit payments are made monthly and may not cover all long-term care expenses incurred.<br/>• If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.<br/>• If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Long-Term Care Inflation Protection Option</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• This rider must be elected at Policy issue.<br/>• Additional cost applies.<br/>• On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.<br/>• If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.</span> Terminal Illness Accelerated Death Benefit Endorsement <span style="font-size:10pt; font-family: Arial, Helvetica;">Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span> Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:<br/>• The lesser of 60% of the current face amount of the Policy or $1,000,000; minus<br/>• Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.<br/>• Minimum acceleration permitted is $15,000<br/>• The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.<br/>• Any acceleration taken will reduce the amount available for Policy Loans and withdrawals. Lapse Protection Endorsement <span style="font-size:10pt; font-family: Arial, Helvetica;">Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.<br/>• Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Dollar-Cost Averaging</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Allows for the systematic transfer of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub-Accounts.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• No transfers may be made into the Fixed Account.<br/>• Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Portfolio Rebalancing</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Optional</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Rebalancing transfers cannot be made into Fixed Account.<br/>• Minimum Variable Account Value of $100 required.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Policy Loans</b></span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Allows Owner to borrow from Policy's Cash Value.</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">Standard</span> <span style="font-size:10pt; font-family: Arial, Helvetica;">• Not available during the first Policy Year.<br/>• Maximum loan amount is 99% of Cash Value.<br/>• Minimum loan amount is $500.<br/>• Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.<br/>• If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.</span> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Long-Term Care Rider.</i></b> This rider is automatically issued with the Policy. This rider provides an acceleration of the death benefits and extended benefits under the Policy for long-term care benefits for Qualified Long-Term Care Services incurred for Home Health Care Services, Adult Day Care Services, Assisted Living Facility Services, and Nursing Home Services. You may make a claim for a Long-Term Care Benefit (the "LTC Benefit"). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met. If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">30-Day Right to Cancel</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">You have 30 days after the rider is first delivered to you to examine and return to us or to the financial professional who sold it to you, if you decide not to keep this rider. <b>We will cancel the rider and the Policy.</b> The returned Policy and rider will be treated if they had never been issued. We will refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to us, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to us.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Rider Terms</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Activities of Daily Living:</b> Means the six basic human functions necessary for a person to live independently are:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Eating</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Toileting</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Transferring oneself into or out of bed, chair, wheelchair</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Bathing</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Dressing</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Continence</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider attached to your Policy contains more detailed information about these self-care functions.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Active Claim Status:</b> Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Assistive Device:</b> Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Chronically Ill:</b> Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Sever Cognitive Impairment.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Elimination Period:</b> Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Family Member:</b> Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Hands-on Assistance:</b> Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Home:</b> Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision or Substantial Assistance with Activities of Daily Living.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Insured:</b> Means the person shown on the Policy Schedule upon whose life the Policy insures.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Licensed Health Care Practitioner:</b> Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Plan of Care:</b> Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured's needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured's care requirements.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Qualified Long-Term Care Services:</b> Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a chronically ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Severe Cognitive Impairment:</b> Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's short or long-term memory,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's orientation as to person (such as who they are), place (such as their location), or time (such as day, date, and year), and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Insured's deductive or abstract reasoning.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Standby Assistance:</b> Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Substantial Assistance:</b> Means Hands-On Assistance or Standby Assistance.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Substantial Supervision:</b> Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Written Certification:</b> Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Eligibility, Limitations, and Exclusions</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">To become eligible for the LTC Benefit payments, the following conditions must be met:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  We receive your written request for the LTC Benefit,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  A Licensed Health Care Practitioner certifies that the Insured is Chronically Ill and prescribes a Plan of Care,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Policy and this rider are in force,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The applicable Elimination Period has been satisfied,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The benefit payment is made in respect to a month when the Insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by, received from, a provider of health care services, within six months preceding the effective date of this rider.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider will not pay benefits for any Chronic Illness caused by:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Any attempt at suicide or intentionally self-inflicted injury, while sane or insane,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Committing or attempting to commit or participating in a riot, insurrection, or involvement in an illegal occupation,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Alcoholism or drug addiction, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Declared or undeclared war or any act of war.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Maximum Monthly LTC Benefit Amount</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Base Maximum Monthly LTC Benefit Amount</b> on the Policy Effective Date, is equal to the amount shown in the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the "Long-Term Care Inflation Protection Option" section and "Impact on Your Policy" section.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date and is equal to:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Base Maximum Monthly LTC Benefit Amount, plus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  80% of the result of the following:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">a)  1/48 of the Current LTC Benefit Pool minus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">b)  the Base Maximum Monthly LTC Benefit Amount</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, that amount may increase and/or decrease as described in the "Benefits While on Claim" section below.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown in the Policy Schedule.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Current LTC Benefit Pool</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Base LTC Benefit Pool,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Market Value LTC Benefit Pool, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Benefit Pool.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the "Benefits While on Claim" provision below.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Unless you have requested a decrease in the Policy's Face Amount or make a withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown in the Policy Schedule minus the sum of any LTC Benefits paid under this rider.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Base LTC Benefit Pool</b> on the Policy Effective Date, is equal to the Base LTC Benefit Pool shown in the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the "Long-Term Care Inflation Protection Option", and "Impact on Your Policy" sections.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Market Value LTC Benefit Pool</b> is equal to the Unloaned Policy Value multiplied by the Market Benefit Multiplier shown on your Policy schedule. This pool may increase or decrease daily and is adjusted as described in the "Long-Term Care Inflation Protection Option" section.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>The Protected LTC Benefit Pool</b> on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on your Policy schedule) multiplied by the Unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on your Policy schedule.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Percentage (shown on the Policy schedule) multiplied by the Unloaned Policy Value as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Protected LTC Pool in effect immediately prior to that Policy Anniversary.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to the Long-Term Care Inflation Protection Option Increases, LTC Benefit payments, withdrawals, loans, and Policy changes.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Claims Provisions</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We prefer that either you or the Insured notify us as soon as the Insured first becomes eligible and may soon need care covered by this rider. We must receive your intent to file a claim for the LTC Benefit at our Administrative Office via written request or by telephone. The Request should include at least the Insured's name, Policy number and the address to which claim forms should be sent.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">provide Written Certification and proof of loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Confirmation from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date of proof would otherwise by required.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A licensed Health Care Practitioner must re-certify that the Insured is Chronically Ill and prescribe a Plan of Care at least once every 12 months. We reserve the right to request a re-certification that the Insured remains Chronically Ill, but not more often than every 90 days, following an initial certification. The practitioner should either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification. After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be conducted until the 90-day period has passed.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agree upon by the Insured and us. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Accumulation Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If, on the date your claim is closed, the Policy's Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as in the Maximum Monthly LTC Benefit Amount and Current LTC Benefit Pool section above, but will be floored at the amounts during claim.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issues. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Extension of LTC Benefits</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The death of the Insured,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Transition from Active Claim Status has completed, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Maximum LTC Benefit Pool has been exhausted.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any extension of benefit is subject to all terms and conditions of this rider including eligibility for LTC Benefits and claim requirements. If the current maximum LTC benefit pool has been exhausted, no death benefit will be due upon the death of the Insured.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Benefits While on Claim</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date. Also, on the date a claim under this rider is approved, </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">we will automatically transfer out any Variable Account Value and transfer to the Fixed Account. See "Impact on Your Policy" below for additional information.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any amounts paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If purchased, the Long-term Care Inflation Protection Option increase will increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Long-Term Care Inflation Protection Option" section.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">An increase and/or decrease in the Policy's Face Amount or a Withdrawal under the Policy will likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Impact on Your Policy" section.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If your claim is closed, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the "Current LTC Benefit Pool" and "Maximum Monthly LTC Benefit Amount" sections, but will be floored at the amounts during claim.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Impact on Your Policy</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Automatic Transfer to Fixed Account.</i> On the date a claim under this rider is approved, we will automatically transfer any Variable Account Value out of the Sub-Accounts and transfer into the Fixed Account. While this rider is in Active Claim Status, no transfers out of the Fixed Account into Sub-Accounts will be permitted. In addition, Net Premiums received during this period will be allocated to the Fixed Account.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>LTC Benefit Payments.</i> While Policy Value is greater than zero, LTC Benefit payments will reduce the Policy Value dollar for dollar and will be taken from the Fixed Account.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>LTC Benefit Payments on Face Amount.</i> While the Policy's Face Amount is greater than zero, benefit payments under this rider will reduce the Policy's Face Amount dollar for dollar. This may reduce the Policy's Face Amount below the minimum.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Monthly Deductions.</i> When this rider is in Active Claim Status, Monthly Deductions required to maintain the Policy continue, however the LTC Rider Monthly Charge is waived.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Policy Changes, Loans, and Withdrawals.</i> When the rider is in Active Claim Status, Policy Changes, Loans, and withdrawals are not permitted.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Interaction with Terminal Illness Accelerated Death Benefit Endorsement.</i> Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under this endorsement.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i>Residual Death Benefit.</i> If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  $10,000.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Protection Against Unintended Lapse</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">To protect against unintended lapse, you may designate at least one person, other than the Owner, to receive notices about potential lapse or Policy termination due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the third-party for services provided to the Insured.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Termination</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The rider will terminate on the earliest of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your written notice to terminate this rider. If you request to terminate this rider the Policy to which it is attached will also be terminated. We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Policy termination,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Failure to pay sufficient premium to maintain the rider,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Death of the Insured,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness or rider attached to the Policy,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date that the Maximum LTC Benefit is exhausted, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Reinstatement</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy terminates and is subsequently reinstated, this rider may also be reinstated subject to the terms and conditions for reinstatement in the Policy. Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">We will reinstate the Policy and this rider without evidence of insurability, if we receive:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The Owner's written request within 5 months after the end of the Grace Period,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Due proof that is satisfactory to us that the Insured was Chronically Ill at the end of the Grace Period outlined in the Policy, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Payment of overdue premium and/or charges for this rider.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><span style="text-decoration:underline">Rider LTC Nonforfeiture Benefit</span></i></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">After the Policy and this rider have been In Force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The death of the Insured, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The date the LTC Nonforfeiture Benefit Limit has been reduced to zero.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  One month's Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates, or</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  An amount equal to the sum of Monthly rider Charges paid for this rider.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider Lapses or terminates, and will not change.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Long-Term Care Inflation Protection Option increases.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">No benefits are payable under this provision until benefits, if any, under the "Extension of LTC Benefits" section are no longer in effect. The sum of any benefits paid under the "Extension of LTC Benefits" section plus any benefits paid under this Rider LTC Nonforfeiture Benefit" section will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Long-Term Care Inflation Protection Option.</i></b> If you selected optional inflation protection, you can purchase a 5% compound inflation protection increase on each Policy Anniversary, with no evidence of insurability. The right to purchase the inflation protection increase in effect on the date the Policy is issued is shown on the Schedule Page. </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Every annual inflation protection increase purchased by you will be factored into the calculation of the following values: Base Maximum Monthly LTC Benefit Value, Base LTC Benefit Pool, Current Maximum Monthly LTC Benefit Value, Current LTC Benefit Pool, if any.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Starting with the first Policy Anniversary, and for as long as you continue to purchase each year's inflation protection increase, we will send you written notification regarding that year's right to purchase. You must return your request to purchase that year's inflation protection increase within the timeframe stated in the notification.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you decline to purchase any annual inflation protection increase, you will no longer have the right to purchase an inflation protection increase on any future Policy Anniversary. The right to purchase inflation protection under this rider cannot be reinstated once terminated.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The right to purchase annual inflation protection increases will continue without regard to the Insured's Attained Age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  You continue to purchase each year's inflation protection increase,</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  The LTC Benefit Limit is greater than zero, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  This rider remains in force.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">On the Policy Anniversary on which you do not purchase that year's inflation protection increase, the following will occur:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  Your right to purchase any future annual inflation protection increase will terminate, and</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  You will no longer be charged the optional Inflation Protection monthly LTC charge.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Even if your right to purchase this rider is terminated, any previously purchased increases will continue to be included in the calculation of benefits under this rider.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Terminal Illness Accelerated Death Benefit Endorsement.</i></b> This endorsement is automatically issued with the Policy. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest. <b>If a claim is filed under this endorsement, the LTC Rider will terminate and when the benefits under the LTC Rider are being utilized (claim is filed under the LTC Rider) no claims under the Terminal Illness Accelerated Death Benefit are allowed.</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the lesser of 60% of the current face amount of the Policy or $1,000,000; minus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Lapse Protection Endorsement.</i></b> The rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule, as long as the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirement and the Policy Debt does not exceed the Cash Value.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For the Maximum Lapse Protection Period, the Policy Value at the end of this period may not be sufficient to keep the Policy in force unless additional premiums are made. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of this period. In addition, during this period any change to the </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement, will be provided to you on a supplemental Policy Schedule, along with any applicable effective date.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Minimum Monthly Requirement each month is equal to the Minimum Monthly Requirement for a given month plus the Accumulated Minimum Monthly Requirement as of the prior month ($0 for the first month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor shown in the Policy Schedule.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Net Payments Received (calculated as of the last day of the month) for each month is equal to:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year), plus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the sum of all the Lapse Protection Net Premium received since the beginning of the month, Plus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Lapse Protection Interest for the month, less</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the reduction in Policy Value for any Withdrawal taken and any applicable Surrender Charges assessed since the beginning of the month.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Lapse Protection Net Premium is the amount after deducting the Lapse Protection Premium Expense Charge for that Policy Year, as shown on the Policy Schedule, for each premium payment.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Lapse Protection Interest is calculated as:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the lesser of the Accumulated Fund Threshold and the sum of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year) PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, MULTIPLIED by the Threshold Accumulation Factor, shown in the Policy Schedule, plus</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the amount of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, in excess of the Accumulated Fund Threshold, if any, MULTIPLIED by the Excess Accumulation Factor, shown on the Policy Schedule.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The Accumulated Fund Threshold for the first month of a Policy Year is equal to:</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Accumulated Fund Threshold for the prior month ($0 for the first month of the first Policy Year) multiplied by 1 plus the Threshold Accumulation Factor, PLUS</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">•  the Annual Threshold Premium, as shown on the Policy Schedule, for that Policy Year.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">For all other months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior month multiplied buy 1 plus the Threshold Accumulation Factor.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Any adjustments made due to a decrease in Face Amount, including payments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If the Policy is maintained under this endorsement, Monthly Deductions will continue.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">This endorsement terminates when the Policy terminates. If the Policy is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $250,000 Face Amount. The Policy Schedule indicates a Lapse Protection Premium Expense Charge of 1.00%, the initial Minimum Monthly Requirement is $161.88, the Threshold Accumulation Factor is 0.446150%, the Excess Accumulation Factor is 0.105844%, and an initial Threshold Premium of $5,980.25. The owner makes an initial premium payment of $200, which is an Lapse Protection Net Premium Received of $198 ($200 less 1.00%, the Lapse Protection Premium Expense Charge).</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">In the first Policy month, the Accumulated Fund Threshold ($5,980.25) is equal to the initial Threshold Premium. The Accumulated Minimum Monthly Requirement is $162.60 which is $161.88 (the initial Minimum Monthly Requirement) multiplied by 1.00446150 (one plus the Threshold Accumulation Factor). The Accumulated Net Payments Received ($198.00) is less than the Accumulated Fund Threshold ($5,980.25), so the Threshold Accumulation Factor is applied to the entire Accumulated Net Payments Received value. The Accumulated Net Payments Received in the first Policy </span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">month, after accumulation, is $198.88 ($198.00 multiplied by 1.00446150). Because the Accumulated Net Payments Received of $198.88 equals or exceeds the Accumulated Minimum Monthly Requirement $162.60, the conditions have been met for the first month for the rider to remain in effect guaranteeing the Policy remains in force.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Assume on each of the 23 subsequent monthly anniversaries, the owner has made premium payments of the same amount and taken no partial surrenders or Policy Loans. The total premiums paid for the Policy equals $4,800.00. The Accumulated Net Payments Received at the end of Policy month 24 is $5,026.30 and the Accumulated Minimum Monthly Requirement is $4,109.26. Because the Accumulated Net Payments Received equals or exceeds the Accumulated Minimum Monthly Requirement, the conditions have been met on this monthly anniversary day. Since the rider remains in effect, the Policy is guaranteed to remain in force. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $250,000.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Assume that starting with the 24th monthly anniversary, the owner misses the next six anticipated monthly premium payments. At the end of Policy month 30, the Accumulated Net Payments Received has accumulated to $5,162.36 while the Accumulated Minimum Monthly Requirement has accumulated to $5,207.02. Also assume that the Cash Value of the Policy is zero. Because the Accumulated Net Payments Received is less than the Accumulated Minimum Monthly Requirement, the owner must pay additional premiums within the 60-day grace period to keep the rider in effect and the Policy in force. Under these circumstances, if the insured dies outside of the 60-day grace period without having made the necessary additional premium payments, the death benefit will be $0.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Dollar-Cost Averaging</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account ("Source Sub-Account") or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29<sup>th</sup>​, 30<sup>th</sup>​, or 31<sup>st</sup>​. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate Source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.</span></p> <p style="margin:4pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Portfolio Rebalancing</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29<sup>th</sup>​, 30<sup>th</sup>​ or 31<sup>st</sup>​. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b><i>Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.</i></b></span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Reservation of Rights</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.</span></p> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>Telephone Transfers</b></span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.</span></p> <div style="margin:8pt 0pt 8pt 0pt;"> <p style="margin:0pt 0pt 6pt 0pt; text-align: center;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><b>APPENDIX:<br/>FUNDS AVAILABLE UNDER THE POLICY</b></span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.</span></p> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund's past performance is not necessarily an indication of future performance.</span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:8pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Asset Allocation Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.24</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Global Growth Fund - Class 1 - Capital Research and Management Company<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.40</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">21.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Growth Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.33</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">20.54</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.66</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Growth-Income Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.28</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.37</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.19</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ New World Fund<sup>®</sup>​ - Class 1 - Capital Research and Management Company<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">28.60</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.53</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.23</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">-0.17</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.38</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Small Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">36.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.89</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Value Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.27</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">45.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA U.S. Large Value Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.21</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.83</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table> </div><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.55</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.12</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Growth Opportunities Portfolio - Initial Class - <i>FMR Investment Management (UK) </i>Limited;<i> Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.56</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">22.02</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.94</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.09</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">17.78</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.70</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Investment Grade Bond Portfolio - Initial Class - <i>FMR Investment Management (UK) Limited; Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.37</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.22</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.06</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.71</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Mid Cap Portfolio - Initial Class - <i>FMR Investment Management (UK) Limited; Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.55</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.75</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Franklin Growth and Income VIP Fund - Class 1<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Franklin Income VIP Fund - Class 1</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.47</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.87</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.92</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Goldman Sachs VIT Core Fixed Income Fund - Institutional Class<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.42</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">-0.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Goldman Sachs VIT Mid Cap Value Fund - Institutional Class<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.02</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Diversified Dividend Fund - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.74</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Global Fund - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.32</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.28</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.00</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Money Market</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. U.S. Government Money Portfolio - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.67</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.76</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table> </div><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.33</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.72</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.34</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.06</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.94</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.04</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.83</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.40</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.91</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.58</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Putnam VT Sustainable Leaders Fund - Class IA - <i>Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.63</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.62</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Royce Capital Small-Cap Portfolio - Investment Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.93</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.66</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.88</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="-keep: true"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Templeton Emerging Markets VIP Fund - Class 1 <i>(formerly, Templeton Developing Markets VIP Fund)</i></span> </span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.12</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">46.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.73</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management, LLC</i> (formerly, TOPS<sup>®</sup>​ Aggressive Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.17</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.69</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.71</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.61</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.25</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC </i>(formerly, TOPS<sup>®</sup>​ Moderate Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table> </div><div style="margin:8pt 0pt 8pt 0pt;"> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC</i> (formerly, TOPS<sup>®</sup>​ Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.79</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.32</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.96</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.62</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.48</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.34</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">28.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.96</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Sector Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - Real Estate Index Portfolio</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.08</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard<sup>®</sup>​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.14</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">6.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.23</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table> <p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.</i></span></p> </div> <p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.</span></p><p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;">The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund's past performance is not necessarily an indication of future performance.</span></p> <table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:8pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Asset Allocation Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.24</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Global Growth Fund - Class 1 - Capital Research and Management Company<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.40</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">21.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Growth Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.33</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">20.54</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.66</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ Growth-Income Fund - Class 1 - Capital Research and Management Company</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.28</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.37</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.19</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">American Funds Insurance Series<sup>®</sup>​ New World Fund<sup>®</sup>​ - Class 1 - Capital Research and Management Company<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">28.60</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.53</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.23</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">-0.17</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.38</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Small Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">36.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.89</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Value Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.27</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">45.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA U.S. Large Value Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.21</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.83</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">% </span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.55</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.12</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Growth Opportunities Portfolio - Initial Class - <i>FMR Investment Management (UK) </i>Limited;<i> Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.56</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">22.02</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.94</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.09</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">17.78</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.70</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Investment Grade Bond Portfolio - Initial Class - <i>FMR Investment Management (UK) Limited; Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.37</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.22</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.06</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.71</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Fidelity<sup>®</sup>​ VIP Mid Cap Portfolio - Initial Class - <i>FMR Investment Management (UK) Limited; Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.55</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.75</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Franklin Growth and Income VIP Fund - Class 1<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Franklin Income VIP Fund - Class 1</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.47</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.87</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.92</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Goldman Sachs VIT Core Fixed Income Fund - Institutional Class<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.42</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.46</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">-0.57</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Goldman Sachs VIT Mid Cap Value Fund - Institutional Class<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.02</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Diversified Dividend Fund - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.74</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Global Fund - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.81</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.32</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.28</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.00</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Money Market</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. U.S. Government Money Portfolio - Series I</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.67</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.76</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.33</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.72</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC<sup>(1)</sup>​</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.34</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.06</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.94</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.10</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.04</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.83</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.40</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.91</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Management Company LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.58</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.05</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.16</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Putnam VT Sustainable Leaders Fund - Class IA - <i>Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.63</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.99</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.62</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.98</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Royce Capital Small-Cap Portfolio - Investment Class</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.18</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.93</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.66</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.88</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="-keep: true"> <span style="font-size:10pt; font-family: Arial, Helvetica;">Templeton Emerging Markets VIP Fund - Class 1 <i>(formerly, Templeton Developing Markets VIP Fund)</i></span> </span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">1.12</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">46.64</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.73</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.68</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management, LLC</i> (formerly, TOPS<sup>®</sup>​ Aggressive Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.17</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.69</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.71</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC</i></span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.39</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.61</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.25</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC </i>(formerly, TOPS<sup>®</sup>​ Moderate Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">15.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">7.20</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table><table border="0" cellpadding="0" style="border-spacing: 0px;" width="100%"> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Asset<br/>Allocation</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Fund - Investment Adviser;</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Current</b></span></p> </td> <td colspan="1"> </td> <td colspan="11" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 243px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Average Annual Total Returns<br/><i>(as of 12/31/2025)</i></b></span> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 102px; text-align: center;" valign="bottom"> <span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Type</b></span> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 852px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b><i>Sub-Adviser(s), as applicable</i></b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>Expenses</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>1 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>5 year</b></span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:8pt; font-family: Arial, Helvetica;"><b>10 year</b></span></p> </td> <td colspan="1"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Allocation</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <span style="font-size:10pt; font-family: Arial, Helvetica;">TOPS<sup>®</sup>​ Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <i>Milliman Financial Risk Management LLC</i> (formerly, TOPS<sup>®</sup>​ Growth ETF Portfolio)</span> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">18.31</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">8.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">9.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.29</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">16.79</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">12.59</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">11.51</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">International Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.32</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">19.96</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.62</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">10.48</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">U.S. Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.34</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">28.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">13.97</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">14.96</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Sector Equity</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - Real Estate Index Portfolio</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.26</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">3.11</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">4.50</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">5.08</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> <tr> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 102px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Taxable Bond</span></p> </td> <td colspan="1"> </td> <td colspan="3" style="padding:6.5pt .7pt 6pt 0pt; width: 852px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt"><span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard<sup>®</sup>​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio</span></p> </td> <td colspan="1"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 53px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">0.14</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">6.85</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 41px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.23</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 27px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 8px;" valign="top"> <span style="-keep: true"> </span> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 43px; text-align: right;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">2.80</span></p> </td> <td colspan="1" style="padding:6.5pt .7pt 6pt 0pt; width: 24px; text-align: left;" valign="top"> <p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><span style="font-size:10pt; font-family: Arial, Helvetica;">%</span></p> </td> <td colspan="1" style="width: 8px;"> </td> </tr> </table><p style="margin:6pt 0pt 6pt 0pt; text-align: left;"><span style="font-size:10pt; font-family: Arial, Helvetica;"><i><sup>(1)</sup>​  These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.</i></span></p> American Funds Insurance Series<sup>®</sup>​ Asset Allocation Fund - Class 1 Capital Research and Management Company 0.0029 0.1616 0.0924 0.1005 American Funds Insurance Series<sup>®</sup>​ Global Growth Fund - Class 1 Capital Research and Management Company 0.004 0.2198 0.0851 0.1246 American Funds Insurance Series<sup>®</sup>​ Growth Fund - Class 1 Capital Research and Management Company 0.0033 0.2054 0.1366 0.1826 American Funds Insurance Series<sup>®</sup>​ Growth-Income Fund - Class 1 Capital Research and Management Company 0.0028 0.1837 0.1419 0.142 American Funds Insurance Series<sup>®</sup>​ New World Fund<sup>®</sup>​ - Class 1 Capital Research and Management Company 0.0057 0.286 0.0559 0.0953 ClearBridge Variable Small Cap Growth Portfolio - Class I Franklin Templeton Fund Adviser, LLC 0.0081 0.0923 -0.0017 0.0938 <span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Small Portfolio - Institutional Class</span> 0.0039 0.3699 0.0889 0.0868 <span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA International Value Portfolio - Institutional Class</span> 0.0027 0.4564 0.1585 0.1046 <span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VA U.S. Large Value Portfolio - Institutional Class</span> 0.0021 0.1583 0.1197 0.1051 <span style="font-size:10pt; font-family: Arial, Helvetica;">Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class</span> 0.0011 0.0755 0.0105 0.0312 Fidelity<sup>®</sup>​ VIP Growth Opportunities Portfolio - Initial Class <i>FMR Investment Management (UK) </i>Limited Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd 0.0056 0.2202 0.1131 0.1994 Fidelity<sup>®</sup>​ VIP Index 500 Portfolio - Initial Class Geode Capital Management, LLC 0.0009 0.1778 0.1431 0.147 Fidelity<sup>®</sup>​ VIP Investment Grade Bond Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd 0.0037 0.0722 0.0006 0.0271 Fidelity<sup>®</sup>​ VIP Mid Cap Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management &amp; Research (Japan) Limited; Fidelity Management &amp; Research (Hong Kong) Ltd 0.0055 0.1175 0.101 0.1059 Franklin Growth and Income VIP Fund - Class 1 0.0059 0.1698 0.1216 0.1139 <span style="font-size:10pt; font-family: Arial, Helvetica;">Franklin Income VIP Fund - Class 1</span> 0.0047 0.1287 0.0792 0.0757 Goldman Sachs VIT Core Fixed Income Fund - Institutional Class 0.0042 0.0746 -0.0057 0.0211 Goldman Sachs VIT Mid Cap Value Fund - Institutional Class 0.0081 0.0939 0.1005 0.1002 <span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Diversified Dividend Fund - Series I</span> 0.0068 0.1574 0.1081 0.092 <span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. Global Fund - Series I</span> 0.0081 0.1532 0.0728 0.11 <span style="font-size:10pt; font-family: Arial, Helvetica;">Invesco<sup>®</sup>​ V.I. U.S. Government Money Portfolio - Series I</span> 0.0067 0.0364 0.028 0.0176 <span style="font-size:10pt; font-family: Arial, Helvetica;">Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC</span> 0.0098 0.0833 0.021 0.0472 Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC 0.0099 0.1598 0.1234 0.1306 PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class Pacific Investment Management Company LLC 0.0094 0.041 0.0118 0.0304 PIMCO VIT Short-Term Portfolio - Institutional Class Pacific Investment Management Company LLC 0.005 0.0483 0.034 0.0291 PIMCO VIT Total Return Portfolio - Institutional Class Pacific Investment Management Company LLC 0.0058 0.0905 0.0016 0.0251 Putnam VT Sustainable Leaders Fund - Class IA Franklin Advisers, Inc Franklin Templeton Investments Management Limited 0.0063 0.1099 0.1062 0.1498 <span style="font-size:10pt; font-family: Arial, Helvetica;">Royce Capital Small-Cap Portfolio - Investment Class</span> 0.0118 0.0893 0.1066 0.0788 <span style="font-size:10pt; font-family: Arial, Helvetica;">Templeton Emerging Markets VIP Fund - Class 1 <i>(formerly, Templeton Developing Markets VIP Fund)</i></span> 0.0112 0.4664 0.0573 0.1068 TOPS<sup>®</sup>​ Aggressive ETF Portfolio - Class 1 Valmark Advisers, Inc. <i>Milliman Financial Risk Management, LLC</i> (formerly, TOPS<sup>®</sup>​ Aggressive Growth ETF Portfolio) 0.0029 0.1917 0.0969 0.1071 TOPS<sup>®</sup>​ Conservative ETF Portfolio - Class 1 Valmark Advisers, Inc. <i>Milliman Financial Risk Management LLC</i> 0.0031 0.1039 0.0461 0.0525 TOPS<sup>®</sup>​ Moderate ETF Portfolio - Class 1 Valmark Advisers, Inc. <i>Milliman Financial Risk Management LLC </i>(formerly, TOPS<sup>®</sup>​ Moderate Growth ETF Portfolio) 0.0029 0.155 0.072 0.0826 TOPS<sup>®</sup>​ Moderately Aggressive ETF Portfolio - Class 1 Valmark Advisers, Inc. <i>Milliman Financial Risk Management LLC</i> (formerly, TOPS<sup>®</sup>​ Growth ETF Portfolio) 0.0029 0.1831 0.0885 0.098 Vanguard Variable Insurance Funds - Equity Income Portfolio Wellington Management Company, LLP and Vanguard Portfolio Management, LLC 0.0029 0.1679 0.1259 0.1151 Vanguard Variable Insurance Funds - International Portfolio Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc. 0.0032 0.1996 0.0062 0.1048 <span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)</span> 0.0034 0.2897 0.1397 0.1496 <span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard Variable Insurance Funds - Real Estate Index Portfolio</span> 0.0026 0.0311 0.045 0.0508 <span style="font-size:10pt; font-family: Arial, Helvetica;">Vanguard<sup>®</sup>​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio</span> 0.0014 0.0685 0.0223 0.028 These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year. N-6/A 0000948923 false As a percentage of Fund assets. The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus. Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction". See definition of Net Amount at Risk in the Special Terms. We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived. The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed). As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death. The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses. These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year. XML 48 R1.htm IDEA: XBRL DOCUMENT v3.26.1
    N-6
    Apr. 24, 2026
    USD ($)
    Prospectus:  
    Document Type N-6/A
    Entity Registrant Name Protective Variable Life Separate Account
    Entity Central Index Key 0000948923
    Entity Investment Company Type N-6
    Document Period End Date Apr. 24, 2026
    Amendment Flag false
    Item 2. Key Information [Line Items]  
    Fees and Expenses [Text Block]

    FEES AND EXPENSES

     

    Charges for Early Withdrawals

      If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.
    If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.80% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,800.
    For additional information about charges for surrenders and early withdrawals, see "CHARGES AND DEDUCTIONS" in the Prospectus.
     

    Transaction Charges

      In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy's Face Amount and transfer fees.
    For additional information about transaction charges, see "CHARGES AND DEDUCTIONS" in the Prospectus.
     
    Ongoing Fees and Expenses (annual
    charges)
      In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance ("COI") under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.
    You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:
     

              

     

    Annual Fee

     

    Minimum

     

    Maximum

     

              

      Fund Options
    (Fund fees and expenses)(1)
     
    0.09%
     
    1.18%
     

              

     

    (1)​ As a percentage of Fund assets.

     
       

    For additional information about ongoing fees and expenses, see "CHARGES AND DEDUCTIONS" in the Prospectus.

     
    Charges for Early Withdrawals [Text Block]

    Charges for Early Withdrawals

      If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25.
    If you surrender the Policy within the first 14 Policy Years, you will be subject to a surrender charge of up to 5.80% of your Initial Face Amount. For example, if you surrender your Policy in the first Policy Year and the Initial Face Amount was $100,000, you could pay a surrender charge of up to $5,800.
    For additional information about charges for surrenders and early withdrawals, see "CHARGES AND DEDUCTIONS" in the Prospectus.
    Surrender Charge Phaseout Period, Years 14
    Surrender Charge (of Purchase Payments) Maximum [Percent] 5.80%
    Surrender Charge Example Maximum [Dollars] $ 5,800
    Transaction Charges [Text Block]

    Transaction Charges

      In addition to withdrawal and surrender charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy, charges in connection with a decrease to your Policy's Face Amount and transfer fees.
    For additional information about transaction charges, see "CHARGES AND DEDUCTIONS" in the Prospectus.
    Ongoing Fees and Expenses [Table Text Block]
    Ongoing Fees and Expenses (annual
    charges)
      In addition to surrender charges and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, including fees and expenses covering the cost of insurance ("COI") under the Policy, administration, mortality and expense risk, loans and the cost of optional benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy.
    You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:
     

              

     

    Annual Fee

     

    Minimum

     

    Maximum

     

              

      Fund Options
    (Fund fees and expenses)(1)
     
    0.09%
     
    1.18%
     

              

     

    (1)​ As a percentage of Fund assets.

     
       

    For additional information about ongoing fees and expenses, see "CHARGES AND DEDUCTIONS" in the Prospectus.

     
    Investment Options (of Average Annual Net Assets) Minimum [Percent] 0.09% [1]
    Investment Options (of Average Annual Net Assets) Maximum [Percent] 1.18% [1]
    Investment Options Footnotes [Text Block] As a percentage of Fund assets.
    Risks [Table Text Block]

    RISKS

     

    Risk of Loss

      You can lose money by investing in this Policy, including loss of principal.
    For additional information about the risk of loss, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" in the Prospectus.
     

    Not a Short-Term Investment

      The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.
    For additional information about the investment profile of the Policy, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "CHARGES AND DEDUCTIONS," "USE OF THE POLICY" and "TAX CONSIDERATIONS — Taxation of Insurance Polices" in the Prospectus.
     
    Risks Associated with Investment
    Options
      An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.
    For additional information about the risks associated with Investment Options, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "THE COMPANY AND THE FIXED ACCOUNT," "THE VARIABLE ACCOUNT AND THE FUNDS" and "FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY" in the Prospectus.
     

    Insurance Company Risks

      An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.
    For additional information about Company risks, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" and "THE COMPANY AND THE FIXED ACCOUNT" in the Prospectus.
     

    Policy Lapse

      Your Policy could terminate if the value of your Policy becomes too low to support the Policy's monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.
    For additional information about Policy Lapse, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "PREMIUMS," "LOANS," and "LAPSE AND REINSTATEMENT" in the Prospectus.
     
    Investment Restrictions [Text Block]

    Investments

      While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing polices described in the Prospectus.
    We reserve the right to remove or substitute Funds as investment options.
    For additional information about Investment Options, see "TRANSFERS" and "ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS" in the Prospectus.
    Optional Benefit Restrictions [Text Block]

    Optional Benefits

      Optional benefits, including Policy loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy's Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.
    For additional information about the optional benefits, see "OTHER BENEFITS AVAILABLE UNDER THE POLICY" and "SUPPLEMENTAL RIDERS AND ENDORSEMENTS" in the Prospectus.
    Tax Implications [Text Block]

    Tax Implications

      You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.
    For additional information about tax implications, see "TAX CONSIDERATIONS" in the Prospectus.
    Investment Professional Compensation [Text Block] Investment Professional
    Compensation
      Some investment professionals have and may receive compensation for selling the Policy to investors, which may include commissions, revenue sharing, and compensation from affiliates and third parties. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment.
    For additional information about compensation, see "SALE OF THE POLICIES" in the Prospectus.
    Exchanges [Text Block]

    Exchanges

      Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy.
    For additional information about exchanges, see "TAX CONSIDERATIONS — Section 1035 Exchanges" in the Prospectus.
    Item 4. Fee Table [Text Block]

    FEE TABLE

    The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).

    The first table describes the fees and expenses that you will pay at the time that you pay premiums, surrender the Policy, allow the Policy to Lapse, decrease the Initial Face Amount, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals.

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Premium Expense Charge:

     

    Upon receipt of each premium payment

     

    5% of each premium payment

     

    3.5% of each premium payment

     

    Surrender Charge:(1)

                 

    Minimum and Maximum Charge

     

    At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

     

    $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Charge for a 49 year old male in the standard unismoke class during the first Policy Year

     

    At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

     

    $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    (1)​  The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Transfer Fee:(2)

     

    Upon each transfer in excess of 12 in a Policy Year

      $25 per transfer   $0 per transfer  

    Withdrawal Charge:

     

    At the time of each withdrawal of Policy Value

     

    The lesser of 2.0% of the amount withdrawn or $25

     

    The lesser of 2.0% of the amount withdrawn or $25

     

    (2)​  Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.

    The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds' fees and expenses.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Base Contract Charge:

                 

    Cost of Insurance:(1)(2)

                 

    Minimum and Maximum Charge

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.01 – $83.33 per $1,000 of Net Amount at Risk(2)

     

    $0.00 – $70.46 per $1,000 of Net Amount at Risk(2)

     

    Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.23 per $1,000 of Net Amount at Risk

     

    $0.03 per $1,000 of Net Amount at Risk

     

    (1)​  Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges

    shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".

    (2)​  See definition of Net Amount at Risk in the Special Terms.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Mortality and Expense Risk Charge:

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount

     

    0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.

     

    Standard Administrative Fee:

     

    On the Policy Effective Date and each Monthly Anniversary Day

      $9.00   $9.00  

    Administrative Charge:(3)

                 

    Minimum and Maximum Charge

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.36 – $3.89 per $1,000 of Initial Face Amount

     

    $0.29 – $2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16 – $1.46 per $1,000 of Initial Face Amount thereafter

     

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $1.11 per $1,000 of Initial Face Amount

     

    $0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter

     

    (3)​  We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Administrative Charge For Face Amount Increases:(4)

                 

    Minimum and Maximum Charge

     

    On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

     

    $1.95 – $4.95 per $1,000 of any increase in Face Amount

     

    $1.95 – $4.95 per $1,000 of any increase in Face Amount

     

    Charge for a 49 year old male in the standard unismoke rate class

     

    On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

     

    $3.45 per $1,000 of any increase in Face Amount

     

    $3.45 per $1,000 of any increase in Face Amount

     

    Long-Term Care Rider Charge:(5)

                 

    Minimum and Maximum Charge

     

    On each Monthly Anniversary Day starting from the Effective Date

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

     

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000

     

    On each Monthly Anniversary Day starting from the Effective Date

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

     

    (4)​  The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    (5)  ​The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Optional Benefit Charges:

                 

    Long-Term Care Inflation Protection Option(#)

     

    On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

     

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Net Cost of Loans(6)

     

    On each Policy Anniversary, as applicable(7)

     

    2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.

     

    2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter

     

    (6)​  The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).

    (7)​  As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.

    Periodic Charges Other Than Series Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Lapse Protection Endorsement

                 

    Minimum and Maximum Charge

     

    Upon receipt of each premium payment

     

    1% of each premium payment

     

    1% of each premium payment

     

    ANNUAL FUND EXPENSES

    The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See "FUND APPENDIX — FUNDS AVAILABLE UNDER THE POLICY".

    ANNUAL FUND EXPENSES

       

    Minimum

         

    Maximum

     
    Total Annual Fund Expenses
    (expenses that are deducted from Fund assets,
    including management fees, distribution and/or
    service 12b-1 fees, and other expenses)
     

    0.09

    %

     

     

    1.18

    %(1)

     

    (1)​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.

    Transaction Expenses [Table Text Block]

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Premium Expense Charge:

     

    Upon receipt of each premium payment

     

    5% of each premium payment

     

    3.5% of each premium payment

     

    Surrender Charge:(1)

                 

    Minimum and Maximum Charge

     

    At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

     

    $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    $3.00 – $57.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Charge for a 49 year old male in the standard unismoke class during the first Policy Year

     

    At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years

     

    $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    $40.75 per $1,000 of Initial Face Amount or decrease in Initial Face Amount, as applicable

     

    (1)​  The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    Transaction Fees

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Transfer Fee:(2)

     

    Upon each transfer in excess of 12 in a Policy Year

      $25 per transfer   $0 per transfer  

    Withdrawal Charge:

     

    At the time of each withdrawal of Policy Value

     

    The lesser of 2.0% of the amount withdrawn or $25

     

    The lesser of 2.0% of the amount withdrawn or $25

     

    (2)​  Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.

    Premium Taxes, Description [Text Block] Premium Expense Charge:
    Premium Taxes, When Deducted [Text Block] Upon receipt of each premium payment
    Premium Taxes (of Premium Payments), Maximum [Percent] 5.00%
    Premium Taxes (of Premium Payments), Current [Percent] 3.50%
    Other Surrender Fees, Description [Text Block] Surrender Charge: [2]
    Other Surrender Fees, When Deducted [Text Block] At the time of any (i) surrender; Lapse; or (ii) decrease in the Initial Face Amount which may occur if a withdrawal is made during the first 14 Policy Years [2]
    Other Surrender Fees, Maximum [Dollars] $ 57.75 [2]
    Other Surrender Fees, Minimum [Dollars] $ 3 [2]
    Other Surrender Fees, Footnotes [Text Block] The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
    Transfer Fees, Description [Text Block] Transfer Fee: [3]
    Transfer Fees, When Deducted [Text Block] Upon each transfer in excess of 12 in a Policy Year [3]
    Transfer Fee, Maximum [Dollars] $ 25 [3]
    Transfer Fee, Current [Dollars] $ 0 [3]
    Transfer Fee, Footnotes [Text Block] Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.
    Other Transaction Fee, Description [Text Block] Standard Administrative Fee:
    Other Transaction Fee, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day
    Other Transaction Fee, Maximum [Dollars] $ 9
    Other Transaction Fee, Current [Dollars] $ 9
    Periodic Charges [Table Text Block]

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Base Contract Charge:

                 

    Cost of Insurance:(1)(2)

                 

    Minimum and Maximum Charge

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.01 – $83.33 per $1,000 of Net Amount at Risk(2)

     

    $0.00 – $70.46 per $1,000 of Net Amount at Risk(2)

     

    Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.23 per $1,000 of Net Amount at Risk

     

    $0.03 per $1,000 of Net Amount at Risk

     

    (1)​  Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges

    shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".

    (2)​  See definition of Net Amount at Risk in the Special Terms.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Mortality and Expense Risk Charge:

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    0.05% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount

     

    0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.

     

    Standard Administrative Fee:

     

    On the Policy Effective Date and each Monthly Anniversary Day

      $9.00   $9.00  

    Administrative Charge:(3)

                 

    Minimum and Maximum Charge

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.36 – $3.89 per $1,000 of Initial Face Amount

     

    $0.29 – $2.72 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.16 – $1.46 per $1,000 of Initial Face Amount thereafter

     

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $1.11 per $1,000 of Initial Face Amount

     

    $0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter

     

    (3)​  We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Administrative Charge For Face Amount Increases:(4)

                 

    Minimum and Maximum Charge

     

    On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

     

    $1.95 – $4.95 per $1,000 of any increase in Face Amount

     

    $1.95 – $4.95 per $1,000 of any increase in Face Amount

     

    Charge for a 49 year old male in the standard unismoke rate class

     

    On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

     

    $3.45 per $1,000 of any increase in Face Amount

     

    $3.45 per $1,000 of any increase in Face Amount

     

    Long-Term Care Rider Charge:(5)

                 

    Minimum and Maximum Charge

     

    On each Monthly Anniversary Day starting from the Effective Date

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.05 – $2.07

     

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000

     

    On each Monthly Anniversary Day starting from the Effective Date

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

     

    (4)​  The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

    (5)  ​The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Optional Benefit Charges:

                 

    Long-Term Care Inflation Protection Option(#)

     

    On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.00 – $0.50

     

    Periodic Charges Other Than Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Net Cost of Loans(6)

     

    On each Policy Anniversary, as applicable(7)

     

    2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carry-over loans.

     

    2.00% (annually) for standard loans, 1.00% for carry-over loans in Policy Years 1 through 10; 0% for all loans (standard and carry-over) in Policy Years 11 and thereafter

     

    (6)​  The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).

    (7)​  As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.

    Periodic Charges Other Than Series Fund Operating Expenses

     

    Charge

      When Charge
    is Deducted
      Amount Deducted —
    Maximum Guaranteed
    Charge
      Amount Deducted —
    Current Charge
     

    Lapse Protection Endorsement

                 

    Minimum and Maximum Charge

     

    Upon receipt of each premium payment

     

    1% of each premium payment

     

    1% of each premium payment

     
    Insurance Cost, Description [Text Block] Cost of Insurance:
    Insurance Cost, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day [4],[5]
    Insurance Cost, Representative Investor [Text Block]

    Charge for a 49 year old male in the standard unismoke rate class during the first Policy Year with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $0.23 per $1,000 of Net Amount at Risk

     

    $0.03 per $1,000 of Net Amount at Risk

    [4],[5]
    Insurance Cost, Maximum [Dollars] $ 83.33 [4],[5]
    Insurance Cost, Current [Dollars] 70.46 [4],[5]
    Insurance Cost, Minimum [Dollars] $ 0.01 [4],[5]
    Insurance Cost, Footnotes [Text Block] Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges

    shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".

    Administrative Expense, Footnotes [Text Block] We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
    Optional Benefit Expense, Footnotes [Text Block] As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.
    Annual Portfolio Company Expenses [Table Text Block]

    ANNUAL FUND EXPENSES

       

    Minimum

         

    Maximum

     
    Total Annual Fund Expenses
    (expenses that are deducted from Fund assets,
    including management fees, distribution and/or
    service 12b-1 fees, and other expenses)
     

    0.09

    %

     

     

    1.18

    %(1)

     

    (1)​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.

    Portfolio Company Expenses [Text Block]

    ANNUAL FUND EXPENSES

    The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund. A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See "FUND APPENDIX — FUNDS AVAILABLE UNDER THE POLICY".

    ANNUAL FUND EXPENSES

       

    Minimum

         

    Maximum

     
    Total Annual Fund Expenses
    (expenses that are deducted from Fund assets,
    including management fees, distribution and/or
    service 12b-1 fees, and other expenses)
     

    0.09

    %

     

     

    1.18

    %(1)

     

    (1)​  The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.

    Portfolio Company Expenses Before Waivers and Reimbursement Minimum [Percent] 0.09%
    Portfolio Company Expenses Before Waivers and Reimbursement Maximum [Percent] 1.18% [6]
    Portfolio Company Expenses, Footnotes [Text Block] The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.
    Item 5. Principal Risks [Table Text Block]

    PRINCIPAL RISKS OF INVESTING IN THE POLICY

    Investment Risk

    If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the

    Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See "The Variable Account and The Funds."

    Risk of Lapse

    There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Surrender Charge, Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See "Lapse and Reinstatement — Lapse" and "Lapse Protection."

    Withdrawal and Surrender Risks. The Surrender Charge under the Policy applies during the first 14 Policy Years. The Surrender Value of the Policy is generally the Policy Value less the Surrender Charge and Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.

    Even if you do not ask to surrender your Policy, Surrender Charges may play a role in determining whether your Policy will Lapse (terminate without value), because Surrender Charges decrease the Surrender Value.

    Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.

    A surrender or withdrawal may have tax consequences. See "Tax Considerations."

    Tax Risks

    Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.

    Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 591/2 at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.

    If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.

    See "Tax Considerations." You should consult a qualified tax adviser for assistance in all Policy related tax matters.

    Loan Risks

    A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.

    Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "Policy Loans" and "Tax Considerations — Tax Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.

    If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

    If a Policy Loan is taken from the Policy while the Long-Term Care Rider is on Active Claim Status, the Long-Term Care Rider will terminate.

    Specialized Uses of the Policy

    Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See "Tax Considerations — Other Considerations."

    Fund Risks

    A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.

    Business Disruption and Cyber Security Risks

    We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds' ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.

    We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.

    Item 10. Standard Death Benefits (N-6) [Table Text Block]

    STANDARD DEATH BENEFITS

    As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner's estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment

    of the Death Benefit Proceeds may have tax consequences. See "Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds" in the Prospectus.

    Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.

    Limits on Policy Rights

    Incontestability. Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider accept as stated below, after the Policy or rider has been in force during the Insured's lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.

    We have the right to void and rescind the Long-Term Care rider or resist an otherwise valid claim based on a misstatement in any application we accept and make part of the Policy as follows:

    •  If this rider has been in force for less than 6 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was material to the issuance of this rider.

    •  If this rider has been in force for at least 6 months but less than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the misstatement was materials to the issuance of this rider and pertains to the condition for which benefits are sought.

    •  If this rider has been in force for more than 24 months from the Policy Effective Date or the effective date of a Reinstatement, we will only take such action if the Insured knowingly and intentionally misrepresented relevant facts relating to the Insured's health.

    Suicide Exclusion. If the Insured dies by suicide, while sane or insane, within two years (or shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide, while sane or insane, within two years (or any shorter period as may be required by applicable law in the state where the Policy is delivered or issued for delivery) after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.

    Misstatement of Age or Sex. If the Insured's age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.

    Calculation of Death Benefit Proceeds

    The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured's death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.

    Federal Tax Compliance Tests. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test. This Policy will only be issued using the Cash Value Accumulation Test.

    The Cash Value Accumulation Test ("CVAT") does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy's cash value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.

    Under this Policy, which provides a level Death Benefit, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater than the Face Amount under the Policy.

    The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary,

    or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured's death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.

    Cash Value Accumulation Test. This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured's death, or (2) the minimum death benefit described below.

    The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

    For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

    Changing the Face Amount

    On or after the first Policy Anniversary, the Owner may request an increase in the Face Amount. The request must be received in writing in Good Order at the Home Office.

    Increasing the Face Amount. Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. The maximum Face Amount is $500,000. In addition, the Insured's current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See "Premiums Upon Increase in Face Amount." The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy's lapse protection is in effect, the Policy's Minimum Monthly Premium amount will also generally be increased.

    An administrative fee will be charged on the Effective Date of the increase and the subsequent eleven (11) Monthly Anniversary Days following an increase in the Face Amount.

    As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "Tax Considerations — Other Considerations." Please consult your tax advisor.

    On or after the third Policy Anniversary, the Owner may request a decrease in the Face Amount. The request must be received in writing in Good Order at the Home Office.

    Decreasing the Face Amount. If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See "Tax Considerations — Policies which are MECs."

    The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.

    Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. However, if the initial Face Amount is decreased during the first 14 Policy Years, a Surrender Charge will apply. Decreasing the Face Amount also may have tax consequences. See "Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years."

    Settlement Options

    The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.

    The following settlement options may be elected.

    Option 1 — Payment for a Fixed Period.  Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

    Option 2 — Life Income with Payments for a Guaranteed Period.  Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

    Option 3 — Interest Income.  Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

    Option 4 — Payments for a Fixed Amount.  Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

    Minimum Amounts. Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life's option.

    Other Requirements. Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured's lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner's estate.

    If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.

    Escheatment of Death Benefit

    Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely

    manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This "escheatment" is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.

    Additional Information about Standard Death Benefits, Note (N-6) [Text Block]

    Cash Value Accumulation Test. This Policy is issued under the Cash Value Accumulation Test. The Death Benefit is determined as follows: the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured's death, or (2) the minimum death benefit described below.

    The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

    For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured reaches Attained Age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

    Changing the Face Amount

    On or after the first Policy Anniversary, the Owner may request an increase in the Face Amount. The request must be received in writing in Good Order at the Home Office.

    Increasing the Face Amount. Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. The maximum Face Amount is $500,000. In addition, the Insured's current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See "Premiums Upon Increase in Face Amount." The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy's lapse protection is in effect, the Policy's Minimum Monthly Premium amount will also generally be increased.

    An administrative fee will be charged on the Effective Date of the increase and the subsequent eleven (11) Monthly Anniversary Days following an increase in the Face Amount.

    As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "Tax Considerations — Other Considerations." Please consult your tax advisor.

    On or after the third Policy Anniversary, the Owner may request a decrease in the Face Amount. The request must be received in writing in Good Order at the Home Office.

    Decreasing the Face Amount. If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See "Tax Considerations — Policies which are MECs."

    The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.

    Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. However, if the initial Face Amount is decreased during the first 14 Policy Years, a Surrender Charge will apply. Decreasing the Face Amount also may have tax consequences. See "Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years."

    Item 11. Other Benefits Available (N-6) [Text Block]

    OTHER BENEFITS AVAILABLE UNDER THE POLICY

    In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.

    Name of Benefit

     

    Purpose

      Is Benefit
    Standard
    or
    Optional?
      Brief Description of
    Restrictions/Limitations
     

    Long-Term Care Rider

     

    Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.

     

    Standard

      • Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.
    • Additional cost applies.
    • Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.
    • Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).
    • Benefit payments are made monthly and may not cover all long-term care expenses incurred.
    • If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.
    • If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.
     

    Name of Benefit

     

    Purpose

      Is Benefit
    Standard
    or
    Optional?
      Brief Description of
    Restrictions/Limitations
     

    Long-Term Care Inflation Protection Option

     

    On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.

     

    Optional

      • This rider must be elected at Policy issue.
    • Additional cost applies.
    • On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.
    • If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.
     

    Terminal Illness Accelerated Death Benefit Endorsement (Automatically included at Policy Issue)

     

    Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.

     

    Standard

      • Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:
    • The lesser of 60% of the current face amount of the Policy or $1,000,000; minus
    • Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.
    • Minimum acceleration permitted is $15,000
    • The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.
    • Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.
     

    Lapse Protection Endorsement (Automatically issued with this Policy)

     

    Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.

     

    Standard

      • The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.
    • Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.
     

    Name of Benefit

     

    Purpose

      Is Benefit
    Standard
    or
    Optional?
      Brief Description of
    Restrictions/Limitations
     

    Dollar-Cost Averaging

     

    Allows for the systematic transfer of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub-Accounts.

     

    Optional

      • No transfers may be made into the Fixed Account.
    • Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.
     

    Portfolio Rebalancing

     

    Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.

     

    Optional

      • Rebalancing transfers cannot be made into Fixed Account.
    • Minimum Variable Account Value of $100 required.
     

    Policy Loans

     

    Allows Owner to borrow from Policy's Cash Value.

     

    Standard

      • Not available during the first Policy Year.
    • Maximum loan amount is 99% of Cash Value.
    • Minimum loan amount is $500.
    • Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.
    • If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.
     

    SUPPLEMENTAL RIDERS AND ENDORSEMENTS

    The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See "Monthly Deduction." Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The Long-Term Care Rider, the Terminal Illness Accelerated Death Benefit Endorsement, and the Lapse Protection Endorsement are automatically added to all Policies at the time of issue. Also, this Policy will not be issued without the Long-Term Care Rider. The Long-Term Care Inflation Protection Option must be purchased at the time the Policy is issued. Please ask your Protective Life agent for further information or contact the Home Office.

    Long-Term Care Rider. This rider is automatically issued with the Policy. This rider provides an acceleration of the death benefits and extended benefits under the Policy for long-term care benefits for Qualified Long-Term Care Services incurred for Home Health Care Services, Adult Day Care Services, Assisted Living Facility Services, and Nursing Home Services. You may make a claim for a Long-Term Care Benefit (the "LTC Benefit"). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met. If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.

    30-Day Right to Cancel

    You have 30 days after the rider is first delivered to you to examine and return to us or to the financial professional who sold it to you, if you decide not to keep this rider. We will cancel the rider and the Policy. The returned Policy and rider will be treated if they had never been issued. We will refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to us, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to us.

    Rider Terms

    Activities of Daily Living: Means the six basic human functions necessary for a person to live independently are:

    •  Eating

    •  Toileting

    •  Transferring oneself into or out of bed, chair, wheelchair

    •  Bathing

    •  Dressing

    •  Continence

    The rider attached to your Policy contains more detailed information about these self-care functions.

    Active Claim Status: Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.

    Assistive Device: Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.

    Chronically Ill: Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:

    •  Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity, or

    •  Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Sever Cognitive Impairment.

    The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.

    Elimination Period: Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.

    Family Member: Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.

    Hands-on Assistance: Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.

    Home: Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision or Substantial Assistance with Activities of Daily Living.

    Insured: Means the person shown on the Policy Schedule upon whose life the Policy insures.

    Licensed Health Care Practitioner: Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.

    Plan of Care: Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured's needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured's care requirements.

    Qualified Long-Term Care Services: Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a chronically ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

    Severe Cognitive Impairment: Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:

    •  The Insured's short or long-term memory,

    •  The Insured's orientation as to person (such as who they are), place (such as their location), or time (such as day, date, and year), and

    •  The Insured's deductive or abstract reasoning.

    Standby Assistance: Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.

    Substantial Assistance: Means Hands-On Assistance or Standby Assistance.

    Substantial Supervision: Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.

    Written Certification: Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.

    Eligibility, Limitations, and Exclusions

    To become eligible for the LTC Benefit payments, the following conditions must be met:

    •  We receive your written request for the LTC Benefit,

    •  A Licensed Health Care Practitioner certifies that the Insured is Chronically Ill and prescribes a Plan of Care,

    •  The Policy and this rider are in force,

    •  The applicable Elimination Period has been satisfied,

    •  We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy, and

    •  The benefit payment is made in respect to a month when the Insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

    We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by, received from, a provider of health care services, within six months preceding the effective date of this rider.

    The rider will not pay benefits for any Chronic Illness caused by:

    •  Any attempt at suicide or intentionally self-inflicted injury, while sane or insane,

    •  Committing or attempting to commit or participating in a riot, insurrection, or involvement in an illegal occupation,

    •  Alcoholism or drug addiction, or

    •  Declared or undeclared war or any act of war.

    Maximum Monthly LTC Benefit Amount

    The Base Maximum Monthly LTC Benefit Amount on the Policy Effective Date, is equal to the amount shown in the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the "Long-Term Care Inflation Protection Option" section and "Impact on Your Policy" section.

    The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date and is equal to:

    •  The Base Maximum Monthly LTC Benefit Amount, plus

    •  80% of the result of the following:

    a)  1/48 of the Current LTC Benefit Pool minus

    b)  the Base Maximum Monthly LTC Benefit Amount

    On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, that amount may increase and/or decrease as described in the "Benefits While on Claim" section below.

    The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown in the Policy Schedule.

    Current LTC Benefit Pool

    The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:

    •  The Base LTC Benefit Pool,

    •  The Market Value LTC Benefit Pool, and

    •  The Protected LTC Benefit Pool.

    On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the "Benefits While on Claim" provision below.

    Unless you have requested a decrease in the Policy's Face Amount or make a withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown in the Policy Schedule minus the sum of any LTC Benefits paid under this rider.

    The Base LTC Benefit Pool on the Policy Effective Date, is equal to the Base LTC Benefit Pool shown in the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the "Long-Term Care Inflation Protection Option", and "Impact on Your Policy" sections.

    The Market Value LTC Benefit Pool is equal to the Unloaned Policy Value multiplied by the Market Benefit Multiplier shown on your Policy schedule. This pool may increase or decrease daily and is adjusted as described in the "Long-Term Care Inflation Protection Option" section.

    The Protected LTC Benefit Pool on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on your Policy schedule) multiplied by the Unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on your Policy schedule.

    On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:

    •  The Protected LTC Percentage (shown on the Policy schedule) multiplied by the Unloaned Policy Value as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier, and

    •  The Protected LTC Pool in effect immediately prior to that Policy Anniversary.

    The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to the Long-Term Care Inflation Protection Option Increases, LTC Benefit payments, withdrawals, loans, and Policy changes.

    Claims Provisions

    We prefer that either you or the Insured notify us as soon as the Insured first becomes eligible and may soon need care covered by this rider. We must receive your intent to file a claim for the LTC Benefit at our Administrative Office via written request or by telephone. The Request should include at least the Insured's name, Policy number and the address to which claim forms should be sent.

    We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you

    provide Written Certification and proof of loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.

    Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Confirmation from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date of proof would otherwise by required.

    A licensed Health Care Practitioner must re-certify that the Insured is Chronically Ill and prescribe a Plan of Care at least once every 12 months. We reserve the right to request a re-certification that the Insured remains Chronically Ill, but not more often than every 90 days, following an initial certification. The practitioner should either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification. After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be conducted until the 90-day period has passed.

    We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agree upon by the Insured and us. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.

    If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Accumulation Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.

    If, on the date your claim is closed, the Policy's Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as in the Maximum Monthly LTC Benefit Amount and Current LTC Benefit Pool section above, but will be floored at the amounts during claim.

    LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issues. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.

    According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.

    Extension of LTC Benefits

    If the Policy terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:

    •  The death of the Insured,

    •  Transition from Active Claim Status has completed, or

    •  The Maximum LTC Benefit Pool has been exhausted.

    Any extension of benefit is subject to all terms and conditions of this rider including eligibility for LTC Benefits and claim requirements. If the current maximum LTC benefit pool has been exhausted, no death benefit will be due upon the death of the Insured.

    Benefits While on Claim

    On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date. Also, on the date a claim under this rider is approved,

    we will automatically transfer out any Variable Account Value and transfer to the Fixed Account. See "Impact on Your Policy" below for additional information.

    Any amounts paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.

    If purchased, the Long-term Care Inflation Protection Option increase will increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Long-Term Care Inflation Protection Option" section.

    An increase and/or decrease in the Policy's Face Amount or a Withdrawal under the Policy will likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Impact on Your Policy" section.

    If your claim is closed, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the "Current LTC Benefit Pool" and "Maximum Monthly LTC Benefit Amount" sections, but will be floored at the amounts during claim.

    Impact on Your Policy

    Automatic Transfer to Fixed Account. On the date a claim under this rider is approved, we will automatically transfer any Variable Account Value out of the Sub-Accounts and transfer into the Fixed Account. While this rider is in Active Claim Status, no transfers out of the Fixed Account into Sub-Accounts will be permitted. In addition, Net Premiums received during this period will be allocated to the Fixed Account.

    LTC Benefit Payments. While Policy Value is greater than zero, LTC Benefit payments will reduce the Policy Value dollar for dollar and will be taken from the Fixed Account.

    LTC Benefit Payments on Face Amount. While the Policy's Face Amount is greater than zero, benefit payments under this rider will reduce the Policy's Face Amount dollar for dollar. This may reduce the Policy's Face Amount below the minimum.

    Monthly Deductions. When this rider is in Active Claim Status, Monthly Deductions required to maintain the Policy continue, however the LTC Rider Monthly Charge is waived.

    Policy Changes, Loans, and Withdrawals. When the rider is in Active Claim Status, Policy Changes, Loans, and withdrawals are not permitted.

    Interaction with Terminal Illness Accelerated Death Benefit Endorsement. Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under this endorsement.

    Residual Death Benefit. If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:

    •  5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment, or

    •  $10,000.

    The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.

    Protection Against Unintended Lapse

    To protect against unintended lapse, you may designate at least one person, other than the Owner, to receive notices about potential lapse or Policy termination due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the third-party for services provided to the Insured.

    Termination

    The rider will terminate on the earliest of:

    •  Your written notice to terminate this rider. If you request to terminate this rider the Policy to which it is attached will also be terminated. We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination,

    •  Policy termination,

    •  Failure to pay sufficient premium to maintain the rider,

    •  Death of the Insured,

    •  Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness or rider attached to the Policy,

    •  The date that the Maximum LTC Benefit is exhausted, and

    •  The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.

    Reinstatement

    If the Policy terminates and is subsequently reinstated, this rider may also be reinstated subject to the terms and conditions for reinstatement in the Policy. Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement.

    We will reinstate the Policy and this rider without evidence of insurability, if we receive:

    •  The Owner's written request within 5 months after the end of the Grace Period,

    •  Due proof that is satisfactory to us that the Insured was Chronically Ill at the end of the Grace Period outlined in the Policy, and

    •  Payment of overdue premium and/or charges for this rider.

    Rider LTC Nonforfeiture Benefit

    After the Policy and this rider have been In Force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:

    •  The death of the Insured, or

    •  The date the LTC Nonforfeiture Benefit Limit has been reduced to zero.

    The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:

    •  One month's Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates, or

    •  An amount equal to the sum of Monthly rider Charges paid for this rider.

    The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider Lapses or terminates, and will not change.

    The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Long-Term Care Inflation Protection Option increases.

    No benefits are payable under this provision until benefits, if any, under the "Extension of LTC Benefits" section are no longer in effect. The sum of any benefits paid under the "Extension of LTC Benefits" section plus any benefits paid under this Rider LTC Nonforfeiture Benefit" section will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.

    Long-Term Care Inflation Protection Option. If you selected optional inflation protection, you can purchase a 5% compound inflation protection increase on each Policy Anniversary, with no evidence of insurability. The right to purchase the inflation protection increase in effect on the date the Policy is issued is shown on the Schedule Page.

    Every annual inflation protection increase purchased by you will be factored into the calculation of the following values: Base Maximum Monthly LTC Benefit Value, Base LTC Benefit Pool, Current Maximum Monthly LTC Benefit Value, Current LTC Benefit Pool, if any.

    Starting with the first Policy Anniversary, and for as long as you continue to purchase each year's inflation protection increase, we will send you written notification regarding that year's right to purchase. You must return your request to purchase that year's inflation protection increase within the timeframe stated in the notification.

    If you decline to purchase any annual inflation protection increase, you will no longer have the right to purchase an inflation protection increase on any future Policy Anniversary. The right to purchase inflation protection under this rider cannot be reinstated once terminated.

    The right to purchase annual inflation protection increases will continue without regard to the Insured's Attained Age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:

    •  You continue to purchase each year's inflation protection increase,

    •  The LTC Benefit Limit is greater than zero, and

    •  This rider remains in force.

    On the Policy Anniversary on which you do not purchase that year's inflation protection increase, the following will occur:

    •  Your right to purchase any future annual inflation protection increase will terminate, and

    •  You will no longer be charged the optional Inflation Protection monthly LTC charge.

    Even if your right to purchase this rider is terminated, any previously purchased increases will continue to be included in the calculation of benefits under this rider.

    Terminal Illness Accelerated Death Benefit Endorsement. This endorsement is automatically issued with the Policy. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest. If a claim is filed under this endorsement, the LTC Rider will terminate and when the benefits under the LTC Rider are being utilized (claim is filed under the LTC Rider) no claims under the Terminal Illness Accelerated Death Benefit are allowed.

    The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.

    The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

    •  the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

    •  any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

    Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

    Lapse Protection Endorsement. The rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule, as long as the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirement and the Policy Debt does not exceed the Cash Value.

    For the Maximum Lapse Protection Period, the Policy Value at the end of this period may not be sufficient to keep the Policy in force unless additional premiums are made. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of this period. In addition, during this period any change to the

    benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement, will be provided to you on a supplemental Policy Schedule, along with any applicable effective date.

    The Accumulated Minimum Monthly Requirement each month is equal to the Minimum Monthly Requirement for a given month plus the Accumulated Minimum Monthly Requirement as of the prior month ($0 for the first month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor shown in the Policy Schedule.

    The Accumulated Net Payments Received (calculated as of the last day of the month) for each month is equal to:

    •  the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year), plus

    •  the sum of all the Lapse Protection Net Premium received since the beginning of the month, Plus

    •  the Lapse Protection Interest for the month, less

    •  the reduction in Policy Value for any Withdrawal taken and any applicable Surrender Charges assessed since the beginning of the month.

    The Lapse Protection Net Premium is the amount after deducting the Lapse Protection Premium Expense Charge for that Policy Year, as shown on the Policy Schedule, for each premium payment.

    The Lapse Protection Interest is calculated as:

    •  the lesser of the Accumulated Fund Threshold and the sum of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year) PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, MULTIPLIED by the Threshold Accumulation Factor, shown in the Policy Schedule, plus

    •  the amount of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, in excess of the Accumulated Fund Threshold, if any, MULTIPLIED by the Excess Accumulation Factor, shown on the Policy Schedule.

    The Accumulated Fund Threshold for the first month of a Policy Year is equal to:

    •  the Accumulated Fund Threshold for the prior month ($0 for the first month of the first Policy Year) multiplied by 1 plus the Threshold Accumulation Factor, PLUS

    •  the Annual Threshold Premium, as shown on the Policy Schedule, for that Policy Year.

    For all other months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior month multiplied buy 1 plus the Threshold Accumulation Factor.

    Any adjustments made due to a decrease in Face Amount, including payments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.

    If the Policy is maintained under this endorsement, Monthly Deductions will continue.

    This endorsement terminates when the Policy terminates. If the Policy is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.

    Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $250,000 Face Amount. The Policy Schedule indicates a Lapse Protection Premium Expense Charge of 1.00%, the initial Minimum Monthly Requirement is $161.88, the Threshold Accumulation Factor is 0.446150%, the Excess Accumulation Factor is 0.105844%, and an initial Threshold Premium of $5,980.25. The owner makes an initial premium payment of $200, which is an Lapse Protection Net Premium Received of $198 ($200 less 1.00%, the Lapse Protection Premium Expense Charge).

    In the first Policy month, the Accumulated Fund Threshold ($5,980.25) is equal to the initial Threshold Premium. The Accumulated Minimum Monthly Requirement is $162.60 which is $161.88 (the initial Minimum Monthly Requirement) multiplied by 1.00446150 (one plus the Threshold Accumulation Factor). The Accumulated Net Payments Received ($198.00) is less than the Accumulated Fund Threshold ($5,980.25), so the Threshold Accumulation Factor is applied to the entire Accumulated Net Payments Received value. The Accumulated Net Payments Received in the first Policy

    month, after accumulation, is $198.88 ($198.00 multiplied by 1.00446150). Because the Accumulated Net Payments Received of $198.88 equals or exceeds the Accumulated Minimum Monthly Requirement $162.60, the conditions have been met for the first month for the rider to remain in effect guaranteeing the Policy remains in force.

    Assume on each of the 23 subsequent monthly anniversaries, the owner has made premium payments of the same amount and taken no partial surrenders or Policy Loans. The total premiums paid for the Policy equals $4,800.00. The Accumulated Net Payments Received at the end of Policy month 24 is $5,026.30 and the Accumulated Minimum Monthly Requirement is $4,109.26. Because the Accumulated Net Payments Received equals or exceeds the Accumulated Minimum Monthly Requirement, the conditions have been met on this monthly anniversary day. Since the rider remains in effect, the Policy is guaranteed to remain in force. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $250,000.

    Assume that starting with the 24th monthly anniversary, the owner misses the next six anticipated monthly premium payments. At the end of Policy month 30, the Accumulated Net Payments Received has accumulated to $5,162.36 while the Accumulated Minimum Monthly Requirement has accumulated to $5,207.02. Also assume that the Cash Value of the Policy is zero. Because the Accumulated Net Payments Received is less than the Accumulated Minimum Monthly Requirement, the owner must pay additional premiums within the 60-day grace period to keep the rider in effect and the Policy in force. Under these circumstances, if the insured dies outside of the 60-day grace period without having made the necessary additional premium payments, the death benefit will be $0.

    Dollar-Cost Averaging

    If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account ("Source Sub-Account") or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.

    Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th​, 30th​, or 31st​. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.

    Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate Source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.

    Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

    Portfolio Rebalancing

    At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th​, 30th​ or 31st​. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.

    Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.

    Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.

    TRANSFERS

    On or after the later of thirty days after the Policy Effective Date or 6 days after the 30-day cancellation period, you may, upon receipt of Written Notice in Good Order to Protective Life at the Home Office transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See "Suspension or Delay of Payments." The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.

    Limitations on frequent transfers, including "market timing" transfers. Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund's portfolio securities and the reflection of that change in the Fund's share price. This strategy, sometimes referred to as "market timing," involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.

    When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:

    •  Increased brokerage trading and transaction costs;

    •  Disruption of planned investment strategies;

    •  Forced and unplanned liquidation and portfolio turnover;

    •  Lost opportunity costs; and

    •  Large asset swings that decrease the Fund's ability to provide maximum investment return to all Policy Owners.

    In order to try to protect our Policy Owners and the Funds from the potential adverse effects of frequent transfer activity, the Company has implemented certain market timing policies and procedures (the "Market Timing Procedures"). Our Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners' beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.

    We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.

    When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.

    In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds' policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.

    Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund's investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund's refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner's transfer request. Some Funds also may impose redemption fees on short-term trading (i.e., redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or tranfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.

    We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.

    Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.

    Reservation of Rights

    Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

    Telephone Transfers

    Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.

    Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.

    A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.

    SURRENDERS AND WITHDRAWALS

    Surrender Privileges

    At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. A Surrender Charge may apply. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See "Tax Considerations.").

    Withdrawal Privileges

    At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge and, if applicable, a Surrender Charge, from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.

    Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.

    The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.

    Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life's then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See "Tax Considerations."

    Item 18. Portfolio Companies (N-6) [Text Block]

    APPENDIX:
    FUNDS AVAILABLE UNDER THE POLICY

    The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

    The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund's past performance is not necessarily an indication of future performance.

    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Allocation

     

    American Funds Insurance Series®​ Asset Allocation Fund - Class 1 - Capital Research and Management Company

     

    0.29

    %

     

    16.16

    %

     

    9.24

    %

     

    10.05

    %

     

    International Equity

     

    American Funds Insurance Series®​ Global Growth Fund - Class 1 - Capital Research and Management Company(1)

     

    0.40

    %

     

    21.98

    %

     

    8.51

    %

     

    12.46

    %

     

    U.S. Equity

     

    American Funds Insurance Series®​ Growth Fund - Class 1 - Capital Research and Management Company

     

    0.33

    %

     

    20.54

    %

     

    13.66

    %

     

    18.26

    %

     

    U.S. Equity

     

    American Funds Insurance Series®​ Growth-Income Fund - Class 1 - Capital Research and Management Company

     

    0.28

    %

     

    18.37

    %

     

    14.19

    %

     

    14.20

    %

     

    International Equity

     

    American Funds Insurance Series®​ New World Fund®​ - Class 1 - Capital Research and Management Company(1)

     

    0.57

    %

     

    28.60

    %

     

    5.59

    %

     

    9.53

    %

     

    U.S. Equity

     

    ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

     

    0.81

    %

     

    9.23

    %

     

    -0.17

    %

     

    9.38

    %

     

    International Equity

     

    Dimensional VA International Small Portfolio - Institutional Class

     

    0.39

    %

     

    36.99

    %

     

    8.89

    %

     

    8.68

    %

     

    International Equity

     

    Dimensional VA International Value Portfolio - Institutional Class

     

    0.27

    %

     

    45.64

    %

     

    15.85

    %

     

    10.46

    %

     

    U.S. Equity

     

    Dimensional VA U.S. Large Value Portfolio - Institutional Class

     

    0.21

    %

     

    15.83

    %

     

    11.97

    %

     

    10.51

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Taxable Bond

     

    Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

     

    0.11

    %

     

    7.55

    %

     

    1.05

    %

     

    3.12

    %

     

    U.S. Equity

      Fidelity®​ VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.56

    %

     

    22.02

    %

     

    11.31

    %

     

    19.94

    %

     

    U.S. Equity

     

    Fidelity®​ VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC

     

    0.09

    %

     

    17.78

    %

     

    14.31

    %

     

    14.70

    %

     

    Taxable Bond

      Fidelity®​ VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.37

    %

     

    7.22

    %

     

    0.06

    %

     

    2.71

    %

     

    U.S. Equity

      Fidelity®​ VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.55

    %

     

    11.75

    %

     

    10.10

    %

     

    10.59

    %

     

    U.S. Equity

     

    Franklin Growth and Income VIP Fund - Class 1(1)

     

    0.59

    %

     

    16.98

    %

     

    12.16

    %

     

    11.39

    %

     

    Allocation

     

    Franklin Income VIP Fund - Class 1

     

    0.47

    %

     

    12.87

    %

     

    7.92

    %

     

    7.57

    %

     

    Taxable Bond

     

    Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)

     

    0.42

    %

     

    7.46

    %

     

    -0.57

    %

     

    2.11

    %

     

    U.S. Equity

     

    Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)

     

    0.81

    %

     

    9.39

    %

     

    10.05

    %

     

    10.02

    %

     

    U.S. Equity

     

    Invesco®​ V.I. Diversified Dividend Fund - Series I

     

    0.68

    %

     

    15.74

    %

     

    10.81

    %

     

    9.20

    %

     

    International Equity

     

    Invesco®​ V.I. Global Fund - Series I

     

    0.81

    %

     

    15.32

    %

     

    7.28

    %

     

    11.00

    %

     

    Money Market

     

    Invesco®​ V.I. U.S. Government Money Portfolio - Series I

     

    0.67

    %

     

    3.64

    %

     

    2.80

    %

     

    1.76

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Taxable Bond

     

    Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

     

    0.98

    %

     

    8.33

    %

     

    2.10

    %

     

    4.72

    %

     

    U.S. Equity

     

    Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC(1)

     

    0.99

    %

     

    15.98

    %

     

    12.34

    %

     

    13.06

    %

     

    Taxable Bond

     

    PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class - Pacific Investment Management Company LLC

     

    0.94

    %

     

    4.10

    %

     

    1.18

    %

     

    3.04

    %

     

    Taxable Bond

     

    PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC

     

    0.50

    %

     

    4.83

    %

     

    3.40

    %

     

    2.91

    %

     

    Taxable Bond

     

    PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Management Company LLC

     

    0.58

    %

     

    9.05

    %

     

    0.16

    %

     

    2.51

    %

     

    U.S. Equity

      Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited  

    0.63

    %

     

    10.99

    %

     

    10.62

    %

     

    14.98

    %

     

    U.S. Equity

     

    Royce Capital Small-Cap Portfolio - Investment Class

     

    1.18

    %

     

    8.93

    %

     

    10.66

    %

     

    7.88

    %

     

    International Equity

      Templeton Emerging Markets VIP Fund - Class 1 (formerly, Templeton Developing Markets VIP Fund)  

    1.12

    %

     

    46.64

    %

     

    5.73

    %

     

    10.68

    %

     

    Allocation

      TOPS®​ Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS®​ Aggressive Growth ETF Portfolio)  

    0.29

    %

     

    19.17

    %

     

    9.69

    %

     

    10.71

    %

     

    Allocation

      TOPS®​ Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC  

    0.31

    %

     

    10.39

    %

     

    4.61

    %

     

    5.25

    %

     

    Allocation

      TOPS®​ Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Moderate Growth ETF Portfolio)  

    0.29

    %

     

    15.50

    %

     

    7.20

    %

     

    8.26

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Allocation

      TOPS®​ Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Growth ETF Portfolio)  

    0.29

    %

     

    18.31

    %

     

    8.85

    %

     

    9.80

    %

     

    U.S. Equity

     

    Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

     

    0.29

    %

     

    16.79

    %

     

    12.59

    %

     

    11.51

    %

     

    International Equity

     

    Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

     

    0.32

    %

     

    19.96

    %

     

    0.62

    %

     

    10.48

    %

     

    U.S. Equity

     

    Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)

     

    0.34

    %

     

    28.97

    %

     

    13.97

    %

     

    14.96

    %

     

    Sector Equity

     

    Vanguard Variable Insurance Funds - Real Estate Index Portfolio

     

    0.26

    %

     

    3.11

    %

     

    4.50

    %

     

    5.08

    %

     

    Taxable Bond

     

    Vanguard®​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio

     

    0.14

    %

     

    6.85

    %

     

    2.23

    %

     

    2.80

    %

     

    (1)​  These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

    Prospectuses Available [Text Block]

    The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

    The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund's past performance is not necessarily an indication of future performance.

    Portfolio Companies [Table Text Block]
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Allocation

     

    American Funds Insurance Series®​ Asset Allocation Fund - Class 1 - Capital Research and Management Company

     

    0.29

    %

     

    16.16

    %

     

    9.24

    %

     

    10.05

    %

     

    International Equity

     

    American Funds Insurance Series®​ Global Growth Fund - Class 1 - Capital Research and Management Company(1)

     

    0.40

    %

     

    21.98

    %

     

    8.51

    %

     

    12.46

    %

     

    U.S. Equity

     

    American Funds Insurance Series®​ Growth Fund - Class 1 - Capital Research and Management Company

     

    0.33

    %

     

    20.54

    %

     

    13.66

    %

     

    18.26

    %

     

    U.S. Equity

     

    American Funds Insurance Series®​ Growth-Income Fund - Class 1 - Capital Research and Management Company

     

    0.28

    %

     

    18.37

    %

     

    14.19

    %

     

    14.20

    %

     

    International Equity

     

    American Funds Insurance Series®​ New World Fund®​ - Class 1 - Capital Research and Management Company(1)

     

    0.57

    %

     

    28.60

    %

     

    5.59

    %

     

    9.53

    %

     

    U.S. Equity

     

    ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

     

    0.81

    %

     

    9.23

    %

     

    -0.17

    %

     

    9.38

    %

     

    International Equity

     

    Dimensional VA International Small Portfolio - Institutional Class

     

    0.39

    %

     

    36.99

    %

     

    8.89

    %

     

    8.68

    %

     

    International Equity

     

    Dimensional VA International Value Portfolio - Institutional Class

     

    0.27

    %

     

    45.64

    %

     

    15.85

    %

     

    10.46

    %

     

    U.S. Equity

     

    Dimensional VA U.S. Large Value Portfolio - Institutional Class

     

    0.21

    %

     

    15.83

    %

     

    11.97

    %

     

    10.51

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Taxable Bond

     

    Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

     

    0.11

    %

     

    7.55

    %

     

    1.05

    %

     

    3.12

    %

     

    U.S. Equity

      Fidelity®​ VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.56

    %

     

    22.02

    %

     

    11.31

    %

     

    19.94

    %

     

    U.S. Equity

     

    Fidelity®​ VIP Index 500 Portfolio - Initial Class - Geode Capital Management, LLC

     

    0.09

    %

     

    17.78

    %

     

    14.31

    %

     

    14.70

    %

     

    Taxable Bond

      Fidelity®​ VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.37

    %

     

    7.22

    %

     

    0.06

    %

     

    2.71

    %

     

    U.S. Equity

      Fidelity®​ VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd  

    0.55

    %

     

    11.75

    %

     

    10.10

    %

     

    10.59

    %

     

    U.S. Equity

     

    Franklin Growth and Income VIP Fund - Class 1(1)

     

    0.59

    %

     

    16.98

    %

     

    12.16

    %

     

    11.39

    %

     

    Allocation

     

    Franklin Income VIP Fund - Class 1

     

    0.47

    %

     

    12.87

    %

     

    7.92

    %

     

    7.57

    %

     

    Taxable Bond

     

    Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)

     

    0.42

    %

     

    7.46

    %

     

    -0.57

    %

     

    2.11

    %

     

    U.S. Equity

     

    Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)

     

    0.81

    %

     

    9.39

    %

     

    10.05

    %

     

    10.02

    %

     

    U.S. Equity

     

    Invesco®​ V.I. Diversified Dividend Fund - Series I

     

    0.68

    %

     

    15.74

    %

     

    10.81

    %

     

    9.20

    %

     

    International Equity

     

    Invesco®​ V.I. Global Fund - Series I

     

    0.81

    %

     

    15.32

    %

     

    7.28

    %

     

    11.00

    %

     

    Money Market

     

    Invesco®​ V.I. U.S. Government Money Portfolio - Series I

     

    0.67

    %

     

    3.64

    %

     

    2.80

    %

     

    1.76

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Taxable Bond

     

    Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

     

    0.98

    %

     

    8.33

    %

     

    2.10

    %

     

    4.72

    %

     

    U.S. Equity

     

    Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC(1)

     

    0.99

    %

     

    15.98

    %

     

    12.34

    %

     

    13.06

    %

     

    Taxable Bond

     

    PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class - Pacific Investment Management Company LLC

     

    0.94

    %

     

    4.10

    %

     

    1.18

    %

     

    3.04

    %

     

    Taxable Bond

     

    PIMCO VIT Short-Term Portfolio - Institutional Class - Pacific Investment Management Company LLC

     

    0.50

    %

     

    4.83

    %

     

    3.40

    %

     

    2.91

    %

     

    Taxable Bond

     

    PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Management Company LLC

     

    0.58

    %

     

    9.05

    %

     

    0.16

    %

     

    2.51

    %

     

    U.S. Equity

      Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investments Management Limited  

    0.63

    %

     

    10.99

    %

     

    10.62

    %

     

    14.98

    %

     

    U.S. Equity

     

    Royce Capital Small-Cap Portfolio - Investment Class

     

    1.18

    %

     

    8.93

    %

     

    10.66

    %

     

    7.88

    %

     

    International Equity

      Templeton Emerging Markets VIP Fund - Class 1 (formerly, Templeton Developing Markets VIP Fund)  

    1.12

    %

     

    46.64

    %

     

    5.73

    %

     

    10.68

    %

     

    Allocation

      TOPS®​ Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS®​ Aggressive Growth ETF Portfolio)  

    0.29

    %

     

    19.17

    %

     

    9.69

    %

     

    10.71

    %

     

    Allocation

      TOPS®​ Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC  

    0.31

    %

     

    10.39

    %

     

    4.61

    %

     

    5.25

    %

     

    Allocation

      TOPS®​ Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Moderate Growth ETF Portfolio)  

    0.29

    %

     

    15.50

    %

     

    7.20

    %

     

    8.26

    %

     
    Asset
    Allocation
     

    Fund - Investment Adviser;

     

    Current

      Average Annual Total Returns
    (as of 12/31/2025)
     
    Type  

    Sub-Adviser(s), as applicable

     

    Expenses

     

    1 year

     

    5 year

     

    10 year

     

    Allocation

      TOPS®​ Moderately Aggressive ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management LLC (formerly, TOPS®​ Growth ETF Portfolio)  

    0.29

    %

     

    18.31

    %

     

    8.85

    %

     

    9.80

    %

     

    U.S. Equity

     

    Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

     

    0.29

    %

     

    16.79

    %

     

    12.59

    %

     

    11.51

    %

     

    International Equity

     

    Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

     

    0.32

    %

     

    19.96

    %

     

    0.62

    %

     

    10.48

    %

     

    U.S. Equity

     

    Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)

     

    0.34

    %

     

    28.97

    %

     

    13.97

    %

     

    14.96

    %

     

    Sector Equity

     

    Vanguard Variable Insurance Funds - Real Estate Index Portfolio

     

    0.26

    %

     

    3.11

    %

     

    4.50

    %

     

    5.08

    %

     

    Taxable Bond

     

    Vanguard®​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio

     

    0.14

    %

     

    6.85

    %

     

    2.23

    %

     

    2.80

    %

     

    (1)​  These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

    Temporary Fee Reductions, Current Expenses [Text Block] These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.
    Business Disruption and Cyber Security Risks [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Business Disruption and Cyber Security Risks

    We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds' ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.

    We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.

    Fund Risks [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Fund Risks

    A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.

    Investment Risk [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Investment Risk

    If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the

    Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See "The Variable Account and The Funds."

    Loan Risks [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Loan Risks

    A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.

    Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "Policy Loans" and "Tax Considerations — Tax Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.

    If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

    If a Policy Loan is taken from the Policy while the Long-Term Care Rider is on Active Claim Status, the Long-Term Care Rider will terminate.

    Specialized Uses of the Policy [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Specialized Uses of the Policy

    Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See "Tax Considerations — Other Considerations."

    Tax Risks [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Tax Risks

    Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.

    Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 591/2 at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.

    If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.

    See "Tax Considerations." You should consult a qualified tax adviser for assistance in all Policy related tax matters.

    Withdrawal and Surrender Risks [Member]  
    Item 2. Key Information [Line Items]  
    Principal Risk [Text Block]

    Withdrawal and Surrender Risks. The Surrender Charge under the Policy applies during the first 14 Policy Years. The Surrender Value of the Policy is generally the Policy Value less the Surrender Charge and Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.

    Even if you do not ask to surrender your Policy, Surrender Charges may play a role in determining whether your Policy will Lapse (terminate without value), because Surrender Charges decrease the Surrender Value.

    Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.

    A surrender or withdrawal may have tax consequences. See "Tax Considerations."

    Risk of Loss [Member]  
    Item 2. Key Information [Line Items]  
    Risk [Text Block] Risk of Loss  You can lose money by investing in this Policy, including loss of principal.
    For additional information about the risk of loss, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" in the Prospectus.
    Not Short Term Investment Risk [Member]  
    Item 2. Key Information [Line Items]  
    Risk [Text Block] Not a Short-Term Investment  The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, surrender charges and federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered.
    For additional information about the investment profile of the Policy, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "CHARGES AND DEDUCTIONS," "USE OF THE POLICY" and "TAX CONSIDERATIONS — Taxation of Insurance Polices" in the Prospectus.
    Investment Options Risk [Member]  
    Item 2. Key Information [Line Items]  
    Risk [Text Block]
    Risks Associated with Investment
    Options
      An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.
    For additional information about the risks associated with Investment Options, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "THE COMPANY AND THE FIXED ACCOUNT," "THE VARIABLE ACCOUNT AND THE FUNDS" and "FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY" in the Prospectus.
     
    Insurance Company Risk [Member]  
    Item 2. Key Information [Line Items]  
    Risk [Text Block]

    Insurance Company Risks

      An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-800-265-1545.
    For additional information about Company risks, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY" and "THE COMPANY AND THE FIXED ACCOUNT" in the Prospectus.
     
    Contract Lapse Risk [Member]  
    Item 2. Key Information [Line Items]  
    Risk [Text Block]

    Policy Lapse

      Your Policy could terminate if the value of your Policy becomes too low to support the Policy's monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.
    For additional information about Policy Lapse, see "PRINCIPAL RISKS OF INVESTING IN THE POLICY," "PREMIUMS," "LOANS," and "LAPSE AND REINSTATEMENT" in the Prospectus.
     
    Principal Risk [Text Block]

    Risk of Lapse

    There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Surrender Charge, Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See "Lapse and Reinstatement — Lapse" and "Lapse Protection."

    American Funds Insurance Series® Asset Allocation Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] American Funds Insurance Series®​ Asset Allocation Fund - Class 1
    Portfolio Company Adviser [Text Block] Capital Research and Management Company
    Current Expenses [Percent] 0.29%
    Average Annual Total Returns, 1 Year [Percent] 16.16%
    Average Annual Total Returns, 5 Years [Percent] 9.24%
    Average Annual Total Returns, 10 Years [Percent] 10.05%
    American Funds Insurance Series® Global Growth Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] American Funds Insurance Series®​ Global Growth Fund - Class 1 [7]
    Portfolio Company Adviser [Text Block] Capital Research and Management Company [7]
    Current Expenses [Percent] 0.40% [7]
    Average Annual Total Returns, 1 Year [Percent] 21.98% [7]
    Average Annual Total Returns, 5 Years [Percent] 8.51% [7]
    Average Annual Total Returns, 10 Years [Percent] 12.46% [7]
    American Funds Insurance Series® Growth Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] American Funds Insurance Series®​ Growth Fund - Class 1
    Portfolio Company Adviser [Text Block] Capital Research and Management Company
    Current Expenses [Percent] 0.33%
    Average Annual Total Returns, 1 Year [Percent] 20.54%
    Average Annual Total Returns, 5 Years [Percent] 13.66%
    Average Annual Total Returns, 10 Years [Percent] 18.26%
    American Funds Insurance Series® Growth-Income Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] American Funds Insurance Series®​ Growth-Income Fund - Class 1
    Portfolio Company Adviser [Text Block] Capital Research and Management Company
    Current Expenses [Percent] 0.28%
    Average Annual Total Returns, 1 Year [Percent] 18.37%
    Average Annual Total Returns, 5 Years [Percent] 14.19%
    Average Annual Total Returns, 10 Years [Percent] 14.20%
    American Funds Insurance Series® New World Fund® - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] American Funds Insurance Series®​ New World Fund®​ - Class 1 [7]
    Portfolio Company Adviser [Text Block] Capital Research and Management Company [7]
    Current Expenses [Percent] 0.57% [7]
    Average Annual Total Returns, 1 Year [Percent] 28.60% [7]
    Average Annual Total Returns, 5 Years [Percent] 5.59% [7]
    Average Annual Total Returns, 10 Years [Percent] 9.53% [7]
    ClearBridge Variable Small Cap Growth Portfolio - Class I [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] ClearBridge Variable Small Cap Growth Portfolio - Class I
    Portfolio Company Adviser [Text Block] Franklin Templeton Fund Adviser, LLC
    Current Expenses [Percent] 0.81%
    Average Annual Total Returns, 1 Year [Percent] 9.23%
    Average Annual Total Returns, 5 Years [Percent] (0.17%)
    Average Annual Total Returns, 10 Years [Percent] 9.38%
    Dimensional VA International Small Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Dimensional VA International Small Portfolio - Institutional Class
    Current Expenses [Percent] 0.39%
    Average Annual Total Returns, 1 Year [Percent] 36.99%
    Average Annual Total Returns, 5 Years [Percent] 8.89%
    Average Annual Total Returns, 10 Years [Percent] 8.68%
    Dimensional VA International Value Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Dimensional VA International Value Portfolio - Institutional Class
    Current Expenses [Percent] 0.27%
    Average Annual Total Returns, 1 Year [Percent] 45.64%
    Average Annual Total Returns, 5 Years [Percent] 15.85%
    Average Annual Total Returns, 10 Years [Percent] 10.46%
    Dimensional VA U.S. Large Value Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Dimensional VA U.S. Large Value Portfolio - Institutional Class
    Current Expenses [Percent] 0.21%
    Average Annual Total Returns, 1 Year [Percent] 15.83%
    Average Annual Total Returns, 5 Years [Percent] 11.97%
    Average Annual Total Returns, 10 Years [Percent] 10.51%
    Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class
    Current Expenses [Percent] 0.11%
    Average Annual Total Returns, 1 Year [Percent] 7.55%
    Average Annual Total Returns, 5 Years [Percent] 1.05%
    Average Annual Total Returns, 10 Years [Percent] 3.12%
    Fidelity® VIP Growth Opportunities Portfolio - Initial Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Fidelity®​ VIP Growth Opportunities Portfolio - Initial Class
    Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited
    Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd
    Current Expenses [Percent] 0.56%
    Average Annual Total Returns, 1 Year [Percent] 22.02%
    Average Annual Total Returns, 5 Years [Percent] 11.31%
    Average Annual Total Returns, 10 Years [Percent] 19.94%
    Fidelity® VIP Index 500 Portfolio - Initial Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Fidelity®​ VIP Index 500 Portfolio - Initial Class
    Portfolio Company Adviser [Text Block] Geode Capital Management, LLC
    Current Expenses [Percent] 0.09%
    Average Annual Total Returns, 1 Year [Percent] 17.78%
    Average Annual Total Returns, 5 Years [Percent] 14.31%
    Average Annual Total Returns, 10 Years [Percent] 14.70%
    Fidelity® VIP Investment Grade Bond Portfolio - Initial Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Fidelity®​ VIP Investment Grade Bond Portfolio - Initial Class
    Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited
    Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd
    Current Expenses [Percent] 0.37%
    Average Annual Total Returns, 1 Year [Percent] 7.22%
    Average Annual Total Returns, 5 Years [Percent] 0.06%
    Average Annual Total Returns, 10 Years [Percent] 2.71%
    Fidelity® VIP Mid Cap Portfolio - Initial Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Fidelity®​ VIP Mid Cap Portfolio - Initial Class
    Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited
    Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Ltd
    Current Expenses [Percent] 0.55%
    Average Annual Total Returns, 1 Year [Percent] 11.75%
    Average Annual Total Returns, 5 Years [Percent] 10.10%
    Average Annual Total Returns, 10 Years [Percent] 10.59%
    Franklin Growth and Income VIP Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Franklin Growth and Income VIP Fund - Class 1 [7]
    Current Expenses [Percent] 0.59% [7]
    Average Annual Total Returns, 1 Year [Percent] 16.98% [7]
    Average Annual Total Returns, 5 Years [Percent] 12.16% [7]
    Average Annual Total Returns, 10 Years [Percent] 11.39% [7]
    Franklin Income VIP Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Franklin Income VIP Fund - Class 1
    Current Expenses [Percent] 0.47%
    Average Annual Total Returns, 1 Year [Percent] 12.87%
    Average Annual Total Returns, 5 Years [Percent] 7.92%
    Average Annual Total Returns, 10 Years [Percent] 7.57%
    Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [7]
    Current Expenses [Percent] 0.42% [7]
    Average Annual Total Returns, 1 Year [Percent] 7.46% [7]
    Average Annual Total Returns, 5 Years [Percent] (0.57%) [7]
    Average Annual Total Returns, 10 Years [Percent] 2.11% [7]
    Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [7]
    Current Expenses [Percent] 0.81% [7]
    Average Annual Total Returns, 1 Year [Percent] 9.39% [7]
    Average Annual Total Returns, 5 Years [Percent] 10.05% [7]
    Average Annual Total Returns, 10 Years [Percent] 10.02% [7]
    Invesco® V.I. Diversified Dividend Fund - Series I [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Invesco®​ V.I. Diversified Dividend Fund - Series I
    Current Expenses [Percent] 0.68%
    Average Annual Total Returns, 1 Year [Percent] 15.74%
    Average Annual Total Returns, 5 Years [Percent] 10.81%
    Average Annual Total Returns, 10 Years [Percent] 9.20%
    Invesco® V.I. Global Fund - Series I [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Invesco®​ V.I. Global Fund - Series I
    Current Expenses [Percent] 0.81%
    Average Annual Total Returns, 1 Year [Percent] 15.32%
    Average Annual Total Returns, 5 Years [Percent] 7.28%
    Average Annual Total Returns, 10 Years [Percent] 11.00%
    Invesco® V.I. U.S. Government Money Portfolio - Series I [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Invesco®​ V.I. U.S. Government Money Portfolio - Series I
    Current Expenses [Percent] 0.67%
    Average Annual Total Returns, 1 Year [Percent] 3.64%
    Average Annual Total Returns, 5 Years [Percent] 2.80%
    Average Annual Total Returns, 10 Years [Percent] 1.76%
    Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC
    Current Expenses [Percent] 0.98%
    Average Annual Total Returns, 1 Year [Percent] 8.33%
    Average Annual Total Returns, 5 Years [Percent] 2.10%
    Average Annual Total Returns, 10 Years [Percent] 4.72%
    Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC [7]
    Current Expenses [Percent] 0.99% [7]
    Average Annual Total Returns, 1 Year [Percent] 15.98% [7]
    Average Annual Total Returns, 5 Years [Percent] 12.34% [7]
    Average Annual Total Returns, 10 Years [Percent] 13.06% [7]
    PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class
    Portfolio Company Adviser [Text Block] Pacific Investment Management Company LLC
    Current Expenses [Percent] 0.94%
    Average Annual Total Returns, 1 Year [Percent] 4.10%
    Average Annual Total Returns, 5 Years [Percent] 1.18%
    Average Annual Total Returns, 10 Years [Percent] 3.04%
    PIMCO VIT Short-Term Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] PIMCO VIT Short-Term Portfolio - Institutional Class
    Portfolio Company Adviser [Text Block] Pacific Investment Management Company LLC
    Current Expenses [Percent] 0.50%
    Average Annual Total Returns, 1 Year [Percent] 4.83%
    Average Annual Total Returns, 5 Years [Percent] 3.40%
    Average Annual Total Returns, 10 Years [Percent] 2.91%
    PIMCO VIT Total Return Portfolio - Institutional Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] PIMCO VIT Total Return Portfolio - Institutional Class
    Portfolio Company Adviser [Text Block] Pacific Investment Management Company LLC
    Current Expenses [Percent] 0.58%
    Average Annual Total Returns, 1 Year [Percent] 9.05%
    Average Annual Total Returns, 5 Years [Percent] 0.16%
    Average Annual Total Returns, 10 Years [Percent] 2.51%
    Putnam VT Sustainable Leaders Fund - Class IA [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Putnam VT Sustainable Leaders Fund - Class IA
    Portfolio Company Adviser [Text Block] Franklin Advisers, Inc
    Portfolio Company Subadviser [Text Block] Franklin Templeton Investments Management Limited
    Current Expenses [Percent] 0.63%
    Average Annual Total Returns, 1 Year [Percent] 10.99%
    Average Annual Total Returns, 5 Years [Percent] 10.62%
    Average Annual Total Returns, 10 Years [Percent] 14.98%
    Royce Capital Small-Cap Portfolio - Investment Class [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Royce Capital Small-Cap Portfolio - Investment Class
    Current Expenses [Percent] 1.18%
    Average Annual Total Returns, 1 Year [Percent] 8.93%
    Average Annual Total Returns, 5 Years [Percent] 10.66%
    Average Annual Total Returns, 10 Years [Percent] 7.88%
    TOPS®​ Aggressive ETF Portfolio - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] TOPS®​ Aggressive ETF Portfolio - Class 1
    Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.
    Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management, LLC (formerly, TOPS®​ Aggressive Growth ETF Portfolio)
    Current Expenses [Percent] 0.29%
    Average Annual Total Returns, 1 Year [Percent] 19.17%
    Average Annual Total Returns, 5 Years [Percent] 9.69%
    Average Annual Total Returns, 10 Years [Percent] 10.71%
    TOPS® Conservative ETF Portfolio - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] TOPS®​ Conservative ETF Portfolio - Class 1
    Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.
    Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management LLC
    Current Expenses [Percent] 0.31%
    Average Annual Total Returns, 1 Year [Percent] 10.39%
    Average Annual Total Returns, 5 Years [Percent] 4.61%
    Average Annual Total Returns, 10 Years [Percent] 5.25%
    TOPS®​ Moderate ETF Portfolio - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] TOPS®​ Moderate ETF Portfolio - Class 1
    Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.
    Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management LLC (formerly, TOPS®​ Moderate Growth ETF Portfolio)
    Current Expenses [Percent] 0.29%
    Average Annual Total Returns, 1 Year [Percent] 15.50%
    Average Annual Total Returns, 5 Years [Percent] 7.20%
    Average Annual Total Returns, 10 Years [Percent] 8.26%
    TOPS®​ Moderately Aggressive ETF Portfolio - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] TOPS®​ Moderately Aggressive ETF Portfolio - Class 1
    Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.
    Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management LLC (formerly, TOPS®​ Growth ETF Portfolio)
    Current Expenses [Percent] 0.29%
    Average Annual Total Returns, 1 Year [Percent] 18.31%
    Average Annual Total Returns, 5 Years [Percent] 8.85%
    Average Annual Total Returns, 10 Years [Percent] 9.80%
    Templeton Emerging Markets VIP Fund - Class 1 [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Templeton Emerging Markets VIP Fund - Class 1 (formerly, Templeton Developing Markets VIP Fund)
    Current Expenses [Percent] 1.12%
    Average Annual Total Returns, 1 Year [Percent] 46.64%
    Average Annual Total Returns, 5 Years [Percent] 5.73%
    Average Annual Total Returns, 10 Years [Percent] 10.68%
    Vanguard Variable Insurance Funds - Equity Income Portfolio [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Equity Income Portfolio
    Portfolio Company Adviser [Text Block] Wellington Management Company, LLP and Vanguard Portfolio Management, LLC
    Current Expenses [Percent] 0.29%
    Average Annual Total Returns, 1 Year [Percent] 16.79%
    Average Annual Total Returns, 5 Years [Percent] 12.59%
    Average Annual Total Returns, 10 Years [Percent] 11.51%
    Vanguard Variable Insurance Funds - International Portfolio [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - International Portfolio
    Portfolio Company Adviser [Text Block] Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.
    Current Expenses [Percent] 0.32%
    Average Annual Total Returns, 1 Year [Percent] 19.96%
    Average Annual Total Returns, 5 Years [Percent] 0.62%
    Average Annual Total Returns, 10 Years [Percent] 10.48%
    Vanguard Variable Insurance Funds - PRIMECAP Portfolio [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named Vanguard Variable Insurance Funds - Capital Growth Portfolio)
    Current Expenses [Percent] 0.34%
    Average Annual Total Returns, 1 Year [Percent] 28.97%
    Average Annual Total Returns, 5 Years [Percent] 13.97%
    Average Annual Total Returns, 10 Years [Percent] 14.96%
    Vanguard Variable Insurance Funds - Real Estate Index Portfolio [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Real Estate Index Portfolio
    Current Expenses [Percent] 0.26%
    Average Annual Total Returns, 1 Year [Percent] 3.11%
    Average Annual Total Returns, 5 Years [Percent] 4.50%
    Average Annual Total Returns, 10 Years [Percent] 5.08%
    Vanguard®​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio [Member]  
    Item 2. Key Information [Line Items]  
    Portfolio Company Name [Text Block] Vanguard®​ Variable Insurance Funds - Short-Term Investment-Grade Portfolio
    Current Expenses [Percent] 0.14%
    Average Annual Total Returns, 1 Year [Percent] 6.85%
    Average Annual Total Returns, 5 Years [Percent] 2.23%
    Average Annual Total Returns, 10 Years [Percent] 2.80%
    Administrative Charge for Face Amount Increases [Member]  
    Item 2. Key Information [Line Items]  
    Administrative Expenses, Description [Text Block] Administrative Charge For Face Amount Increases: [8]
    Administrative Expenses, When Deducted [Text Block] On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days [8]
    Administrative Expenses, Representative Investor [Text Block]

    Charge for a 49 year old male in the standard unismoke rate class

     

    On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days

     

    $3.45 per $1,000 of any increase in Face Amount

     

    $3.45 per $1,000 of any increase in Face Amount

    [8]
    Administrative Expense, Maximum [Dollars] $ 4.95 [8]
    Administrative Expense, Current [Dollars] 4.95 [8]
    Administrative Expense, Minimum [Dollars] 1.95 [8]
    Administrative Charge Initial Face Amount After The First2 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Administrative Expense, Current [Dollars] 1.46 [9]
    Administrative Expense, Minimum [Dollars] 0.16 [9]
    Administrative Charge Initial Face Amount During The First2 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Administrative Expense, Current [Dollars] 2.72 [9]
    Administrative Expense, Minimum [Dollars] $ 0.29 [9]
    Administrative Charge [Member]  
    Item 2. Key Information [Line Items]  
    Insurance Cost, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day [9]
    Administrative Expenses, Description [Text Block] Administrative Charge: [9]
    Administrative Expenses, Representative Investor [Text Block]

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000.

     

    On the Policy Effective Date and each Monthly Anniversary Day

     

    $1.11 per $1,000 of Initial Face Amount

     

    $0.82 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.44 per $1,000 of Initial Face Amount thereafter

    [9]
    Administrative Expense, Maximum [Dollars] $ 3.89 [9]
    Administrative Expense, Minimum [Dollars] $ 0.36 [9]
    Dollar-Cost Averaging [Member]  
    Item 2. Key Information [Line Items]  
    Name of Benefit [Text Block] Dollar-Cost Averaging
    Purpose of Benefit [Text Block] Allows for the systematic transfer of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub-Accounts.
    Brief Restrictions / Limitations [Text Block] • No transfers may be made into the Fixed Account.
    • Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.
    Name of Benefit [Text Block] Dollar-Cost Averaging
    Benefit Standard or Optional [Text Block] Optional
    Operation of Benefit [Text Block]

    Dollar-Cost Averaging

    If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account ("Source Sub-Account") or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.

    Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th​, 30th​, or 31st​. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.

    Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate Source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.

    Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

    Interest Rate [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee, Current [Percent] 3.00%
    Other Transaction Fee (of Other Amount), Maximum [Percent] 3.00%
    Lapse Protection Endorsement [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee, Description [Text Block] Lapse Protection Endorsement
    Other Transaction Fee, When Deducted [Text Block] Upon receipt of each premium payment
    Other Transaction Fee, Current [Percent] 1.00%
    Other Transaction Fee (of Other Amount), Maximum [Percent] 1.00%
    Name of Benefit [Text Block] Lapse Protection Endorsement
    Purpose of Benefit [Text Block] Guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule.
    Brief Restrictions / Limitations [Text Block] • The Minimum Monthly Requirement will vary by Policy benefits, Issue Age, sex and rate class of the Insured.
    • Any change in the benefits provided by this Policy made subsequent to the Policy Effective Date and during the Maximum Lapse Protection Period, may result in a change to the Minimum Monthly Requirement associated rates and values shown in the Policy Schedule.
    Name of Benefit [Text Block] Lapse Protection Endorsement
    Benefit Standard or Optional [Text Block] Standard
    Operation of Benefit [Text Block]

    Lapse Protection Endorsement. The rider guarantees that your Policy will not Lapse during the Maximum Lapse Protection Period set forth in your Policy Schedule, as long as the Accumulated Net Payments Received, less any Policy Debt, is greater than or equal to the Accumulated Minimum Monthly Requirement and the Policy Debt does not exceed the Cash Value.

    For the Maximum Lapse Protection Period, the Policy Value at the end of this period may not be sufficient to keep the Policy in force unless additional premiums are made. However, if the Policy Value is sufficient to pay Monthly Deductions, the Policy will not lapse, even after the end of this period. In addition, during this period any change to the

    benefits provided by the Policy may result in a change to the Minimum Monthly Requirement. If this occurs, the new Minimum Monthly Requirement, and associated values described in this endorsement, will be provided to you on a supplemental Policy Schedule, along with any applicable effective date.

    The Accumulated Minimum Monthly Requirement each month is equal to the Minimum Monthly Requirement for a given month plus the Accumulated Minimum Monthly Requirement as of the prior month ($0 for the first month of the first Policy Year) multiplied by one plus the Threshold Accumulation Factor shown in the Policy Schedule.

    The Accumulated Net Payments Received (calculated as of the last day of the month) for each month is equal to:

    •  the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year), plus

    •  the sum of all the Lapse Protection Net Premium received since the beginning of the month, Plus

    •  the Lapse Protection Interest for the month, less

    •  the reduction in Policy Value for any Withdrawal taken and any applicable Surrender Charges assessed since the beginning of the month.

    The Lapse Protection Net Premium is the amount after deducting the Lapse Protection Premium Expense Charge for that Policy Year, as shown on the Policy Schedule, for each premium payment.

    The Lapse Protection Interest is calculated as:

    •  the lesser of the Accumulated Fund Threshold and the sum of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year) PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, MULTIPLIED by the Threshold Accumulation Factor, shown in the Policy Schedule, plus

    •  the amount of the Accumulated Net Payments Received for the prior month ($0 for the first month of the first Policy Year PLUS the sum of all the Lapse Protection Net Premium received since the beginning of the month, in excess of the Accumulated Fund Threshold, if any, MULTIPLIED by the Excess Accumulation Factor, shown on the Policy Schedule.

    The Accumulated Fund Threshold for the first month of a Policy Year is equal to:

    •  the Accumulated Fund Threshold for the prior month ($0 for the first month of the first Policy Year) multiplied by 1 plus the Threshold Accumulation Factor, PLUS

    •  the Annual Threshold Premium, as shown on the Policy Schedule, for that Policy Year.

    For all other months, the Accumulated Fund Threshold is equal to the Accumulated Fund Threshold for the prior month multiplied buy 1 plus the Threshold Accumulation Factor.

    Any adjustments made due to a decrease in Face Amount, including payments made due to benefits provided by any rider attached to the Policy, may reduce the Accumulated Net Payments Received, Accumulated Minimum Monthly Requirements, and Accumulated Fund Threshold.

    If the Policy is maintained under this endorsement, Monthly Deductions will continue.

    This endorsement terminates when the Policy terminates. If the Policy is reinstated according to the applicable Policy provisions, this endorsement will also be reinstated.

    Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $250,000 Face Amount. The Policy Schedule indicates a Lapse Protection Premium Expense Charge of 1.00%, the initial Minimum Monthly Requirement is $161.88, the Threshold Accumulation Factor is 0.446150%, the Excess Accumulation Factor is 0.105844%, and an initial Threshold Premium of $5,980.25. The owner makes an initial premium payment of $200, which is an Lapse Protection Net Premium Received of $198 ($200 less 1.00%, the Lapse Protection Premium Expense Charge).

    In the first Policy month, the Accumulated Fund Threshold ($5,980.25) is equal to the initial Threshold Premium. The Accumulated Minimum Monthly Requirement is $162.60 which is $161.88 (the initial Minimum Monthly Requirement) multiplied by 1.00446150 (one plus the Threshold Accumulation Factor). The Accumulated Net Payments Received ($198.00) is less than the Accumulated Fund Threshold ($5,980.25), so the Threshold Accumulation Factor is applied to the entire Accumulated Net Payments Received value. The Accumulated Net Payments Received in the first Policy

    month, after accumulation, is $198.88 ($198.00 multiplied by 1.00446150). Because the Accumulated Net Payments Received of $198.88 equals or exceeds the Accumulated Minimum Monthly Requirement $162.60, the conditions have been met for the first month for the rider to remain in effect guaranteeing the Policy remains in force.

    Assume on each of the 23 subsequent monthly anniversaries, the owner has made premium payments of the same amount and taken no partial surrenders or Policy Loans. The total premiums paid for the Policy equals $4,800.00. The Accumulated Net Payments Received at the end of Policy month 24 is $5,026.30 and the Accumulated Minimum Monthly Requirement is $4,109.26. Because the Accumulated Net Payments Received equals or exceeds the Accumulated Minimum Monthly Requirement, the conditions have been met on this monthly anniversary day. Since the rider remains in effect, the Policy is guaranteed to remain in force. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $250,000.

    Assume that starting with the 24th monthly anniversary, the owner misses the next six anticipated monthly premium payments. At the end of Policy month 30, the Accumulated Net Payments Received has accumulated to $5,162.36 while the Accumulated Minimum Monthly Requirement has accumulated to $5,207.02. Also assume that the Cash Value of the Policy is zero. Because the Accumulated Net Payments Received is less than the Accumulated Minimum Monthly Requirement, the owner must pay additional premiums within the 60-day grace period to keep the rider in effect and the Policy in force. Under these circumstances, if the insured dies outside of the 60-day grace period without having made the necessary additional premium payments, the death benefit will be $0.

    Long-Term Care Inflation Protection Option [Member]  
    Item 2. Key Information [Line Items]  
    Optional Benefit Charge, Description [Text Block] Long-Term Care Inflation Protection Option
    Optional Benefit Charge, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day when Inflation Protection Option is selected
    Optional Benefit Expense, Maximum [Dollars] $ 0.5
    Optional Benefit Expense, Current [Dollars] 0.5
    Optional Benefit Expense, Minimum [Dollars] $ 0
    Name of Benefit [Text Block] Long-Term Care Inflation Protection Option
    Purpose of Benefit [Text Block] On each Policy Anniversary where this increase is purchased, this protection will provide for a 5% compound increase on each Policy Anniversary that will be factored into the calculation of various values used to calculate benefits under the Long-Term Care Rider.
    Brief Restrictions / Limitations [Text Block] • This rider must be elected at Policy issue.
    • Additional cost applies.
    • On each Policy Anniversary, the increase provided for under this rider must be elected and purchased.
    • If you decline to purchase any increase under this rider on a Policy Anniversary, you will no longer have the right to purchase increases on any future Policy Anniversary.
    Name of Benefit [Text Block] Long-Term Care Inflation Protection Option
    Benefit Standard or Optional [Text Block] Optional
    Operation of Benefit [Text Block]

    Long-Term Care Inflation Protection Option. If you selected optional inflation protection, you can purchase a 5% compound inflation protection increase on each Policy Anniversary, with no evidence of insurability. The right to purchase the inflation protection increase in effect on the date the Policy is issued is shown on the Schedule Page.

    Every annual inflation protection increase purchased by you will be factored into the calculation of the following values: Base Maximum Monthly LTC Benefit Value, Base LTC Benefit Pool, Current Maximum Monthly LTC Benefit Value, Current LTC Benefit Pool, if any.

    Starting with the first Policy Anniversary, and for as long as you continue to purchase each year's inflation protection increase, we will send you written notification regarding that year's right to purchase. You must return your request to purchase that year's inflation protection increase within the timeframe stated in the notification.

    If you decline to purchase any annual inflation protection increase, you will no longer have the right to purchase an inflation protection increase on any future Policy Anniversary. The right to purchase inflation protection under this rider cannot be reinstated once terminated.

    The right to purchase annual inflation protection increases will continue without regard to the Insured's Attained Age, claim status, claim history, or length of time the Insured has been covered under this rider, as long as the following conditions are satisfied:

    •  You continue to purchase each year's inflation protection increase,

    •  The LTC Benefit Limit is greater than zero, and

    •  This rider remains in force.

    On the Policy Anniversary on which you do not purchase that year's inflation protection increase, the following will occur:

    •  Your right to purchase any future annual inflation protection increase will terminate, and

    •  You will no longer be charged the optional Inflation Protection monthly LTC charge.

    Even if your right to purchase this rider is terminated, any previously purchased increases will continue to be included in the calculation of benefits under this rider.

    Long-Term Care Rider Charge [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee, Description [Text Block] Long-Term Care Rider Charge: [10]
    Other Transaction Fee, Maximum [Dollars] $ 2.07 [10]
    Other Transaction Fee, Current [Dollars] 2.07 [10]
    Other Transaction Fee, Minimum [Dollars] $ 0.05 [10]
    Insurance Cost, Representative Investor [Text Block]

    Charge for a 49 year old male in the standard unismoke rate class with a Face Amount of $100,000

     

    On each Monthly Anniversary Day starting from the Effective Date

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

     

    The Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19 plus the Current LTC Benefit Pool less the Base LTC Benefit Pool divided by 1,000 and that result multiplied by $0.19

    [4],[5]
    Administrative Expenses, When Deducted [Text Block] On each Monthly Anniversary Day starting from the Effective Date [10]
    Long-Term Care Rider [Member]  
    Item 2. Key Information [Line Items]  
    Name of Benefit [Text Block] Long-Term Care Rider
    Purpose of Benefit [Text Block] Provides access to Death Benefit proceeds and extended benefit pool if the Insured has been certified by a Licensed Health Care Practitioner as chronically ill as defined in the rider.
    Brief Restrictions / Limitations [Text Block] • Automatically issued on your Policy if eligibility requirements are met. The Policy will not be issued without this rider.
    • Additional cost applies.
    • Subject to the eligibility and other conditions for benefits as described in the rider. Some of the conditions include the Insured being certified as chronically ill and meeting the 90-day Elimination Period before benefits are payable.
    • Chronic Illness must be certified by a Licensed health care practitioner (not including the Owner, Insured, or a family member).
    • Benefit payments are made monthly and may not cover all long-term care expenses incurred.
    • If an LTC claim is made and benefit payments are in effect, no claims may be filed under the Terminal Illness Accelerated Death Benefit Endorsement.
    • If a Policy Loan or partial withdrawal is taken while the rider is in Active Claim Status, this rider will terminate.
    Name of Benefit [Text Block] Long-Term Care Rider
    Benefit Standard or Optional [Text Block] Standard
    Operation of Benefit [Text Block]

    Long-Term Care Rider. This rider is automatically issued with the Policy. This rider provides an acceleration of the death benefits and extended benefits under the Policy for long-term care benefits for Qualified Long-Term Care Services incurred for Home Health Care Services, Adult Day Care Services, Assisted Living Facility Services, and Nursing Home Services. You may make a claim for a Long-Term Care Benefit (the "LTC Benefit"). The LTC Benefit is subject to the restrictions contained in this rider and all conditions for eligibility must be met. If a claim for the LTC Benefit is approved, we will pay you for Qualified Long-Term Care Services subject to the Maximum Monthly LTC Benefit Amount and the Current Maximum LTC Benefit.

    30-Day Right to Cancel

    You have 30 days after the rider is first delivered to you to examine and return to us or to the financial professional who sold it to you, if you decide not to keep this rider. We will cancel the rider and the Policy. The returned Policy and rider will be treated if they had never been issued. We will refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to us, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to us.

    Rider Terms

    Activities of Daily Living: Means the six basic human functions necessary for a person to live independently are:

    •  Eating

    •  Toileting

    •  Transferring oneself into or out of bed, chair, wheelchair

    •  Bathing

    •  Dressing

    •  Continence

    The rider attached to your Policy contains more detailed information about these self-care functions.

    Active Claim Status: Means that the Insured has satisfied all conditions in the Eligibility for LTC Benefits, we have approved the LTC Benefit claim, and LTC Benefit payments have begun. Active Claim Status ends if the Insured no longer satisfies conditions for Eligibility for LTC Benefits.

    Assistive Device: Means a device that enables a person to perform an Activity of Daily Living that they otherwise would not be able to perform independently. Some examples of Assistive Devices include a walker, transfer chair, and grab bars.

    Chronically Ill: Means that the Insured has been certified, within the preceding 12 months, by a Licensed Health Care Practitioner as:

    •  Being unable to perform, without Substantial Assistance from another individual, at least two Activities of Daily Living for 90 consecutive days due to a loss of functional capacity, or

    •  Requiring Substantial Supervision to protect the Insured from threats to health and safety due to Sever Cognitive Impairment.

    The Insured shall be deemed to be capable of performing an Activity of Daily Living without Substantial Assistance if the Insured can perform the Activity of Daily Living while using an Assistive Device.

    Elimination Period: Means a period of 90 calendar days beginning the day after the Insured is certified as Chronically Ill and receiving Qualified Long-Term Care Services. Benefits are not paid for Qualified Long-Term Care Services during the Elimination Period but will be paid retroactively once the Elimination Period has been satisfied. If the Insured does not remain Chronically Ill for 90 consecutive calendar days, the Insured may combine multiple periods of being Chronically Ill to satisfy the Elimination Period. However, the required 90 days of the Elimination Period must be accumulated within a continuous period of 730 days.

    Family Member: Means the Owner or Insured's spouse and anyone who is related to the Owner or Insured or the Owner's or Insured's spouse by the following degree by blood, marriage, divorce, adoption or operation of law: parents, in-laws, grandparents, siblings, children, grandchildren, aunts, uncles, nephews and nieces.

    Hands-on Assistance: Means physical assistance (minimal, moderate or maximal) without which the Insured would not be able to perform the Activities of Daily Living.

    Home: Means the Insured's primary residence where Qualified Long-Term Care Services are provided. Home does not include any facility in which the Insured resides and is dependent on others for Substantial Supervision or Substantial Assistance with Activities of Daily Living.

    Insured: Means the person shown on the Policy Schedule upon whose life the Policy insures.

    Licensed Health Care Practitioner: Means any physician (as defined in section 1861(r)(1) of the Social Security Act) and any registered professional nurse, licensed social worker, or other individual who meets such requirements as may be prescribed by the Secretary of the Treasury. It does not include the Owner, Insured or a Family Member.

    Plan of Care: Means a written plan for Qualified Long-Term Care Services prepared by a Licensed Health Care Practitioner for the Insured. This Plan of Care must detail information such as the type, frequency, anticipated duration, daily hours, and provider qualifications for all services necessary to address the Insured's needs. All services must adhere to generally accepted standards of practice appropriate and consistent for a Chronically Ill Individual and be suitable to fulfill the Insured's care requirements.

    Qualified Long-Term Care Services: Means services that meet the requirements of Section 7702B(c)(1) of the Internal Revenue Code of 1986, as amended, as follows: necessary diagnostic, preventive, therapeutic, curative, treatment, mitigation and rehabilitative services, and maintenance or personal care services which are required by a chronically ill individual and are provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

    Severe Cognitive Impairment: Means a loss or deterioration in the Insured's intellectual capacity that is (i) comparable to (and includes) Alzheimer's disease and similar forms of irreversible dementia, and (ii) measured by clinical evidence and standardized tests that reliably measure impairment in the following areas:

    •  The Insured's short or long-term memory,

    •  The Insured's orientation as to person (such as who they are), place (such as their location), or time (such as day, date, and year), and

    •  The Insured's deductive or abstract reasoning.

    Standby Assistance: Means the presence of another person within arm's reach of the Insured that is necessary, by physical intervention, to prevent injury to the Insured while the Insured is performing the Activities of Daily Living.

    Substantial Assistance: Means Hands-On Assistance or Standby Assistance.

    Substantial Supervision: Means continual supervision (which may include cuing by verbal prompting, gestures, or other demonstrations) by another person that is necessary to protect the Insured from threats to his or her health or safety due to Severe Cognitive Impairment.

    Written Certification: Means written documentation from a Licensed Health Care Practitioner certifying that the Insured is Chronically Ill and prescribing a Plan of Care.

    Eligibility, Limitations, and Exclusions

    To become eligible for the LTC Benefit payments, the following conditions must be met:

    •  We receive your written request for the LTC Benefit,

    •  A Licensed Health Care Practitioner certifies that the Insured is Chronically Ill and prescribes a Plan of Care,

    •  The Policy and this rider are in force,

    •  The applicable Elimination Period has been satisfied,

    •  We receive written consent from any irrevocable beneficiaries or assignee of record named in the Policy, and

    •  The benefit payment is made in respect to a month when the Insured is Chronically Ill and only for Qualified Long-Term Care Services provided pursuant to a Plan of Care prescribed by a Licensed Health Care Practitioner.

    We will not pay LTC Benefits arising in whole or in part from a pre-existing condition. A pre-existing condition is any condition for which medical advice or treatment was recommended by, received from, a provider of health care services, within six months preceding the effective date of this rider.

    The rider will not pay benefits for any Chronic Illness caused by:

    •  Any attempt at suicide or intentionally self-inflicted injury, while sane or insane,

    •  Committing or attempting to commit or participating in a riot, insurrection, or involvement in an illegal occupation,

    •  Alcoholism or drug addiction, or

    •  Declared or undeclared war or any act of war.

    Maximum Monthly LTC Benefit Amount

    The Base Maximum Monthly LTC Benefit Amount on the Policy Effective Date, is equal to the amount shown in the Policy Schedule. The Base Maximum Monthly LTC Benefit Amount may increase or decrease after the Policy Effective Date as described in the "Long-Term Care Inflation Protection Option" section and "Impact on Your Policy" section.

    The Maximum Monthly LTC Benefit Amount is the maximum monthly benefit amount available each calendar month under this rider on any date on or after the Policy Date and is equal to:

    •  The Base Maximum Monthly LTC Benefit Amount, plus

    •  80% of the result of the following:

    a)  1/48 of the Current LTC Benefit Pool minus

    b)  the Base Maximum Monthly LTC Benefit Amount

    On the date a claim is approved, the Maximum Monthly LTC Benefit Amount will be fixed at the amount in effect on that date. For the duration of the claim, that amount may increase and/or decrease as described in the "Benefits While on Claim" section below.

    The Maximum Monthly LTC Benefit Amount will never be less than the Base Maximum Monthly LTC Benefit Amount shown in the Policy Schedule.

    Current LTC Benefit Pool

    The Current LTC Benefit Pool is the total dollar amount available for LTC Benefits under this rider at the time of claim. The Current LTC Benefit Amount Pool is equal to the greatest of:

    •  The Base LTC Benefit Pool,

    •  The Market Value LTC Benefit Pool, and

    •  The Protected LTC Benefit Pool.

    On the date a claim is approved, the Current LTC Benefit Pool will be fixed at the dollar amount in effect on that date. The Current LTC Benefit Pool in effect will be the prior month Current LTC Benefit Pool adjusted for any premium, Face Amount changes, Withdrawals or loans during the month. For the duration of the claim, the Current LTC Benefit Pool will change as described in the "Benefits While on Claim" provision below.

    Unless you have requested a decrease in the Policy's Face Amount or make a withdrawal under the Policy, the Current LTC Benefit Pool will never be less than the Base LTC Benefit Pool shown in the Policy Schedule minus the sum of any LTC Benefits paid under this rider.

    The Base LTC Benefit Pool on the Policy Effective Date, is equal to the Base LTC Benefit Pool shown in the Policy Schedule. The Base LTC Benefit Pool may increase or decrease after the Policy Date as described in the "Long-Term Care Inflation Protection Option", and "Impact on Your Policy" sections.

    The Market Value LTC Benefit Pool is equal to the Unloaned Policy Value multiplied by the Market Benefit Multiplier shown on your Policy schedule. This pool may increase or decrease daily and is adjusted as described in the "Long-Term Care Inflation Protection Option" section.

    The Protected LTC Benefit Pool on the first Policy Anniversary is equal to the Protected LTC Percentage (shown on your Policy schedule) multiplied by the Unloaned Policy Value as of the end of the first Policy Year multiplied by the Market Benefit Multiplier shown on your Policy schedule.

    On each subsequent Policy Anniversary while this rider is in force, the Protected LTC Benefit Pool will equal the greater of:

    •  The Protected LTC Percentage (shown on the Policy schedule) multiplied by the Unloaned Policy Value as of the end of the previous Policy Year multiplied by the Market Benefit Multiplier, and

    •  The Protected LTC Pool in effect immediately prior to that Policy Anniversary.

    The Protected LTC Benefit Pool in effect for any Policy Year may increase and/or decrease due to the Long-Term Care Inflation Protection Option Increases, LTC Benefit payments, withdrawals, loans, and Policy changes.

    Claims Provisions

    We prefer that either you or the Insured notify us as soon as the Insured first becomes eligible and may soon need care covered by this rider. We must receive your intent to file a claim for the LTC Benefit at our Administrative Office via written request or by telephone. The Request should include at least the Insured's name, Policy number and the address to which claim forms should be sent.

    We have forms used for making a claim and for providing Proof of Loss. These forms will be sent to you within 15 days of the date we receive your Notice of Claim. If the claim forms are not sent within this 15 day period, and you

    provide Written Certification and proof of loss in a format other than our claim forms, you will be deemed to have complied with the claim requirement.

    Completed claim forms and Written Certification verifying the occurrence of a Chronic Illness must be submitted within 90 days after you receive Written Confirmation from a Licensed Health Care Practitioner. Failure to provide proof within this period will not invalidate or diminish the claim, provided that the required proof is submitted as soon as reasonably possible and, except in cases of legal incapacity, no later than one year from the date of proof would otherwise by required.

    A licensed Health Care Practitioner must re-certify that the Insured is Chronically Ill and prescribe a Plan of Care at least once every 12 months. We reserve the right to request a re-certification that the Insured remains Chronically Ill, but not more often than every 90 days, following an initial certification. The practitioner should either prescribe a new Plan of Care or confirm the existing Plan of Care during each re-certification. After we confirm Chronic Illness status, the certification cannot be rescinded, and no additional certifications will be conducted until the 90-day period has passed.

    We reserve the right to independently assess the Insured's Chronic Illness and benefit eligibility. As part of this assessment we have the right to require that the Insured be examined by a Licensed Health Care Practitioner chosen by us. We will pay for this examination. In the event of conflicting opinions, eligibility for LTC Benefits will be determined by a third medical opinion provided by a Licensed Health Care Practitioner who is mutually agree upon by the Insured and us. The Insured must be certified as Chronically Ill for the entire period for which LTC Benefits are being paid.

    If the Insured is not re-certified as Chronically Ill, or at your request, we will close your claim. Prior to closing your claim, we will send you written notification of the remaining benefits and options for reallocating any remaining Fixed Account Value and future Net Premium Payments. If you leave the Accumulation Value, if any, in the Fixed Account and continue to allocate any future Net Premium Payments to the Fixed Account, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit amount will remain fixed.

    If, on the date your claim is closed, the Policy's Face Amount and/or Policy Value are greater than zero, and you submit a request to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate any future Net Premium Payments to the Sub-Account(s), the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed, and will be calculated as in the Maximum Monthly LTC Benefit Amount and Current LTC Benefit Pool section above, but will be floored at the amounts during claim.

    LTC Benefits will be paid for comparable Qualified Long-Term Care Services received in any state or jurisdiction within the United States, its territories, or possessions other than the state of issue, provided such LTC Benefits would have been payable in the state or jurisdiction where this rider was originally issues. This applies regardless of differences in facility licensing, certification, registration, or similar regulatory requirements between states.

    According to the terms and conditions of this rider, we will pay claims for Qualified Long-Term Care Services provided outside of the United States, its territories or possessions. The Insured is not required to return to the United States for benefit certification. However, the Licensed Health Care Practitioner providing the Plan of Care must be licensed to practice in the United States, its territories or possessions and all claims information and medical records must be submitted in English.

    Extension of LTC Benefits

    If the Policy terminates while the rider is in Active Claim Status, we will continue to pay the LTC Benefit until the earliest of:

    •  The death of the Insured,

    •  Transition from Active Claim Status has completed, or

    •  The Maximum LTC Benefit Pool has been exhausted.

    Any extension of benefit is subject to all terms and conditions of this rider including eligibility for LTC Benefits and claim requirements. If the current maximum LTC benefit pool has been exhausted, no death benefit will be due upon the death of the Insured.

    Benefits While on Claim

    On the date a claim under this rider is approved, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will be fixed at the dollar amount in effect on that date. Also, on the date a claim under this rider is approved,

    we will automatically transfer out any Variable Account Value and transfer to the Fixed Account. See "Impact on Your Policy" below for additional information.

    Any amounts paid in a calendar month under this rider will reduce the Current LTC Benefit Pool and the Face Amount, dollar for dollar. The Base LTC Benefit Pool will be reduced by a pro-rata amount to the Face Amount.

    If purchased, the Long-term Care Inflation Protection Option increase will increase the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Long-Term Care Inflation Protection Option" section.

    An increase and/or decrease in the Policy's Face Amount or a Withdrawal under the Policy will likewise increase and/or decrease the Maximum Monthly LTC Benefit and the Current LTC Benefit Pool, as described in the "Impact on Your Policy" section.

    If your claim is closed, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit will remain fixed unless you choose to transfer any remaining Fixed Account Value to the Sub-Account(s) and/or allocate future Net Premiums to the Sub-Account(s). Upon your Request to make such transfer and/or allocation, the Current LTC Benefit Pool and the Maximum Monthly LTC Benefit Amount will no longer be fixed and will be calculated as described in the "Current LTC Benefit Pool" and "Maximum Monthly LTC Benefit Amount" sections, but will be floored at the amounts during claim.

    Impact on Your Policy

    Automatic Transfer to Fixed Account. On the date a claim under this rider is approved, we will automatically transfer any Variable Account Value out of the Sub-Accounts and transfer into the Fixed Account. While this rider is in Active Claim Status, no transfers out of the Fixed Account into Sub-Accounts will be permitted. In addition, Net Premiums received during this period will be allocated to the Fixed Account.

    LTC Benefit Payments. While Policy Value is greater than zero, LTC Benefit payments will reduce the Policy Value dollar for dollar and will be taken from the Fixed Account.

    LTC Benefit Payments on Face Amount. While the Policy's Face Amount is greater than zero, benefit payments under this rider will reduce the Policy's Face Amount dollar for dollar. This may reduce the Policy's Face Amount below the minimum.

    Monthly Deductions. When this rider is in Active Claim Status, Monthly Deductions required to maintain the Policy continue, however the LTC Rider Monthly Charge is waived.

    Policy Changes, Loans, and Withdrawals. When the rider is in Active Claim Status, Policy Changes, Loans, and withdrawals are not permitted.

    Interaction with Terminal Illness Accelerated Death Benefit Endorsement. Upon satisfying all the conditions in Eligibility for LTC Benefits and after we approve the long-term care claim, acceleration of the death benefit for terminal illness is not permitted under this endorsement.

    Residual Death Benefit. If the LTC Benefit payments deplete the Face Amount that was effective on the date of your first LTC Benefit payment, a Residual Death Benefit will be determined. The Residual Death Benefit will be the lesser of:

    •  5% of the Face Amount effective on the date immediately prior to your first LTC Benefit payment, or

    •  $10,000.

    The Residual Death Benefit will be reduced by an amount equal to 5% of any Policy Debt. Repayment of Policy Debt will increase the Residual Death Benefit by an amount equal to 5% of the repayment.

    Protection Against Unintended Lapse

    To protect against unintended lapse, you may designate at least one person, other than the Owner, to receive notices about potential lapse or Policy termination due to nonpayment of Planned Premium. We will remind you at least every two years after the Policy Effective Date of your right to make this designation. You are not required to designate an additional person to receive notices. The designation does not constitute acceptance of any liability on the third-party for services provided to the Insured.

    Termination

    The rider will terminate on the earliest of:

    •  Your written notice to terminate this rider. If you request to terminate this rider the Policy to which it is attached will also be terminated. We shall refund a pro rata share of any modal premium paid by the Insured for any period past the requested month of termination,

    •  Policy termination,

    •  Failure to pay sufficient premium to maintain the rider,

    •  Death of the Insured,

    •  Your submission, after all of the conditions in Eligibility for Benefits are first satisfied, of a valid claim for any benefits provided by an accelerated death benefit for terminal illness or rider attached to the Policy,

    •  The date that the Maximum LTC Benefit is exhausted, and

    •  The date that a Partial Surrender or a Policy Loan is taken from the Policy while on Active Claim Status.

    Reinstatement

    If the Policy terminates and is subsequently reinstated, this rider may also be reinstated subject to the terms and conditions for reinstatement in the Policy. Upon reinstatement, this rider will only provide benefits for Qualified Long-Term Care Services incurred after the date of reinstatement.

    We will reinstate the Policy and this rider without evidence of insurability, if we receive:

    •  The Owner's written request within 5 months after the end of the Grace Period,

    •  Due proof that is satisfactory to us that the Insured was Chronically Ill at the end of the Grace Period outlined in the Policy, and

    •  Payment of overdue premium and/or charges for this rider.

    Rider LTC Nonforfeiture Benefit

    After the Policy and this rider have been In Force for three Policy Years, subject to the terms and conditions of this rider and the limitations and conditions outlined below, this provision will cover eligible claims for Qualified Long-Term Care Services up to the limit described below which begin at any time after this rider has lapsed or terminated for any reason. The Nonforfeiture Benefit under this provision will continue as paid-up long-term care coverage until the earlier of:

    •  The death of the Insured, or

    •  The date the LTC Nonforfeiture Benefit Limit has been reduced to zero.

    The LTC Nonforfeiture Benefit Limit will be an amount equal to the greater of:

    •  One month's Maximum Monthly LTC Benefit Amount as of the date this rider lapses or terminates, or

    •  An amount equal to the sum of Monthly rider Charges paid for this rider.

    The Maximum Monthly LTC Nonforfeiture Benefit will be an amount equal to the applicable Maximum Monthly LTC Benefit elected at initial claim or at time of the first claim under the Nonforfeiture Benefit if no prior claim has occurred, as of the date this rider Lapses or terminates, and will not change.

    The LTC Nonforfeiture Benefit Limit and the Maximum Monthly LTC Nonforfeiture Benefit are not subject to Long-Term Care Inflation Protection Option increases.

    No benefits are payable under this provision until benefits, if any, under the "Extension of LTC Benefits" section are no longer in effect. The sum of any benefits paid under the "Extension of LTC Benefits" section plus any benefits paid under this Rider LTC Nonforfeiture Benefit" section will not exceed the LTC Benefit Limit on the date this rider lapsed or terminated.

    Maximum Surrender Charge [Member]  
    Item 2. Key Information [Line Items]  
    Other Surrender Fees, Current [Dollars] $ 57.75 [2]
    Minimum Surrender Charge [Member]  
    Item 2. Key Information [Line Items]  
    Other Surrender Fees, Minimum [Dollars] $ 3 [2]
    Mortality and Expense Risk Charge [Member]  
    Item 2. Key Information [Line Items]  
    Mortality and Expense Risk Fees, Description [Text Block] Mortality and Expense Risk Charge:
    Mortality and Expense Risk Fees, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day
    Mortality And Expense Risk Fees (of Other Amount), Maximum [Percent] 0.60%
    Mortality And Expense Risk Fees (of Other Amount), Current [Percent] 0.096%
    Mortality and Expense Risk Charge [Member] | First 10 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Mortality And Expense Risk Fees (of Other Amount), Current [Percent] 0.204%
    Net Cost of Loans For Carryover Loans After the First 10 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee, Current [Percent] 3.00%
    Other Transaction Fee (of Other Amount), Maximum [Percent] 3.25%
    Optional Benefit Expense (of Benefit Base), Maximum [Percent] 0.25% [11]
    Net Cost of Loans for Carryover Loans During The First 10 Policy Loans [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee, Current [Percent] 4.00%
    Other Transaction Fee (of Other Amount), Maximum [Percent] 5.00%
    Optional Benefit Expense (of Benefit Base), Maximum [Percent] 2.00% [11]
    Optional Benefit Expense (of Benefit Base), Current [Percent] 1.00% [11]
    Net Cost of Loans for Standard Loans After the First 10 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Optional Benefit Expense (of Benefit Base), Current [Percent] 0.00% [11]
    Net Cost of Loans For Standard Loans During the First 10 Policy Years [Member]  
    Item 2. Key Information [Line Items]  
    Other Transaction Fee (of Other Amount), Maximum [Percent] 5.00%
    Optional Benefit Expense (of Benefit Base), Current [Percent] 2.00% [11]
    Net Cost of Loans [Member]  
    Item 2. Key Information [Line Items]  
    Optional Benefit Charge, Description [Text Block] Net Cost of Loans [11]
    Optional Benefit Charge, When Deducted [Text Block] On each Policy Anniversary, as applicable [11],[12]
    Option 1 Death Benefit [Member]  
    Item 2. Key Information [Line Items]  
    Standard Death Benefit [Text Block]

    Option 1 — Payment for a Fixed Period.  Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

    Option 2 Death Benefit [Member]  
    Item 2. Key Information [Line Items]  
    Standard Death Benefit [Text Block]

    Option 2 — Life Income with Payments for a Guaranteed Period.  Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

    Option 3 Death Benefit [Member]  
    Item 2. Key Information [Line Items]  
    Standard Death Benefit [Text Block]

    Option 3 — Interest Income.  Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

    Option 4 Death Benefit [Member]  
    Item 2. Key Information [Line Items]  
    Standard Death Benefit [Text Block]

    Option 4 — Payments for a Fixed Amount.  Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

    Policy Loans [Member]  
    Item 2. Key Information [Line Items]  
    Name of Benefit [Text Block] Policy Loans
    Purpose of Benefit [Text Block] Allows Owner to borrow from Policy's Cash Value.
    Brief Restrictions / Limitations [Text Block] • Not available during the first Policy Year.
    • Maximum loan amount is 99% of Cash Value.
    • Minimum loan amount is $500.
    • Certain Policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a Policy loan.
    • If a Policy Loan is taken while the Long-term Care Rider is in active claim status, the rider will terminate.
    Name of Benefit [Text Block] Policy Loans
    Benefit Standard or Optional [Text Block] Standard
    Portfolio Rebalancing [Member]  
    Item 2. Key Information [Line Items]  
    Name of Benefit [Text Block] Portfolio Rebalancing
    Purpose of Benefit [Text Block] Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.
    Brief Restrictions / Limitations [Text Block] • Rebalancing transfers cannot be made into Fixed Account.
    • Minimum Variable Account Value of $100 required.
    Name of Benefit [Text Block] Portfolio Rebalancing
    Benefit Standard or Optional [Text Block] Optional
    Operation of Benefit [Text Block]

    Portfolio Rebalancing

    At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th​, 30th​ or 31st​. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.

    Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.

    Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.

    Reservation of Rights [Member]  
    Item 2. Key Information [Line Items]  
    Operation of Benefit [Text Block]

    Reservation of Rights

    Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

    Telephone Transfers [Member]  
    Item 2. Key Information [Line Items]  
    Operation of Benefit [Text Block]

    Telephone Transfers

    Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.

    Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.

    A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.

    Terminal Illness Accelerated Death Benefit Endorsement [Member]  
    Item 2. Key Information [Line Items]  
    Name of Benefit [Text Block] Terminal Illness Accelerated Death Benefit Endorsement
    Purpose of Benefit [Text Block] Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.
    Brief Restrictions / Limitations [Text Block] Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:
    • The lesser of 60% of the current face amount of the Policy or $1,000,000; minus
    • Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.
    • Minimum acceleration permitted is $15,000
    • The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.
    • Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.
    Name of Benefit [Text Block] Terminal Illness Accelerated Death Benefit Endorsement
    Benefit Standard or Optional [Text Block] Standard
    Operation of Benefit [Text Block]

    Terminal Illness Accelerated Death Benefit Endorsement. This endorsement is automatically issued with the Policy. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest. If a claim is filed under this endorsement, the LTC Rider will terminate and when the benefits under the LTC Rider are being utilized (claim is filed under the LTC Rider) no claims under the Terminal Illness Accelerated Death Benefit are allowed.

    The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.

    The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

    •  the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

    •  any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

    Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

    Withdrawal Charge [Member]  
    Item 2. Key Information [Line Items]  
    Other Surrender Fees, Current [Dollars] $ 25
    Other Transaction Fee, Description [Text Block] Withdrawal Charge:
    Other Transaction Fee, When Deducted [Text Block] At the time of each withdrawal of Policy Value
    Other Transaction Fee, Maximum [Dollars] $ 25
    Other Transaction Fee, Current [Dollars] $ 25
    Other Transaction Fee (of Other Amount), Maximum [Percent] 2.00%
    [1] As a percentage of Fund assets.
    [2] The Surrender Charge varies based on individual characteristics such as the Insured's Issue Age, sex and rate class, and decreases each Policy Year until it reaches zero after the fourteenth Policy Year. The Surrender Charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
    [3] Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See "CHARGES AND DEDUCTIONS, Transfer Fee" in the Prospectus.
    [4] Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges

    shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "Charges and Deductions-Monthly Deduction".

    [5] See definition of Net Amount at Risk in the Special Terms.
    [6] The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.
    [7] These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.
    [8] The administrative charge for Face Amount increases varies based on the Insured's Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
    [9] We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured's Issue Age, sex and rate class and the Face Amount. The administrative charge will be higher in the first 2 Policy Years compared to thereafter. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy's specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
    [10] The charge for the Long-Term Care Rider varies based on the Insured's Issue Age, sex, rate class, and the Long-Term Care Inflation Protection Option if elected. The rider charge shown for the representative insured may not be typical of the charges you will pay. Your Policy's specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. If the rider is in Active Claim Status, the monthly charge for this rider will be waived.
    [11] The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% current (5.00% guaranteed) for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans (standard and carry-over) in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed).
    [12] As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured's death.

    XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 80 101 1 true 79 0 false 2 false false R1.htm 010006 - Disclosure - N-6 Sheet http://xbrl.sec.gov/vip/role/N6 N-6 Cover 1 false false All Reports Book All Reports ck0000948923-20260424.xsd ck0000948923-20260424_def.xml ck0000948923-20260424_lab.xml ck0000948923-20260424_pre.xml tm268049d6_n6a.htm http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/vip/2026 true false JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm268049d6_n6a.htm": { "nsprefix": "ck0000948923", "nsuri": "http://protectivelife.com/20260424", "dts": { "schema": { "local": [ "ck0000948923-20260424.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.sec.gov/dei/2026/dei-2026.xsd", "https://xbrl.sec.gov/vip/2026/vip-2026.xsd", "https://xbrl.sec.gov/vip/2026/vip-n6-2026.xsd" ] }, "definitionLink": { "local": [ "ck0000948923-20260424_def.xml" ] }, "labelLink": { "local": [ "ck0000948923-20260424_lab.xml" ] }, "presentationLink": { "local": [ "ck0000948923-20260424_pre.xml" ] }, "inline": { "local": [ "tm268049d6_n6a.htm" ] } }, "keyStandard": 101, "keyCustom": 0, "axisStandard": 4, "axisCustom": 0, "memberStandard": 5, "memberCustom": 74, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2026": 3 }, "contextCount": 80, "entityCount": 1, "segmentCount": 79, "elementCount": 375, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/vip/2026": 391, "http://xbrl.sec.gov/dei/2026": 6 }, "report": { "R1": { "role": "http://xbrl.sec.gov/vip/role/N6", "longName": "010006 - Disclosure - N-6", "shortName": "N-6", "isDefault": "true", "groupType": "Prospectus", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm268049d6_n6a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm268049d6_n6a.htm", "first": true, "unique": true } } }, "tag": { "vip_AdditionalInformationStandardDeathBenefitsNoteN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdditionalInformationStandardDeathBenefitsNoteN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Additional Information about Standard Death Benefits, Note (N-6) [Text Block]" } } }, "auth_ref": [ "r3" ] }, "ck0000948923_AdministrativeChargeForFaceAmountIncreasesMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AdministrativeChargeForFaceAmountIncreasesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge for Face Amount Increases [Member]", "label": "Administrative Charge For Face Amount Increases Member" } } }, "auth_ref": [] }, "ck0000948923_AdministrativeChargeInitialFaceAmountAfterTheFirst2PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AdministrativeChargeInitialFaceAmountAfterTheFirst2PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge Initial Face Amount After The First2 Policy Years [Member]", "label": "Administrative Charge Initial Face Amount After The First2 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_AdministrativeChargeInitialFaceAmountDuringTheFirst2PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AdministrativeChargeInitialFaceAmountDuringTheFirst2PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge Initial Face Amount During The First2 Policy Years [Member]", "label": "Administrative Charge Initial Face Amount During The First2 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_AdministrativeChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AdministrativeChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge [Member]", "label": "Administrative Charge Member" } } }, "auth_ref": [] }, "vip_AdministrativeExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Current [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, Description [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, Representative Investor [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, When Deducted [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AllBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllBenefitsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Benefits:" } } }, "auth_ref": [ "r5" ] }, "vip_AllClassesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllClassesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Classes:" } } }, "auth_ref": [ "r41" ] }, "vip_AllContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllContractsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Contracts:" } } }, "auth_ref": [ "r41" ] }, "vip_AllPortfolioCompaniesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllPortfolioCompaniesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Portfolio Companies:" } } }, "auth_ref": [ "r16" ] }, "vip_AllRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "auth_ref": [ "r31" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Asset Allocation Fund - Class 1 [Member]", "label": "American Funds Insurance Series Asset Allocation Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Global Growth Fund - Class 1 [Member]", "label": "American Funds Insurance Series Global Growth Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesGrowthFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AmericanFundsInsuranceSeriesGrowthFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Growth Fund - Class 1 [Member]", "label": "American Funds Insurance Series Growth Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Growth-Income Fund - Class 1 [Member]", "label": "American Funds Insurance Series Growth Income Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesNewWorldFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "AmericanFundsInsuranceSeriesNewWorldFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae New World Fund\u00ae - Class 1 [Member]", "label": "American Funds Insurance Series New World Fund Class1 Member" } } }, "auth_ref": [] }, "vip_AnnualMaintenanceFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Current [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Description [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Current [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Maximum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Minimum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Representative Investor [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, When Deducted [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualPortfolioCompanyExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualPortfolioCompanyExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Portfolio Company Expenses [Table Text Block]" } } }, "auth_ref": [ "r56" ] }, "vip_AverageAnnualTotalReturns10YearsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns10YearsPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 10 Years [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_AverageAnnualTotalReturns1YearPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns1YearPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 1 Year [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_AverageAnnualTotalReturns5YearsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns5YearsPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 5 Years [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_BenefitAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit [Axis]" } } }, "auth_ref": [ "r5" ] }, "vip_BenefitNotAvailablePortfolioCompanyFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitNotAvailablePortfolioCompanyFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit Not Available for Portfolio Company [Flag]" } } }, "auth_ref": [ "r18" ] }, "vip_BenefitStandardOrOptionalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitStandardOrOptionalTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit Standard or Optional [Text Block]" } } }, "auth_ref": [ "r13" ] }, "vip_BenefitsAvailablePortfolioCompaniesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsAvailablePortfolioCompaniesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Available for Portfolio Companies [Table Text Block]" } } }, "auth_ref": [ "r19" ] }, "vip_BenefitsAvailableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsAvailableTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Available [Table Text Block]" } } }, "auth_ref": [ "r5" ] }, "vip_BenefitsDescriptionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsDescriptionTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Description [Table Text Block]" } } }, "auth_ref": [ "r15" ] }, "vip_BenefitsLimitationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsLimitationTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Limitation [Table Text Block]" } } }, "auth_ref": [ "r9" ] }, "vip_BriefRestrictionsLimitationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BriefRestrictionsLimitationsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Brief Restrictions / Limitations [Text Block]" } } }, "auth_ref": [ "r14" ] }, "ck0000948923_BusinessDisruptionandCyberSecurityRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "BusinessDisruptionandCyberSecurityRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Business Disruption and Cyber Security Risks [Member]", "label": "Business Disruptionand Cyber Security Risks Member" } } }, "auth_ref": [] }, "vip_CalculationMethodOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CalculationMethodOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Calculation Method of Benefit [Text Block]" } } }, "auth_ref": [ "r8" ] }, "vip_ChargesContractValuesNoteN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ChargesContractValuesNoteN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Charges and Contract Values, Note (N-6) [Text Block]" } } }, "auth_ref": [ "r4" ] }, "vip_ChargesForEarlyWithdrawalsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ChargesForEarlyWithdrawalsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Charges for Early Withdrawals [Text Block]" } } }, "auth_ref": [ "r26" ] }, "vip_ClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ClassAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Class [Axis]" } } }, "auth_ref": [ "r41" ] }, "ck0000948923_ClearBridgeVariableSmallCapGrowthPortfolioClassIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "ClearBridgeVariableSmallCapGrowthPortfolioClassIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "ClearBridge Variable Small Cap Growth Portfolio - Class I [Member]", "label": "Clear Bridge Variable Small Cap Growth Portfolio Class IMember" } } }, "auth_ref": [] }, "vip_ContractAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ContractAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Contract [Axis]" } } }, "auth_ref": [ "r41" ] }, "vip_ContractLapseRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ContractLapseRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Contract Lapse Risk [Member]" } } }, "auth_ref": [ "r35" ] }, "vip_CurrentExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentExpensesPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Expenses [Percent]" } } }, "auth_ref": [ "r21" ] }, "vip_CurrentExpensesPlatformChargePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentExpensesPlatformChargePercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Expenses + Platform Charge [Percent]" } } }, "auth_ref": [ "r23" ] }, "vip_CurrentGenerationMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentGenerationMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Generation:" } } }, "auth_ref": [ "r5" ] }, "vip_DeferredSalesChargeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesChargeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Charge, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_DeferredSalesChargeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesChargeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Charge, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_DeferredSalesLoadCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Current [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Footnotes [Text Block]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Maximum [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Minimum [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "ck0000948923_DimensionalVAInternationalSmallPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "DimensionalVAInternationalSmallPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA International Small Portfolio - Institutional Class [Member]", "label": "Dimensional VAInternational Small Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAInternationalValuePortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "DimensionalVAInternationalValuePortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA International Value Portfolio - Institutional Class [Member]", "label": "Dimensional VAInternational Value Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAUSLargeValuePortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "DimensionalVAUSLargeValuePortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA U.S. Large Value Portfolio - Institutional Class [Member]", "label": "Dimensional VAUSLarge Value Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class [Member]", "label": "Dimensional VITInflation Protected Securities Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ck0000948923_DollarCostAveragingMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "DollarCostAveragingMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dollar-Cost Averaging [Member]", "label": "Dollar Cost Averaging Member" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Investment Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r60" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "vip_ExpenseRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_FeeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "FeeTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 4. Fee Table [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_FeesCostsBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "FeesCostsBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Fees and Costs of Benefit [Text Block]" } } }, "auth_ref": [ "r7" ] }, "ck0000948923_FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Growth Opportunities Portfolio - Initial Class [Member]", "label": "Fidelity VIPGrowth Opportunities Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPIndex500PortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FidelityVIPIndex500PortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Index 500 Portfolio - Initial Class [Member]", "label": "Fidelity VIPIndex500 Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPInvestmentGradeBondPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FidelityVIPInvestmentGradeBondPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Investment Grade Bond Portfolio - Initial Class [Member]", "label": "Fidelity VIPInvestment Grade Bond Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPMidCapPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FidelityVIPMidCapPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Mid Cap Portfolio - Initial Class [Member]", "label": "Fidelity VIPMid Cap Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_First10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "First10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "First 10 Policy Years [Member]", "label": "First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_FranklinGrowthAndIncomeVIPFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FranklinGrowthAndIncomeVIPFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Franklin Growth and Income VIP Fund - Class 1 [Member]", "label": "Franklin Growth And Income VIPFund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_FranklinIncomeVIPFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FranklinIncomeVIPFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Franklin Income VIP Fund - Class 1 [Member]", "label": "Franklin Income VIPFund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_FundRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "FundRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fund Risks [Member]", "label": "Fund Risks Member" } } }, "auth_ref": [] }, "vip_GenerationAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GenerationAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Generation [Axis]" } } }, "auth_ref": [ "r5" ] }, "ck0000948923_GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [Member]", "label": "Goldman Sachs VITCore Fixed Income Fund Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_GoldmanSachsVITMidCapValueFundInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "GoldmanSachsVITMidCapValueFundInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [Member]", "label": "Goldman Sachs VITMid Cap Value Fund Institutional Class Member" } } }, "auth_ref": [] }, "vip_GuaranteedMinimumAccumulationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumAccumulationTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Accumulation [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumDeathBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumDeathBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Death Benefit [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Income [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumWithdrawalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumWithdrawalTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Withdrawal [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_InsuranceCompanyRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCompanyRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Company Risk [Member]" } } }, "auth_ref": [ "r34" ] }, "vip_InsuranceCostCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Current [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Description [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Footnotes [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Maximum [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Minimum [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Representative Investor [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, When Deducted [Text Block]" } } }, "auth_ref": [ "r50" ] }, "ck0000948923_InterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "InterestRateMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate [Member]", "label": "Interest Rate Member" } } }, "auth_ref": [] }, "ck0000948923_InvescoVIDiversifiedDividendFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "InvescoVIDiversifiedDividendFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. Diversified Dividend Fund - Series I [Member]", "label": "Invesco VIDiversified Dividend Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVIGlobalFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "InvescoVIGlobalFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. Global Fund - Series I [Member]", "label": "Invesco VIGlobal Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVIUSGovernmentMoneyPortfolioSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "InvescoVIUSGovernmentMoneyPortfolioSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. U.S. Government Money Portfolio - Series I [Member]", "label": "Invesco VIUSGovernment Money Portfolio Series IMember" } } }, "auth_ref": [] }, "vip_InvestmentOptionsFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options Footnotes [Text Block]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfAverageAnnualNetAssetsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfAverageAnnualNetAssetsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Average Annual Net Assets) Maximum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfAverageAnnualNetAssetsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfAverageAnnualNetAssetsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Average Annual Net Assets) Minimum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Other Amount) Maximum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Other Amount) Minimum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options Risk [Member]" } } }, "auth_ref": [ "r33" ] }, "ck0000948923_InvestmentRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "InvestmentRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Risk [Member]", "label": "Investment Risk Member" } } }, "auth_ref": [] }, "vip_Item2KeyInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "Item2KeyInformationLineItems", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 2. Key Information [Line Items]" } } }, "auth_ref": [ "r24" ] }, "vip_KeyExchangesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyExchangesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Exchanges [Text Block]" } } }, "auth_ref": [ "r40" ] }, "vip_KeyFeesExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyFeesExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Fees and Expenses [Text Block]" } } }, "auth_ref": [ "r25" ] }, "vip_KeyInvestmentProfessionalCompensationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyInvestmentProfessionalCompensationTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Professional Compensation [Text Block]" } } }, "auth_ref": [ "r39" ] }, "vip_KeyInvestmentRestrictionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyInvestmentRestrictionsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Restrictions [Text Block]" } } }, "auth_ref": [ "r36" ] }, "vip_KeyOptionalBenefitRestrictionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyOptionalBenefitRestrictionsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Restrictions [Text Block]" } } }, "auth_ref": [ "r37" ] }, "vip_KeyTaxImplicationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyTaxImplicationsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Tax Implications [Text Block]" } } }, "auth_ref": [ "r38" ] }, "ck0000948923_LapseProtectionEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LapseProtectionEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Lapse Protection Endorsement [Member]", "label": "Lapse Protection Endorsement Member" } } }, "auth_ref": [] }, "vip_LimitationsRestrictionsRisksTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "LimitationsRestrictionsRisksTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Limitations, Restrictions, and Risks of Benefit [Text Block]" } } }, "auth_ref": [ "r9" ] }, "ck0000948923_LoanRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LoanRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Loan Risks [Member]", "label": "Loan Risks Member" } } }, "auth_ref": [] }, "ck0000948923_LongTermCareInflationProtectionOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LongTermCareInflationProtectionOptionMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Care Inflation Protection Option [Member]", "label": "Long Term Care Inflation Protection Option Member" } } }, "auth_ref": [] }, "ck0000948923_LongTermCareRiderChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LongTermCareRiderChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Care Rider Charge [Member]", "label": "Long Term Care Rider Charge Member" } } }, "auth_ref": [] }, "ck0000948923_LongTermCareRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LongTermCareRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Care Rider [Member]", "label": "Long Term Care Rider Member" } } }, "auth_ref": [] }, "ck0000948923_LordAbbettSeriesFundBondDebenturePortfolioClassVCMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LordAbbettSeriesFundBondDebenturePortfolioClassVCMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC [Member]", "label": "Lord Abbett Series Fund Bond Debenture Portfolio Class VCMember" } } }, "auth_ref": [] }, "ck0000948923_LordAbbettSeriesFundDividendGrowthPortfolioClassVCMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "LordAbbettSeriesFundDividendGrowthPortfolioClassVCMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Lord Abbett Series Fund - Dividend Growth Portfolio - Class VC [Member]", "label": "Lord Abbett Series Fund Dividend Growth Portfolio Class VCMember" } } }, "auth_ref": [] }, "ck0000948923_MaximumSurrenderChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "MaximumSurrenderChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum Surrender Charge [Member]", "label": "Maximum Surrender Charge Member" } } }, "auth_ref": [] }, "ck0000948923_MinimumSurrenderChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "MinimumSurrenderChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum Surrender Charge [Member]", "label": "Minimum Surrender Charge Member" } } }, "auth_ref": [] }, "ck0000948923_MortalityAndExpenseRiskChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "MortalityAndExpenseRiskChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Mortality and Expense Risk Charge [Member]", "label": "Mortality And Expense Risk Charge Member" } } }, "auth_ref": [] }, "vip_MortalityAndExpenseRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_NameOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "NameOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Name of Benefit [Text Block]" } } }, "auth_ref": [ "r12" ] }, "ck0000948923_NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans For Carryover Loans After the First 10 Policy Years [Member]", "label": "Net Cost Of Loans For Carryover Loans After The First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans for Carryover Loans During The First 10 Policy Loans [Member]", "label": "Net Cost Of Loans For Carryover Loans During The First10 Policy Loans Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans for Standard Loans After the First 10 Policy Years [Member]", "label": "Net Cost Of Loans For Standard Loans After The First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans For Standard Loans During the First 10 Policy Years [Member]", "label": "Net Cost Of Loans For Standard Loans During The First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "NetCostOfLoansMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans [Member]", "label": "Net Cost Of Loans Member" } } }, "auth_ref": [] }, "vip_NotShortTermInvestmentRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "NotShortTermInvestmentRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Not Short Term Investment Risk [Member]" } } }, "auth_ref": [ "r32" ] }, "vip_OfferedEndingDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OfferedEndingDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Offered Ending [Date]" } } }, "auth_ref": [ "r42" ] }, "vip_OfferedStartingDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OfferedStartingDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Offered Starting [Date]" } } }, "auth_ref": [ "r42" ] }, "vip_OngoingFeesAndExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OngoingFeesAndExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Ongoing Fees and Expenses [Table Text Block]" } } }, "auth_ref": [ "r28" ] }, "vip_OperationOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OperationOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Operation of Benefit [Text Block]" } } }, "auth_ref": [ "r6" ] }, "ck0000948923_Option1DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "Option1DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 1 Death Benefit [Member]", "label": "Option1 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option2DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "Option2DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 2 Death Benefit [Member]", "label": "Option2 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option3DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "Option3DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 3 Death Benefit [Member]", "label": "Option3 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option4DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "Option4DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 4 Death Benefit [Member]", "label": "Option4 Death Benefit Member" } } }, "auth_ref": [] }, "vip_OptionalBenefitChargeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, Description [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitChargeRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, Representative [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitChargeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, When Deducted [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Current [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Current [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Maximum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Minimum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit [Flag]" } } }, "auth_ref": [ "r13" ] }, "vip_OtherAnnualExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Current [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Description [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Representative [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, When Deducted [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherBenefitsAvailableN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherBenefitsAvailableN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 11. Other Benefits Available (N-6) [Text Block]" } } }, "auth_ref": [ "r5" ] }, "vip_OtherSurrenderFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Current [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Description [Text Block]" } } }, "auth_ref": [ "r46" ] }, "vip_OtherSurrenderFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherTransactionFee1CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Description [Text Block]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, When Deducted [Text Block]" } } }, "auth_ref": [ "r48" ] }, "ck0000948923_PIMCOVITInternationalBondPortfolioUSDollarHedgedInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PIMCOVITInternationalBondPortfolioUSDollarHedgedInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "PIMCO VIT International Bond Portfolio (U.S. Dollar-Hedged) - Institutional Class [Member]", "label": "PIMCOVITInternational Bond Portfolio USDollar Hedged Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_PIMCOVITShortTermPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PIMCOVITShortTermPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "PIMCO VIT Short-Term Portfolio - Institutional Class [Member]", "label": "PIMCOVITShort Term Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_PIMCOVITTotalReturnPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PIMCOVITTotalReturnPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "PIMCO VIT Total Return Portfolio - Institutional Class [Member]", "label": "PIMCOVITTotal Return Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "vip_PeriodicChargesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PeriodicChargesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Periodic Charges [Table Text Block]" } } }, "auth_ref": [ "r49" ] }, "vip_PlatformChargePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PlatformChargePercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Platform Charge [Percent]" } } }, "auth_ref": [ "r22" ] }, "vip_PlatformChargeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PlatformChargeTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Platform Charge [Text Block]" } } }, "auth_ref": [ "r22" ] }, "ck0000948923_PolicyLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PolicyLoansMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policy Loans [Member]", "label": "Policy Loans Member" } } }, "auth_ref": [] }, "vip_PortfolioCompaniesN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompaniesN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 18. Portfolio Companies (N-6) [Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompaniesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompaniesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Companies [Table Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanyAdviserTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAdviserTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Adviser [Text Block]" } } }, "auth_ref": [ "r20" ] }, "vip_PortfolioCompanyAvailableWithBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAvailableWithBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Available with Benefit [Flag]" } } }, "auth_ref": [ "r18" ] }, "vip_PortfolioCompanyAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company [Axis]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanyExpensesAfterWaiversAndReimbursementMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesAfterWaiversAndReimbursementMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses After Waivers and Reimbursement Maximum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesAfterWaiversAndReimbursementMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesAfterWaiversAndReimbursementMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses After Waivers and Reimbursement Minimum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesBeforeWaiversAndReimbursementMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Before Waivers and Reimbursement Maximum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesBeforeWaiversAndReimbursementMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Before Waivers and Reimbursement Minimum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses, Footnotes [Text Block]" } } }, "auth_ref": [ "r58" ] }, "vip_PortfolioCompanyExpensesMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Maximum [Percent] (Deprecated 2026-01-31)" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Minimum [Percent] (Deprecated 2026-01-31)" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses [Text Block]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyNameTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyNameTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Name [Text Block]" } } }, "auth_ref": [ "r20" ] }, "vip_PortfolioCompanyObjectiveTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyObjectiveTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Objective [Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanySubadviserTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanySubadviserTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Subadviser [Text Block]" } } }, "auth_ref": [ "r20" ] }, "ck0000948923_PortfolioRebalancingMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PortfolioRebalancingMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Portfolio Rebalancing [Member]", "label": "Portfolio Rebalancing Member" } } }, "auth_ref": [] }, "vip_PremiumTaxesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Current [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_PremiumTaxesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Footnotes [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Maximum [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Minimum [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Current [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Maximum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Minimum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_PreviouslyOfferedMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PreviouslyOfferedMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Previously Offered [Member]" } } }, "auth_ref": [ "r5" ] }, "vip_PrincipalRiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PrincipalRiskTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Principal Risk [Text Block]" } } }, "auth_ref": [ "r59" ] }, "vip_PrincipalRisksTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PrincipalRisksTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 5. Principal Risks [Table Text Block]" } } }, "auth_ref": [ "r59" ] }, "vip_ProspectusLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusLineItems", "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "auth_ref": [] }, "vip_ProspectusTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusTable", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "auth_ref": [] }, "vip_ProspectusesAvailableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusesAvailableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Prospectuses Available [Text Block]" } } }, "auth_ref": [ "r17" ] }, "vip_PurposeOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PurposeOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Purpose of Benefit [Text Block]" } } }, "auth_ref": [ "r10" ] }, "ck0000948923_PutnamVTSustainableLeadersFundClassIAMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "PutnamVTSustainableLeadersFundClassIAMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Putnam VT Sustainable Leaders Fund - Class IA [Member]", "label": "Putnam VTSustainable Leaders Fund Class IAMember" } } }, "auth_ref": [] }, "ck0000948923_ReservationOfRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "ReservationOfRightsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Reservation of Rights [Member]", "label": "Reservation Of Rights Member" } } }, "auth_ref": [] }, "vip_RiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "auth_ref": [ "r31" ] }, "vip_RiskOfLossMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskOfLossMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk of Loss [Member]" } } }, "auth_ref": [ "r31" ] }, "vip_RiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "auth_ref": [ "r30" ] }, "vip_RisksTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RisksTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risks [Table Text Block]" } } }, "auth_ref": [ "r30" ] }, "ck0000948923_RoyceCapitalSmallCapPortfolioInvestmentClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "RoyceCapitalSmallCapPortfolioInvestmentClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Royce Capital Small-Cap Portfolio - Investment Class [Member]", "label": "Royce Capital Small Cap Portfolio Investment Class Member" } } }, "auth_ref": [] }, "vip_SalesLoadDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_SalesLoadFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, Footnotes [Text Block]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Current [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Maximum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Minimum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_SomePortfolioCompaniesNotAvailableForAllBenefitsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SomePortfolioCompaniesNotAvailableForAllBenefitsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Some Portfolio Companies not Available for All Benefits [Text Block]" } } }, "auth_ref": [ "r18" ] }, "ck0000948923_SpecializedUsesOfThePolicyMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "SpecializedUsesOfThePolicyMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Specialized Uses of the Policy [Member]", "label": "Specialized Uses Of The Policy Member" } } }, "auth_ref": [] }, "vip_StandardBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Standard Benefit [Flag]" } } }, "auth_ref": [ "r13" ] }, "vip_StandardDeathBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardDeathBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Standard Death Benefit [Text Block]" } } }, "auth_ref": [ "r1" ] }, "vip_StandardDeathBenefitsN6TableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardDeathBenefitsN6TableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 10. Standard Death Benefits (N-6) [Table Text Block]" } } }, "auth_ref": [ "r2" ] }, "vip_SurrenderChargeExampleMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeExampleMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Example Maximum [Dollars]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Footnotes [Text Block]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfAmountSurrenderedMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfAmountSurrenderedMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Amount Surrendered) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Other Amount) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfPurchasePaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfPurchasePaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Purchase Payments) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargePeriodYears": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargePeriodYears", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Phaseout Period, Years" } } }, "auth_ref": [ "r26" ] }, "ck0000948923_TOPSAggressiveETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TOPSAggressiveETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae\u200b Aggressive ETF Portfolio - Class 1 [Member]", "label": "TOPSAggressive ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSConservativeETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TOPSConservativeETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae Conservative ETF Portfolio - Class 1 [Member]", "label": "TOPSConservative ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSModerateETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TOPSModerateETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae\u200b Moderate ETF Portfolio - Class 1 [Member]", "label": "TOPSModerate ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSModeratelyAggressiveETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TOPSModeratelyAggressiveETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae\u200b Moderately Aggressive ETF Portfolio - Class 1 [Member]", "label": "TOPSModerately Aggressive ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TaxRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TaxRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Risks [Member]", "label": "Tax Risks Member" } } }, "auth_ref": [] }, "ck0000948923_TelephoneTransfersMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TelephoneTransfersMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Telephone Transfers [Member]", "label": "Telephone Transfers Member" } } }, "auth_ref": [] }, "ck0000948923_TempletonEmergingMarketsVIPFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TempletonEmergingMarketsVIPFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Templeton Emerging Markets VIP Fund - Class 1 [Member]", "label": "Templeton Emerging Markets VIPFund Class1 Member" } } }, "auth_ref": [] }, "vip_TemporaryFeeReductionsCurrentExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TemporaryFeeReductionsCurrentExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Temporary Fee Reductions, Current Expenses [Text Block]" } } }, "auth_ref": [ "r21" ] }, "ck0000948923_TerminalIllnessAcceleratedDeathBenefitEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "TerminalIllnessAcceleratedDeathBenefitEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Terminal Illness Accelerated Death Benefit Endorsement [Member]", "label": "Terminal Illness Accelerated Death Benefit Endorsement Member" } } }, "auth_ref": [] }, "vip_TransactionChargesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransactionChargesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transaction Charges [Text Block]" } } }, "auth_ref": [ "r27" ] }, "vip_TransactionExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransactionExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transaction Expenses [Table Text Block]" } } }, "auth_ref": [ "r45" ] }, "vip_TransferFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Current [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Current [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Maximum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Minimum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fees, Description [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_TransferFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "ck0000948923_VanguardVariableInsuranceFundsEquityIncomePortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "VanguardVariableInsuranceFundsEquityIncomePortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Equity Income Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Equity Income Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsInternationalPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "VanguardVariableInsuranceFundsInternationalPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - International Portfolio [Member]", "label": "Vanguard Variable Insurance Funds International Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsPRIMECAPPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "VanguardVariableInsuranceFundsPRIMECAPPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - PRIMECAP Portfolio [Member]", "label": "Vanguard Variable Insurance Funds PRIMECAPPortfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Real Estate Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Real Estate Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsShortTermInvestmentGradePortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "VanguardVariableInsuranceFundsShortTermInvestmentGradePortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard\u00ae\u200b Variable Insurance Funds - Short-Term Investment-Grade Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Short Term Investment Grade Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_WithdrawalAndSurrenderRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "WithdrawalAndSurrenderRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Withdrawal and Surrender Risks [Member]", "label": "Withdrawal And Surrender Risks Member" } } }, "auth_ref": [] }, "ck0000948923_WithdrawalChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260424", "localname": "WithdrawalChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Withdrawal Charge [Member]", "label": "Withdrawal Charge Member" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "a" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "b" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "c" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "2" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "3" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "4" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "c" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "1" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "2" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "4" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "5" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "b" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "f" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "f", "Sentence": "2" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "3" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "4" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "5" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "6" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "a" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "b" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c", "Sentence": "ii" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "a" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "b" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "c" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "d" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "e" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "a" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "b" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "5" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "6", "Subparagraph": "a" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "6", "Subparagraph": "b" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "3" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4" }, "r43": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r44": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "e" }, "r45": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2" }, "r46": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "a" }, "r47": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "b" }, "r48": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c" }, "r49": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3" }, "r50": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "b" }, "r51": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "c" }, "r52": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "d" }, "r53": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "e" }, "r54": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "f" }, "r55": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "h" }, "r56": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4" }, "r57": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "a" }, "r58": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "b" }, "r59": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "5" }, "r60": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" } } }